"brandDrugName","originalDrugName","drugName","drugId","sponsor","properties","therapeuticArea","indication","diseaseName","diseaseIds","diseaseClass","reviewType","yearApproval","OriginalDrugId","targetIds","interactorIds","relatedIds"
"Accrufer","Ferric maltol","FERRICMALTOL","CHEMBL4298110","Shield Therapeutics","Iron replacement product","No human target","Iron deficiency anaemia","iron deficiency anemia","HP_0001891","Not serious","S","2019","CHEMBL4298110","NA","NA","EFO_0004272"
"Adakveo","Crizanlizumab","CRIZANLIZUMAB","CHEMBL4297734","Novartis","P-selectin blocker","Other indication","Painful complications of SCD","sickle cell disease and related diseases","MONDO_0017146","Serious","P,O,B","2019","CHEMBL4297734","ENSG00000174175","ENSG00000110876","NA"
"Adbry","Tralokinumab","Tralokinumab","CHEMBL1743081","LEO Pharma","IL-13-targeted mAb","Other indication","Atopic dermatitis","atopic eczema","EFO_0000274","Not serious","S","2021","CHEMBL1743081","ENSG00000169194","ENSG00000123496,ENSG00000131724","MONDO_0002406,HP_0000964"
"Addyi","Flibanserin","FLIBANSERIN","CHEMBL231068","Sprout","Serotonin receptor modulator","Other indication","Hypoactive sexual desire disorder","sexual dysfunction","EFO_0004714","Not serious","S","2015","CHEMBL231068","ENSG00000069696,ENSG00000178394,ENSG00000102468","ENSG00000043591,ENSG00000077782,ENSG00000111142,ENSG00000125967,ENSG00000147246,ENSG00000136854,ENSG00000170214,ENSG00000107186,ENSG00000118432,ENSG00000135914,ENSG00000142192,ENSG00000166573,ENSG00000183840,ENSG00000069696,ENSG00000164082,ENSG00000172020,ENSG00000102468","EFO_0008343"
"Adempas","Riociguat","RIOCIGUAT","CHEMBL2107834","Bayer","Soluble guanylyl cyclase stimulator","Other indication","Persistent or recurrent chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension","pulmonary arterial hypertension","EFO_0001361","Serious","P,O","2013","CHEMBL2107834","ENSG00000152402,ENSG00000123201,ENSG00000061918,ENSG00000164116","ENSG00000075711,ENSG00000063515,ENSG00000172164,ENSG00000074319,ENSG00000180900,ENSG00000061918,ENSG00000132535,ENSG00000164116,ENSG00000101400","EFO_0000537"
"Adlyxin","Lixisenatide","LIXISENATIDE","CHEMBL2108336","Sanofi","GLP1 receptor agonist","Other indication","Diabetes","diabetes mellitus","EFO_0000400","Not concordant","S","2016","CHEMBL2108336","ENSG00000112164","ENSG00000254997,ENSG00000221880,ENSG00000272804,ENSG00000186860,ENSG00000188581,ENSG00000221837,ENSG00000187766,ENSG00000197191,ENSG00000264343,ENSG00000286219","NA"
"Aduhelm","Aducanumab","Aducanumab","CHEMBL3039540","Biogen/Eisai","Amyloid-beta-targeted mAb","Other indication","Alzheimers disease","Alzheimers disease","MONDO_0004975","Serious","P,A,F","2021","CHEMBL3039540","ENSG00000142192","ENSG00000002330,ENSG00000008382,ENSG00000010017,ENSG00000011132,ENSG00000068001,ENSG00000078596,ENSG00000084234,ENSG00000108468,ENSG00000109971,ENSG00000111640,ENSG00000113575,ENSG00000115041,ENSG00000117984,ENSG00000120899,ENSG00000122861,ENSG00000124145,ENSG00000129515,ENSG00000132589,ENSG00000133816,ENSG00000134243,ENSG00000137642,ENSG00000137801,ENSG00000140941,ENSG00000143933,ENSG00000144744,ENSG00000145675,ENSG00000147955,ENSG00000151694,ENSG00000154096,ENSG00000158747,ENSG00000158828,ENSG00000160307,ENSG00000161011,ENSG00000163932,ENSG00000165025,ENSG00000168477,ENSG00000169783,ENSG00000169884,ENSG00000170276,ENSG00000178175,ENSG00000182240,ENSG00000183098,ENSG00000184144,ENSG00000184634,ENSG00000188157,ENSG00000198400,ENSG00000198668,ENSG00000198805,ENSG00000205572,ENSG00000256762,ENSG00000277586,ENSG00000278195,ENSG00000014216,ENSG00000049540,ENSG00000065320,ENSG00000072062,ENSG00000101439,ENSG00000102804,ENSG00000105851,ENSG00000107938,ENSG00000113140,ENSG00000113805,ENSG00000114646,ENSG00000118271,ENSG00000120885,ENSG00000121691,ENSG00000123384,ENSG00000123560,ENSG00000124214,ENSG00000126214,ENSG00000128482,ENSG00000130522,ENSG00000132703,ENSG00000132773,ENSG00000133858,ENSG00000134318,ENSG00000134853,ENSG00000135218,ENSG00000137463,ENSG00000137752,ENSG00000139318,ENSG00000141433,ENSG00000141551,ENSG00000142156,ENSG00000150093,ENSG00000151224,ENSG00000153002,ENSG00000156697,ENSG00000157450,ENSG00000157578,ENSG00000159593,ENSG00000160695,ENSG00000167004,ENSG00000170348,ENSG00000172466,ENSG00000175344,ENSG00000179218,ENSG00000180210,ENSG00000185933,ENSG00000196230,ENSG00000196531,ENSG00000196549,ENSG00000197386,ENSG00000204301,ENSG00000221914,ENSG00000023318,ENSG00000051382,ENSG00000054523,ENSG00000070756,ENSG00000075651,ENSG00000080824,ENSG00000100505,ENSG00000101204,ENSG00000102974,ENSG00000105376,ENSG00000117505,ENSG00000119912,ENSG00000119917,ENSG00000123143,ENSG00000128989,ENSG00000130234,ENSG00000132692,ENSG00000135698,ENSG00000136156,ENSG00000136827,ENSG00000137098,ENSG00000137845,ENSG00000138095,ENSG00000143369,ENSG00000144339,ENSG00000144381,ENSG00000144619,ENSG00000148082,ENSG00000153234,ENSG00000156475,ENSG00000157766,ENSG00000161202,ENSG00000161955,ENSG00000163879,ENSG00000164953,ENSG00000165059,ENSG00000165916,ENSG00000166228,ENSG00000166949,ENSG00000167770,ENSG00000168610,ENSG00000170315,ENSG00000171132,ENSG00000173548,ENSG00000176884,ENSG00000183775,ENSG00000184986,ENSG00000186868,ENSG00000188153,ENSG00000188517,ENSG00000196136,ENSG00000196712,ENSG00000196776,ENSG00000196924,ENSG00000198959,ENSG00000204305,ENSG00000204843,ENSG00000205302,ENSG00000232810,ENSG00000067560,ENSG00000069329,ENSG00000069696,ENSG00000073060,ENSG00000076248,ENSG00000078114,ENSG00000078549,ENSG00000080815,ENSG00000088832,ENSG00000101266,ENSG00000106211,ENSG00000106333,ENSG00000108387,ENSG00000113721,ENSG00000119041,ENSG00000120948,ENSG00000124788,ENSG00000126934,ENSG00000128052,ENSG00000130066,ENSG00000131508,ENSG00000134259,ENSG00000134287,ENSG00000135823,ENSG00000139182,ENSG00000139719,ENSG00000141646,ENSG00000143801,ENSG00000147224,ENSG00000154277,ENSG00000157212,ENSG00000158560,ENSG00000162604,ENSG00000167037,ENSG00000168077,ENSG00000168765,ENSG00000170345,ENSG00000171049,ENSG00000171055,ENSG00000176697,ENSG00000181773,ENSG00000182585,ENSG00000184203,ENSG00000185345,ENSG00000189403,ENSG00000214087,ENSG00000239697,ENSG00000241837,ENSG00000275700,ENSG00000007047,ENSG00000036672,ENSG00000044574,ENSG00000062725,ENSG00000063660,ENSG00000066027,ENSG00000067113,ENSG00000070748,ENSG00000087245,ENSG00000087884,ENSG00000092969,ENSG00000101412,ENSG00000102030,ENSG00000108179,ENSG00000108578,ENSG00000109501,ENSG00000112592,ENSG00000115234,ENSG00000115414,ENSG00000116133,ENSG00000116141,ENSG00000121653,ENSG00000123416,ENSG00000123643,ENSG00000124222,ENSG00000127445,ENSG00000134709,ENSG00000136535,ENSG00000139329,ENSG00000142192,ENSG00000146072,ENSG00000148798,ENSG00000158792,ENSG00000159023,ENSG00000162366,ENSG00000163697,ENSG00000167552,ENSG00000168484,ENSG00000171497,ENSG00000171603,ENSG00000171989,ENSG00000172058,ENSG00000172977,ENSG00000175203,ENSG00000175582,ENSG00000177426,ENSG00000177606,ENSG00000178127,ENSG00000184702,ENSG00000196470,ENSG00000198736,ENSG00000198804,ENSG00000239886,ENSG00000006125,ENSG00000034053,ENSG00000065154,ENSG00000072506,ENSG00000075624,ENSG00000100285,ENSG00000100985,ENSG00000102003,ENSG00000102879,ENSG00000103415,ENSG00000104805,ENSG00000105329,ENSG00000105974,ENSG00000106617,ENSG00000112769,ENSG00000116288,ENSG00000123091,ENSG00000125656,ENSG00000125977,ENSG00000129219,ENSG00000132155,ENSG00000132535,ENSG00000133703,ENSG00000135018,ENSG00000137312,ENSG00000143153,ENSG00000143514,ENSG00000146648,ENSG00000146731,ENSG00000147257,ENSG00000148400,ENSG00000157168,ENSG00000164305,ENSG00000164402,ENSG00000166033,ENSG00000167900,ENSG00000169604,ENSG00000171564,ENSG00000171867,ENSG00000172059,ENSG00000172115,ENSG00000178741,ENSG00000185499,ENSG00000188130,ENSG00000197442,ENSG00000197565,ENSG00000198840,ENSG00000204264,ENSG00000210082,ENSG00000011465,ENSG00000019169,ENSG00000064300,ENSG00000071242,ENSG00000077942,ENSG00000095970,ENSG00000100030,ENSG00000100083,ENSG00000102466,ENSG00000105229,ENSG00000105290,ENSG00000107282,ENSG00000107959,ENSG00000108551,ENSG00000109099,ENSG00000109846,ENSG00000113108,ENSG00000115091,ENSG00000115884,ENSG00000117362,ENSG00000118526,ENSG00000120910,ENSG00000122194,ENSG00000127824,ENSG00000128595,ENSG00000130024,ENSG00000130203,ENSG00000136238,ENSG00000137947,ENSG00000138798,ENSG00000140395,ENSG00000143870,ENSG00000145335,ENSG00000152256,ENSG00000160691,ENSG00000160963,ENSG00000162236,ENSG00000163956,ENSG00000166313,ENSG00000166598,ENSG00000168385,ENSG00000169375,ENSG00000170312,ENSG00000171314,ENSG00000171791,ENSG00000172020,ENSG00000173020,ENSG00000173406,ENSG00000179399,ENSG00000185825,ENSG00000188313,ENSG00000196262,ENSG00000196535,ENSG00000198055,ENSG00000204463,ENSG00000242689,ENSG00000010810,ENSG00000051128,ENSG00000064012,ENSG00000069424,ENSG00000070182,ENSG00000070808,ENSG00000074317,ENSG00000082701,ENSG00000089685,ENSG00000092201,ENSG00000099250,ENSG00000105723,ENSG00000106305,ENSG00000108443,ENSG00000111237,ENSG00000115318,ENSG00000123080,ENSG00000125848,ENSG00000126767,ENSG00000127022,ENSG00000130669,ENSG00000131042,ENSG00000136854,ENSG00000138449,ENSG00000138613,ENSG00000138685,ENSG00000140564,ENSG00000141434,ENSG00000142875,ENSG00000143196,ENSG00000144711,ENSG00000153071,ENSG00000157005,ENSG00000160014,ENSG00000162733,ENSG00000164885,ENSG00000166851,ENSG00000166913,ENSG00000167755,ENSG00000167772,ENSG00000168615,ENSG00000168702,ENSG00000172531,ENSG00000177706,ENSG00000182871,ENSG00000184937,ENSG00000186318,ENSG00000187554,ENSG00000197746,ENSG00000197971,ENSG00000205155,ENSG00000205542,ENSG00000108107,ENSG00000118137,ENSG00000131187,ENSG00000133961,ENSG00000241563,ENSG00000254087","NA"
"Aemcolo","Rifamycin","RIFAMYCIN","CHEMBL437765","Cosmo Technologies","Ansamycin antibacterial","No human target","Travellers diarrhoea","Diarrhea","HP_0002014","Not serious","P,F","2018","CHEMBL437765","NA","NA","NA"
"Aimovig","Erenumab","ERENUMAB","CHEMBL3833329","Amgen/Novartis","CGRP receptor antibody","Other indication","Migraine","migraine disorder","MONDO_0005277","Not serious","S","2018","CHEMBL3833329","ENSG00000064989","ENSG00000148926,ENSG00000110680,ENSG00000131477,ENSG00000132329","NA"
"Ajovy","Fremanezumab","FREMANEZUMAB","CHEMBL4297756","Teva","CGRP antibody","Other indication","Migraine","migraine disorder","MONDO_0005277","Not serious","P","2018","CHEMBL4297756","ENSG00000110680,ENSG00000175868","ENSG00000064989,ENSG00000157087,ENSG00000186469,ENSG00000058668,ENSG00000087460,ENSG00000110680,ENSG00000132329,ENSG00000185043,ENSG00000078369,ENSG00000167522","NA"
"Aklief","Trifarotene","TRIFAROTENE","CHEMBL3707313","Galderma","Retinoic acid receptor agonist","Other indication","Acne vulgaris","acne","EFO_0003894","Not serious","S","2019","CHEMBL3707313","ENSG00000172819","ENSG00000143171,ENSG00000111049,ENSG00000204231,ENSG00000188191,ENSG00000140463","NA"
"Akynzeo","Netupitant, palonosetron","NETUPITANT,PALONOSETRON","CHEMBL1189679,CHEMBL206253","Helsinn","An NK1-receptor antagonist plus a 5-HT3-receptor antagonist","Other indication","Chemotherapy-related nausea","Chemotherapy-induced nausea and vomiting","EFO_0006911","Not serious","S","2014","CHEMBL206253,CHEMBL1189679","ENSG00000166736,ENSG00000115353","ENSG00000178084,ENSG00000186038,ENSG00000186090,ENSG00000149305,ENSG00000198937,ENSG00000105677","NA"
"Akynzeo IV","Palonosetron, fosnetupitant","PALONOSETRON,FOSNETUPITANT","CHEMBL1189679,CHEMBL3989917","Helsinn Group","5-HT3-receptor antagonist and NK1-receptor antagonist","Other indication","Chemotherapy-induced emesis","Chemotherapy-induced nausea and vomiting","EFO_0006911","Not serious","S","2018","CHEMBL1189679,CHEMBL3989917","ENSG00000166736,ENSG00000115353","ENSG00000178084,ENSG00000186038,ENSG00000186090,ENSG00000149305,ENSG00000198937,ENSG00000105677","NA"
"Alecensa","Alectinib","ALECTINIB","CHEMBL1738797","Roche","ALK inhibitor","Oncology","NSCLC","non-small cell lung carcinoma","EFO_0003060","Serious","P,O,B,A","2015","CHEMBL1738797","ENSG00000165731,ENSG00000171094,ENSG00000143924","ENSG00000110395,ENSG00000127329,ENSG00000189292,ENSG00000096384,ENSG00000146648,ENSG00000171094,ENSG00000149177,ENSG00000164305,ENSG00000264343,ENSG00000106278,ENSG00000137076,ENSG00000151414,ENSG00000160867,ENSG00000165731,ENSG00000180447,ENSG00000107882,ENSG00000149806,ENSG00000154237,ENSG00000196711,ENSG00000269335,ENSG00000124181,ENSG00000144724,ENSG00000168610,ENSG00000067225","NA"
"Aliqopa","Copanlisib dihydrochloride","COPANLISIB","CHEMBL3218576","Bayer","PI3Kalpha/‚Äö√¢√†‚àö‚â†¬¨¬®‚Äö√Ñ¬¢ inhibitor","Oncology","Follicular lymphoma","follicular lymphoma","MONDO_0018906","Serious","P,O,A,F","2017","CHEMBL3218576","ENSG00000121879,ENSG00000171608","ENSG00000177885,ENSG00000117461,ENSG00000065361,ENSG00000066427,ENSG00000105647,ENSG00000170345,ENSG00000124788,ENSG00000169047,ENSG00000197386,ENSG00000100368,ENSG00000145675,ENSG00000121879,ENSG00000170145","EFO_0000183"
"Alunbrig","Brigatinib","BRIGATINIB","CHEMBL3545311","Ariad Pharmaceuticals/Takeda","ALK inhibitor","Oncology","ALK-positive NSCLC","non-small cell lung carcinoma","EFO_0003060","Serious","P,O,B,A","2017","CHEMBL3545311","ENSG00000146648,ENSG00000171094","ENSG00000008735,ENSG00000012061,ENSG00000043462,ENSG00000061273,ENSG00000067606,ENSG00000069345,ENSG00000081237,ENSG00000090520,ENSG00000100170,ENSG00000100591,ENSG00000104341,ENSG00000104756,ENSG00000104904,ENSG00000106211,ENSG00000107317,ENSG00000110395,ENSG00000110651,ENSG00000113070,ENSG00000115085,ENSG00000115415,ENSG00000120053,ENSG00000124942,ENSG00000126561,ENSG00000127329,ENSG00000130340,ENSG00000131016,ENSG00000134308,ENSG00000136573,ENSG00000138363,ENSG00000142669,ENSG00000143322,ENSG00000143933,ENSG00000151491,ENSG00000160014,ENSG00000162704,ENSG00000163235,ENSG00000182636,ENSG00000182718,ENSG00000183918,ENSG00000189292,ENSG00000198909,ENSG00000000938,ENSG00000006125,ENSG00000058262,ENSG00000064999,ENSG00000091831,ENSG00000096384,ENSG00000100614,ENSG00000103876,ENSG00000107643,ENSG00000111816,ENSG00000115145,ENSG00000115540,ENSG00000116254,ENSG00000117152,ENSG00000117461,ENSG00000124207,ENSG00000133124,ENSG00000135506,ENSG00000135823,ENSG00000136205,ENSG00000137267,ENSG00000140575,ENSG00000141198,ENSG00000146648,ENSG00000154556,ENSG00000157500,ENSG00000158092,ENSG00000160255,ENSG00000166313,ENSG00000168036,ENSG00000171094,ENSG00000171132,ENSG00000174791,ENSG00000182473,ENSG00000186868,ENSG00000196961,ENSG00000197943,ENSG00000204388,ENSG00000213658,ENSG00000214193,ENSG00000004478,ENSG00000008056,ENSG00000044115,ENSG00000044574,ENSG00000071537,ENSG00000080031,ENSG00000096060,ENSG00000096968,ENSG00000100324,ENSG00000102606,ENSG00000105245,ENSG00000105976,ENSG00000113013,ENSG00000113580,ENSG00000114805,ENSG00000118363,ENSG00000121653,ENSG00000125731,ENSG00000126088,ENSG00000126581,ENSG00000132669,ENSG00000133961,ENSG00000135046,ENSG00000137463,ENSG00000142208,ENSG00000145016,ENSG00000145335,ENSG00000147010,ENSG00000148053,ENSG00000148082,ENSG00000149177,ENSG00000154277,ENSG00000154710,ENSG00000159352,ENSG00000161203,ENSG00000169375,ENSG00000170312,ENSG00000182511,ENSG00000184557,ENSG00000185046,ENSG00000185483,ENSG00000185634,ENSG00000186834,ENSG00000197122,ENSG00000198561,ENSG00000206052,ENSG00000014641,ENSG00000042753,ENSG00000071051,ENSG00000075415,ENSG00000101182,ENSG00000102189,ENSG00000103653,ENSG00000109321,ENSG00000109684,ENSG00000109971,ENSG00000110011,ENSG00000111252,ENSG00000111679,ENSG00000113263,ENSG00000115325,ENSG00000127191,ENSG00000129946,ENSG00000141480,ENSG00000141655,ENSG00000142949,ENSG00000144749,ENSG00000149428,ENSG00000168003,ENSG00000169047,ENSG00000170248,ENSG00000170293,ENSG00000172757,ENSG00000178568,ENSG00000183020,ENSG00000184524,ENSG00000196154,ENSG00000198668,ENSG00000015479,ENSG00000027869,ENSG00000046653,ENSG00000057294,ENSG00000067992,ENSG00000072135,ENSG00000077232,ENSG00000092820,ENSG00000097007,ENSG00000101336,ENSG00000103266,ENSG00000105974,ENSG00000106278,ENSG00000106299,ENSG00000107295,ENSG00000110711,ENSG00000111640,ENSG00000114737,ENSG00000124882,ENSG00000127824,ENSG00000134242,ENSG00000134853,ENSG00000135052,ENSG00000137076,ENSG00000137486,ENSG00000140600,ENSG00000141736,ENSG00000142627,ENSG00000143294,ENSG00000149925,ENSG00000155926,ENSG00000165025,ENSG00000165731,ENSG00000167601,ENSG00000169045,ENSG00000169398,ENSG00000174808,ENSG00000198853,ENSG00000204389,ENSG00000033327,ENSG00000034713,ENSG00000065361,ENSG00000067182,ENSG00000087586,ENSG00000099942,ENSG00000100280,ENSG00000101082,ENSG00000101213,ENSG00000101558,ENSG00000105971,ENSG00000106070,ENSG00000109458,ENSG00000117450,ENSG00000120694,ENSG00000131746,ENSG00000132155,ENSG00000150403,ENSG00000151834,ENSG00000153707,ENSG00000154237,ENSG00000159176,ENSG00000163697,ENSG00000164615,ENSG00000165527,ENSG00000167552,ENSG00000170606,ENSG00000177885,ENSG00000179295,ENSG00000184575,ENSG00000185499,ENSG00000185896,ENSG00000188191,ENSG00000189043,ENSG00000196711,ENSG00000198799,ENSG00000254087,ENSG00000269335,ENSG00000011132,ENSG00000011485,ENSG00000050748,ENSG00000094631,ENSG00000095370,ENSG00000101134,ENSG00000102309,ENSG00000104814,ENSG00000105401,ENSG00000105613,ENSG00000116285,ENSG00000123384,ENSG00000124181,ENSG00000125170,ENSG00000127947,ENSG00000130402,ENSG00000131558,ENSG00000132970,ENSG00000138798,ENSG00000140009,ENSG00000141968,ENSG00000142192,ENSG00000144554,ENSG00000144724,ENSG00000145675,ENSG00000145715,ENSG00000149269,ENSG00000159228,ENSG00000162591,ENSG00000166598,ENSG00000168610,ENSG00000170581,ENSG00000173801,ENSG00000174437,ENSG00000175203,ENSG00000175866,ENSG00000178078,ENSG00000178188,ENSG00000184144,ENSG00000185359,ENSG00000197102,ENSG00000198399,ENSG00000204305,ENSG00000240972,ENSG00000253729,ENSG00000067225,ENSG00000069869,ENSG00000080824,ENSG00000085063,ENSG00000085733,ENSG00000088930,ENSG00000092758,ENSG00000100351,ENSG00000100485,ENSG00000102010,ENSG00000105647,ENSG00000105701,ENSG00000107263,ENSG00000111669,ENSG00000113108,ENSG00000115904,ENSG00000123908,ENSG00000130558,ENSG00000130706,ENSG00000131171,ENSG00000132639,ENSG00000132670,ENSG00000136810,ENSG00000137193,ENSG00000137462,ENSG00000138698,ENSG00000139625,ENSG00000146674,ENSG00000148180,ENSG00000154127,ENSG00000154229,ENSG00000157168,ENSG00000158402,ENSG00000160691,ENSG00000164924,ENSG00000166913,ENSG00000167193,ENSG00000168439,ENSG00000169139,ENSG00000170677,ENSG00000173020,ENSG00000175793,ENSG00000176105,ENSG00000177666,ENSG00000182585,ENSG00000196396,ENSG00000250722,ENSG00000254772,ENSG00000039068,ENSG00000105649,ENSG00000133056,ENSG00000136235","NA"
"Amondys 45","Casimersen","Casimersen","CHEMBL4297566","Sarepta","Exon 45-skipping ASO","Other indication","DMD","Duchenne muscular dystrophy","MONDO_0010679","Serious","P,O,A,F","2021","CHEMBL4297566","ENSG00000198947","ENSG00000152240,ENSG00000171345,ENSG00000101400,ENSG00000168807,ENSG00000171873,ENSG00000119326,ENSG00000138101,ENSG00000173402,ENSG00000187555,ENSG00000101076,ENSG00000171621,ENSG00000134769,ENSG00000172164,ENSG00000100151","NA"
"Amvuttra","Vutrisiran","Vutrisiran","CHEMBL4594511","Alnylam","TTR-targeted siRNA","Other indication","Polyneuropathy of hereditary TTR-mediated amyloidosis","familial amyloid neuropathy","EFO_0004129","Serious","S,O,F","2022","CHEMBL4594511","ENSG00000118271","ENSG00000116039,ENSG00000130294,ENSG00000138207,ENSG00000143379,ENSG00000145675,ENSG00000147724,ENSG00000168936,ENSG00000169136,ENSG00000197409,ENSG00000278828,ENSG00000070476,ENSG00000115239,ENSG00000120253,ENSG00000158941,ENSG00000163885,ENSG00000170035,ENSG00000171055,ENSG00000187678,ENSG00000213380,ENSG00000274750,ENSG00000070061,ENSG00000099864,ENSG00000119614,ENSG00000128272,ENSG00000165637,ENSG00000197153,ENSG00000277775,ENSG00000286522,ENSG00000287080,ENSG00000072415,ENSG00000076321,ENSG00000087250,ENSG00000101911,ENSG00000104413,ENSG00000123154,ENSG00000129103,ENSG00000132016,ENSG00000139372,ENSG00000140743,ENSG00000141030,ENSG00000142192,ENSG00000162852,ENSG00000165188,ENSG00000242247,ENSG00000264522,ENSG00000103154,ENSG00000106772,ENSG00000119537,ENSG00000122042,ENSG00000128609,ENSG00000167770,ENSG00000198959,ENSG00000275379,ENSG00000026025,ENSG00000149557,ENSG00000054611,ENSG00000105472,ENSG00000118271,ENSG00000153885,ENSG00000165898,ENSG00000273983,ENSG00000159459,ENSG00000163563,ENSG00000165171,ENSG00000166595,ENSG00000170004,ENSG00000187037,ENSG00000196220,ENSG00000204305,ENSG00000275714","NA"
"Annovera","Segesterone acetate, ethinyl estradiol","SEGESTERONEACETATE,ETHINYLESTRADIOL","CHEMBL691,CHEMBL3707377","TherapeuticsMD","Progestin and estrogen combined hormonal contraceptive","Other indication","Female contraception","contraception","EFO_0009520","Not serious","S","2018","CHEMBL3707377,CHEMBL691","ENSG00000091831,ENSG00000082175","ENSG00000029363,ENSG00000054793,ENSG00000074696,ENSG00000087510,ENSG00000089157,ENSG00000100316,ENSG00000100345,ENSG00000102054,ENSG00000104356,ENSG00000105939,ENSG00000109819,ENSG00000111875,ENSG00000115109,ENSG00000116251,ENSG00000116478,ENSG00000119231,ENSG00000125944,ENSG00000128487,ENSG00000131759,ENSG00000134419,ENSG00000135679,ENSG00000137497,ENSG00000137656,ENSG00000143575,ENSG00000145741,ENSG00000147604,ENSG00000165502,ENSG00000166986,ENSG00000173039,ENSG00000174748,ENSG00000178035,ENSG00000178175,ENSG00000231500,ENSG00000241343,ENSG00000280789,ENSG00000070756,ENSG00000075151,ENSG00000077097,ENSG00000089009,ENSG00000100320,ENSG00000111679,ENSG00000118520,ENSG00000123416,ENSG00000125931,ENSG00000129691,ENSG00000130254,ENSG00000130255,ENSG00000131747,ENSG00000132467,ENSG00000136146,ENSG00000137154,ENSG00000143546,ENSG00000145220,ENSG00000146112,ENSG00000163346,ENSG00000165795,ENSG00000167216,ENSG00000169813,ENSG00000171456,ENSG00000175110,ENSG00000178896,ENSG00000180530,ENSG00000183207,ENSG00000196586,ENSG00000197728,ENSG00000239306,ENSG00000239789,ENSG00000011485,ENSG00000061794,ENSG00000072110,ENSG00000072274,ENSG00000075624,ENSG00000087470,ENSG00000091831,ENSG00000095015,ENSG00000096063,ENSG00000100764,ENSG00000101306,ENSG00000106397,ENSG00000107874,ENSG00000115468,ENSG00000118689,ENSG00000128641,ENSG00000132300,ENSG00000133226,ENSG00000135372,ENSG00000140575,ENSG00000141367,ENSG00000142235,ENSG00000143621,ENSG00000147548,ENSG00000148303,ENSG00000155974,ENSG00000156030,ENSG00000156697,ENSG00000160208,ENSG00000163902,ENSG00000163938,ENSG00000169750,ENSG00000182944,ENSG00000196396,ENSG00000247077,ENSG00000265681,ENSG00000054118,ENSG00000082175,ENSG00000089280,ENSG00000105127,ENSG00000107625,ENSG00000110955,ENSG00000114391,ENSG00000122140,ENSG00000123268,ENSG00000126561,ENSG00000130193,ENSG00000131023,ENSG00000138756,ENSG00000141456,ENSG00000142541,ENSG00000148180,ENSG00000151893,ENSG00000160014,ENSG00000161960,ENSG00000164587,ENSG00000166619,ENSG00000170315,ENSG00000172977,ENSG00000176014,ENSG00000181163,ENSG00000185591,ENSG00000186468,ENSG00000197077,ENSG00000197879,ENSG00000215301,ENSG00000006125,ENSG00000008988,ENSG00000105193,ENSG00000106638,ENSG00000107223,ENSG00000108298,ENSG00000115875,ENSG00000118523,ENSG00000124151,ENSG00000127603,ENSG00000133315,ENSG00000134987,ENSG00000135387,ENSG00000135486,ENSG00000135829,ENSG00000140553,ENSG00000140988,ENSG00000142937,ENSG00000143799,ENSG00000143870,ENSG00000147140,ENSG00000164880,ENSG00000164934,ENSG00000168028,ENSG00000170776,ENSG00000187555,ENSG00000188846,ENSG00000196843,ENSG00000197535,ENSG00000198900,ENSG00000213553,ENSG00000215021,ENSG00000012048,ENSG00000052749,ENSG00000063177,ENSG00000084676,ENSG00000088205,ENSG00000092841,ENSG00000100393,ENSG00000104447,ENSG00000105640,ENSG00000107485,ENSG00000109606,ENSG00000112306,ENSG00000112592,ENSG00000113048,ENSG00000114867,ENSG00000115415,ENSG00000122779,ENSG00000124214,ENSG00000125686,ENSG00000130826,ENSG00000131051,ENSG00000132153,ENSG00000132382,ENSG00000138434,ENSG00000145675,ENSG00000149257,ENSG00000150907,ENSG00000161547,ENSG00000165119,ENSG00000167526,ENSG00000168610,ENSG00000171490,ENSG00000172845,ENSG00000173801,ENSG00000187624,ENSG00000187855,ENSG00000189266,ENSG00000196591,ENSG00000197756,ENSG00000005022,ENSG00000070495,ENSG00000099783,ENSG00000101361,ENSG00000107937,ENSG00000108312,ENSG00000109501,ENSG00000115053,ENSG00000117222,ENSG00000118705,ENSG00000134697,ENSG00000135624,ENSG00000145425,ENSG00000146648,ENSG00000147274,ENSG00000147403,ENSG00000160310,ENSG00000165732,ENSG00000167548,ENSG00000170144,ENSG00000172216,ENSG00000174444,ENSG00000196924,ENSG00000197122,ENSG00000197785,ENSG00000198431,ENSG00000042753,ENSG00000063244,ENSG00000084774,ENSG00000091513,ENSG00000092621,ENSG00000100201,ENSG00000100284,ENSG00000102738,ENSG00000105357,ENSG00000108592,ENSG00000108654,ENSG00000109320,ENSG00000109971,ENSG00000124228,ENSG00000130787,ENSG00000135250,ENSG00000136450,ENSG00000139675,ENSG00000140009,ENSG00000140396,ENSG00000143933,ENSG00000148773,ENSG00000153827,ENSG00000156802,ENSG00000158623,ENSG00000159251,ENSG00000166441,ENSG00000170889,ENSG00000186298,ENSG00000198034,ENSG00000198668,ENSG00000123064,ENSG00000161016,ENSG00000183495","NA"
"Anoro Ellipta","Umeclidinium, vilanterol","UMECLIDINIUM,VILANTEROL","CHEMBL1198857,CHEMBL1187833","GSK","Anticholinergic and a LABA","Other indication","Chronic obstructive pulmonary disease","chronic obstructive pulmonary disease","EFO_0000341","Serious","S","2013","CHEMBL1187833,CHEMBL1198857","ENSG00000169252,ENSG00000133019","ENSG00000130770,ENSG00000143001,ENSG00000111361,ENSG00000118985,ENSG00000212864,ENSG00000229715,ENSG00000106462,ENSG00000129173,ENSG00000183666,ENSG00000185658,ENSG00000197971,ENSG00000074416,ENSG00000100603,ENSG00000113369,ENSG00000184984,ENSG00000109062,ENSG00000111224,ENSG00000134758,ENSG00000163485,ENSG00000163749,ENSG00000081026,ENSG00000096070,ENSG00000165119,ENSG00000240021,ENSG00000077254,ENSG00000141480,ENSG00000171867,ENSG00000197122,ENSG00000169252","NA"
"Anthim","Obiltoxaximab","OBILTOXAXIMAB","CHEMBL3544926","Elusys Therapeutics","mAb against anthrax toxin","No human target","Anthrax","anthrax infection","EFO_0000778","Serious","S,O,F","2016","CHEMBL3544926","NA","NA","NA"
"Aptiom","Eslicarbazepine","ESLICARBAZEPINE","CHEMBL315985","Sunovion","MOA unknown, but thought to involve voltage-gated sodium channels","Other indication","Partial-onset seizures","Seizure","HP_0001250","Not concordant","S","2013","CHEMBL315985","ENSG00000136531,ENSG00000153253,ENSG00000196876,ENSG00000183873,ENSG00000185313,ENSG00000144285,ENSG00000169432,ENSG00000007314,ENSG00000136546,ENSG00000168356","ENSG00000015171,ENSG00000069869,ENSG00000105711,ENSG00000143933,ENSG00000160014,ENSG00000163060,ENSG00000172530,NA,ENSG00000102466,ENSG00000165724,ENSG00000185238,ENSG00000064999,ENSG00000100908,ENSG00000126457,ENSG00000137693,ENSG00000145349,ENSG00000198668,ENSG00000101460,ENSG00000172554,ENSG00000187555,ENSG00000070159,ENSG00000114279,ENSG00000151150","NA"
"Aristada","Aripiprazole lauroxil","ARIPIPRAZOLELAUROXIL","CHEMBL2219425","Alkermes","Extended release atypical antipsychotic","Other indication","Schizophrenia","schizophrenia","MONDO_0005090","Not concordant","S","2015","CHEMBL2219425","ENSG00000178394,ENSG00000149295,ENSG00000102468","ENSG00000077782,ENSG00000147955,ENSG00000166573,ENSG00000135914,ENSG00000149295,ENSG00000102468,ENSG00000162946,ENSG00000164082,ENSG00000118432,ENSG00000183840,ENSG00000128271,ENSG00000107186,ENSG00000147246,ENSG00000078369,ENSG00000142319","NA"
"Artesunate","Artesunate","ARTESUNATE","CHEMBL361497","Amivas","Artemisinin antimalarial","No human target","Serious malaria","malaria","EFO_0001068","Serious","P,O,B,F","2020","CHEMBL361497","NA","NA","NA"
"Asparlas","Calaspargase pegol","CALASPARGASEPEGOL","CHEMBL2108728","Servier","Asparagine specific enzyme","Oncology","ALL","acute lymphoblastic leukemia","EFO_0000220","Serious","S,O","2018","CHEMBL2108728","ENSG00000166183","ENSG00000086548,ENSG00000125409,ENSG00000064218,ENSG00000124237,ENSG00000126062,ENSG00000188011,ENSG00000131475,ENSG00000148082,ENSG00000036672,ENSG00000104518,ENSG00000164591","NA"
"Austedo","Deutetrabenazine","DUTETRABENAZINE","CHEMBL3137326","Teva","VMAT2 inhibitor","Other indication","Chorea associated with Huntington disease","chorea; Huntington disease","EFO_0004152,MONDO_0007739","Serious","S,O","2017","CHEMBL3137326","ENSG00000165646","ENSG00000182544,ENSG00000110108,ENSG00000214736,ENSG00000173250,ENSG00000180871,ENSG00000182685,ENSG00000139514,ENSG00000166091,ENSG00000105374,ENSG00000134389","NA"
"Avycaz","Avibactam, ceftazidime","AVIBACTAM,CEFTAZIDIME","CHEMBL1689063,CHEMBL44354","Allergan","A beta-lactamase inhibitor and a cephalosporin","No human target","Complicated intra-abdominal infections and complicated urinary tract infections","infection","EFO_0000544","Serious","P,F","2015","CHEMBL1689063,CHEMBL44354","NA","NA","Orphanet_169142"
"Axumin","Fluciclovine F-18","FLUCICLOVINEF-18","CHEMBL3707267","Blue Earth","Radioactive diagnostic","Other indication","Suspected prostate cancer recurrence","prostate cancer","MONDO_0008315","Serious","P","2016","CHEMBL3707267","ENSG00000105281,ENSG00000155465,ENSG00000165349","ENSG00000204308,NA,ENSG00000155755,ENSG00000100652,ENSG00000123560,ENSG00000128284","NA"
"Ayvakit","Avapritinib","AVAPRITINIB","CHEMBL4204794","Blueprint Medicines","PDGFRA, PDGFRA mutants and KIT kinase inhibitor","Oncology","GIST with PDGFRA exon 18 mutations","gastrointestinal stromal tumor","MONDO_0011719","Serious","P,O,B,F","2020","CHEMBL4204794","ENSG00000157404,ENSG00000134853","ENSG00000049130,ENSG00000097007,ENSG00000100351,ENSG00000101213,ENSG00000111077,ENSG00000136573,ENSG00000137936,ENSG00000145715,ENSG00000170677,ENSG00000197461,ENSG00000105647,ENSG00000171150,ENSG00000136205,ENSG00000161609,ENSG00000176105,ENSG00000179295,ENSG00000184557,ENSG00000196684,ENSG00000197943,ENSG00000074966,ENSG00000096063,ENSG00000117461,ENSG00000120833,ENSG00000143322,ENSG00000145431,ENSG00000160691,ENSG00000000938,ENSG00000027869,ENSG00000071051,ENSG00000095585,ENSG00000107338,ENSG00000111252,ENSG00000124181,ENSG00000134215,ENSG00000158092,ENSG00000198574,ENSG00000067225,ENSG00000115085,ENSG00000135605,ENSG00000145675,ENSG00000167193,ENSG00000197122,ENSG00000254087,ENSG00000035720,ENSG00000092108,ENSG00000095370,ENSG00000101082,ENSG00000101336,ENSG00000129946,ENSG00000141738,ENSG00000142192,ENSG00000149177,ENSG00000165025,ENSG00000177885,ENSG00000182511,ENSG00000183918,ENSG00000087266,ENSG00000099942,ENSG00000100311,ENSG00000113721,ENSG00000146648,ENSG00000148082,ENSG00000182866,ENSG00000185634,ENSG00000205808,ENSG00000079308","NA"
"Azstarys","Dexmethylphenidate, serdexmethylphenidate","Dexmethylphenidate,serdexmethylphenidate","CHEMBL827,CHEMBL4301162","Commave Therapeutics","CNS stimulant","Other indication","ADHD","attention deficit hyperactivity disorder","EFO_0003888","Not serious","S","2021","CHEMBL827,CHEMBL4301162","ENSG00000142319,ENSG00000103546","ENSG00000145335,ENSG00000100151,ENSG00000152214,ENSG00000170775,ENSG00000116729,ENSG00000149295","NA"
"Balversa","Erdafitinib","ERDAFITINIB","CHEMBL3545376","Janssen /J&J","FGFR inhibitor","Oncology","Bladder cancer","urinary bladder carcinoma","MONDO_0004986","Serious","P,B,A","2019","CHEMBL3545376","ENSG00000068078,ENSG00000066468,ENSG00000077782,ENSG00000160867","ENSG00000066468,ENSG00000070718,ENSG00000072415,ENSG00000073150,ENSG00000093010,ENSG00000104824,ENSG00000109083,ENSG00000111328,ENSG00000113578,ENSG00000123178,ENSG00000124659,ENSG00000131351,ENSG00000131791,ENSG00000137478,ENSG00000140386,ENSG00000143382,ENSG00000143420,ENSG00000146021,ENSG00000147457,ENSG00000149357,ENSG00000154237,ENSG00000159445,ENSG00000163072,ENSG00000166452,ENSG00000167965,ENSG00000169905,ENSG00000174738,ENSG00000175592,ENSG00000178104,ENSG00000185345,ENSG00000185658,ENSG00000187778,ENSG00000198369,ENSG00000204472,ENSG00000242259,ENSG00000064195,ENSG00000068078,ENSG00000069535,ENSG00000070193,ENSG00000078328,ENSG00000079974,ENSG00000084072,ENSG00000092068,ENSG00000104228,ENSG00000113070,ENSG00000115738,ENSG00000116918,ENSG00000117625,ENSG00000118523,ENSG00000119965,ENSG00000120094,ENSG00000124762,ENSG00000126107,ENSG00000130717,ENSG00000131408,ENSG00000141582,ENSG00000147647,ENSG00000149084,ENSG00000150783,ENSG00000151962,ENSG00000153044,ENSG00000156127,ENSG00000158246,ENSG00000162344,ENSG00000162624,ENSG00000166595,ENSG00000167861,ENSG00000171388,ENSG00000171425,ENSG00000173039,ENSG00000181781,ENSG00000185753,ENSG00000185880,ENSG00000186977,ENSG00000198081,ENSG00000203780,ENSG00000203857,ENSG00000236699,ENSG00000249481,ENSG00000065361,ENSG00000077782,ENSG00000095539,ENSG00000095794,ENSG00000101457,ENSG00000102931,ENSG00000106462,ENSG00000107485,ENSG00000107831,ENSG00000109787,ENSG00000119703,ENSG00000129173,ENSG00000130770,ENSG00000136279,ENSG00000138131,ENSG00000141232,ENSG00000141753,ENSG00000144681,ENSG00000148604,ENSG00000152102,ENSG00000154358,ENSG00000163530,ENSG00000163995,ENSG00000166037,ENSG00000166579,ENSG00000180155,ENSG00000182040,ENSG00000183640,ENSG00000184937,ENSG00000185432,ENSG00000198003,ENSG00000002834,ENSG00000040633,ENSG00000067225,ENSG00000077721,ENSG00000096070,ENSG00000100225,ENSG00000100379,ENSG00000101290,ENSG00000103423,ENSG00000104147,ENSG00000110811,ENSG00000111224,ENSG00000111241,ENSG00000117475,ENSG00000118960,ENSG00000125945,ENSG00000132680,ENSG00000133687,ENSG00000134198,ENSG00000134962,ENSG00000139219,ENSG00000143507,ENSG00000146776,ENSG00000147533,ENSG00000147601,ENSG00000147689,ENSG00000156831,ENSG00000157851,ENSG00000162869,ENSG00000163885,ENSG00000166272,ENSG00000166508,ENSG00000166925,ENSG00000167193,ENSG00000167323,ENSG00000168591,ENSG00000170485,ENSG00000170500,ENSG00000171208,ENSG00000171357,ENSG00000175866,ENSG00000177463,ENSG00000182196,ENSG00000183856,ENSG00000184857,ENSG00000186951,ENSG00000198034,ENSG00000204619,ENSG00000212864,ENSG00000240021,ENSG00000004975,ENSG00000010379,ENSG00000054282,ENSG00000068028,ENSG00000072182,ENSG00000076321,ENSG00000089116,ENSG00000099817,ENSG00000104341,ENSG00000104413,ENSG00000116691,ENSG00000118972,ENSG00000123908,ENSG00000125968,ENSG00000127914,ENSG00000134248,ENSG00000136404,ENSG00000136738,ENSG00000147324,ENSG00000151332,ENSG00000158747,ENSG00000163596,ENSG00000163875,ENSG00000165731,ENSG00000168779,ENSG00000169087,ENSG00000170608,ENSG00000173933,ENSG00000173991,ENSG00000177189,ENSG00000177606,ENSG00000178394,ENSG00000179295,ENSG00000183666,ENSG00000197157,ENSG00000205838,ENSG00000229715,ENSG00000244362,ENSG00000011332,ENSG00000066248,ENSG00000075388,ENSG00000075426,ENSG00000099956,ENSG00000100519,ENSG00000100916,ENSG00000102145,ENSG00000102678,ENSG00000106615,ENSG00000115145,ENSG00000115165,ENSG00000123374,ENSG00000123405,ENSG00000131143,ENSG00000134419,ENSG00000134758,ENSG00000140153,ENSG00000140285,ENSG00000140941,ENSG00000152684,ENSG00000154764,ENSG00000155975,ENSG00000160695,ENSG00000160867,ENSG00000162377,ENSG00000163492,ENSG00000164649,ENSG00000164743,ENSG00000168769,ENSG00000170312,ENSG00000171223,ENSG00000171345,ENSG00000177181,ENSG00000183674,ENSG00000185246,ENSG00000185869,ENSG00000187678,ENSG00000244687,ENSG00000257949,ENSG00000260027,ENSG00000264522,ENSG00000087365,ENSG00000088970,ENSG00000092010,ENSG00000096384,ENSG00000102178,ENSG00000105401,ENSG00000108961,ENSG00000113595,ENSG00000116299,ENSG00000125571,ENSG00000127423,ENSG00000129472,ENSG00000131738,ENSG00000137822,ENSG00000140320,ENSG00000140632,ENSG00000140859,ENSG00000142856,ENSG00000144381,ENSG00000147144,ENSG00000147548,ENSG00000148735,ENSG00000158773,ENSG00000160961,ENSG00000164252,ENSG00000166225,ENSG00000166681,ENSG00000170262,ENSG00000170469,ENSG00000172399,ENSG00000177885,ENSG00000178750,ENSG00000179348,ENSG00000181513,ENSG00000183304,ENSG00000187855,ENSG00000204220,ENSG00000225855,ENSG00000240184,ENSG00000288547,ENSG00000011201,ENSG00000017797,ENSG00000039068,ENSG00000039650,ENSG00000041988,ENSG00000060982,ENSG00000066697,ENSG00000069869,ENSG00000071082,ENSG00000077157,ENSG00000089916,ENSG00000092529,ENSG00000099814,ENSG00000100603,ENSG00000104064,ENSG00000104892,ENSG00000111879,ENSG00000118985,ENSG00000120333,ENSG00000121766,ENSG00000123388,ENSG00000124181,ENSG00000124302,ENSG00000129351,ENSG00000130830,ENSG00000136982,ENSG00000136997,ENSG00000138685,ENSG00000139053,ENSG00000140092,ENSG00000143001,ENSG00000143340,ENSG00000143952,ENSG00000145675,ENSG00000154822,ENSG00000158517,ENSG00000160972,ENSG00000163749,ENSG00000164675,ENSG00000165417,ENSG00000165898,ENSG00000167182,ENSG00000168036,ENSG00000170677,ENSG00000170684,ENSG00000179094,ENSG00000184515,ENSG00000186451,ENSG00000187510,ENSG00000187514,ENSG00000278619,ENSG00000126768,ENSG00000136811,ENSG00000140995,ENSG00000152240,ENSG00000185386","NA"
"Barhemsys","Amisulpride","AMISULPRIDE","CHEMBL243712","Acacia","Dopamine receptors D2 & D3 antagonist","Other indication","Nausea and vomiting after surgery","Nausea and vomiting","HP_0002017","Not serious","S","2020","CHEMBL243712","ENSG00000158748,ENSG00000147246,ENSG00000135914,ENSG00000102468,ENSG00000166736,ENSG00000164270,ENSG00000178394,ENSG00000149295,ENSG00000179546,ENSG00000179097,ENSG00000157219,ENSG00000151577,ENSG00000186038,ENSG00000149305,ENSG00000178084,ENSG00000186090,ENSG00000135312,ENSG00000168830,ENSG00000148680","ENSG00000010810,ENSG00000102468,ENSG00000180720,ENSG00000186090,ENSG00000204175,ENSG00000131711,ENSG00000183840,ENSG00000029364,ENSG00000100528,ENSG00000107186,ENSG00000142319,ENSG00000162946,ENSG00000164082,NA,ENSG00000128271,ENSG00000134640,ENSG00000143570,ENSG00000147246,ENSG00000149295,ENSG00000134531,ENSG00000166573,ENSG00000166736,ENSG00000075711,ENSG00000135914,ENSG00000139644,ENSG00000147955,ENSG00000149305,ENSG00000178084,ENSG00000077522,ENSG00000077782,ENSG00000105677,ENSG00000106511,ENSG00000158301,ENSG00000164270,ENSG00000168412,ENSG00000170775,ENSG00000186038,ENSG00000198932,ENSG00000015479,ENSG00000078369,ENSG00000112559,ENSG00000118432,ENSG00000123240,ENSG00000139910,ENSG00000180900","NA"
"Bavencio","Avelumab","AVELUMAB","CHEMBL3833373","Merck KGaA/Pfizer","PDL1-blocking antibody","Oncology","Merkel cell carcinoma","Merkel cell skin cancer","EFO_1001471","Serious","P,O,B,A,F","2017","CHEMBL3833373","ENSG00000120217","ENSG00000091317,ENSG00000121594,ENSG00000183723,ENSG00000188389,ENSG00000197646","NA"
"Baxdela","Delafloxacin","DELAFLOXACIN","CHEMBL2105637","Melinta Therapeutics","Fluoroquinolone antibacterial","No human target","Acute bacterial skin and skin structure infections","staphylococcal skin infections","EFO_1001849","Not serious","P,F","2017","CHEMBL2105637","NA","NA","NA"
"Beleodaq","Belinostat","BELINOSTAT","CHEMBL408513","Spectrum","Histone-deacetylase inhibitor","Other indication","Peripheral T-cell lymphoma","unspecified peripheral T-cell lymphoma","EFO_0000211","Serious","P,O,A,F","2014","CHEMBL408513","ENSG00000116478,ENSG00000061273,ENSG00000068024,ENSG00000196591,ENSG00000171720,ENSG00000108840,ENSG00000163517,ENSG00000094631,ENSG00000147099,ENSG00000048052,ENSG00000100429","ENSG00000054267,ENSG00000070831,ENSG00000101255,ENSG00000107485,ENSG00000109089,ENSG00000114107,ENSG00000117155,ENSG00000121741,ENSG00000127152,ENSG00000132005,ENSG00000136238,ENSG00000139687,ENSG00000141526,ENSG00000147130,ENSG00000150347,ENSG00000156374,ENSG00000164283,ENSG00000164576,ENSG00000166913,ENSG00000170788,ENSG00000172062,ENSG00000173020,ENSG00000178691,ENSG00000266074,ENSG00000270276,ENSG00000007062,ENSG00000053702,ENSG00000064703,ENSG00000080561,ENSG00000085733,ENSG00000094796,ENSG00000100916,ENSG00000101849,ENSG00000124496,ENSG00000131149,ENSG00000131737,ENSG00000135365,ENSG00000141510,ENSG00000141736,ENSG00000143256,ENSG00000149480,ENSG00000150459,ENSG00000155330,ENSG00000155959,ENSG00000164331,ENSG00000164916,ENSG00000164924,ENSG00000169083,ENSG00000170234,ENSG00000173805,ENSG00000174197,ENSG00000180530,ENSG00000181163,ENSG00000182195,ENSG00000196498,ENSG00000197238,ENSG00000197978,ENSG00000198160,ENSG00000204209,ENSG00000204220,ENSG00000213523,ENSG00000213999,ENSG00000270882,ENSG00000275221,ENSG00000278637,ENSG00000005436,ENSG00000011243,ENSG00000066739,ENSG00000068400,ENSG00000100201,ENSG00000103202,ENSG00000110092,ENSG00000124216,ENSG00000124782,ENSG00000125630,ENSG00000129654,ENSG00000130816,ENSG00000131738,ENSG00000132522,ENSG00000135624,ENSG00000136436,ENSG00000137478,ENSG00000142182,ENSG00000143614,ENSG00000145335,ENSG00000145358,ENSG00000149923,ENSG00000158636,ENSG00000159692,ENSG00000160207,ENSG00000167604,ENSG00000170004,ENSG00000170027,ENSG00000171720,ENSG00000172534,ENSG00000172936,ENSG00000178568,ENSG00000179409,ENSG00000181090,ENSG00000183323,ENSG00000185345,ENSG00000196591,ENSG00000196700,ENSG00000196747,ENSG00000196843,ENSG00000197061,ENSG00000204371,ENSG00000205571,ENSG00000275126,ENSG00000277157,ENSG00000057935,ENSG00000064961,ENSG00000065361,ENSG00000081189,ENSG00000083799,ENSG00000086061,ENSG00000100109,ENSG00000100395,ENSG00000101040,ENSG00000101266,ENSG00000103275,ENSG00000105127,ENSG00000106511,ENSG00000108840,ENSG00000108953,ENSG00000109906,ENSG00000128596,ENSG00000129195,ENSG00000131910,ENSG00000134308,ENSG00000135363,ENSG00000139146,ENSG00000141027,ENSG00000146648,ENSG00000157933,ENSG00000158406,ENSG00000159086,ENSG00000162367,ENSG00000164105,ENSG00000166716,ENSG00000166851,ENSG00000167110,ENSG00000167552,ENSG00000169375,ENSG00000173039,ENSG00000181449,ENSG00000185963,ENSG00000186628,ENSG00000196535,ENSG00000196787,ENSG00000197837,ENSG00000268606,ENSG00000004487,ENSG00000074266,ENSG00000091831,ENSG00000101945,ENSG00000102144,ENSG00000103254,ENSG00000109320,ENSG00000111328,ENSG00000120948,ENSG00000125457,ENSG00000127511,ENSG00000129911,ENSG00000134686,ENSG00000137404,ENSG00000138100,ENSG00000141741,ENSG00000142599,ENSG00000163618,ENSG00000163697,ENSG00000167967,ENSG00000168036,ENSG00000169744,ENSG00000171940,ENSG00000183092,ENSG00000183690,ENSG00000185591,ENSG00000197079,ENSG00000198795,ENSG00000204713,ENSG00000204889,ENSG00000215193,ENSG00000223501,ENSG00000020633,ENSG00000073614,ENSG00000095066,ENSG00000101126,ENSG00000101412,ENSG00000102054,ENSG00000111642,ENSG00000113068,ENSG00000113916,ENSG00000115484,ENSG00000116478,ENSG00000122042,ENSG00000128245,ENSG00000133818,ENSG00000135249,ENSG00000136715,ENSG00000140743,ENSG00000143373,ENSG00000146731,ENSG00000150991,ENSG00000156261,ENSG00000158773,ENSG00000162924,ENSG00000166946,ENSG00000167771,ENSG00000169016,ENSG00000169554,ENSG00000169750,ENSG00000171360,ENSG00000172638,ENSG00000174744,ENSG00000177565,ENSG00000178951,ENSG00000183305,ENSG00000186432,ENSG00000196363,ENSG00000196388,ENSG00000197114,ENSG00000031691,ENSG00000066185,ENSG00000071655,ENSG00000089902,ENSG00000100151,ENSG00000101457,ENSG00000104964,ENSG00000105287,ENSG00000111707,ENSG00000117625,ENSG00000120438,ENSG00000135951,ENSG00000141644,ENSG00000143321,ENSG00000143390,ENSG00000147223,ENSG00000157259,ENSG00000163848,ENSG00000166226,ENSG00000168556,ENSG00000172216,ENSG00000176903,ENSG00000180357,ENSG00000181472,ENSG00000182979,ENSG00000185658,ENSG00000198176,ENSG00000198681,ENSG00000204843,ENSG00000205643,ENSG00000274618,ENSG00000276180,ENSG00000288547,ENSG00000066427,ENSG00000068024,ENSG00000068305,ENSG00000068903,ENSG00000100697,ENSG00000101493,ENSG00000105556,ENSG00000108654,ENSG00000109099,ENSG00000109118,ENSG00000116288,ENSG00000117475,ENSG00000123240,ENSG00000123349,ENSG00000128340,ENSG00000132938,ENSG00000134046,ENSG00000136997,ENSG00000137055,ENSG00000137575,ENSG00000138738,ENSG00000139083,ENSG00000140382,ENSG00000146809,ENSG00000148400,ENSG00000149639,ENSG00000150753,ENSG00000153046,ENSG00000156030,ENSG00000157500,ENSG00000159363,ENSG00000160972,ENSG00000162390,ENSG00000162521,ENSG00000162676,ENSG00000163468,ENSG00000167491,ENSG00000171446,ENSG00000172380,ENSG00000175793,ENSG00000179348,ENSG00000182095,ENSG00000184619,ENSG00000197386,ENSG00000273542,ENSG00000276966,ENSG00000278677,ENSG00000278705,ENSG00000151612,ENSG00000276903","NA"
"Belsomra","Suvorexant","SUVOREXANT","CHEMBL1083659","Merck & Co.","Orexin-receptor antagonist","Other indication","Insomnia","insomnia","EFO_0004698","Not serious","S","2014","CHEMBL1083659","ENSG00000121764,ENSG00000137252","ENSG00000121853,ENSG00000196262,ENSG00000116678","EFO_0005271,EFO_0008568"
"Benznidazole","Benznidazole","BENZNIDAZOLE","CHEMBL110","Chemo Research","Nitroimidazole antimicrobial","No human target","Chagas disease","Chagas disease","MONDO_0001444","Serious","P,O,A","2017","CHEMBL110","NA","NA","NA"
"Beovu","Brolucizumab","BROLUCIZUMAB","CHEMBL3707357","Novartis","VEGF inhibitor","Other indication","Wet age-related macular degeneration","macular degeneration","EFO_0009606","Not concordant","S","2019","CHEMBL3707357","ENSG00000112715","ENSG00000112715,ENSG00000155755,ENSG00000148346,ENSG00000169562,ENSG00000080189,ENSG00000102755,ENSG00000128052,ENSG00000099250","NA"
"Besponsa","Inotuzumab ozogamicin","INOTUZUMABOZOGAMICIN","CHEMBL2108611","Pfizer","CD22-directed antibody‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚àö√´‚Äö√†√∂¬¨¬Ædrug conjugate","Oncology","B cell precursor ALL","precursor B-cell acute lymphoblastic leukemia","MONDO_0020511","Serious","P,O,B","2017","CHEMBL2108611","ENSG00000012124","ENSG00000156795,ENSG00000165025,ENSG00000111679,ENSG00000254087,ENSG00000124181,ENSG00000146859,ENSG00000186106","EFO_1001938"
"Besremi","Ropeginterferon alfa-2b","Ropeginterferonalfa-2b","CHEMBL4297819","Pharmaessentia","PEGylated interferon alpha-2b","Oncology","Polycythaemia vera","polycythemia vera","EFO_0002429","Serious","S,O","2021","CHEMBL4297819","ENSG00000159110,ENSG00000142166","ENSG00000115415,ENSG00000204628,ENSG00000170581,ENSG00000005339,ENSG00000162434,ENSG00000213928,ENSG00000177047,ENSG00000104341,ENSG00000105397,ENSG00000159110,ENSG00000072803,ENSG00000188379","NA"
"Bevyxxa","Betrixaban","BETRIXABAN","CHEMBL512351","Portola Pharmaceuticals","FXa inhibitor","Other indication","Prophylaxis of venous thromboembolism","venous thromboembolism","EFO_0004286","Serious","P,F","2017","CHEMBL512351","ENSG00000126218","ENSG00000117601,ENSG00000140093,ENSG00000106333,ENSG00000188021,ENSG00000286219","NA"
"Biktarvy","Bictegravir, emtricitabine, tenofovir alafenamide","BICTEGRAVIR,EMTRICITABINE,TENOFOVIRALAFENAMIDE","CHEMBL3989866,CHEMBL885,CHEMBL2107825","Gilead Sciences","HIV-1 integrase inhibitor and HIV-1 nucleoside/nucleotide reverse transcriptase inhibitors","No human target","HIV","hiv infection","EFO_0000764","Serious","P","2018","CHEMBL3989866,CHEMBL885,CHEMBL2107825","NA","NA","NA"
"Blenrep","Belantamab mafodotin","BELANTAMABMAFODOTIN","CHEMBL4298209","GlaxoSmithKline","BCMA-directed ADC, with microtubule inhibitor","Oncology","Multiple myeloma","multiple myeloma","EFO_0001378","Serious","P,O,B,A","2020","CHEMBL4298209","ENSG00000101162,ENSG00000196230,ENSG00000137267,ENSG00000167552,ENSG00000176014,ENSG00000258947,ENSG00000167553,ENSG00000198033,ENSG00000152086,ENSG00000137285,ENSG00000123416,ENSG00000104833,ENSG00000188229,ENSG00000261456,ENSG00000048462,ENSG00000127824","ENSG00000100603,ENSG00000102003,ENSG00000105993,ENSG00000106211,ENSG00000115484,ENSG00000123416,ENSG00000123609,ENSG00000141837,ENSG00000155959,ENSG00000268606,ENSG00000080824,ENSG00000083799,ENSG00000086061,ENSG00000090520,ENSG00000091831,ENSG00000114904,ENSG00000116106,ENSG00000119689,ENSG00000123358,ENSG00000126581,ENSG00000135624,ENSG00000156475,ENSG00000177954,ENSG00000196730,ENSG00000001626,ENSG00000084774,ENSG00000123349,ENSG00000143575,ENSG00000146731,ENSG00000147601,ENSG00000166170,ENSG00000167900,ENSG00000177606,ENSG00000186868,ENSG00000258947,NA,ENSG00000094631,ENSG00000103423,ENSG00000104427,ENSG00000109501,ENSG00000115514,ENSG00000131697,ENSG00000133124,ENSG00000139644,ENSG00000147676,ENSG00000166091,ENSG00000166135,ENSG00000183386,ENSG00000196504,ENSG00000197386,ENSG00000204463,ENSG00000026025,ENSG00000065361,ENSG00000102119,ENSG00000129559,ENSG00000136319,ENSG00000138794,ENSG00000142192,ENSG00000145555,ENSG00000146648,ENSG00000150753,ENSG00000166226,ENSG00000167553,ENSG00000176148,ENSG00000177674,ENSG00000178127,ENSG00000183305,ENSG00000204843,ENSG00000254999,ENSG00000069345,ENSG00000112208,ENSG00000121680,ENSG00000136997,ENSG00000152359,ENSG00000156261,ENSG00000160181,ENSG00000161011,ENSG00000188906,ENSG00000054523,ENSG00000092330,ENSG00000102977,ENSG00000114416,ENSG00000142168,ENSG00000143256,ENSG00000145335,ENSG00000162946,ENSG00000164924,ENSG00000173020,ENSG00000005893,ENSG00000097033,ENSG00000115317,ENSG00000120438,ENSG00000124214,ENSG00000126934,ENSG00000130779,ENSG00000133112,ENSG00000139517,ENSG00000151414,ENSG00000151849,ENSG00000153551,ENSG00000163468,ENSG00000166046,ENSG00000167552,ENSG00000179218,ENSG00000182168,ENSG00000265763,ENSG00000277586,ENSG00000127824,ENSG00000170801","MONDO_0004095"
"Blincyto","Blinatumomab","BLINATUMOMAB","CHEMBL1742992","Amgen","CD19- and CD3-bispecific antibody","Oncology","B-ALL","precursor B-cell acute lymphoblastic leukemia","MONDO_0020511","Serious","P,O,B,A","2014","CHEMBL1742992","ENSG00000160654,ENSG00000198851,ENSG00000177455,ENSG00000167286","ENSG00000139291,ENSG00000169550,ENSG00000071051,ENSG00000127564,ENSG00000165025,ENSG00000109099,ENSG00000121900,ENSG00000134531,ENSG00000115085,ENSG00000131037,ENSG00000211899,ENSG00000149451,ENSG00000162300,ENSG00000172005,ENSG00000176171,ENSG00000187713,ENSG00000213658,ENSG00000126777,ENSG00000197860,ENSG00000158092,ENSG00000187066","EFO_1001938"
"Braftovi","Encorafenib","ENCORAFENIB","CHEMBL3301612","Array BioPharma","BRAF inhibitor","Oncology","BRAF-mutated melanoma","melanoma","EFO_0000756","Serious","S,O","2018","CHEMBL3301612","ENSG00000157764","ENSG00000078061,ENSG00000108953,ENSG00000113013,ENSG00000126934,ENSG00000134308,ENSG00000095015,ENSG00000044574,ENSG00000157764,ENSG00000170027,ENSG00000109971,ENSG00000133703,ENSG00000140575,ENSG00000213281,ENSG00000132155,ENSG00000169032,ENSG00000174775,ENSG00000187555,ENSG00000096384,ENSG00000105401,ENSG00000128245,ENSG00000141564,ENSG00000164924,ENSG00000171132,ENSG00000175793,ENSG00000166913","NA"
"Breo Ellipta","Fluticasone, vilanterol","FLUTICASONE,VILANTEROL","CHEMBL1198857,CHEMBL1473","GSK","Corticosteroid plus LABA","Other indication","Chronic obstructive pulmonary disease","chronic obstructive pulmonary disease","EFO_0000341","Serious","S","2013","CHEMBL1473,CHEMBL1198857","ENSG00000169252,ENSG00000113580","ENSG00000130770,ENSG00000143001,ENSG00000080824,ENSG00000111361,ENSG00000118985,ENSG00000142208,ENSG00000168439,ENSG00000212864,ENSG00000229715,ENSG00000106462,ENSG00000125354,ENSG00000129173,ENSG00000168875,ENSG00000182866,ENSG00000183666,ENSG00000185658,ENSG00000197971,ENSG00000074416,ENSG00000100603,ENSG00000113369,ENSG00000109062,ENSG00000111224,ENSG00000146648,ENSG00000204231,ENSG00000204389,ENSG00000134758,ENSG00000163485,ENSG00000163749,ENSG00000189367,ENSG00000081026,ENSG00000096070,ENSG00000165119,ENSG00000204388,ENSG00000240021,ENSG00000010810,ENSG00000077254,ENSG00000141480,ENSG00000144747,ENSG00000171867,ENSG00000175793,ENSG00000197122,ENSG00000169252","NA"
"Brexafemme","Ibrexafungerp","Ibrexafungerp","CHEMBL4297513","Scynexis","Triterpenoid antifungal","No human target","Vulvovaginal candidiasis","NA","NA","NA","P,F","2021","CHEMBL4297513","NA","NA","NA"
"Bridion","Sugammadex","SUGAMMADEX","CHEMBL2111107","Merck & Co.","A modified gamma cyclodextrin","No human target","Reversal of neuromuscular blockade during surgery","neuromuscular disease","EFO_1001902","Serious","P","2015","CHEMBL2111107","NA","NA","NA"
"Brineura","Cerliponase alfa","CERLIPONASEALFA","CHEMBL3544921","BioMarin Pharmaceutical","Tripeptidyl peptidase","Other indication","Tripeptidyl peptidase 1 deficiency (neuronal ceroid lipofuscinosis type 2*)","neuronal ceroid lipofuscinosis 2","MONDO_0008769","Serious","P,O,B","2017","CHEMBL3544921","ENSG00000166340","ENSG00000037637,ENSG00000165188,ENSG00000198373,ENSG00000076604,ENSG00000111667,ENSG00000112234,ENSG00000148331,ENSG00000164362,ENSG00000178971,ENSG00000114737,ENSG00000177311,ENSG00000167770,ENSG00000107960,ENSG00000138180","NA"
"Brintellix","Vortioxetine","VORTIOXETINE","CHEMBL2104993","Takeda","Serotonin reuptake inhibitor","Other indication","Major depressive disorder","major depressive disorder","MONDO_0002009","Not serious","S","2013","CHEMBL2104993","ENSG00000108576,ENSG00000166736,ENSG00000178394","NA,ENSG00000178084,ENSG00000077782,ENSG00000166573,ENSG00000149305,ENSG00000183840,ENSG00000186038,ENSG00000186090","NA"
"Briumvi","Ublituximab","Ublituximab","CHEMBL2108354","TG Therapeutics","CD20-targeted mAb","Other indication","Relapsing forms of multiple sclerosis","relapsing-remitting multiple sclerosis","EFO_0003929","Serious","S","2022","CHEMBL2108354","ENSG00000156738","ENSG00000120370,ENSG00000126251,ENSG00000144648,ENSG00000148110,ENSG00000198189,ENSG00000204308,ENSG00000108960,ENSG00000116514,ENSG00000176435,ENSG00000100652,ENSG00000112212,ENSG00000157613,ENSG00000176946,ENSG00000213921,ENSG00000036565,ENSG00000132563,ENSG00000168685,ENSG00000170509,ENSG00000090661,ENSG00000156738,ENSG00000213593,ENSG00000124103,ENSG00000168476,ENSG00000187783,ENSG00000080189,ENSG00000145283,ENSG00000160856,ENSG00000086159,ENSG00000122033,ENSG00000161609,ENSG00000188167","MONDO_0005301"
"Briviact","Brivaracetam","BRIVARACETAM","CHEMBL607400","UCB","Anticonvulsant with unknown MOA, binds to SV2A","Other indication","Partial-onset seizures","Focal-onset seizure","HP_0007359","Not concordant","S","2016","CHEMBL607400","ENSG00000159164,ENSG00000144285","ENSG00000140941,ENSG00000187555,ENSG00000069869,ENSG00000114279,ENSG00000137693,ENSG00000142655","HP_0001250"
"Brukinsa","Zanubrutinib","ZANUBRUTINIB","CHEMBL3936761","BeiGene","BTK inhibitor","Oncology","Mantle cell lymphoma","mantle cell lymphoma","EFO_1001469","Serious","P,O,B,A,F","2019","CHEMBL3936761","ENSG00000010671","ENSG00000065675,ENSG00000177885,ENSG00000005700,ENSG00000100124,ENSG00000105976,ENSG00000117560,ENSG00000010671,ENSG00000117461,ENSG00000169083,ENSG00000096384,ENSG00000116017,ENSG00000172005,ENSG00000106511,ENSG00000143537,ENSG00000095585,ENSG00000135378,ENSG00000263001,ENSG00000109458,ENSG00000131370","NA"
"Byfavo","Remimazolam","REMIMAZOLAM","CHEMBL4297526","Acacia","Benzodiazepine","Other indication","Procedural sedation","sedation","EFO_0009868","Not serious","S","2020","CHEMBL4297526","ENSG00000113327,ENSG00000163285,ENSG00000166206,ENSG00000022355,ENSG00000145863,ENSG00000182256,ENSG00000109158,ENSG00000094755,ENSG00000011677,ENSG00000145864,ENSG00000186297,ENSG00000163288,ENSG00000102287,ENSG00000187730,ENSG00000151834,ENSG00000268089","ENSG00000170296,ENSG00000123240,ENSG00000166206,NA,ENSG00000022355,ENSG00000135018,ENSG00000146648,ENSG00000124713,ENSG00000113327,ENSG00000264343,ENSG00000112559","EFO_0003843"
"Bylvay","Odevixibat","Odevixibat","CHEMBL4297588","Albireo","IBAT inhibitor","Other indication","Pruritus in PFIC","familial intrahepatic cholestasis","MONDO_0017290","Serious","P,O,F","2021","CHEMBL4297588","ENSG00000125255","ENSG00000205155,ENSG00000276070,ENSG00000164081,ENSG00000137404,ENSG00000186501,ENSG00000114638,ENSG00000142089,ENSG00000114529,ENSG00000184349,ENSG00000205279","EFO_0005653"
"Cabenuva Kit","Cabotegravir, rilpivirine","Cabotegravir,rilpivirine","CHEMBL2403238,CHEMBL175691","ViiV","INSTI and an NNRTI","No human target","HIV-1 infection","NA","NA","NA","P,F","2021","CHEMBL2403238,CHEMBL175691","NA","NA","NA"
"Cablivi","Caplacizumab","CAPLACIZUMAB","CHEMBL2109624","Sanofi/Ablynx","vWF-directed nanobody","Other indication","ATTP","thrombotic thrombocytopenic purpura","MONDO_0018896","Serious","P,O,F","2019","CHEMBL2109624","ENSG00000110799","ENSG00000067369,ENSG00000160323,ENSG00000185010,ENSG00000185245,ENSG00000241404,ENSG00000123240,ENSG00000187624,ENSG00000110799,ENSG00000187855,ENSG00000259207","NA"
"Calquence","Acalabrutinib","ACALABRUTINIB","CHEMBL3707348","AstraZeneca/Acerta Pharma","BTK inhibitor","Oncology","Mantle cell lymphoma","Mantle cell lymphoma","EFO_1001469","Serious","P,O,B,A","2017","CHEMBL3707348","ENSG00000010671","ENSG00000065675,ENSG00000177885,ENSG00000005700,ENSG00000100124,ENSG00000105976,ENSG00000117560,ENSG00000010671,ENSG00000117461,ENSG00000169083,ENSG00000096384,ENSG00000116017,ENSG00000172005,ENSG00000106511,ENSG00000143537,ENSG00000095585,ENSG00000135378,ENSG00000263001,ENSG00000109458,ENSG00000131370","NA"
"Camzyos","Mavacamten","Mavacamten","CHEMBL4297517","Bristol Myers Squibb","Cardiac myosin inhibitor","Other indication","Classes of obstructive HCM (Hypertrophic Obstructive Cardiomyopathy)","hypertrophic cardiomyopathy","EFO_0000538","Serious","S,O,B","2022","CHEMBL4297517","ENSG00000092054","ENSG00000122477,ENSG00000134571,ENSG00000146352,ENSG00000105700","NA"
"Caplyta","Lumateperone","LUMATEPERONE","CHEMBL3306803","Intra-Cellular Therapies","Atypical antipsychotic","Other indication","Schizophrenia","schizophrenia","MONDO_0005090","Not concordant","S,F","2019","CHEMBL3306803","ENSG00000108576,ENSG00000149295,ENSG00000102468","NA,ENSG00000147955,ENSG00000135914,ENSG00000149295,ENSG00000102468,ENSG00000162946,ENSG00000164082,ENSG00000118432,ENSG00000128271,ENSG00000107186,ENSG00000147246,ENSG00000078369,ENSG00000142319","NA"
"Cerdelga","Eliglustat","ELIGLUSTAT","CHEMBL2110588","Genzyme","Glucosylceramide-synthase inhibitor","Other indication","Gaucher's disease","Gaucher disease","MONDO_0018150","Serious","P,O","2014","CHEMBL2110588","ENSG00000148154","NA","NA"
"Cholbam","Cholic acid","CHOLICACID","CHEMBL205596","Retrophin","A primary bile acid","No human target","Bile acid synthesis disorders and peroxisomal disorders","peroxisomal disease; Disorder of bile acid synthesis","MONDO_0019053,Orphanet_79168","Serious","P,O","2015","CHEMBL205596","NA","NA","NA"
"Cibinqo","Abrocitinib","Abrocitinib","CHEMBL3655081","Pfizer","JAK inhibitor","Other indication","Atopic dermatitis","atopic eczema","EFO_0000274","Not serious","P,B","2022","CHEMBL3655081","ENSG00000162434","ENSG00000096968,ENSG00000115145,ENSG00000134352,ENSG00000141736,ENSG00000115415,ENSG00000159110,ENSG00000168610","MONDO_0002406,HP_0000964"
"Cinqair","Reslizumab","RESLIZUMAB","CHEMBL2107884","Teva","IL-5 antagonist","Other indication","Serious asthma","Status Asthmaticus","EFO_0008590","Serious","S","2016","CHEMBL2107884","ENSG00000113525","ENSG00000100368,ENSG00000091181","MONDO_0004979"
"Copiktra","Duvelisib","DUVELISIB","CHEMBL3039502","Verastem","PI3K inhibitor","Oncology","CLL, FL and SLL","chronic lymphocytic leukemia; follicular lymphoma","EFO_0000095,MONDO_0018906","Serious","P,O,A,F","2018","CHEMBL3039502","ENSG00000171608,ENSG00000105851","ENSG00000145675,ENSG00000117461,ENSG00000152270,ENSG00000105851,ENSG00000166501,ENSG00000174775,ENSG00000142192","NA,EFO_0000183"
"Copper dotatate Cu-64","Copper dotatate Cu-64","COPPERDOTATATECU-64","CHEMBL4297339","Radiomedix","Radioactive diagnostic","Other indication","Imaging, cancer","neuroendocrine neoplasm","EFO_1001901","Serious","P,O,F","2020","CHEMBL4297339","ENSG00000180616","ENSG00000141480,ENSG00000162009,ENSG00000145675,ENSG00000278195","NA"
"Corlanor","Ivabradine","IVABRADINE","CHEMBL471737","Amgen","Hyperpolarization-activated cyclic nucleotide-gated channel blocker","Other indication","Chronic heart failure","Abnormality of the cardiovascular system","HP_0001626","Serious","P,F","2015","CHEMBL471737","ENSG00000138622","ENSG00000114757,ENSG00000138622","NA"
"Cosela","Trilaciclib","Trilaciclib","CHEMBL3894860","G1 Therapeutics","CDK4 and CDK6 kinase inhibitor","Oncology","Chemotherapy-induced myelosuppression","myelosuppression; small cell lung carcinoma","EFO_0000702,EFO_0007053","Serious","P,B","2021","CHEMBL3894860","ENSG00000105810,ENSG00000135446","ENSG00000005302,ENSG00000065328,ENSG00000065883,ENSG00000103343,ENSG00000111206,ENSG00000116754,ENSG00000118689,ENSG00000119866,ENSG00000136709,ENSG00000136754,ENSG00000140464,ENSG00000143442,ENSG00000147883,ENSG00000161956,ENSG00000163950,ENSG00000197933,ENSG00000205250,ENSG00000080824,ENSG00000095637,ENSG00000096717,ENSG00000099326,ENSG00000101745,ENSG00000105227,ENSG00000111087,ENSG00000111701,ENSG00000126767,ENSG00000147889,ENSG00000148516,ENSG00000197444,ENSG00000206181,ENSG00000213676,ENSG00000097046,ENSG00000100146,ENSG00000106462,ENSG00000108349,ENSG00000111276,ENSG00000115875,ENSG00000116604,ENSG00000123080,ENSG00000134058,ENSG00000145687,ENSG00000152467,ENSG00000198026,ENSG00000237441,ENSG00000073111,ENSG00000080839,ENSG00000100211,ENSG00000132646,ENSG00000134324,ENSG00000154548,ENSG00000165588,ENSG00000184708,ENSG00000088881,ENSG00000096384,ENSG00000100461,ENSG00000109819,ENSG00000112576,ENSG00000118816,ENSG00000118971,ENSG00000137497,ENSG00000139687,ENSG00000143379,ENSG00000144560,ENSG00000160570,ENSG00000164190,ENSG00000165804,ENSG00000168779,ENSG00000182606,ENSG00000197343,ENSG00000072736,ENSG00000096060,ENSG00000102921,ENSG00000119139,ENSG00000129355,ENSG00000161547,ENSG00000163877,ENSG00000164548,ENSG00000185122,ENSG00000204610,ENSG00000094804,ENSG00000104859,ENSG00000159216,ENSG00000136997,ENSG00000139517,ENSG00000171540,ENSG00000134480,ENSG00000161405,ENSG00000175197,ENSG00000204463,ENSG00000103479,ENSG00000136450,ENSG00000147130,ENSG00000105401,ENSG00000134283,ENSG00000134709,ENSG00000196388,ENSG00000198176,ENSG00000016082,ENSG00000088325,ENSG00000134532,ENSG00000154277,ENSG00000155090,ENSG00000172403,ENSG00000066279,ENSG00000110092,ENSG00000136527,ENSG00000171843,ENSG00000179750,ENSG00000124762,ENSG00000181896","NA"
"Cosentyx","Secukinumab","SECUKINUMAB","CHEMBL1743068","Novartis","IL-17A antagonist","Other indication","Plaque psoriasis, *psoriatic arthritis, ankylosing spondylitis, along with other joint inflammatory disorders.","psoriasis vulgaris","EFO_1001494","Not serious","S","2015","CHEMBL1743068","ENSG00000112115","ENSG00000132768,ENSG00000185774","EFO_0000676"
"Cotellic","Cobimetinib","COBIMETINIB","CHEMBL2146883","Genentech","MEK inhibitor","Oncology","Melanoma with BRAFV600E/K mutations","melanoma","EFO_0000756","Serious","P,O,F","2015","CHEMBL2146883","ENSG00000169032,ENSG00000126934","ENSG00000028116,ENSG00000078061,ENSG00000108953,ENSG00000124678,ENSG00000134020,ENSG00000134308,ENSG00000172680,ENSG00000127824,ENSG00000141068,ENSG00000075711,ENSG00000121022,ENSG00000127445,ENSG00000166167,ENSG00000157764,ENSG00000170027,ENSG00000109971,ENSG00000142192,ENSG00000165119,ENSG00000171435,ENSG00000172530,ENSG00000175895,ENSG00000102882,ENSG00000132155,ENSG00000166946,ENSG00000067225,ENSG00000100030,ENSG00000101843,ENSG00000128245,ENSG00000137693,ENSG00000164924,ENSG00000166913","NA"
"Cresemba","Isavuconazonium","ISAVUCONAZONIUM","CHEMBL1183349","Astellas","Azole antifungal","No human target","Antifungal","aspergillosis; mucormycosis","EFO_0007380,EFO_0007157","Serious","P,O","2015","CHEMBL1183349","NA","NA","NA"
"Crysvita","Burosumab","BUROSUMAB","CHEMBL3707326","Ultragenyx Pharmaceutical/Kyowa Hakko Kirin","FGF23 antibody","Other indication","X-linked hypophosphataemia","Hypophosphatemia","HP_0002148","Not serious","P,O,B,F","2018","CHEMBL3707326","ENSG00000118972","ENSG00000077782","NA"
"Cyramza","Ramucirumab","RAMUCIRUMAB","CHEMBL1743062","Eli Lilly","VEGFR2 antagonist","Oncology","Gastric cancer","gastric cancer","MONDO_0001056","Serious","P,O,F","2014","CHEMBL1743062","ENSG00000128052","ENSG00000158092,ENSG00000099250,ENSG00000067225,ENSG00000160691,ENSG00000166923,ENSG00000142192,ENSG00000037280,ENSG00000150630,ENSG00000186432,ENSG00000100097,ENSG00000112715,ENSG00000142798,ENSG00000011201,ENSG00000157193,ENSG00000111679,ENSG00000128052,ENSG00000149177,ENSG00000169495,ENSG00000179776,ENSG00000197122,ENSG00000249915","NA"
"Cytalux","Pafolacianine","Pafolacianine","CHEMBL4297412","On Target Labs","Fluorescent FR imaging agent","Other indication","Ovarian cancer imaging","ovarian carcinoma","EFO_0001075","Serious","P,O,F","2021","CHEMBL4297412","ENSG00000110195","ENSG00000213699","NA"
"Daklinza","Daclatasvir","DACLATASVIR","CHEMBL2023898","Bristol-Myers Squibb","NS5A inhibitor","No human target","HCV","hepatitis C virus infection","EFO_0003047","Serious","P,F","2015","CHEMBL2023898","NA","NA","NA"
"Dalvance","Dalbavancin","DALBAVANCIN","CHEMBL3301669","Durata","Semisynthetic lipoglycopeptide","No human target","ABSSSI (Acute Bacterial Skin and Skin Structure Infections)","staphylococcal skin infections","EFO_1001849","Not serious","P,F","2014","CHEMBL3301669","NA","NA","NA"
"Danyelza","Naxitamab","NAXITAMAB","CHEMBL4297984","Y-mAbs Therapeutics","GD2-directed mAb","NA","High-risk neuroblastoma","neuroblastoma","EFO_0000621","Serious","P,O,B,A","2020","CHEMBL4297984","NA","NA","NA"
"Darzalex","Daratumumab","DARATUMUMAB","CHEMBL1743007","Johnson & Johnson","CD38-directed mAb","Oncology","Multiple myeloma","multiple myeloma","EFO_0001378","Serious","P,O,B,A,F","2015","CHEMBL1743007","ENSG00000004468","NA","MONDO_0004095"
"Daurismo","Glasdegib","GLASDEGIB","CHEMBL2043437","Pfizer","Hedgehog pathway inhibitor","Oncology","AML","acute myeloid leukemia","EFO_0000222","Serious","P,O","2018","CHEMBL2043437","ENSG00000128602","ENSG00000185920,ENSG00000186469","NA"
"Daxxify","DaxibotulinumtoxinA","DaxibotulinumtoxinA","CHEMBL3707359","Revance","Botulinum toxin","Other indication","Glabellar lines","Facial wrinkling","HP_0009762","Not serious","S","2022","CHEMBL3707359","ENSG00000132639","ENSG00000135604,ENSG00000137288,ENSG00000146648,ENSG00000186908,ENSG00000220205,ENSG00000178750,ENSG00000188629,ENSG00000106089,ENSG00000197386,ENSG00000143761,ENSG00000136854,ENSG00000132639,ENSG00000145335,ENSG00000168993,ENSG00000120860","NA"
"Dayvigo","Lemborexant","LEMBOREXANT","CHEMBL3545367","Eisai","Orexin receptor antagonist","Other indication","Insomnia","insomnia","EFO_0004698","Not serious","S","2019","CHEMBL3545367","ENSG00000121764,ENSG00000137252","ENSG00000121853,ENSG00000196262,ENSG00000116678","EFO_0005271,EFO_0008568"
"Defitelio","Defibrotide sodium","DEFIBROTIDESODIUM","CHEMBL3707226","Gentium","Profibrinolytic","Other indication","Hepatic veno-occlusive disease","hepatic veno-occlusive disease","MONDO_0019514","Serious","P,O,F","2016","CHEMBL3707226","ENSG00000122194","ENSG00000091583,ENSG00000106333,ENSG00000152939,ENSG00000122861,ENSG00000107020,ENSG00000113083,ENSG00000142192,ENSG00000273514","MONDO_0002405"
"Diacomit","Stiripentol","STIRIPENTOL","CHEMBL1983350","Biocodex","GABA reuptake inhibitor","Other indication","Dravet syndrome","dravet syndrome","Orphanet_33069","Serious","P,O","2018","CHEMBL1983350","ENSG00000022355","ENSG00000166206,ENSG00000113327","MONDO_0020072"
"Dojolvi","Triheptanoin","TRIHEPTANOIN","CHEMBL4297585","Ultragenyx","Medium-chain triglyceride","No human target","LC-FAODs","inherited fatty acid metabolism disorder","MONDO_0037858","Serious","S,O,F","2020","CHEMBL4297585","NA","NA","NA"
"Doptelet","Avatrombopag","AVATROMBOPAG","CHEMBL2103883","Dova Pharmaceuticals","Thrombopoietin receptor agonist","Other indication","Thrombocytopenia","thrombocytopenia","HP_0001873","Not concordant","P","2018","CHEMBL2103883","ENSG00000117400","ENSG00000096968","NA"
"Dotarem","Gadoterate meglumine","GADOTERATEMEGLUMINE","CHEMBL2219415","Guerbet","Gadolinium-based contrast agent","No human target","Contrast agent to visualize disruption of the blood-brain barrier","NA","NA","NA","P","2013","CHEMBL2219415","NA","NA","NA"
"Duavee","Bazedoxifene acetate, oestrogens","BAZEDOXIFENEACETATE,ESTROGENS,CONJUGATED","CHEMBL2106615,CHEMBL1201649","Pfizer","Conjugated oestrogens with an oestrogen receptor modulator","Other indication","Moderate to Serious vasomotor symptoms associated with menopause and prevention of postmenopausal osteoporosis","menopause; postmenopausal osteoporosis","EFO_0003854,EFO_0003922","Not serious","S","2013","CHEMBL2106615,CHEMBL1201649","ENSG00000091831,ENSG00000140009","ENSG00000063244,ENSG00000077097,ENSG00000100284,ENSG00000100393,ENSG00000100650,ENSG00000106397,ENSG00000106638,ENSG00000108312,ENSG00000118520,ENSG00000129691,ENSG00000131759,ENSG00000135250,ENSG00000137154,ENSG00000140396,ENSG00000142235,ENSG00000143546,ENSG00000145220,ENSG00000145741,ENSG00000147403,ENSG00000147604,ENSG00000150907,ENSG00000162244,ENSG00000167216,ENSG00000167526,ENSG00000167978,ENSG00000174444,ENSG00000186468,ENSG00000186930,ENSG00000189091,ENSG00000197122,ENSG00000231500,ENSG00000005022,ENSG00000011485,ENSG00000072110,ENSG00000077235,ENSG00000084774,ENSG00000089009,ENSG00000095015,ENSG00000102753,ENSG00000105127,ENSG00000105640,ENSG00000107223,ENSG00000108829,ENSG00000110090,ENSG00000110700,ENSG00000111679,ENSG00000122779,ENSG00000123064,ENSG00000133226,ENSG00000135372,ENSG00000135457,ENSG00000135972,ENSG00000139675,ENSG00000140575,ENSG00000141456,ENSG00000143575,ENSG00000143631,ENSG00000143870,ENSG00000148303,ENSG00000155974,ENSG00000156802,ENSG00000163902,ENSG00000165119,ENSG00000167548,ENSG00000168028,ENSG00000169750,ENSG00000170144,ENSG00000172845,ENSG00000178035,ENSG00000180530,ENSG00000187624,ENSG00000188846,ENSG00000197191,ENSG00000198900,ENSG00000215301,ENSG00000001497,ENSG00000054793,ENSG00000063177,ENSG00000070756,ENSG00000088205,ENSG00000091831,ENSG00000100316,ENSG00000101306,ENSG00000102081,ENSG00000114391,ENSG00000115109,ENSG00000116251,ENSG00000119231,ENSG00000123268,ENSG00000130255,ENSG00000130783,ENSG00000134987,ENSG00000147140,ENSG00000147274,ENSG00000150316,ENSG00000151893,ENSG00000153147,ENSG00000158406,ENSG00000164880,ENSG00000164934,ENSG00000165732,ENSG00000178175,ENSG00000178209,ENSG00000182872,ENSG00000183495,ENSG00000185088,ENSG00000196591,ENSG00000196843,ENSG00000197785,ENSG00000213553,ENSG00000241343,ENSG00000278637,ENSG00000008988,ENSG00000012048,ENSG00000100320,ENSG00000100345,ENSG00000102054,ENSG00000104447,ENSG00000111875,ENSG00000114867,ENSG00000115468,ENSG00000118689,ENSG00000125484,ENSG00000125691,ENSG00000125944,ENSG00000132300,ENSG00000132467,ENSG00000135829,ENSG00000138756,ENSG00000140009,ENSG00000140988,ENSG00000142937,ENSG00000146112,ENSG00000153827,ENSG00000155561,ENSG00000158623,ENSG00000164587,ENSG00000165795,ENSG00000166619,ENSG00000167604,ENSG00000170315,ENSG00000170776,ENSG00000172977,ENSG00000184363,ENSG00000189266,ENSG00000196586,ENSG00000203786,ENSG00000239306,ENSG00000029363,ENSG00000052749,ENSG00000054118,ENSG00000061794,ENSG00000065268,ENSG00000096063,ENSG00000104356,ENSG00000105991,ENSG00000124228,ENSG00000125931,ENSG00000133315,ENSG00000134697,ENSG00000141367,ENSG00000143799,ENSG00000147548,ENSG00000160014,ENSG00000161960,ENSG00000163346,ENSG00000174748,ENSG00000175110,ENSG00000184432,ENSG00000205571,ENSG00000275126,ENSG00000276180,ENSG00000084676,ENSG00000100201,ENSG00000102738,ENSG00000109320,ENSG00000109819,ENSG00000115415,ENSG00000124214,ENSG00000130787,ENSG00000135486,ENSG00000136146,ENSG00000137497,ENSG00000156697,ENSG00000160208,ENSG00000171456,ENSG00000197238,ENSG00000197535,ENSG00000197879,ENSG00000198668,ENSG00000247077,ENSG00000072274,ENSG00000091513,ENSG00000100764,ENSG00000101361,ENSG00000105939,ENSG00000109501,ENSG00000109971,ENSG00000112306,ENSG00000116898,ENSG00000126561,ENSG00000128641,ENSG00000130193,ENSG00000142541,ENSG00000143375,ENSG00000151846,ENSG00000156030,ENSG00000161016,ENSG00000166441,ENSG00000166986,ENSG00000172216,ENSG00000173692,ENSG00000178896,ENSG00000182944,ENSG00000185591,ENSG00000187555,ENSG00000270882,ENSG00000273542,ENSG00000042753,ENSG00000113048,ENSG00000115875,ENSG00000117222,ENSG00000118181,ENSG00000118523,ENSG00000123416,ENSG00000125686,ENSG00000130254,ENSG00000131051,ENSG00000135387,ENSG00000148180,ENSG00000149257,ENSG00000149273,ENSG00000183207,ENSG00000196924,ENSG00000197061,ENSG00000197728,ENSG00000198718,ENSG00000276966,ENSG00000026025,ENSG00000042429,ENSG00000075151,ENSG00000092621,ENSG00000105193,ENSG00000105357,ENSG00000108298,ENSG00000109606,ENSG00000127603,ENSG00000131023,ENSG00000131747,ENSG00000138078,ENSG00000160310,ENSG00000163938,ENSG00000165502,ENSG00000172062,ENSG00000239789,ENSG00000070495,ENSG00000092841,ENSG00000099783,ENSG00000110955,ENSG00000118705,ENSG00000122140,ENSG00000132153,ENSG00000132382,ENSG00000135679,ENSG00000143621,ENSG00000146648,ENSG00000173801,ENSG00000181163,ENSG00000186298,ENSG00000187855,ENSG00000196396,ENSG00000197837,ENSG00000274618,ENSG00000277157,ENSG00000280789,ENSG00000074696,ENSG00000082175,ENSG00000112559,ENSG00000116478,ENSG00000130826,ENSG00000135624,ENSG00000136450,ENSG00000138434,ENSG00000143933,ENSG00000148773,ENSG00000166946,ENSG00000173039,ENSG00000198034,ENSG00000265681,ENSG00000270276,ENSG00000278705,ENSG00000089280,ENSG00000107485,ENSG00000107625,ENSG00000161547,ENSG00000188573,ENSG00000197077,ENSG00000197756,ENSG00000087510,ENSG00000100462,ENSG00000108654,ENSG00000137656,ENSG00000140553,ENSG00000142534,ENSG00000145425,ENSG00000159251,ENSG00000176014,ENSG00000188313,ENSG00000215021,ENSG00000087470,ENSG00000089157,ENSG00000107874,ENSG00000107937,ENSG00000115053,ENSG00000124151,ENSG00000145675,ENSG00000171490,ENSG00000198431,ENSG00000075624,ENSG00000108592,ENSG00000134419,ENSG00000148308,ENSG00000169813,ENSG00000170889,ENSG00000128487","NA"
"Dupixent","Dupilumab","DUPILUMAB","CHEMBL2108675","Regeneron/Sanofi","IL-4Ralpha antagonist","Other indication","Atopic dermatitis","atopic eczema","EFO_0000274","Not serious","P,B","2017","CHEMBL2108675","ENSG00000077238","ENSG00000169047,ENSG00000111679,ENSG00000077238,ENSG00000147168,ENSG00000131724,ENSG00000166888,ENSG00000113520","MONDO_0002406,HP_0000964"
"Ebanga","Ansuvimab","ANSUVIMAB","CHEMBL4594388","Ridgeback","Ebola glycoprotein-directed mAb","No human target","Ebola virus","Ebola hemorrhagic fever","EFO_0007243","Serious","P,O,B","2020","CHEMBL4594388","NA","NA","NA"
"Egaten","Triclabendazole","TRICLABENDAZOLE","CHEMBL1086440","Novartis","Anthelmintic","No human target","Fascioliasis","fascioliasis","EFO_1001324","Not concordant","P,O,F","2019","CHEMBL1086440","NA","NA","NA"
"Elahere","Mirvetuximab soravtansine","Mirvetuximabsoravtansine","CHEMBL3545132","ImmunoGen","FR_-targeted antibody-drug conjugate","Oncology","Ovarian cancer","ovarian carcinoma","EFO_0001075","Serious","P,O,A,F","2022","CHEMBL3545132","ENSG00000167552,ENSG00000137285,ENSG00000104833,ENSG00000258947,ENSG00000127824,ENSG00000137267,ENSG00000196230,ENSG00000123416,ENSG00000261456,ENSG00000176014,ENSG00000101162,ENSG00000167553,ENSG00000198033,ENSG00000152086,ENSG00000188229,ENSG00000110195","ENSG00000104427,ENSG00000115484,ENSG00000116106,ENSG00000120438,ENSG00000123349,ENSG00000123358,ENSG00000145555,ENSG00000147601,ENSG00000150753,ENSG00000164924,ENSG00000166046,ENSG00000166170,ENSG00000167900,ENSG00000170801,ENSG00000177674,NA,ENSG00000054523,ENSG00000069345,ENSG00000080824,ENSG00000100603,ENSG00000103423,ENSG00000114416,ENSG00000127824,ENSG00000160181,ENSG00000166135,ENSG00000173020,ENSG00000186868,ENSG00000196504,ENSG00000197386,ENSG00000268606,ENSG00000090520,ENSG00000094631,ENSG00000097033,ENSG00000123609,ENSG00000129559,ENSG00000133112,ENSG00000138794,ENSG00000142168,ENSG00000146731,ENSG00000196730,ENSG00000277586,ENSG00000001626,ENSG00000065361,ENSG00000083799,ENSG00000086061,ENSG00000091831,ENSG00000115514,ENSG00000124214,ENSG00000135624,ENSG00000156475,ENSG00000167552,ENSG00000176148,ENSG00000177954,ENSG00000204843,ENSG00000254999,ENSG00000005893,ENSG00000102119,ENSG00000102977,ENSG00000112208,ENSG00000126581,ENSG00000136319,ENSG00000151849,ENSG00000156261,ENSG00000166226,ENSG00000183305,ENSG00000258947,ENSG00000265763,ENSG00000084774,ENSG00000102003,ENSG00000131697,ENSG00000136997,ENSG00000139517,ENSG00000142192,ENSG00000147676,ENSG00000179218,ENSG00000188906,ENSG00000204463,ENSG00000092330,ENSG00000106211,ENSG00000114904,ENSG00000115317,ENSG00000130779,ENSG00000152359,ENSG00000162946,ENSG00000163468,ENSG00000166091,ENSG00000182168,ENSG00000213699,ENSG00000026025,ENSG00000105993,ENSG00000109501,ENSG00000126934,ENSG00000133124,ENSG00000141837,ENSG00000143256,ENSG00000143575,ENSG00000145335,ENSG00000146648,ENSG00000155959,ENSG00000167553,ENSG00000177606,ENSG00000178127,ENSG00000183386,ENSG00000119689,ENSG00000123416,ENSG00000151414,ENSG00000161011","NA"
"Elucirem","Gadopiclenol","Gadopiclenol","CHEMBL4297634","Guerbet","Gadolinium-based contrast agent","No human target","Lesions with abnormal vascularity","NA","NA","NA","P","2022","CHEMBL4297634","NA","NA","NA"
"Elzonris","Tagraxofusp","TAGRAXOFUSP","CHEMBL4297573","Stemline Therapeutics","IL-3 and diphtheria toxin fusion protein","Oncology","Blastic plasmacytoid dendritic cell neoplasm","blastic plasmacytoid dendritic cell neoplasm","EFO_0010580","Serious","P,O,B","2018","CHEMBL4297573","ENSG00000185291,ENSG00000167658","ENSG00000170545,ENSG00000213203,ENSG00000162946,ENSG00000170027,ENSG00000171135,ENSG00000177885,ENSG00000197386,ENSG00000204070,ENSG00000163217,ENSG00000112062,ENSG00000137819,ENSG00000143379,ENSG00000154229,ENSG00000072506,ENSG00000171840,ENSG00000172375,ENSG00000172977,ENSG00000048540,ENSG00000133678,ENSG00000164007,ENSG00000132406,ENSG00000142227,ENSG00000164983,ENSG00000168899,ENSG00000188906,ENSG00000105677,ENSG00000120742","NA"
"Emflaza","Deflazacort","DEFLAZACORT","CHEMBL1201891","PTC Therapeutics","Corticosteroid","Other indication","Duchenne muscular dystrophy","Duchenne muscular dystrophy","MONDO_0010679","Serious","P,O,F","2017","CHEMBL1201891","ENSG00000113580","ENSG00000010810,ENSG00000189367,ENSG00000080824,ENSG00000146648,ENSG00000142208,ENSG00000144747,ENSG00000204231,ENSG00000168875,ENSG00000168439,ENSG00000125354,ENSG00000175793,ENSG00000182866,ENSG00000204389,ENSG00000204388","NA"
"Emgality","Galcanezumab","GALCANEZUMAB","CHEMBL3707328","Eli Lilly","CGRP antibody","Other indication","Migraine","migraine disorder","MONDO_0005277","Not serious","S,F","2018","CHEMBL3707328","ENSG00000110680,ENSG00000175868","ENSG00000064989,ENSG00000157087,ENSG00000186469,ENSG00000058668,ENSG00000087460,ENSG00000110680,ENSG00000132329,ENSG00000185043,ENSG00000078369,ENSG00000167522","NA"
"Empaveli","Pegcetacoplan","Pegcetacoplan","CHEMBL4298211","Apellis","Complement protein C3 inhibitor","Other indication","PNH","paroxysmal nocturnal hemoglobinuria","MONDO_0100244","Serious","P,O,F","2021","CHEMBL4298211","ENSG00000125730","ENSG00000000971,ENSG00000117322,ENSG00000117335,ENSG00000163661,ENSG00000187908,ENSG00000205403,ENSG00000243649,ENSG00000172638,ENSG00000197978,ENSG00000106541,ENSG00000155659,ENSG00000125730,ENSG00000134365,ENSG00000187766,ENSG00000203710,ENSG00000244414,ENSG00000080910,ENSG00000094796,ENSG00000175895,ENSG00000177706","NA"
"Empliciti","Elotuzumab","ELOTUZUMAB","CHEMBL1743010","Bristol-Myers Squibb","SLAMF7-directed mAb","Oncology","Multiple myeloma","multiple myeloma","EFO_0001378","Serious","P,O,B","2015","CHEMBL1743010","ENSG00000026751","ENSG00000026751,ENSG00000198574,ENSG00000183918","MONDO_0004095"
"Enhertu","Trastuzumab deruxtecan","TRASTUZUMABDERUXTECAN","CHEMBL4297844","Daiichi Sankyo/AstraZeneca","HER2-directed ADC","Oncology","HER2-positive breast cancer","HER2 Positive Breast Carcinoma","EFO_1000294","Serious","P,B,A,F","2019","CHEMBL4297844","ENSG00000141736,ENSG00000198900","ENSG00000075415,ENSG00000080824,ENSG00000081237,ENSG00000086061,ENSG00000101082,ENSG00000115053,ENSG00000115325,ENSG00000116161,ENSG00000116285,ENSG00000122707,ENSG00000123983,ENSG00000125944,ENSG00000127022,ENSG00000138095,ENSG00000147140,ENSG00000153201,ENSG00000160691,ENSG00000162434,ENSG00000067225,ENSG00000087266,ENSG00000121653,ENSG00000122566,ENSG00000129946,ENSG00000134215,ENSG00000134242,ENSG00000143799,ENSG00000144724,ENSG00000169047,ENSG00000174791,ENSG00000178568,ENSG00000179295,ENSG00000185046,ENSG00000000938,ENSG00000008735,ENSG00000100351,ENSG00000102189,ENSG00000105197,ENSG00000106278,ENSG00000109111,ENSG00000112473,ENSG00000130193,ENSG00000144028,ENSG00000153233,ENSG00000187837,ENSG00000189043,ENSG00000007264,ENSG00000014257,ENSG00000015285,ENSG00000069345,ENSG00000071051,ENSG00000072135,ENSG00000082898,ENSG00000085832,ENSG00000090776,ENSG00000094631,ENSG00000105401,ENSG00000113108,ENSG00000116560,ENSG00000127329,ENSG00000133124,ENSG00000135829,ENSG00000136205,ENSG00000136450,ENSG00000136573,ENSG00000148082,ENSG00000151422,ENSG00000151490,ENSG00000153187,ENSG00000162692,ENSG00000168439,ENSG00000168610,ENSG00000169398,ENSG00000174231,ENSG00000189410,ENSG00000197122,ENSG00000253729,ENSG00000010810,ENSG00000068654,ENSG00000070159,ENSG00000072274,ENSG00000096063,ENSG00000096384,ENSG00000105701,ENSG00000111077,ENSG00000114737,ENSG00000117461,ENSG00000143322,ENSG00000145675,ENSG00000145715,ENSG00000146648,ENSG00000160999,ENSG00000163399,ENSG00000165025,ENSG00000167193,ENSG00000173406,ENSG00000058262,ENSG00000064999,ENSG00000065361,ENSG00000100201,ENSG00000100938,ENSG00000101213,ENSG00000102010,ENSG00000105647,ENSG00000108424,ENSG00000125170,ENSG00000125731,ENSG00000127947,ENSG00000131747,ENSG00000131876,ENSG00000132669,ENSG00000133056,ENSG00000135486,ENSG00000135605,ENSG00000149177,ENSG00000155926,ENSG00000157168,ENSG00000165119,ENSG00000165629,ENSG00000167034,ENSG00000177885,ENSG00000197785,ENSG00000197943,ENSG00000198574,ENSG00000066044,ENSG00000091831,ENSG00000092199,ENSG00000099942,ENSG00000101558,ENSG00000111252,ENSG00000113263,ENSG00000124181,ENSG00000136997,ENSG00000140575,ENSG00000141736,ENSG00000152894,ENSG00000160293,ENSG00000185338,ENSG00000206052,ENSG00000027869,ENSG00000044574,ENSG00000074966,ENSG00000075336,ENSG00000075624,ENSG00000095585,ENSG00000097007,ENSG00000109684,ENSG00000111640,ENSG00000113648,ENSG00000115415,ENSG00000124164,ENSG00000128656,ENSG00000137076,ENSG00000137936,ENSG00000141738,ENSG00000141968,ENSG00000144749,ENSG00000165732,ENSG00000181163,ENSG00000166313","NA"
"Enjaymo","Sutimlimab","Sutimlimab","CHEMBL4297832","Bioverativ","C1s-targeted mAb","Other indication","RBC transfusion due to haemolysis in CAD (cold agglutinin disease)","Anemia, Hemolytic, Autoimmune","EFO_1001264","Serious","P,O,B","2022","CHEMBL4297832","ENSG00000182326","ENSG00000149131,ENSG00000168476,ENSG00000107175,ENSG00000159403,ENSG00000166278,ENSG00000182326","NA"
"Enspryng","Satralizumab","SATRALIZUMAB","CHEMBL3833307","Roche/Genentech","IL-6R-directed mAb","Other indication","NMOSD","neuromyelitis optica","EFO_0004256","Serious","S,O,B,F","2020","CHEMBL3833307","ENSG00000134352,ENSG00000160712","ENSG00000115041,ENSG00000242689,ENSG00000099985,ENSG00000137642,ENSG00000182132,ENSG00000197860,ENSG00000128342,ENSG00000162434,ENSG00000185247,ENSG00000104969,ENSG00000136244,ENSG00000110801,ENSG00000135018","MONDO_0000568"
"Entresto","Sacubitril, valsartan","SACUBITRIL,VALSARTAN","CHEMBL3137301,CHEMBL1069","Novartis","A neprilysin inhibitor plus an angiotensin II receptor blocker","Other indication","Chronic heart failure","congestive heart failure","EFO_0000373","Serious","P,F","2015","CHEMBL3137301,CHEMBL1069","ENSG00000196549,ENSG00000144891","ENSG00000102081,ENSG00000106211,ENSG00000126698,ENSG00000139053,ENSG00000165637,ENSG00000204389,ENSG00000010278,ENSG00000104904,ENSG00000134817,ENSG00000142002,ENSG00000142192,ENSG00000143153,ENSG00000172292,ENSG00000176746,ENSG00000204388","NA"
"Entyvio","Vedolizumab","VEDOLIZUMAB","CHEMBL1743087","Takeda","Integrin-receptor antagonist","Other indication","Ulcerative colitis and Crohn's disease","ulcerative colitis; Crohn's disease","EFO_0000384,EFO_0000729","Serious","P,F","2014","CHEMBL1743087","ENSG00000115232,ENSG00000139626","ENSG00000115414,ENSG00000144366,ENSG00000111077,ENSG00000150093,ENSG00000159788,ENSG00000254087,ENSG00000121653,ENSG00000162692,ENSG00000185046,ENSG00000011454,ENSG00000136754,ENSG00000151491,ENSG00000139626,ENSG00000196924,ENSG00000089159,ENSG00000115232","NA"
"Epclusa","Sofosbuvir, velpatasvir","SOFOSBUVIR,VELPATASVIR","CHEMBL1259059,CHEMBL3545062","Gilead Sciences","A nucleotide analogue NS5B polymerase inhibitor plus an HCV NS5A inhibitor","No human target","genotype 1, 2, 3 or 4 chronic hepatitis C virus (HCV)","hepatitis C virus infection","EFO_0003047","Serious","P,B,F","2016","CHEMBL1259059,CHEMBL3545062","NA","NA","NA"
"Epidiolex","Cannabidiol","CANNABIDIOL","CHEMBL190461","GW Pharmaceuticals","Cannabinoid","Other indication","Dravet syndrome and Lennox-Gastaut syndrome","Dravet syndrome; Lennox-Gastaut syndrome","MONDO_0016532,Orphanet_33069","Serious","P,O,F","2018","CHEMBL190461","ENSG00000118432","ENSG00000102468,ENSG00000118432,ENSG00000149295,ENSG00000128271,ENSG00000188822","MONDO_0020072"
"Erleada","Apalutamide","APALUTAMIDE","CHEMBL3183409","Johnson & Johnson","Androgen receptor inhibitor","Oncology","Prostate cancer","prostate cancer","MONDO_0008315","Serious","P,F","2018","CHEMBL3183409","ENSG00000169083","ENSG00000000938,ENSG00000012817,ENSG00000013561,ENSG00000110092,ENSG00000117450,ENSG00000125686,ENSG00000132437,ENSG00000145675,ENSG00000163565,ENSG00000164190,ENSG00000167548,ENSG00000168036,ENSG00000169291,ENSG00000176105,ENSG00000183918,ENSG00000197122,ENSG00000198646,ENSG00000010671,ENSG00000035720,ENSG00000107338,ENSG00000131746,ENSG00000134954,ENSG00000140396,ENSG00000185634,ENSG00000196684,ENSG00000197943,ENSG00000254087,ENSG00000079308,ENSG00000095585,ENSG00000115641,ENSG00000116030,ENSG00000124151,ENSG00000130522,ENSG00000136826,ENSG00000141867,ENSG00000160293,ENSG00000165025,ENSG00000165458,ENSG00000170365,ENSG00000171988,ENSG00000177885,ENSG00000178028,ENSG00000179295,ENSG00000182866,ENSG00000184557,ENSG00000100351,ENSG00000101213,ENSG00000106462,ENSG00000136504,ENSG00000141027,ENSG00000145715,ENSG00000157554,ENSG00000160691,ENSG00000169083,ENSG00000097007,ENSG00000101336,ENSG00000109685,ENSG00000111837,ENSG00000116288,ENSG00000141738,ENSG00000141968,ENSG00000148180,ENSG00000167193,ENSG00000184634,ENSG00000253729,ENSG00000266412,ENSG00000005339,ENSG00000084676,ENSG00000089280,ENSG00000118058,ENSG00000129514,ENSG00000129691,ENSG00000159388,ENSG00000170677,ENSG00000178585,ENSG00000004478,ENSG00000007264,ENSG00000068024,ENSG00000095370,ENSG00000124181,ENSG00000134215,ENSG00000160973,ENSG00000170734,ENSG00000182511,ENSG00000198574,ENSG00000204209,ENSG00000027869,ENSG00000105647,ENSG00000117461,ENSG00000136573,ENSG00000142515,ENSG00000143322,ENSG00000148082,ENSG00000172977,ENSG00000175215,ENSG00000196363,ENSG00000127870","NA"
"Esbriet","Pirfenidone","PIRFENIDONE","CHEMBL1256391","InterMune","MOA unknown","No human target","IPF (idiopathic pulmonary fibrosis)","idiopathic pulmonary fibrosis","EFO_0000768","Serious","P,O,B,F","2014","CHEMBL1256391","NA","NA","NA"
"Eucrisa","Crisaborole","CRISABOROLE","CHEMBL484785","Pfizer/Anacor Pharmaceuticals","PDE4 inhibitor","Other indication","Atopic dermatitis","atopic eczema","EFO_0000274","Not serious","S","2016","CHEMBL484785","ENSG00000184588,ENSG00000105650,ENSG00000065989,ENSG00000113448","NA,ENSG00000005102,ENSG00000075142,ENSG00000114395,ENSG00000138794,ENSG00000145358,ENSG00000213809,ENSG00000123240,ENSG00000175676,ENSG00000171509,ENSG00000097033,ENSG00000121058,ENSG00000153684,ENSG00000158571,ENSG00000005893,ENSG00000106511,ENSG00000140961,ENSG00000007372,ENSG00000056558,ENSG00000141480,ENSG00000186908,ENSG00000063515,ENSG00000169548,ENSG00000183629,ENSG00000196504,ENSG00000197172","MONDO_0002406,HP_0000964"
"Evenity","Romosozumab","ROMOSOZUMAB","CHEMBL2107874","Amgen","Sclerostin inhibitor","Other indication","Osteoporosis","osteoporosis","EFO_0003882","Not serious","S","2019","CHEMBL2107874","ENSG00000167941","ENSG00000134569,ENSG00000162337,ENSG00000175895,ENSG00000070018","NA"
"Evkeeza","Evinacumab","Evinacumab","CHEMBL3545191","Regeneron","ANGPTL3-targeted mAb","Other indication","HoFH","homozygous familial hypercholesterolemia","MONDO_0018328","Serious","P,O,B","2021","CHEMBL3545191","ENSG00000132855","ENSG00000175445","EFO_0004611"
"Evrysdi","Risdiplam","RISDIPLAM","CHEMBL4297528","Roche/Genentech","SMN2 splicing modifier","Other indication","Spinal muscular atrophy","spinal muscular atrophy","EFO_0008525","Serious","P,O,F","2020","CHEMBL4297528","ENSG00000205571","ENSG00000113790,ENSG00000123892,ENSG00000125531,ENSG00000126945,ENSG00000171055,ENSG00000183640,ENSG00000186925,ENSG00000204410,ENSG00000064703,ENSG00000079805,ENSG00000109534,ENSG00000112578,ENSG00000138398,ENSG00000142252,ENSG00000149089,ENSG00000160679,ENSG00000163517,ENSG00000172336,ENSG00000179409,ENSG00000185386,ENSG00000186930,ENSG00000186977,ENSG00000205302,ENSG00000125835,ENSG00000160948,ENSG00000179222,ENSG00000186451,ENSG00000187191,ENSG00000092208,ENSG00000102471,ENSG00000104381,ENSG00000105202,ENSG00000108424,ENSG00000108590,ENSG00000132591,ENSG00000137463,ENSG00000143889,ENSG00000152147,ENSG00000167037,ENSG00000177138,ENSG00000180098,ENSG00000181222,ENSG00000010810,ENSG00000033800,ENSG00000087365,ENSG00000089280,ENSG00000100462,ENSG00000134996,ENSG00000139343,ENSG00000140009,ENSG00000144711,ENSG00000175899,ENSG00000197386,ENSG00000197442,ENSG00000240432,ENSG00000244362,ENSG00000082516,ENSG00000099956,ENSG00000105323,ENSG00000109103,ENSG00000121058,ENSG00000136379,ENSG00000169057,ENSG00000176108,ENSG00000176302,ENSG00000182004,ENSG00000100138,ENSG00000101888,ENSG00000102048,ENSG00000104164,ENSG00000104852,ENSG00000115317,ENSG00000132382,ENSG00000134046,ENSG00000158710,ENSG00000164675,ENSG00000167088,ENSG00000171453,ENSG00000172062,ENSG00000184351,ENSG00000184724,ENSG00000187026,ENSG00000268988,ENSG00000023734,ENSG00000046647,ENSG00000107290,ENSG00000116918,ENSG00000141499,ENSG00000143977,ENSG00000151923,ENSG00000164404,ENSG00000176105,ENSG00000185246,ENSG00000198353,ENSG00000198513,ENSG00000205571,ENSG00000125743,ENSG00000168090","NA"
"ExEm Foam","Air polymer-type A","AIRPOLYMER-TYPEA","CHEMBL4594264","Giskit","Ultrasound contrast agent","No human target","Assess fallopian tube patency in women with known or suspected infertility","infertility","EFO_0000545","Not serious","S","2019","CHEMBL4594264","NA","NA","NA"
"Exkivity","Mobocertinib","Mobocertinib","CHEMBL4650319","Takeda","EGFR kinase inhibitor","Oncology","EGFR exon 20-mutated NSCLC","non-small cell lung carcinoma","EFO_0003060","Serious","P,O,B,A,F","2021","CHEMBL4650319","ENSG00000146648","ENSG00000008735,ENSG00000012061,ENSG00000043462,ENSG00000061273,ENSG00000067606,ENSG00000069345,ENSG00000081237,ENSG00000090520,ENSG00000100170,ENSG00000100591,ENSG00000104341,ENSG00000104756,ENSG00000104904,ENSG00000106211,ENSG00000107317,ENSG00000110395,ENSG00000110651,ENSG00000113070,ENSG00000115085,ENSG00000115415,ENSG00000120053,ENSG00000124942,ENSG00000126561,ENSG00000127329,ENSG00000130340,ENSG00000131016,ENSG00000134308,ENSG00000136573,ENSG00000138363,ENSG00000142669,ENSG00000143322,ENSG00000143933,ENSG00000151491,ENSG00000160014,ENSG00000162704,ENSG00000163235,ENSG00000182636,ENSG00000182718,ENSG00000183918,ENSG00000198909,ENSG00000000938,ENSG00000006125,ENSG00000058262,ENSG00000064999,ENSG00000091831,ENSG00000096384,ENSG00000100614,ENSG00000103876,ENSG00000107643,ENSG00000111816,ENSG00000115145,ENSG00000115540,ENSG00000116254,ENSG00000117152,ENSG00000117461,ENSG00000124207,ENSG00000133124,ENSG00000135506,ENSG00000135823,ENSG00000136205,ENSG00000137267,ENSG00000140575,ENSG00000141198,ENSG00000146648,ENSG00000154556,ENSG00000157500,ENSG00000158092,ENSG00000160255,ENSG00000166313,ENSG00000168036,ENSG00000171132,ENSG00000174791,ENSG00000182473,ENSG00000186868,ENSG00000196961,ENSG00000197943,ENSG00000204388,ENSG00000213658,ENSG00000214193,ENSG00000004478,ENSG00000008056,ENSG00000044115,ENSG00000044574,ENSG00000071537,ENSG00000080031,ENSG00000096060,ENSG00000096968,ENSG00000100324,ENSG00000102606,ENSG00000105245,ENSG00000105976,ENSG00000113013,ENSG00000113580,ENSG00000114805,ENSG00000118363,ENSG00000121653,ENSG00000125731,ENSG00000126088,ENSG00000126581,ENSG00000132669,ENSG00000133961,ENSG00000135046,ENSG00000137463,ENSG00000142208,ENSG00000145016,ENSG00000145335,ENSG00000147010,ENSG00000148053,ENSG00000148082,ENSG00000149177,ENSG00000154277,ENSG00000154710,ENSG00000159352,ENSG00000161203,ENSG00000169375,ENSG00000170312,ENSG00000182511,ENSG00000184557,ENSG00000185046,ENSG00000185483,ENSG00000185634,ENSG00000186834,ENSG00000197122,ENSG00000198561,ENSG00000206052,ENSG00000014641,ENSG00000042753,ENSG00000071051,ENSG00000075415,ENSG00000101182,ENSG00000102189,ENSG00000103653,ENSG00000109321,ENSG00000109684,ENSG00000109971,ENSG00000110011,ENSG00000111252,ENSG00000111679,ENSG00000113263,ENSG00000115325,ENSG00000127191,ENSG00000129946,ENSG00000141480,ENSG00000141655,ENSG00000142949,ENSG00000144749,ENSG00000149428,ENSG00000168003,ENSG00000169047,ENSG00000170248,ENSG00000170293,ENSG00000172757,ENSG00000178568,ENSG00000183020,ENSG00000184524,ENSG00000196154,ENSG00000198668,ENSG00000015479,ENSG00000027869,ENSG00000046653,ENSG00000057294,ENSG00000067992,ENSG00000072135,ENSG00000077232,ENSG00000092820,ENSG00000097007,ENSG00000101336,ENSG00000103266,ENSG00000105974,ENSG00000106299,ENSG00000107295,ENSG00000110711,ENSG00000111640,ENSG00000114737,ENSG00000124882,ENSG00000127824,ENSG00000134242,ENSG00000134853,ENSG00000135052,ENSG00000137076,ENSG00000137486,ENSG00000140600,ENSG00000141736,ENSG00000142627,ENSG00000143294,ENSG00000149925,ENSG00000155926,ENSG00000165025,ENSG00000165731,ENSG00000167601,ENSG00000169045,ENSG00000169398,ENSG00000174808,ENSG00000198853,ENSG00000204389,ENSG00000033327,ENSG00000034713,ENSG00000065361,ENSG00000067182,ENSG00000087586,ENSG00000099942,ENSG00000100280,ENSG00000101082,ENSG00000101213,ENSG00000101558,ENSG00000105971,ENSG00000106070,ENSG00000109458,ENSG00000117450,ENSG00000120694,ENSG00000131746,ENSG00000132155,ENSG00000150403,ENSG00000151834,ENSG00000153707,ENSG00000154237,ENSG00000159176,ENSG00000163697,ENSG00000164615,ENSG00000165527,ENSG00000167552,ENSG00000170606,ENSG00000177885,ENSG00000179295,ENSG00000184575,ENSG00000185499,ENSG00000185896,ENSG00000188191,ENSG00000189043,ENSG00000198799,ENSG00000254087,ENSG00000269335,ENSG00000011132,ENSG00000011485,ENSG00000050748,ENSG00000094631,ENSG00000095370,ENSG00000101134,ENSG00000102309,ENSG00000104814,ENSG00000105401,ENSG00000105613,ENSG00000116285,ENSG00000123384,ENSG00000124181,ENSG00000125170,ENSG00000127947,ENSG00000130402,ENSG00000131558,ENSG00000132970,ENSG00000138798,ENSG00000140009,ENSG00000141968,ENSG00000142192,ENSG00000144554,ENSG00000144724,ENSG00000145675,ENSG00000145715,ENSG00000149269,ENSG00000159228,ENSG00000162591,ENSG00000166598,ENSG00000168610,ENSG00000170581,ENSG00000173801,ENSG00000174437,ENSG00000175203,ENSG00000175866,ENSG00000178078,ENSG00000178188,ENSG00000184144,ENSG00000185359,ENSG00000197102,ENSG00000198399,ENSG00000204305,ENSG00000240972,ENSG00000253729,ENSG00000067225,ENSG00000069869,ENSG00000080824,ENSG00000085063,ENSG00000085733,ENSG00000088930,ENSG00000092758,ENSG00000100351,ENSG00000100485,ENSG00000102010,ENSG00000105647,ENSG00000105701,ENSG00000107263,ENSG00000111669,ENSG00000113108,ENSG00000115904,ENSG00000123908,ENSG00000130558,ENSG00000130706,ENSG00000131171,ENSG00000132639,ENSG00000132670,ENSG00000136810,ENSG00000137193,ENSG00000137462,ENSG00000138698,ENSG00000139625,ENSG00000146674,ENSG00000148180,ENSG00000154127,ENSG00000154229,ENSG00000157168,ENSG00000158402,ENSG00000160691,ENSG00000164924,ENSG00000166913,ENSG00000167193,ENSG00000168439,ENSG00000169139,ENSG00000170677,ENSG00000173020,ENSG00000175793,ENSG00000176105,ENSG00000177666,ENSG00000182585,ENSG00000196396,ENSG00000250722,ENSG00000254772,ENSG00000039068,ENSG00000105649,ENSG00000133056,ENSG00000136235","NA"
"Exondys 51","Eteplirsen","ETEPLIRSEN","CHEMBL2108278","Sarepta Therapeutics","ASO designed to target dystrophin pre-mRNA","Other indication","Duchenne muscular dystrophy","Duchenne muscular dystrophy","MONDO_0010679","Serious","P,O,A,F","2016","CHEMBL2108278","ENSG00000198947","ENSG00000152240,ENSG00000171345,ENSG00000101400,ENSG00000168807,ENSG00000171873,ENSG00000119326,ENSG00000138101,ENSG00000173402,ENSG00000187555,ENSG00000101076,ENSG00000171621,ENSG00000134769,ENSG00000172164,ENSG00000100151","NA"
"Farxiga","Dapagliflozin","DAPAGLIFLOZIN","CHEMBL429910","AstraZeneca","SGLT2 inhibitor","Other indication","Type 2 diabetes","type 2 diabetes mellitus","MONDO_0005148","Not concordant","S,F","2014","CHEMBL429910","ENSG00000140675","NA","Orphanet_79161,HP_0003076"
"Farydak","Panobinostat","PANOBINOSTAT","CHEMBL483254","Novartis","Histone deacetylase inhibitor","Oncology","Multiple myeloma","multiple myeloma","EFO_0001378","Serious","P,O,A","2015","CHEMBL483254","ENSG00000061273,ENSG00000116478,ENSG00000196591,ENSG00000171720,ENSG00000068024,ENSG00000163517,ENSG00000094631,ENSG00000108840,ENSG00000100429,ENSG00000048052,ENSG00000147099","ENSG00000031691,ENSG00000057935,ENSG00000101457,ENSG00000103202,ENSG00000103254,ENSG00000107485,ENSG00000109089,ENSG00000110092,ENSG00000113068,ENSG00000114107,ENSG00000115484,ENSG00000117475,ENSG00000124496,ENSG00000124782,ENSG00000128340,ENSG00000128596,ENSG00000132005,ENSG00000135365,ENSG00000137404,ENSG00000140382,ENSG00000141644,ENSG00000142599,ENSG00000147223,ENSG00000150459,ENSG00000155959,ENSG00000157259,ENSG00000158406,ENSG00000158636,ENSG00000164916,ENSG00000169083,ENSG00000169744,ENSG00000172534,ENSG00000174744,ENSG00000176903,ENSG00000178691,ENSG00000180530,ENSG00000196591,ENSG00000197978,ENSG00000268606,ENSG00000276180,ENSG00000053702,ENSG00000070831,ENSG00000083799,ENSG00000086061,ENSG00000089902,ENSG00000091831,ENSG00000100151,ENSG00000100697,ENSG00000100916,ENSG00000101266,ENSG00000105556,ENSG00000123240,ENSG00000134046,ENSG00000135624,ENSG00000135951,ENSG00000137575,ENSG00000138100,ENSG00000149480,ENSG00000153046,ENSG00000159363,ENSG00000162521,ENSG00000166716,ENSG00000167491,ENSG00000167604,ENSG00000169554,ENSG00000170234,ENSG00000182095,ENSG00000185658,ENSG00000185963,ENSG00000197061,ENSG00000197837,ENSG00000215193,ENSG00000274618,ENSG00000007062,ENSG00000011243,ENSG00000064703,ENSG00000101255,ENSG00000101412,ENSG00000103275,ENSG00000108953,ENSG00000111328,ENSG00000111707,ENSG00000116288,ENSG00000117155,ENSG00000123349,ENSG00000127152,ENSG00000127511,ENSG00000131737,ENSG00000132522,ENSG00000133818,ENSG00000135249,ENSG00000136436,ENSG00000139687,ENSG00000146731,ENSG00000158773,ENSG00000163848,ENSG00000164105,ENSG00000164576,ENSG00000169375,ENSG00000171360,ENSG00000171720,ENSG00000172216,ENSG00000172380,ENSG00000173039,ENSG00000173805,ENSG00000178951,ENSG00000181449,ENSG00000184619,ENSG00000185591,ENSG00000186432,ENSG00000197238,ENSG00000198176,ENSG00000198681,ENSG00000205571,ENSG00000213999,ENSG00000074266,ENSG00000102144,ENSG00000104964,ENSG00000109320,ENSG00000109906,ENSG00000124216,ENSG00000135363,ENSG00000143614,ENSG00000147130,ENSG00000148400,ENSG00000149639,ENSG00000149923,ENSG00000156374,ENSG00000160972,ENSG00000162924,ENSG00000167110,ENSG00000170027,ENSG00000171446,ENSG00000172062,ENSG00000179409,ENSG00000180357,ENSG00000181090,ENSG00000185345,ENSG00000196747,ENSG00000197079,ENSG00000197386,ENSG00000198795,ENSG00000278677,ENSG00000020633,ENSG00000065361,ENSG00000068903,ENSG00000081189,ENSG00000101945,ENSG00000105287,ENSG00000106511,ENSG00000109099,ENSG00000122042,ENSG00000128245,ENSG00000129654,ENSG00000129911,ENSG00000130816,ENSG00000131910,ENSG00000139146,ENSG00000141736,ENSG00000141741,ENSG00000145358,ENSG00000146648,ENSG00000146809,ENSG00000150347,ENSG00000150753,ENSG00000151612,ENSG00000156030,ENSG00000157500,ENSG00000163618,ENSG00000163697,ENSG00000164283,ENSG00000166226,ENSG00000166851,ENSG00000166913,ENSG00000168036,ENSG00000169016,ENSG00000170788,ENSG00000179348,ENSG00000183305,ENSG00000183323,ENSG00000196363,ENSG00000196498,ENSG00000196535,ENSG00000204843,ENSG00000276966,ENSG00000278637,ENSG00000005436,ENSG00000073614,ENSG00000085733,ENSG00000100201,ENSG00000121741,ENSG00000125630,ENSG00000131738,ENSG00000136238,ENSG00000136715,ENSG00000136997,ENSG00000137478,ENSG00000141027,ENSG00000156261,ENSG00000159692,ENSG00000162390,ENSG00000164331,ENSG00000166946,ENSG00000167771,ENSG00000168556,ENSG00000172638,ENSG00000174197,ENSG00000175793,ENSG00000177565,ENSG00000178568,ENSG00000181163,ENSG00000183092,ENSG00000183690,ENSG00000196388,ENSG00000196700,ENSG00000196787,ENSG00000204209,ENSG00000204220,ENSG00000204889,ENSG00000205643,ENSG00000213523,ENSG00000270276,ENSG00000066185,ENSG00000066427,ENSG00000068305,ENSG00000101040,ENSG00000101126,ENSG00000102054,ENSG00000113916,ENSG00000116478,ENSG00000129195,ENSG00000137055,ENSG00000138738,ENSG00000139083,ENSG00000141510,ENSG00000141526,ENSG00000142182,ENSG00000143256,ENSG00000143390,ENSG00000145335,ENSG00000150991,ENSG00000164924,ENSG00000169750,ENSG00000173020,ENSG00000181472,ENSG00000182195,ENSG00000198160,ENSG00000204713,ENSG00000223501,ENSG00000266074,ENSG00000273542,ENSG00000275221,ENSG00000276903,ENSG00000278705,ENSG00000288547,ENSG00000054267,ENSG00000066739,ENSG00000068024,ENSG00000068400,ENSG00000071655,ENSG00000080561,ENSG00000094796,ENSG00000095066,ENSG00000100395,ENSG00000101493,ENSG00000101849,ENSG00000105127,ENSG00000108654,ENSG00000108840,ENSG00000109118,ENSG00000117625,ENSG00000120438,ENSG00000125457,ENSG00000131149,ENSG00000134308,ENSG00000134686,ENSG00000140743,ENSG00000143321,ENSG00000143373,ENSG00000155330,ENSG00000159086,ENSG00000160207,ENSG00000162676,ENSG00000163468,ENSG00000167552,ENSG00000170004,ENSG00000172936,ENSG00000182979,ENSG00000186628,ENSG00000196843,ENSG00000197114,ENSG00000204371,ENSG00000270882,ENSG00000275126,ENSG00000277157,ENSG00000004487,ENSG00000064961,ENSG00000100109,ENSG00000111642,ENSG00000120948,ENSG00000132938,ENSG00000157933,ENSG00000162367,ENSG00000167967,ENSG00000171940","MONDO_0004095"
"Fasenra","Benralizumab","BENRALIZUMAB","CHEMBL1742991","AstraZeneca","IL-5Ralpha-directed monoclonal antibody","Other indication","Serious asthma","Status Asthmaticus","EFO_0008590","Serious","S","2017","CHEMBL1742991","ENSG00000091181","ENSG00000100368,ENSG00000113525,ENSG00000137575,ENSG00000096968","MONDO_0004979"
"Fetroja","Cefiderocol","CEFIDEROCOL","CHEMBL3989974","Shionogi","Cephalosporin antibacterial","No human target","Complicated urinary tract infections","urinary tract infection","EFO_0003103","Not serious","P,F","2019","CHEMBL3989974","NA","NA","NA"
"Fexinidazole","Fexinidazole","Fexinidazole","CHEMBL1631694","Sanofi/DNDi","Nitroimidazole antimicrobial","No human target","Sleeping sickness","NA","NA","NA","P,O","2021","CHEMBL1631694","NA","NA","NA"
"Firdapse","Amifampridine","AMIFAMPRIDINE","CHEMBL354077","Catalyst Pharmaceuticals","Potassium channel blocker","Other indication","Lambert-Eaton myasthenic syndrome","Lambert-Eaton myasthenic syndrome","Orphanet_43393","Serious","P,O","2018","CHEMBL354077","ENSG00000182255,ENSG00000130037,ENSG00000182674,ENSG00000177272,ENSG00000143105,ENSG00000151079,ENSG00000111262,ENSG00000104848,ENSG00000184611,ENSG00000102057,ENSG00000124134,ENSG00000166006,ENSG00000158445,ENSG00000117013,ENSG00000075043,ENSG00000184156,ENSG00000185760,ENSG00000170745,ENSG00000026559,ENSG00000171126,ENSG00000183960,ENSG00000168418,ENSG00000140015,ENSG00000131398,ENSG00000178342,ENSG00000173826,ENSG00000162975,ENSG00000171385,ENSG00000184408,ENSG00000135519,ENSG00000177301,ENSG00000164794,ENSG00000143473,ENSG00000129159,ENSG00000116396,ENSG00000053918,ENSG00000168263,ENSG00000156486,ENSG00000055118,ENSG00000089558","ENSG00000077522,ENSG00000107882,ENSG00000175283,NA,ENSG00000111262,ENSG00000130066,ENSG00000134049,ENSG00000137210,ENSG00000143384,ENSG00000175514,ENSG00000179029,ENSG00000182132,ENSG00000187555,ENSG00000196937,ENSG00000112038,ENSG00000137575,ENSG00000171517,ENSG00000176105,ENSG00000179593,ENSG00000186318,ENSG00000120742,ENSG00000156795,ENSG00000164615,ENSG00000172005,ENSG00000180509,ENSG00000104969,ENSG00000120049,ENSG00000128335,ENSG00000139644,ENSG00000145982,ENSG00000171703,ENSG00000206560,ENSG00000049656,ENSG00000100300,ENSG00000147378,ENSG00000198668,ENSG00000215251,ENSG00000055118,ENSG00000112473,ENSG00000115687,ENSG00000126251,ENSG00000126391,ENSG00000143105,ENSG00000160014,ENSG00000197191,ENSG00000286219,ENSG00000105974,ENSG00000132535,ENSG00000137693,ENSG00000143933,ENSG00000151117,ENSG00000171135,ENSG00000177272","NA"
"Flortaucipir F-18","Flortaucipir F-18","FLORTAUCIPIRF-18","CHEMBL3545253","Eli Lilly","Radioactive diagnostic","Other indication","Imaging, tau in Alzheimer disease","Alzheimer disease","MONDO_0004975","Serious","P","2020","CHEMBL3545253","ENSG00000186868","ENSG00000006659,ENSG00000103266,ENSG00000109971,ENSG00000143933,ENSG00000198668,ENSG00000096060,ENSG00000124214,ENSG00000136367,ENSG00000175166,ENSG00000185624,ENSG00000197122,ENSG00000204389,ENSG00000134308,ENSG00000136059,ENSG00000153944,ENSG00000175793,ENSG00000177189,ENSG00000186868,ENSG00000188906,ENSG00000204843,ENSG00000072518,ENSG00000110367,ENSG00000110436,ENSG00000115687,ENSG00000134516,ENSG00000165732,ENSG00000170027,ENSG00000182718,ENSG00000185345,ENSG00000275700,ENSG00000108953,ENSG00000136717,ENSG00000142192,ENSG00000164924,ENSG00000167552,ENSG00000175203,ENSG00000075624,ENSG00000100784,ENSG00000117676,ENSG00000118515,ENSG00000135097,ENSG00000146648,ENSG00000166033,ENSG00000171867,ENSG00000229359,ENSG00000084764,ENSG00000096384,ENSG00000130203,ENSG00000142208,ENSG00000142330,ENSG00000145335,ENSG00000004478,ENSG00000010810,ENSG00000082701,ENSG00000105723,ENSG00000108443,ENSG00000160014,ENSG00000164885,ENSG00000108107","NA"
"Fluorodopa F-18","Fluorodopa F-18","FLUORODOPAF-18","CHEMBL3400972","Feinstein Institutes","Radioactive diagnostic","No human target","Diagnosis of parkinsonian syndromes","Parkinson disease","MONDO_0005180","Serious","S","2019","CHEMBL3400972","NA","NA","NA"
"Fluoroestradiol F-18","Fluoroestradiol F-18","FLUOROESTRADIOLF-18","CHEMBL4594261","Zionexa","Radioactive diagnostic","Other indication","Imaging, breast cancer","breast carcinoma","EFO_0000305","Serious","S","2020","CHEMBL4594261","ENSG00000186868","ENSG00000006659,ENSG00000143933,ENSG00000146648,ENSG00000188906,ENSG00000198668,ENSG00000204389,ENSG00000204843,ENSG00000096384,ENSG00000165732,ENSG00000185624,ENSG00000229359,ENSG00000108107,ENSG00000109971,ENSG00000110367,ENSG00000124214,ENSG00000166033,ENSG00000175793,ENSG00000100784,ENSG00000108443,ENSG00000130203,ENSG00000134516,ENSG00000142330,ENSG00000082701,ENSG00000105723,ENSG00000108953,ENSG00000118515,ENSG00000136367,ENSG00000136717,ENSG00000175203,ENSG00000010810,ENSG00000084764,ENSG00000115687,ENSG00000164885,ENSG00000164924,ENSG00000167552,ENSG00000177189,ENSG00000182718,ENSG00000185345,ENSG00000186868,ENSG00000072518,ENSG00000096060,ENSG00000103266,ENSG00000110436,ENSG00000117676,ENSG00000136059,ENSG00000153944,ENSG00000160014,ENSG00000170027,ENSG00000175166,ENSG00000275700,ENSG00000004478,ENSG00000134308,ENSG00000135097,ENSG00000142192,ENSG00000142208,ENSG00000171867,ENSG00000197122,ENSG00000075624,ENSG00000145335","NA"
"Fotivda","Tivozanib","Tivozanib","CHEMBL1289494","Aveo","VEGFR kinase inhibitor","Oncology","Renal cell carcinoma","renal cell carcinoma","EFO_0000681","Serious","S","2021","CHEMBL1289494","ENSG00000113721,ENSG00000128052,ENSG00000102755,ENSG00000157404,ENSG00000037280","ENSG00000065054,ENSG00000100097,ENSG00000102755,ENSG00000109062,ENSG00000111077,ENSG00000111252,ENSG00000120833,ENSG00000127947,ENSG00000137936,ENSG00000143322,ENSG00000144724,ENSG00000150630,ENSG00000157193,ENSG00000197943,ENSG00000000938,ENSG00000074966,ENSG00000094796,ENSG00000095585,ENSG00000100311,ENSG00000101213,ENSG00000105647,ENSG00000134242,ENSG00000136205,ENSG00000145715,ENSG00000148082,ENSG00000165025,ENSG00000167193,ENSG00000171862,ENSG00000011201,ENSG00000035720,ENSG00000081237,ENSG00000107338,ENSG00000117153,ENSG00000119630,ENSG00000134215,ENSG00000135605,ENSG00000154133,ENSG00000158092,ENSG00000185634,ENSG00000198799,ENSG00000205439,ENSG00000254087,ENSG00000071051,ENSG00000095370,ENSG00000101336,ENSG00000101624,ENSG00000131737,ENSG00000151490,ENSG00000154237,ENSG00000176105,ENSG00000179295,ENSG00000182511,ENSG00000010278,ENSG00000097007,ENSG00000099250,ENSG00000099942,ENSG00000101082,ENSG00000110395,ENSG00000115085,ENSG00000134853,ENSG00000136573,ENSG00000141738,ENSG00000142192,ENSG00000152894,ENSG00000164916,ENSG00000166923,ENSG00000177885,ENSG00000183918,ENSG00000196684,ENSG00000203786,ENSG00000221837,ENSG00000010810,ENSG00000049130,ENSG00000070018,ENSG00000087266,ENSG00000111679,ENSG00000117461,ENSG00000129946,ENSG00000130164,ENSG00000132334,ENSG00000155926,ENSG00000179776,ENSG00000186432,ENSG00000198574,ENSG00000037280,ENSG00000067225,ENSG00000079308,ENSG00000087077,ENSG00000096063,ENSG00000100351,ENSG00000128052,ENSG00000142798,ENSG00000149177,ENSG00000169495,ENSG00000170677,ENSG00000171150,ENSG00000182866,ENSG00000269335,ENSG00000027869,ENSG00000096384,ENSG00000112715,ENSG00000127329,ENSG00000145675,ENSG00000153233,ENSG00000160691,ENSG00000184557,ENSG00000196396,ENSG00000197122,ENSG00000197461,ENSG00000249915,ENSG00000124181","NA"
"Galafold","Migalastat","MIGALASTAT","CHEMBL110458","Amicus Therapeutics","beta-galactosidase regulator","Other indication","Fabry disease","fabry disease","MONDO_0010526","Serious","P,O,A,F","2018","CHEMBL110458","ENSG00000102393","ENSG00000134243","NA"
"Gallium dotatoc Ga-68","Gallium dotatoc Ga-68","GALLIUMDOTATOCGA-68","CHEMBL4297340","UIHC PET Imaging Center","Radioactive diagnostic","Other indication","Localization of somatostatin receptor-positive neuroendocrine tumours","neuroendocrine neoplasm","EFO_1001901","Serious","S,O","2019","CHEMBL4297340","ENSG00000180616","ENSG00000141480,ENSG00000162009,ENSG00000145675,ENSG00000278195","NA"
"Gamifant","Emapalumab","EMAPALUMAB","CHEMBL3989977","Novimmune","Interferon-‚Äö√¢√†‚àö‚â†‚Äö√Ñ√∂‚àö¬¢‚Äö√Ñ¬¢-blocking antibody","Other indication","Primary haemophagocytic lymphohistiocytosis","genetic hemophagocytic lymphohistiocytosis","MONDO_0015541","Serious","P,O,B","2018","CHEMBL3989977","ENSG00000111537","ENSG00000027697","NA"
"Gavreto","Pralsetinib","PRALSETINIB","CHEMBL4582651","Blueprint Medicines/Roche","RET kinase inhibitor","Oncology","RET fusion-positive NSCLC","non-small cell lung carcinoma","EFO_0003060","Serious","P,O,B,A","2020","CHEMBL4582651","ENSG00000108091,ENSG00000165731,ENSG00000170759","ENSG00000023608,ENSG00000104695,ENSG00000109670,ENSG00000110395,ENSG00000115641,ENSG00000120896,ENSG00000127445,ENSG00000132938,ENSG00000134308,ENSG00000141013,ENSG00000160207,ENSG00000005249,ENSG00000031691,ENSG00000102021,ENSG00000106511,ENSG00000140382,ENSG00000146648,ENSG00000171094,ENSG00000196391,ENSG00000007372,ENSG00000106536,ENSG00000149923,ENSG00000154845,ENSG00000163820,ENSG00000164305,ENSG00000170759,ENSG00000264343,ENSG00000179562,ENSG00000196150,ENSG00000105568,ENSG00000108091,ENSG00000127903,ENSG00000137076,ENSG00000138136,ENSG00000160062,ENSG00000160867,ENSG00000165731,ENSG00000180447,ENSG00000101266,ENSG00000106052,ENSG00000106785,ENSG00000149806,ENSG00000154237,ENSG00000163126,ENSG00000169136,ENSG00000177842,ENSG00000188191,ENSG00000269335,ENSG00000017797,ENSG00000096401,ENSG00000100109,ENSG00000107187,ENSG00000113575,ENSG00000124181,ENSG00000140743,ENSG00000148356,ENSG00000156735,ENSG00000166484,ENSG00000168002,ENSG00000168610,ENSG00000170027,ENSG00000067225,ENSG00000100055,ENSG00000128245,ENSG00000164924,ENSG00000166913,ENSG00000223501","NA"
"Gazyva","Obinutuzumab","OBINUTUZUMAB","CHEMBL1743048","Genentech","Humanized CD20-specific monoclonal antibody","Oncology","Previously untreated chronic lymphocytic leukaemia","chronic lymphocytic leukemia","EFO_0000095","Serious","P,O,B","2013","CHEMBL1743048","ENSG00000156738","ENSG00000086159,ENSG00000126251,ENSG00000145283,ENSG00000198189,ENSG00000204308,ENSG00000213921,ENSG00000122033,ENSG00000124103,ENSG00000160856,ENSG00000176946,ENSG00000080189,ENSG00000120370,ENSG00000161609,ENSG00000176435,ENSG00000157613,ENSG00000187783,ENSG00000213593,ENSG00000090661,ENSG00000116514,ENSG00000132563,ENSG00000144648,ENSG00000148110,ENSG00000156738,ENSG00000036565,ENSG00000100652,ENSG00000108960,ENSG00000112212,ENSG00000168476,ENSG00000188167,ENSG00000168685,ENSG00000170509","NA"
"Gemtesa","Vibegron","VIBEGRON","CHEMBL2107826","Urovant Sciences","Beta-3 adrenergic receptor agonist","Other indication","Overactive bladder","overactive bladder","EFO_1000781","Not serious","S","2020","CHEMBL2107826","ENSG00000188778","NA","NA"
"Genvoya","Elvitegravir, cobicistat, emtricitabine, tenofovir","ELVITEGRAVIR,COBICISTAT,EMTRICITABINE,TENOFOVIR","CHEMBL2095208,CHEMBL204656,CHEMBL885,CHEMBL483","Gilead","An INSTI plus a CYP3A inhibitor plus two nucleoside analogue reverse transcriptase inhibitors","No human target","HIV","HIV infection","EFO_0000764","Serious","S,F","2015","CHEMBL204656,CHEMBL2095208,CHEMBL885,CHEMBL483","ENSG00000160868,NA,ENSG00000021461,ENSG00000160870,ENSG00000106258","ENSG00000101856,NA,ENSG00000166347,ENSG00000197386,ENSG00000221829,ENSG00000187624","NA"
"Giapreza","Angiotensin II","ANGIOTENSINII","CHEMBL408403","La Jolla Pharmaceutical Company","Synthetic human angiotensin","Other indication","Blood pressure in adults with septic or other distributive shock","septic shock; blood pressure","EFO_0004325,EFO_0006834","Serious","P","2017","CHEMBL408403","ENSG00000144891","ENSG00000165637,ENSG00000104904,ENSG00000126698,ENSG00000143153,ENSG00000139053,ENSG00000176746,ENSG00000134817,ENSG00000172292,ENSG00000142002","NA"
"Gilotrif","Afatinib","AFATINIB","CHEMBL1173655","Boehringer Ingelheim","EGFR (ERBB1), HER2 (ERBB2), and HER4 (ERRB4) kinase inhibitor","Oncology","First-line treatment of patients with metastatic NSCLC whose tumours have EGFR exon 19 deletions or exon 21 (L858R) substitution mutations as detected by an FDA-approved test","non-small cell lung carcinoma","EFO_0003060","Serious","P,O,F","2013","CHEMBL1173655","ENSG00000146648,ENSG00000141736,ENSG00000178568","ENSG00000008735,ENSG00000012061,ENSG00000043462,ENSG00000061273,ENSG00000067606,ENSG00000068654,ENSG00000069345,ENSG00000078747,ENSG00000081237,ENSG00000086061,ENSG00000090520,ENSG00000100170,ENSG00000100591,ENSG00000104341,ENSG00000104756,ENSG00000104904,ENSG00000106211,ENSG00000107317,ENSG00000108424,ENSG00000110395,ENSG00000110651,ENSG00000113070,ENSG00000115085,ENSG00000115415,ENSG00000120053,ENSG00000124942,ENSG00000126561,ENSG00000127329,ENSG00000130340,ENSG00000131016,ENSG00000134308,ENSG00000136573,ENSG00000138363,ENSG00000142669,ENSG00000143322,ENSG00000143933,ENSG00000151422,ENSG00000151490,ENSG00000151491,ENSG00000160014,ENSG00000162434,ENSG00000162704,ENSG00000163235,ENSG00000182636,ENSG00000182718,ENSG00000183918,ENSG00000197785,ENSG00000198909,ENSG00000000938,ENSG00000006125,ENSG00000010810,ENSG00000014257,ENSG00000058262,ENSG00000064999,ENSG00000074966,ENSG00000085832,ENSG00000091831,ENSG00000096063,ENSG00000096384,ENSG00000100614,ENSG00000103876,ENSG00000107643,ENSG00000111816,ENSG00000112578,ENSG00000115145,ENSG00000115540,ENSG00000116254,ENSG00000117152,ENSG00000117461,ENSG00000124164,ENSG00000124207,ENSG00000133124,ENSG00000135506,ENSG00000135823,ENSG00000136205,ENSG00000137267,ENSG00000140575,ENSG00000141198,ENSG00000146648,ENSG00000154556,ENSG00000157500,ENSG00000158092,ENSG00000160255,ENSG00000166313,ENSG00000168036,ENSG00000171132,ENSG00000174791,ENSG00000182473,ENSG00000185338,ENSG00000186868,ENSG00000196961,ENSG00000197943,ENSG00000198574,ENSG00000204388,ENSG00000213658,ENSG00000214193,ENSG00000004478,ENSG00000008056,ENSG00000044115,ENSG00000044574,ENSG00000071537,ENSG00000080031,ENSG00000090776,ENSG00000096060,ENSG00000096968,ENSG00000100324,ENSG00000100938,ENSG00000102606,ENSG00000105245,ENSG00000105976,ENSG00000112473,ENSG00000113013,ENSG00000113580,ENSG00000114805,ENSG00000118363,ENSG00000121653,ENSG00000125731,ENSG00000126088,ENSG00000126581,ENSG00000127022,ENSG00000132669,ENSG00000133961,ENSG00000135046,ENSG00000135605,ENSG00000137463,ENSG00000142208,ENSG00000145016,ENSG00000145335,ENSG00000147010,ENSG00000148053,ENSG00000148082,ENSG00000149177,ENSG00000153201,ENSG00000154277,ENSG00000154710,ENSG00000159352,ENSG00000161203,ENSG00000165629,ENSG00000169375,ENSG00000170312,ENSG00000173406,ENSG00000182511,ENSG00000184557,ENSG00000185046,ENSG00000185483,ENSG00000185634,ENSG00000186834,ENSG00000197122,ENSG00000198561,ENSG00000206052,ENSG00000007264,ENSG00000014641,ENSG00000042753,ENSG00000071051,ENSG00000075415,ENSG00000101182,ENSG00000102189,ENSG00000103653,ENSG00000109111,ENSG00000109321,ENSG00000109684,ENSG00000109971,ENSG00000110011,ENSG00000111077,ENSG00000111252,ENSG00000111679,ENSG00000113263,ENSG00000115325,ENSG00000127191,ENSG00000128656,ENSG00000129946,ENSG00000141480,ENSG00000141655,ENSG00000141738,ENSG00000142949,ENSG00000144749,ENSG00000149428,ENSG00000168003,ENSG00000169047,ENSG00000170248,ENSG00000170293,ENSG00000172757,ENSG00000178568,ENSG00000183020,ENSG00000184524,ENSG00000196154,ENSG00000198668,ENSG00000015479,ENSG00000027869,ENSG00000046653,ENSG00000057294,ENSG00000067992,ENSG00000072135,ENSG00000075336,ENSG00000075624,ENSG00000077232,ENSG00000082898,ENSG00000092820,ENSG00000095585,ENSG00000097007,ENSG00000101336,ENSG00000103266,ENSG00000105974,ENSG00000106278,ENSG00000106299,ENSG00000107295,ENSG00000110711,ENSG00000111640,ENSG00000114737,ENSG00000116161,ENSG00000124882,ENSG00000127824,ENSG00000130193,ENSG00000132535,ENSG00000134215,ENSG00000134242,ENSG00000134853,ENSG00000135052,ENSG00000137076,ENSG00000137486,ENSG00000138095,ENSG00000140600,ENSG00000141736,ENSG00000142627,ENSG00000143294,ENSG00000149925,ENSG00000152894,ENSG00000155926,ENSG00000165025,ENSG00000165731,ENSG00000167601,ENSG00000169045,ENSG00000169398,ENSG00000174808,ENSG00000198853,ENSG00000204389,ENSG00000033327,ENSG00000034713,ENSG00000065361,ENSG00000067182,ENSG00000087586,ENSG00000099942,ENSG00000100280,ENSG00000101082,ENSG00000101213,ENSG00000101558,ENSG00000105971,ENSG00000106070,ENSG00000109458,ENSG00000113648,ENSG00000117450,ENSG00000120694,ENSG00000131746,ENSG00000132155,ENSG00000137693,ENSG00000150403,ENSG00000151834,ENSG00000153707,ENSG00000154237,ENSG00000159176,ENSG00000163399,ENSG00000163697,ENSG00000164615,ENSG00000165527,ENSG00000167552,ENSG00000170606,ENSG00000177885,ENSG00000179295,ENSG00000184575,ENSG00000185499,ENSG00000185896,ENSG00000188191,ENSG00000189043,ENSG00000198799,ENSG00000254087,ENSG00000269335,ENSG00000011132,ENSG00000011485,ENSG00000050748,ENSG00000094631,ENSG00000095370,ENSG00000101134,ENSG00000102309,ENSG00000104814,ENSG00000105197,ENSG00000105401,ENSG00000105613,ENSG00000116285,ENSG00000123384,ENSG00000123983,ENSG00000124181,ENSG00000125170,ENSG00000127947,ENSG00000130402,ENSG00000131558,ENSG00000132970,ENSG00000137936,ENSG00000138798,ENSG00000140009,ENSG00000141968,ENSG00000142192,ENSG00000144554,ENSG00000144724,ENSG00000145675,ENSG00000145715,ENSG00000149269,ENSG00000153233,ENSG00000159228,ENSG00000160999,ENSG00000162591,ENSG00000166598,ENSG00000168610,ENSG00000170581,ENSG00000173801,ENSG00000174437,ENSG00000175203,ENSG00000175866,ENSG00000178078,ENSG00000178188,ENSG00000184144,ENSG00000185359,ENSG00000197102,ENSG00000198399,ENSG00000204305,ENSG00000240972,ENSG00000253729,ENSG00000067225,ENSG00000069869,ENSG00000070159,ENSG00000072274,ENSG00000080824,ENSG00000085063,ENSG00000085733,ENSG00000087266,ENSG00000088930,ENSG00000092758,ENSG00000100351,ENSG00000100485,ENSG00000102010,ENSG00000105647,ENSG00000105701,ENSG00000107263,ENSG00000111669,ENSG00000113108,ENSG00000115904,ENSG00000122707,ENSG00000123908,ENSG00000130558,ENSG00000130706,ENSG00000131171,ENSG00000132639,ENSG00000132670,ENSG00000135451,ENSG00000136810,ENSG00000137193,ENSG00000137462,ENSG00000138698,ENSG00000139625,ENSG00000146674,ENSG00000148180,ENSG00000154127,ENSG00000154229,ENSG00000157168,ENSG00000158402,ENSG00000160691,ENSG00000164924,ENSG00000166913,ENSG00000167193,ENSG00000168439,ENSG00000169139,ENSG00000170677,ENSG00000173020,ENSG00000175793,ENSG00000176105,ENSG00000177666,ENSG00000182585,ENSG00000189410,ENSG00000196396,ENSG00000250722,ENSG00000254772,ENSG00000039068,ENSG00000105649,ENSG00000133056,ENSG00000136235,ENSG00000160293","NA"
"Givlaari","Givosiran","GIVOSIRAN","CHEMBL4297760","Alnylam","ALAS1-directed siRNA","Other indication","Acute hepatic porphyria","acute hepatic porphyria","Orphanet_95157","Serious","P,O,B","2019","CHEMBL4297760","ENSG00000023330","ENSG00000083535,ENSG00000103852,ENSG00000105497,ENSG00000115935,ENSG00000136878,ENSG00000169683,ENSG00000004142,ENSG00000023330,ENSG00000163961,ENSG00000171103,ENSG00000112186,ENSG00000118898,ENSG00000130119,ENSG00000134371,ENSG00000146410,ENSG00000154359,ENSG00000162999,ENSG00000234616,ENSG00000115998,ENSG00000125870,ENSG00000163879,ENSG00000072121,ENSG00000104611,ENSG00000106078,ENSG00000100422,ENSG00000132613,ENSG00000149243,ENSG00000167208,ENSG00000205542,ENSG00000212747,ENSG00000034510,ENSG00000088727,ENSG00000105376,ENSG00000110987,ENSG00000135722,ENSG00000163060,ENSG00000183495,ENSG00000171703,ENSG00000204536,ENSG00000215203,ENSG00000226742,ENSG00000249709,ENSG00000253797","NA"
"Harvoni","Ledipasvir, sofosbuvir","LEDIPASVIR,SOFOSBUVIR","CHEMBL2374220,CHEMBL1259059","Gilead Sciences","An NS5A inhibitor plus an HCV nucleotide-analogue NS5B-polymerase inhibitor","No human target","Genotype 1 HCV","hepatitis C virus infection","EFO_0003047","Serious","P,B,F","2014","CHEMBL2374220,CHEMBL1259059","NA","NA","NA"
"Hemlibra","Emicizumab","EMICIZUMAB","CHEMBL3833393","Roche/Genentech","Bispecific FIX and FX-directed antibody","Other indication","Haemophilia A","hemophilia A","MONDO_0010602","Serious","P,O,B","2017","CHEMBL3833393","ENSG00000101981,ENSG00000126218","ENSG00000185010,ENSG00000140093,ENSG00000106333,ENSG00000117601,ENSG00000188021,ENSG00000286219","NA"
"Hetlioz","Tasimelteon","TASIMELTEON","CHEMBL2103822","Vanda","Melatonin-receptor agonist","Other indication","Non-24-hour sleep-wake disorder","sleep-wake disorder","MONDO_0003406","Not serious","P,O","2014","CHEMBL2103822","ENSG00000134640,ENSG00000168412","ENSG00000069329,ENSG00000101856,ENSG00000134308,ENSG00000168412,ENSG00000196924,ENSG00000115241,ENSG00000147509,ENSG00000134640,ENSG00000136238,ENSG00000197191,ENSG00000241973,ENSG00000116473,ENSG00000124164,ENSG00000133124,ENSG00000135916,ENSG00000147246,ENSG00000221880,ENSG00000084733,ENSG00000179218,ENSG00000044574,ENSG00000078369,ENSG00000109133,ENSG00000114353,ENSG00000127955,ENSG00000143870,ENSG00000172354,ENSG00000122218,ENSG00000065135,ENSG00000108829,ENSG00000114450,ENSG00000127022,ENSG00000173786,ENSG00000177733,ENSG00000254772","EFO_0008328"
"Ibrance","Palbociclib","PALBOCICLIB","CHEMBL189963","Pfizer","CDK4 and CDK6 inhibitor","Oncology","ER-positive, HER2-negative advanced breast cancer","HER2 negative breast carcinoma","EFO_0009780","Serious","P,B,A","2015","CHEMBL189963","ENSG00000135446,ENSG00000105810,ENSG00000110092","ENSG00000096060,ENSG00000100211,ENSG00000104859,ENSG00000111087,ENSG00000111276,ENSG00000116754,ENSG00000119866,ENSG00000132646,ENSG00000134709,ENSG00000136754,ENSG00000147130,ENSG00000147883,ENSG00000160570,ENSG00000196388,ENSG00000204610,ENSG00000012048,ENSG00000065883,ENSG00000088325,ENSG00000096384,ENSG00000096717,ENSG00000097046,ENSG00000103264,ENSG00000106459,ENSG00000111701,ENSG00000116604,ENSG00000129355,ENSG00000145687,ENSG00000159216,ENSG00000175197,ENSG00000197444,ENSG00000197933,ENSG00000213676,ENSG00000072736,ENSG00000080839,ENSG00000103343,ENSG00000105810,ENSG00000106462,ENSG00000134480,ENSG00000137497,ENSG00000148516,ENSG00000164548,ENSG00000065328,ENSG00000100461,ENSG00000105227,ENSG00000118689,ENSG00000134283,ENSG00000134324,ENSG00000143379,ENSG00000161956,ENSG00000163950,ENSG00000165804,ENSG00000168779,ENSG00000171540,ENSG00000171720,ENSG00000171843,ENSG00000181896,ENSG00000198026,ENSG00000237441,ENSG00000020633,ENSG00000080824,ENSG00000088881,ENSG00000099326,ENSG00000115875,ENSG00000115947,ENSG00000123374,ENSG00000134058,ENSG00000139517,ENSG00000147889,ENSG00000172403,ENSG00000206181,ENSG00000066279,ENSG00000073111,ENSG00000094804,ENSG00000108349,ENSG00000111206,ENSG00000112576,ENSG00000136450,ENSG00000143442,ENSG00000144560,ENSG00000152467,ENSG00000154277,ENSG00000154548,ENSG00000179750,ENSG00000198176,ENSG00000204463,ENSG00000005302,ENSG00000016082,ENSG00000102921,ENSG00000103479,ENSG00000118816,ENSG00000140464,ENSG00000164190,ENSG00000165588,ENSG00000170312,ENSG00000004897,ENSG00000095637,ENSG00000100146,ENSG00000101745,ENSG00000105401,ENSG00000110092,ENSG00000118971,ENSG00000119139,ENSG00000123080,ENSG00000124762,ENSG00000126767,ENSG00000134532,ENSG00000135446,ENSG00000136709,ENSG00000136997,ENSG00000139687,ENSG00000147854,ENSG00000155090,ENSG00000161405,ENSG00000161547,ENSG00000169083,ENSG00000185122,ENSG00000197343,ENSG00000205250,ENSG00000109819,ENSG00000136527,ENSG00000163877,ENSG00000182606,ENSG00000184708","EFO_0000305"
"Ibsrela","Tenapanor","TENAPANOR","CHEMBL3304485","Ardelyx","NHE3 inhibitor","Other indication","IBS with constipation","irritable bowel syndrome","EFO_0000555","Not serious","S","2019","CHEMBL3304485","ENSG00000066230","ENSG00000086015","NA"
"Idhifa","Enasidenib mesylate","ENASIDENIBMESYLATE","CHEMBL3989931","Celgene/Agios","IDH2 inhibitor","Oncology","IDH2-mutated AML","acute myeloid leukemia","EFO_0000222","Serious","P,O,F","2017","CHEMBL3989931","ENSG00000182054","ENSG00000182054","NA"
"Ilumya","Tildrakizumab","TILDRAKIZUMAB","CHEMBL2108681","Sun Pharma","IL-23 antibody","Other indication","Plaque psoriasis","psoriasis vulgaris","EFO_1001494","Not serious","S","2018","CHEMBL2108681","ENSG00000110944,ENSG00000113302","ENSG00000162594,ENSG00000168811,ENSG00000110944,ENSG00000113302,ENSG00000162735","EFO_0000676"
"Imbruvica","Ibrutinib","IBRUTINIB","CHEMBL1873475","Pharmacyclics","Bruton's tyrosine kinase inhibitor","Oncology","Mantle cell lymphoma","Mantle cell lymphoma","EFO_1001469","Serious","P,O,B,F","2013","CHEMBL1873475","ENSG00000010671","ENSG00000065675,ENSG00000177885,ENSG00000005700,ENSG00000100124,ENSG00000105976,ENSG00000117560,ENSG00000010671,ENSG00000117461,ENSG00000169083,ENSG00000096384,ENSG00000116017,ENSG00000172005,ENSG00000106511,ENSG00000143537,ENSG00000095585,ENSG00000135378,ENSG00000263001,ENSG00000109458,ENSG00000131370","NA"
"Imcivree","Setmelanotide","SETMELANOTIDE","CHEMBL3301624","Rhythm","Melanocortin receptor 4 agonist","Other indication","Rare genetic diseases of obesity","Bardet-Biedl syndrome","MONDO_0015229","Serious","P,O,B","2020","CHEMBL3301624","ENSG00000166603","NA","NA"
"Imfinzi","Durvalumab","DURVALUMAB","CHEMBL3301587","AstraZeneca","PDL1-blocking antibody","Oncology","Urothelial carcinoma","urothelial carcinoma","EFO_0008528","Serious","P,B,A","2017","CHEMBL3301587","ENSG00000120217","ENSG00000188389,ENSG00000091317,ENSG00000197646,ENSG00000121594,ENSG00000183723","NA"
"Imjudo","Tremelimumab","Tremelimumab","CHEMBL2108658","AstraZeneca","CTLA4-targeted mAb","Oncology","Hepatocellular carcinoma","hepatocellular carcinoma","EFO_0000182","Serious","S,O","2022","CHEMBL2108658","ENSG00000163599","ENSG00000114013,ENSG00000121594,ENSG00000205279,ENSG00000144063,ENSG00000145675,ENSG00000150433","MONDO_0018531"
"Impavido","Miltefosine","MILTEFOSINE","CHEMBL125","Knight","MOA unknown","No human target","Leishmaniasis","Leishmaniasis","EFO_0005044","Not concordant","P,O,F","2014","CHEMBL125","NA","NA","NA"
"Ingrezza","Valbenazine","VALBENAZINE","CHEMBL2364639","Neurocrine Biosciences","VMAT2 inhibitor","Other indication","Tardive dyskinesia","movement disorder","EFO_0004280","Not concordant","P,B,F","2017","CHEMBL2364639","ENSG00000165646","ENSG00000139514,ENSG00000134389,ENSG00000166091,ENSG00000180871,ENSG00000214736,ENSG00000182544,ENSG00000105374,ENSG00000110108,ENSG00000182685,ENSG00000173250","NA"
"Inmazeb","Atoltivimab, odesivimab, maftivimab","ATOLTIVIMAB,ODESIVIMAB,MAFTIVIMAB","CHEMBL4298183,CHEMBL4298188,CHEMBL4298184","Regeneron","Cocktail of Ebola glycoprotein-directed mAbs","No human target","Ebola virus","Ebola hemorrhagic fever","EFO_0007243","Serious","P,O,B","2020","CHEMBL4298183,CHEMBL4298188,CHEMBL4298184","NA","NA","NA"
"Inqovi","Cedazuridine, decitabine","CEDAZURIDINE,DECITABINE","CHEMBL1201129,CHEMBL3237547","Otsuka","Cytidine deaminase inhibitor; nucleoside metabolic inhibitor","Other indication","Myelodysplastic syndromes","myelodysplastic syndrome","EFO_0000198","Serious","P,O","2020","CHEMBL3237547,CHEMBL1201129","ENSG00000130816,ENSG00000119772,ENSG00000158825","ENSG00000088305,ENSG00000142208,ENSG00000183640,ENSG00000213638,ENSG00000067066,ENSG00000094916,ENSG00000100151,ENSG00000115806,ENSG00000132475,ENSG00000142182,ENSG00000163795,ENSG00000188486,ENSG00000198945,ENSG00000050628,ENSG00000074266,ENSG00000096717,ENSG00000112365,ENSG00000112559,ENSG00000115507,ENSG00000125531,ENSG00000129084,ENSG00000139990,ENSG00000158825,ENSG00000184724,ENSG00000276043,ENSG00000109101,ENSG00000134046,ENSG00000143799,ENSG00000156795,ENSG00000168036,ENSG00000072201,ENSG00000100462,ENSG00000116478,ENSG00000137575,ENSG00000180530,ENSG00000106511,ENSG00000109501,ENSG00000113369,ENSG00000114166,ENSG00000143379,ENSG00000145358,ENSG00000145391,ENSG00000100721,ENSG00000115762,ENSG00000196388,ENSG00000006125,ENSG00000106462,ENSG00000119772,ENSG00000163041,ENSG00000187555","NA"
"Inrebic","Fedratinib","FEDRATINIB","CHEMBL1287853","Celgene/BMS","JAK2 and FLT3 inhibitor","Other indication","Myelofibrosis","myelofibrosis","MONDO_0044903","Serious","P,O","2019","CHEMBL1287853","ENSG00000122025,ENSG00000096968","ENSG00000099942,ENSG00000149177,ENSG00000167193,ENSG00000196396,ENSG00000097007,ENSG00000101460,ENSG00000106070,ENSG00000115415,ENSG00000122025,ENSG00000165025,ENSG00000010810,ENSG00000096968,ENSG00000091181,ENSG00000117400,ENSG00000145715,ENSG00000170677,ENSG00000179295,ENSG00000136573,ENSG00000146648,ENSG00000178188,ENSG00000182866,ENSG00000065361,ENSG00000079308,ENSG00000100368,ENSG00000140941,ENSG00000162434,ENSG00000176105,ENSG00000269335,ENSG00000067225,ENSG00000143322","NA"
"Invokana","Canagliflozin","CANAGLIFLOZIN,CANAGLIFLOZIN","CHEMBL4594217,CHEMBL2048484","Janssen","SGLT2 inhibitor","Other indication","Type 2 diabetes","type 2 diabetes mellitus","MONDO_0005148","Not concordant","S","2013","CHEMBL4594217,CHEMBL2048484","ENSG00000140675","NA","Orphanet_79161,HP_0003076"
"Isturisa","Osilodrostat","OSILODROSTAT","CHEMBL3099695","Recordati Rare Diseases","Cortisol synthesis inhibitor","Other indication","Cushing disease","Cushing syndrome","EFO_0003099","Not concordant","S,O","2020","CHEMBL3099695","ENSG00000160882","NA","NA"
"Jardiance","Empagliflozin","EMPAGLIFLOZIN","CHEMBL2107830","Boehringer Ingelheim","SGLT2 inhibitor","Other indication","Type 2 diabetes","type 2 diabetes mellitus","MONDO_0005148","Not concordant","S,F","2014","CHEMBL2107830","ENSG00000140675","NA","Orphanet_79161,HP_0003076"
"Jemperli","Dostarlimab","Dostarlimab","CHEMBL4298124","GlaxoSmithKline","PD1-targeted mAb","Oncology","Endometrial cancer","endometrial cancer","MONDO_0011962","Serious","P,B,A","2021","CHEMBL4298124","ENSG00000188389","ENSG00000179295,ENSG00000197646,ENSG00000120217,ENSG00000006125,ENSG00000121594","NA"
"Jeuveau","Prabotulinumtoxin A","PRABOTULINUMTOXINA","CHEMBL4297229","Evolus","Acetylcholine release inhibitor and a neuromuscular blocking agent","Other indication","Glabellar lines associated with corrugator and/or procerus muscle activity","Facial wrinkling","HP_0009762","Not serious","S","2019","CHEMBL4297229","ENSG00000132639","ENSG00000135604,ENSG00000137288,ENSG00000146648,ENSG00000186908,ENSG00000220205,ENSG00000178750,ENSG00000188629,ENSG00000106089,ENSG00000197386,ENSG00000143761,ENSG00000136854,ENSG00000132639,ENSG00000145335,ENSG00000168993,ENSG00000120860","NA"
"Jublia","Efinaconazole","EFINACONAZOLE","CHEMBL2103877","Dow","Azole antifungal","No human target","Onychomycosis of the toenails","paronychia","EFO_0007421","Not serious","S","2014","CHEMBL2103877","NA","NA","NA"
"Kadcyla","Ado-trastuzumab emtansine","TRASTUZUMABEMTANSINE","CHEMBL1743082","Genentech","HER2-targeted antibody and microtubule inhibitor conjugate","Oncology","HER2-positive metastatic breast cancer","HER2 Positive Breast Carcinoma","EFO_1000294","Serious","P,F","2013","CHEMBL1743082","ENSG00000141736,ENSG00000167552,ENSG00000101162,ENSG00000196230,ENSG00000167553,ENSG00000258947,ENSG00000137267,ENSG00000176014,ENSG00000123416,ENSG00000127824,ENSG00000137285,ENSG00000104833,ENSG00000188229,ENSG00000152086,ENSG00000261456,ENSG00000198033","ENSG00000075415,ENSG00000080824,ENSG00000081237,ENSG00000086061,ENSG00000100603,ENSG00000101082,ENSG00000115325,ENSG00000115484,ENSG00000115514,ENSG00000116161,ENSG00000116285,ENSG00000122707,ENSG00000123416,ENSG00000123983,ENSG00000127022,ENSG00000133112,ENSG00000138095,ENSG00000138794,ENSG00000143256,ENSG00000153201,ENSG00000160691,ENSG00000162434,ENSG00000162946,ENSG00000163468,ENSG00000179218,ENSG00000001626,ENSG00000067225,ENSG00000087266,ENSG00000092330,ENSG00000102119,ENSG00000105993,ENSG00000121653,ENSG00000127824,ENSG00000129946,ENSG00000134215,ENSG00000134242,ENSG00000139517,ENSG00000144724,ENSG00000145335,ENSG00000151849,ENSG00000152359,ENSG00000164924,ENSG00000169047,ENSG00000174791,ENSG00000176148,ENSG00000177674,ENSG00000178568,ENSG00000179295,ENSG00000185046,ENSG00000265763,ENSG00000000938,ENSG00000008735,ENSG00000083799,ENSG00000100351,ENSG00000102189,ENSG00000105197,ENSG00000106278,ENSG00000109111,ENSG00000112473,ENSG00000129559,ENSG00000130193,ENSG00000141837,ENSG00000146731,ENSG00000147601,ENSG00000153233,ENSG00000161011,ENSG00000167900,ENSG00000183305,ENSG00000189043,ENSG00000196504,ENSG00000197386,ENSG00000204463,ENSG00000007264,ENSG00000014257,ENSG00000026025,ENSG00000054523,ENSG00000069345,ENSG00000071051,ENSG00000072135,ENSG00000082898,ENSG00000085832,ENSG00000090776,ENSG00000094631,ENSG00000105401,ENSG00000112208,ENSG00000113108,ENSG00000123358,ENSG00000127329,ENSG00000133124,ENSG00000136205,ENSG00000136573,ENSG00000145555,ENSG00000148082,ENSG00000151422,ENSG00000151490,ENSG00000155959,ENSG00000166170,ENSG00000168439,ENSG00000168610,ENSG00000169398,ENSG00000177606,ENSG00000189410,ENSG00000196730,ENSG00000197122,ENSG00000268606,ENSG00000010810,ENSG00000068654,ENSG00000070159,ENSG00000072274,ENSG00000084774,ENSG00000096063,ENSG00000096384,ENSG00000105701,ENSG00000111077,ENSG00000114737,ENSG00000116106,ENSG00000117461,ENSG00000120438,ENSG00000123349,ENSG00000124214,ENSG00000126581,ENSG00000126934,ENSG00000136319,ENSG00000142168,ENSG00000143322,ENSG00000145675,ENSG00000145715,ENSG00000146648,ENSG00000147676,ENSG00000156261,ENSG00000160181,ENSG00000160999,ENSG00000163399,ENSG00000165025,ENSG00000166135,ENSG00000167193,ENSG00000167552,ENSG00000167553,ENSG00000173020,ENSG00000173406,ENSG00000177954,ENSG00000178127,ENSG00000183386,ENSG00000186868,ENSG00000258947,NA,ENSG00000058262,ENSG00000064999,ENSG00000065361,ENSG00000090520,ENSG00000100938,ENSG00000101213,ENSG00000102003,ENSG00000102010,ENSG00000102977,ENSG00000105647,ENSG00000108424,ENSG00000119689,ENSG00000125170,ENSG00000125731,ENSG00000127947,ENSG00000132669,ENSG00000133056,ENSG00000135605,ENSG00000143575,ENSG00000149177,ENSG00000155926,ENSG00000156475,ENSG00000157168,ENSG00000165629,ENSG00000166226,ENSG00000170801,ENSG00000177885,ENSG00000188906,ENSG00000197785,ENSG00000197943,ENSG00000198574,ENSG00000091831,ENSG00000097033,ENSG00000099942,ENSG00000101558,ENSG00000109501,ENSG00000111252,ENSG00000113263,ENSG00000114904,ENSG00000115317,ENSG00000123609,ENSG00000124181,ENSG00000130779,ENSG00000136997,ENSG00000140575,ENSG00000141736,ENSG00000142192,ENSG00000151414,ENSG00000152894,ENSG00000160293,ENSG00000166046,ENSG00000182168,ENSG00000185338,ENSG00000206052,ENSG00000277586,ENSG00000005893,ENSG00000027869,ENSG00000044574,ENSG00000074966,ENSG00000075336,ENSG00000075624,ENSG00000095585,ENSG00000097007,ENSG00000103423,ENSG00000104427,ENSG00000106211,ENSG00000109684,ENSG00000111640,ENSG00000113648,ENSG00000114416,ENSG00000115415,ENSG00000124164,ENSG00000128656,ENSG00000131697,ENSG00000135624,ENSG00000137076,ENSG00000137936,ENSG00000141738,ENSG00000141968,ENSG00000144749,ENSG00000150753,ENSG00000166091,ENSG00000204843,ENSG00000254999,ENSG00000166313","NA"
"Kanuma","Sebelipase alfa","SEBELIPASEALFA","CHEMBL3039537","Alexion","Enzyme replacement therapy","Other indication","LAL deficiency","lysosomal acid lipase deficiency","MONDO_0010204","Serious","P,O,B,F","2015","CHEMBL3039537","ENSG00000107798","NA","NA"
"Kengreal","Cangrelor","CANGRELOR","CHEMBL334966","Medicines Company","P2Y12 platelet inhibitor","Other indication","Myocardial infarction, repeat coronary revascularization, and stent thrombosis","myocardial infarction","EFO_0000612","Serious","S","2015","CHEMBL334966","ENSG00000169313","NA","NA"
"Kerendia","Finerenone","Finerenone","CHEMBL2181927","Bayer","Non-steroidal MR antagonist","Other indication","CKD with type 2 diabetes","chronic kidney disease","EFO_0003884","Serious","P,F","2021","CHEMBL2181927","ENSG00000151623","ENSG00000142655","HP_0012594"
"Kerydin","Tavaborole","TAVABOROLE","CHEMBL443052","Anacor","Oxaborole antifungal","No human target","Onychomycosis of the toenails","paronychia","EFO_0007421","Not serious","S","2014","CHEMBL443052","NA","NA","NA"
"Kevzara","Sarilumab","SARILUMAB","CHEMBL2108730","Sanofi/Regeneron","IL-6 receptor antagonist","Other indication","Rheumatoid arthritis","rheumatoid arthritis","EFO_0000685","Serious","S","2017","CHEMBL2108730","ENSG00000160712","ENSG00000197860,ENSG00000136244,ENSG00000137642,ENSG00000110801","NA"
"Keytruda","Pembrolizumab","PEMBROLIZUMAB","CHEMBL3137343","Merck & Co.","PD1-specific antibody","Oncology","Metastatic melanoma *and others (2021 approval)","metastatic melanoma","EFO_0002617","Serious","P,O,B,A","2014","CHEMBL3137343","ENSG00000188389","ENSG00000121594,ENSG00000006125,ENSG00000120217,ENSG00000179295,ENSG00000197646","EFO_0000756"
"Kimmtrak","Tebentafusp","Tebentafusp","CHEMBL4297990","Immunocore","gp100 peptide HLA _ CD3 bispecific T-cell engager","Oncology","Uveal melanoma","Uveal Melanoma","EFO_1000616","Serious","P,O,B","2022","CHEMBL4297990","ENSG00000185664","ENSG00000185664","NA"
"Kisqali","Ribociclib","RIBOCICLIB","CHEMBL3545110","Novartis","CDK4/6 inhibitor","Oncology","HR-positive, HER2-negative breast cancer","HER2 negative breast carcinoma","EFO_0009780","Serious","P,B","2017","CHEMBL3545110","ENSG00000135446,ENSG00000105810","ENSG00000096060,ENSG00000100211,ENSG00000104859,ENSG00000111087,ENSG00000111276,ENSG00000116754,ENSG00000119866,ENSG00000132646,ENSG00000134709,ENSG00000136754,ENSG00000147130,ENSG00000147883,ENSG00000160570,ENSG00000196388,ENSG00000204610,ENSG00000065883,ENSG00000088325,ENSG00000096384,ENSG00000096717,ENSG00000097046,ENSG00000111701,ENSG00000116604,ENSG00000129355,ENSG00000145687,ENSG00000159216,ENSG00000175197,ENSG00000197444,ENSG00000197933,ENSG00000213676,ENSG00000072736,ENSG00000080839,ENSG00000103343,ENSG00000106462,ENSG00000134480,ENSG00000137497,ENSG00000148516,ENSG00000164548,ENSG00000065328,ENSG00000100461,ENSG00000105227,ENSG00000118689,ENSG00000134283,ENSG00000134324,ENSG00000143379,ENSG00000161956,ENSG00000163950,ENSG00000165804,ENSG00000168779,ENSG00000171540,ENSG00000171843,ENSG00000181896,ENSG00000198026,ENSG00000237441,ENSG00000080824,ENSG00000088881,ENSG00000099326,ENSG00000115875,ENSG00000134058,ENSG00000139517,ENSG00000147889,ENSG00000172403,ENSG00000206181,ENSG00000066279,ENSG00000073111,ENSG00000094804,ENSG00000108349,ENSG00000111206,ENSG00000112576,ENSG00000136450,ENSG00000143442,ENSG00000144560,ENSG00000152467,ENSG00000154277,ENSG00000154548,ENSG00000179750,ENSG00000198176,ENSG00000204463,ENSG00000005302,ENSG00000016082,ENSG00000102921,ENSG00000103479,ENSG00000118816,ENSG00000140464,ENSG00000164190,ENSG00000165588,ENSG00000095637,ENSG00000100146,ENSG00000101745,ENSG00000105401,ENSG00000110092,ENSG00000118971,ENSG00000119139,ENSG00000123080,ENSG00000124762,ENSG00000126767,ENSG00000134532,ENSG00000136709,ENSG00000136997,ENSG00000139687,ENSG00000155090,ENSG00000161405,ENSG00000161547,ENSG00000185122,ENSG00000197343,ENSG00000205250,ENSG00000109819,ENSG00000136527,ENSG00000163877,ENSG00000182606,ENSG00000184708","EFO_0000305"
"Klisyri","Tirbanibulin","TIRBANIBULIN","CHEMBL571546","Athenex","Microtubule inhibitor","Other indication","Actinic keratosis","actinic keratosis","EFO_0002496","Not serious","S","2020","CHEMBL571546","ENSG00000197122","ENSG00000039068,ENSG00000065361,ENSG00000106070,ENSG00000115850,ENSG00000132670,ENSG00000137845,ENSG00000156515,ENSG00000157404,ENSG00000163884,ENSG00000180370,ENSG00000185499,ENSG00000196396,ENSG00000241794,ENSG00000072201,ENSG00000076201,ENSG00000126581,ENSG00000143537,ENSG00000147403,ENSG00000153317,ENSG00000164342,ENSG00000254087,ENSG00000065357,ENSG00000079805,ENSG00000080824,ENSG00000096384,ENSG00000101266,ENSG00000109458,ENSG00000136205,ENSG00000136754,ENSG00000141736,ENSG00000146648,ENSG00000160691,ENSG00000165119,ENSG00000172005,ENSG00000183918,ENSG00000186868,ENSG00000072110,ENSG00000106976,ENSG00000118579,ENSG00000145675,ENSG00000151651,ENSG00000168036,ENSG00000261371,ENSG00000111276,ENSG00000141480,ENSG00000148848,ENSG00000152465,ENSG00000168610,ENSG00000185483,ENSG00000197122,ENSG00000198574,ENSG00000265972,ENSG00000050820,ENSG00000085832,ENSG00000097007,ENSG00000117461,ENSG00000120899,ENSG00000128052,ENSG00000134954,ENSG00000135074,ENSG00000163814,ENSG00000169083,ENSG00000169398,ENSG00000179295,ENSG00000269335,ENSG00000082175,ENSG00000091831,ENSG00000105976,ENSG00000109079,ENSG00000121774,ENSG00000130396,ENSG00000134324,ENSG00000167840,ENSG00000169252,ENSG00000170248,ENSG00000174775,ENSG00000187855,ENSG00000010810,ENSG00000105401,ENSG00000110395,ENSG00000137486,ENSG00000185236","EFO_0003784"
"Korsuva","Difelikefalin","Difelikefalin","CHEMBL3989915","Cara Therapeutics","kappa-Opioid receptor agonist","Other indication","Pruritus associated with CKD","chronic kidney disease","EFO_0003884","Serious","P,B","2021","CHEMBL3989915","ENSG00000082556","ENSG00000139112,ENSG00000198932,ENSG00000134817,ENSG00000105374","HP_0012594"
"Koselugo","Selumetinib","SELUMETINIB","CHEMBL1614701","AstraZeneca","MEK1/2 kinase inhibitor","Other indication","Neurofibromatosis type 1","neurofibromatosis type 1","MONDO_0018975","Serious","P,O,B","2020","CHEMBL1614701","ENSG00000126934,ENSG00000169032","ENSG00000109971,ENSG00000127445,ENSG00000100030,ENSG00000124678,ENSG00000132155,ENSG00000166167,ENSG00000171435,ENSG00000172530,ENSG00000028116,ENSG00000121022,ENSG00000128245,ENSG00000165119,ENSG00000175895,ENSG00000102882,ENSG00000108953,ENSG00000134308,ENSG00000137693,ENSG00000067225,ENSG00000075711,ENSG00000078061,ENSG00000134020,ENSG00000141068,ENSG00000166946,ENSG00000101843,ENSG00000142192,ENSG00000166913,ENSG00000127824,ENSG00000157764,ENSG00000164924,ENSG00000170027,ENSG00000172680","EFO_0008514"
"Krazati","Adagrasib","Adagrasib","CHEMBL4594350","Mirati","KRAS-G12C inhibitor","Oncology","KRASG12C-mutated NSCLC","non-small cell lung carcinoma","EFO_0003060","Serious","S,O,B,A,F","2022","CHEMBL4594350","ENSG00000133703","ENSG00000157764,ENSG00000067560,ENSG00000101265,ENSG00000132155,ENSG00000133703,ENSG00000143398,ENSG00000144746,ENSG00000156973,ENSG00000078061,ENSG00000117528,ENSG00000142192","NA"
"Krintafel","Tafenoquine","TAFENOQUINE","CHEMBL298470","Medicines for Malaria Venture/GlaxoSmithKline","8-Aminoquinoline antimalarial","No human target","Plasmodium vivax malaria","Plasmodium vivax malaria","EFO_0007445","Serious","P,O,B,F","2018","CHEMBL298470","NA","NA","NA"
"Kybella","Deoxycholic acid","DEOXYCHOLICACID","CHEMBL406393","Kythera","Cytolytic drug","No human target","Fat below the chin","body fat distribution","EFO_0004341","Not serious","S","2015","CHEMBL406393","NA","NA","NA"
"Kynamro","Mipomersen","MIPOMERSEN","CHEMBL2219536","Genzyme","Oligonucleotide inhibitor of apolipoprotein B100 synthesis","Other indication","Homozygous familial hypercholesterolaemia","homozygous familial hypercholesterolemia","MONDO_0018328","Serious","S,O","2013","CHEMBL2219536","ENSG00000084674","ENSG00000130164,ENSG00000165280,ENSG00000115307,ENSG00000138823","EFO_0004611"
"Lampit","Nifurtimox","NIFURTIMOX","CHEMBL290960","Bayer","Nitrofuran antiprotozoal","No human target","Chagas disease","chagas disease","MONDO_0001444","Serious","P,O,A","2020","CHEMBL290960","NA","NA","NA"
"Lartruvo","Olaratumab","OLARATUMAB","CHEMBL1743049","Eli Lilly","PDGFRalpha-blocking antibody","Oncology","Soft tissue sarcoma","soft tissue sarcoma","EFO_1001968","Serious","P,O,B,A,F","2016","CHEMBL1743049","ENSG00000134853","ENSG00000205808,ENSG00000067225,ENSG00000092108,ENSG00000096063,ENSG00000113721,ENSG00000124181,ENSG00000197461,ENSG00000142192,ENSG00000145431,ENSG00000161609,ENSG00000100311,ENSG00000146648,ENSG00000099942,ENSG00000167193","NA"
"Lenvima","Lenvatinib","LENVATINIB","CHEMBL1289601","Eisai","VEGFR inhibitor","Oncology","Thyroid cancer","thyroid cancer","MONDO_0002108","Serious","P,O","2015","CHEMBL1289601","ENSG00000102755,ENSG00000128052,ENSG00000037280","ENSG00000112715,ENSG00000119630,ENSG00000150630,ENSG00000157193,ENSG00000158092,ENSG00000160691,ENSG00000110395,ENSG00000142798,ENSG00000011201,ENSG00000096063,ENSG00000166923,ENSG00000100097,ENSG00000154133,ENSG00000067225,ENSG00000142192,ENSG00000249915,ENSG00000096384,ENSG00000099250,ENSG00000130164,ENSG00000149177,ENSG00000179776,ENSG00000197122,ENSG00000128052,ENSG00000145675,ENSG00000186432,ENSG00000269335,ENSG00000037280,ENSG00000099942,ENSG00000102755,ENSG00000111679,ENSG00000154237,ENSG00000169495","NA"
"Leqvio","Inclisiran","Inclisiran","CHEMBL3990033","Novartis/Alnylam","PCSK9-targeted siRNA","Other indication","HeFH or ASCVD","coronary atherosclerosis","MONDO_0021661","Serious","S","2021","CHEMBL3990033","ENSG00000169174","ENSG00000130164,ENSG00000087245,ENSG00000182718,ENSG00000177706,ENSG00000169174","NA"
"Libtayo","Cemiplimab","CEMIPLIMAB","CHEMBL4297723","Regeneron/Sanofi","PD1 antibody","Oncology","CSCC, BCC(*), NSCLC(*)","cutaneous squamous cell carcinoma; basal cell carcinoma; non-small cell lung carcinoma","EFO_1001927,EFO_0003060,EFO_0004193","Serious","P,B","2018","CHEMBL4297723","ENSG00000188389","ENSG00000006125,ENSG00000121594,ENSG00000197646,ENSG00000179295,ENSG00000120217","NA"
"Livmarli","Maralixibat","Maralixibat","CHEMBL363392","Mirum","IBAT inhibitor","Other indication","Pruritus in Alagille syndrome","Alagille syndrome","MONDO_0007318","Serious","P,O,B","2021","CHEMBL363392","ENSG00000125255","ENSG00000164081,ENSG00000114638,ENSG00000276070,ENSG00000184349,ENSG00000186501,ENSG00000205279,ENSG00000205155,ENSG00000137404,ENSG00000114529,ENSG00000142089","EFO_0005653"
"Livtencity","Maribavir","Maribavir","CHEMBL515408","Takeda","CMV pUL97 kinase inhibitor","No human target","Post-transplant CMV infection","NA","NA","NA","P,O,B","2021","CHEMBL515408","NA","NA","NA"
"Lokelma","Sodium zirconium cyclosilicate","SODIUMZIRCONIUMCYCLOSILICATE","CHEMBL3301592","AstraZeneca","Potassium binder","No human target","Hyperkalaemia","hyperkalemia","HP_0002153","Not concordant","S","2018","CHEMBL3301592","NA","NA","NA"
"Lonsurf","Tipiracil, trifluridine","TIPIRACIL,TRIFLURIDINE","CHEMBL235668,CHEMBL1129","Taiho","Thymidine phosphorylase inhibitor plus a nucleoside metabolic inhibitor","Oncology","Colorectal cancer","colorectal cancer","EFO_0005842","Serious","S,F","2015","CHEMBL235668,CHEMBL1129","ENSG00000025708,ENSG00000176890","ENSG00000117899,ENSG00000066185,ENSG00000162692","NA"
"Lorbrena","Lorlatinib","LORLATINIB","CHEMBL3286830","Pfizer","ALK and ROS1 inhibitor","Oncology","ALK-positive NSCLC","non-small cell lung carcinoma","EFO_0003060","Serious","P,O,B,A","2018","CHEMBL3286830","ENSG00000171094,ENSG00000143924","ENSG00000127329,ENSG00000189292,ENSG00000096384,ENSG00000171094,ENSG00000149177,ENSG00000106278,ENSG00000151414,ENSG00000165731,ENSG00000107882,ENSG00000196711,ENSG00000144724,ENSG00000067225","NA"
"Lucemyra","Lofexidine","LOFEXIDINE","CHEMBL17860","US WorldMeds","beta2-adrenoceptor agonist","Other indication","Opioid withdrawal","opioid dependence","EFO_0005611","Not serious","P,F","2018","CHEMBL17860","ENSG00000184160,ENSG00000150594,ENSG00000274286","ENSG00000134138,ENSG00000150594,ENSG00000159214,ENSG00000175946,ENSG00000131737,ENSG00000179455,ENSG00000186153,ENSG00000106153,ENSG00000184160,ENSG00000149380,ENSG00000167964,ENSG00000112559,ENSG00000257727,ENSG00000185359","NA"
"Lumakras","Sotorasib","Sotorasib","CHEMBL4535757","Amgen","KRAS-G12C inhibitor","Oncology","KRASG12C-mutated NSCLC","non-small cell lung carcinoma","EFO_0003060","Serious","P,O,B,A,F","2021","CHEMBL4535757","ENSG00000133703","ENSG00000157764,ENSG00000067560,ENSG00000101265,ENSG00000132155,ENSG00000133703,ENSG00000143398,ENSG00000144746,ENSG00000156973,ENSG00000078061,ENSG00000117528,ENSG00000142192","NA"
"Lumason","Sulfur hexafluoride lipid-type A microspheres","SULFURHEXAFLUORIDELIPID-TYPEAMICROSPHERES","NA","Bracco","Ultrasound contrast agent","No human target","Cardiovascular imaging","NA","NA","NA","S","2014","NA","NA","NA","NA"
"Lumoxiti","Moxetumomab pasudotox","MOXETUMOMABPASUDOTOX","CHEMBL1743043","AstraZeneca","CD22-directed antibody‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚àö√´‚Äö√†√∂¬¨¬Ædrug conjugate","Oncology","Hairy cell leukaemia","hairy cell leukemia","EFO_1000956","Serious","P,O,F","2018","CHEMBL1743043","ENSG00000012124,ENSG00000167658","ENSG00000124181,ENSG00000177885,ENSG00000186106,ENSG00000162946,ENSG00000197386,ENSG00000146859,ENSG00000156795,ENSG00000188906,ENSG00000112062,ENSG00000072506,ENSG00000165025,ENSG00000254087,ENSG00000111679","NA"
"Lunsumio","Mosunetuzumab","Mosunetuzumab","CHEMBL4297788","Roche/Genentech","CD20 _ CD3 bispecific antibody","Oncology","Follicular lymphoma","follicular lymphoma","MONDO_0018906","Serious","P,O,B,A","2022","CHEMBL4297788","ENSG00000156738,ENSG00000198851,ENSG00000160654,ENSG00000167286","ENSG00000090661,ENSG00000115085,ENSG00000156738,ENSG00000158092,ENSG00000160856,ENSG00000170509,ENSG00000176171,ENSG00000204308,ENSG00000036565,ENSG00000108960,ENSG00000120370,ENSG00000121900,ENSG00000162300,ENSG00000165025,ENSG00000187713,ENSG00000187783,ENSG00000198189,ENSG00000213921,ENSG00000100652,ENSG00000124103,ENSG00000127564,ENSG00000131037,ENSG00000139291,ENSG00000148110,ENSG00000122033,ENSG00000161609,ENSG00000168476,ENSG00000086159,ENSG00000126251,ENSG00000132563,ENSG00000134531,ENSG00000149451,ENSG00000169550,ENSG00000187066,ENSG00000188167,ENSG00000109099,ENSG00000168685,ENSG00000176946,ENSG00000213658,ENSG00000071051,ENSG00000126777,ENSG00000144648,ENSG00000157613,ENSG00000080189,ENSG00000112212,ENSG00000116514,ENSG00000145283,ENSG00000172005,ENSG00000176435,ENSG00000197860,ENSG00000213593","EFO_0000183"
"Lupkynis","Voclosporin","Voclosporin","CHEMBL2218919","Aurinia","Calcineurin inhibitor","Other indication","Lupus nephritis","lupus nephritis","EFO_0005761","Serious","P,F","2021","CHEMBL2218919","ENSG00000138814","ENSG00000131196,ENSG00000179841,ENSG00000221823,ENSG00000078053,ENSG00000109103,ENSG00000154319,ENSG00000162105,ENSG00000143772,ENSG00000146476,ENSG00000138443,ENSG00000154102,ENSG00000142168,ENSG00000152818,ENSG00000177885,ENSG00000002834,ENSG00000101096,ENSG00000131746,ENSG00000177238,ENSG00000101557","MONDO_0007915"
"Lutathera","Lutetium Lu 177 dotatate","LUTETIUMLU177DOTATATE","CHEMBL3989924","Advanced Accelerator Applications/Novartis","Somatostatin receptor-targeted radiopharmaceutical","Oncology","GEP-NETs","digestive system neuroendocrine neoplasm","MONDO_0024503","Serious","P,O,F","2018","CHEMBL3989924","ENSG00000180616,ENSG00000132671,ENSG00000139874,ENSG00000278195,ENSG00000162009","ENSG00000278195,ENSG00000141480,ENSG00000162009,ENSG00000180616,ENSG00000142192,ENSG00000132671,ENSG00000139874,ENSG00000107186,ENSG00000145675","NA"
"Luzu","Luliconazole","LULICONAZOLE","CHEMBL2105689","Medicis","Azole antifungal","No human target","Interdigital tinea pedis, tinea cruris and tinea corporis caused by Trichophyton rubrum and Epidermophyton floccosum","tinea","EFO_0007510","Not serious","S","2013","CHEMBL2105689","NA","NA","NA"
"Lybalvi","Olanzapine, samidorphan","samidorphan,Olanzapine","CHEMBL426084,CHEMBL715","Alkermes","Atypical antipsychotic and opioid antagonist","Other indication","Schizophrenia and bipolar I disorder","Schizophrenia; bipolar I disorder","EFO_0009963,MONDO_0005090","Serious","S","2021","CHEMBL426084,CHEMBL715","ENSG00000112038,ENSG00000069696,ENSG00000149295,ENSG00000116329,ENSG00000147246,ENSG00000102468,ENSG00000082556,ENSG00000151577","ENSG00000010017,ENSG00000043591,ENSG00000078369,ENSG00000111142,ENSG00000113504,ENSG00000121022,ENSG00000121542,ENSG00000125170,ENSG00000132965,ENSG00000133065,ENSG00000135914,ENSG00000139112,ENSG00000142089,ENSG00000144063,ENSG00000168412,ENSG00000172243,ENSG00000172375,ENSG00000174437,ENSG00000198937,NA,ENSG00000103249,ENSG00000134640,ENSG00000147955,ENSG00000159840,ENSG00000103042,ENSG00000125967,ENSG00000127022,ENSG00000139644,ENSG00000142227,ENSG00000156284,ENSG00000241399,ENSG00000134873,ENSG00000142192,ENSG00000149295,ENSG00000155755,ENSG00000164081,ENSG00000177300,ENSG00000256660,ENSG00000008283,ENSG00000029364,ENSG00000101460,ENSG00000102468,ENSG00000105223,ENSG00000143570,ENSG00000147246,ENSG00000149451,ENSG00000151778,ENSG00000162975,ENSG00000168515,ENSG00000168824,ENSG00000172020,ENSG00000177519,ENSG00000180720,ENSG00000181788,ENSG00000187513,ENSG00000197769,ENSG00000213658,ENSG00000105677,ENSG00000109099,ENSG00000113790,ENSG00000148483,ENSG00000162946,ENSG00000164082,ENSG00000164707,ENSG00000115307,ENSG00000128271,ENSG00000136854,ENSG00000180900,ENSG00000205279,ENSG00000069696,ENSG00000118432,ENSG00000170545,ENSG00000175489,ENSG00000185883,ENSG00000196924,ENSG00000100528,ENSG00000101558,ENSG00000169903,ENSG00000171517,ENSG00000185049,ENSG00000198932,ENSG00000158014,ENSG00000168958,ENSG00000134817,ENSG00000170214,ENSG00000107186,ENSG00000113732,ENSG00000116729,ENSG00000196470,ENSG00000075711,ENSG00000134531,ENSG00000172005,ENSG00000142319,ENSG00000105374","NA"
"Lymphoseek kit","Technetium TC 99m tilmanocept","TECHNETIUMTC99MTILMANOCEPT","CHEMBL2108726","Navidea","Radioactive diagnostic agent","Other indication","Lymphatic mapping in patients with breast cancer or melanoma","breast cancer; melanoma","MONDO_0007254,EFO_0000756","Serious","S","2013","CHEMBL2108726","ENSG00000260314","NA","NA"
"Lynparza","Olaparib","OLAPARIB","CHEMBL521686","AstraZeneca","PARP inhibitor","Oncology","Advanced BRCA-mutated ovarian cancer","ovarian cancer","MONDO_0008170","Serious","P,O,A,F","2014","CHEMBL521686","ENSG00000129484,ENSG00000143799,ENSG00000041880","ENSG00000064703,ENSG00000072609,ENSG00000100442,ENSG00000124216,ENSG00000130816,ENSG00000144681,ENSG00000154511,ENSG00000157554,ENSG00000159335,ENSG00000165138,ENSG00000165392,ENSG00000166845,ENSG00000166884,ENSG00000196419,ENSG00000227345,ENSG00000240563,ENSG00000278828,ENSG00000011638,ENSG00000092847,ENSG00000102882,ENSG00000147874,ENSG00000167987,ENSG00000169955,ENSG00000275379,ENSG00000101191,ENSG00000116209,ENSG00000124596,ENSG00000134684,ENSG00000136240,ENSG00000138684,ENSG00000160208,ENSG00000169551,ENSG00000175198,ENSG00000178764,ENSG00000213699,ENSG00000273983,ENSG00000287080,ENSG00000004700,ENSG00000079246,ENSG00000104490,ENSG00000119698,ENSG00000147885,ENSG00000150991,ENSG00000152102,ENSG00000168036,ENSG00000169621,ENSG00000189043,ENSG00000198900,ENSG00000275714,ENSG00000131778,ENSG00000140481,ENSG00000144354,ENSG00000169490,ENSG00000169598,ENSG00000245848,ENSG00000286522,ENSG00000078269,ENSG00000082805,ENSG00000091831,ENSG00000106511,ENSG00000116815,ENSG00000141510,ENSG00000148702,ENSG00000162892,ENSG00000163637,ENSG00000173614,ENSG00000196511,ENSG00000203852,ENSG00000213801,ENSG00000253729,ENSG00000274750,ENSG00000277775,ENSG00000063978,ENSG00000073050,ENSG00000113163,ENSG00000133318,ENSG00000137074,ENSG00000156052,ENSG00000158773,ENSG00000178075,ENSG00000188486,ENSG00000189403,ENSG00000197153,ENSG00000197409,ENSG00000007038,ENSG00000100030,ENSG00000101412,ENSG00000101938,ENSG00000105229,ENSG00000118518,ENSG00000131747,ENSG00000143799,ENSG00000148737,ENSG00000151553,ENSG00000154767,ENSG00000159884,ENSG00000164305,ENSG00000164338,ENSG00000168298,ENSG00000176658,ENSG00000198830,ENSG00000143321,ENSG00000168395,ENSG00000183598,ENSG00000203811","NA"
"Lytgobi","Futibatinib","Futibatinib","CHEMBL3701238","Taiho Oncology","FGFR kinase inhibitor","Oncology","FGFR2-aberrant intrahepatic cholangiocarcinoma","intrahepatic cholangiocarcinoma","EFO_1001961","Serious","P,O,B,A,F","2022","CHEMBL3701238","ENSG00000068078,ENSG00000066468,ENSG00000077782,ENSG00000160867","ENSG00000039650,ENSG00000068078,ENSG00000076321,ENSG00000077157,ENSG00000092010,ENSG00000100916,ENSG00000101290,ENSG00000104147,ENSG00000106462,ENSG00000109083,ENSG00000113070,ENSG00000115145,ENSG00000118985,ENSG00000125968,ENSG00000127914,ENSG00000131791,ENSG00000136982,ENSG00000140995,ENSG00000144381,ENSG00000148604,ENSG00000151332,ENSG00000152102,ENSG00000159445,ENSG00000160961,ENSG00000163885,ENSG00000166508,ENSG00000167323,ENSG00000169905,ENSG00000170677,ENSG00000172399,ENSG00000173039,ENSG00000173933,ENSG00000179348,ENSG00000183674,ENSG00000187855,ENSG00000205838,ENSG00000225855,ENSG00000004975,ENSG00000069535,ENSG00000095539,ENSG00000095794,ENSG00000099956,ENSG00000100379,ENSG00000102178,ENSG00000106615,ENSG00000109787,ENSG00000110811,ENSG00000111328,ENSG00000117475,ENSG00000117625,ENSG00000118523,ENSG00000118972,ENSG00000119965,ENSG00000123374,ENSG00000124302,ENSG00000136738,ENSG00000140153,ENSG00000141582,ENSG00000143507,ENSG00000143952,ENSG00000147144,ENSG00000147324,ENSG00000147601,ENSG00000147689,ENSG00000153044,ENSG00000158517,ENSG00000163530,ENSG00000163875,ENSG00000166452,ENSG00000166595,ENSG00000166925,ENSG00000167965,ENSG00000171208,ENSG00000171357,ENSG00000171388,ENSG00000177463,ENSG00000185345,ENSG00000185386,ENSG00000186451,ENSG00000198369,ENSG00000204472,ENSG00000204619,ENSG00000240021,ENSG00000240184,ENSG00000242259,ENSG00000244362,ENSG00000264522,ENSG00000060982,ENSG00000069869,ENSG00000070193,ENSG00000072182,ENSG00000084072,ENSG00000092068,ENSG00000113595,ENSG00000116691,ENSG00000120094,ENSG00000131351,ENSG00000132680,ENSG00000134758,ENSG00000134962,ENSG00000136997,ENSG00000139053,ENSG00000139219,ENSG00000140386,ENSG00000140859,ENSG00000147647,ENSG00000148735,ENSG00000150783,ENSG00000156127,ENSG00000160695,ENSG00000163492,ENSG00000163749,ENSG00000163995,ENSG00000164649,ENSG00000165417,ENSG00000166225,ENSG00000166579,ENSG00000171425,ENSG00000175866,ENSG00000181781,ENSG00000183304,ENSG00000184515,ENSG00000185246,ENSG00000185432,ENSG00000185658,ENSG00000185869,ENSG00000203857,ENSG00000204220,ENSG00000010379,ENSG00000079974,ENSG00000093010,ENSG00000099814,ENSG00000100225,ENSG00000100519,ENSG00000102145,ENSG00000104824,ENSG00000107831,ENSG00000113578,ENSG00000116918,ENSG00000126107,ENSG00000130830,ENSG00000143001,ENSG00000149357,ENSG00000155975,ENSG00000160972,ENSG00000162624,ENSG00000168779,ENSG00000170500,ENSG00000175592,ENSG00000177189,ENSG00000183856,ENSG00000198034,ENSG00000212864,ENSG00000288547,ENSG00000040633,ENSG00000065361,ENSG00000071082,ENSG00000072415,ENSG00000075388,ENSG00000087365,ENSG00000088970,ENSG00000089116,ENSG00000102931,ENSG00000104064,ENSG00000104413,ENSG00000104892,ENSG00000105401,ENSG00000108961,ENSG00000115738,ENSG00000120333,ENSG00000124762,ENSG00000130717,ENSG00000130770,ENSG00000136279,ENSG00000136404,ENSG00000136811,ENSG00000141232,ENSG00000141753,ENSG00000142856,ENSG00000143340,ENSG00000143382,ENSG00000143420,ENSG00000145675,ENSG00000154358,ENSG00000156831,ENSG00000158747,ENSG00000160867,ENSG00000162344,ENSG00000164675,ENSG00000165898,ENSG00000166681,ENSG00000168036,ENSG00000170262,ENSG00000170684,ENSG00000177885,ENSG00000179295,ENSG00000183640,ENSG00000184937,ENSG00000187678,ENSG00000244687,ENSG00000278619,ENSG00000011201,ENSG00000011332,ENSG00000017797,ENSG00000041988,ENSG00000064195,ENSG00000073150,ENSG00000075426,ENSG00000078328,ENSG00000100603,ENSG00000102678,ENSG00000104228,ENSG00000111241,ENSG00000115165,ENSG00000123405,ENSG00000129173,ENSG00000129351,ENSG00000131143,ENSG00000137478,ENSG00000138685,ENSG00000140285,ENSG00000140941,ENSG00000144681,ENSG00000146021,ENSG00000147457,ENSG00000154237,ENSG00000154764,ENSG00000158773,ENSG00000162377,ENSG00000164743,ENSG00000168769,ENSG00000170485,ENSG00000171223,ENSG00000174738,ENSG00000177606,ENSG00000178750,ENSG00000182040,ENSG00000184857,ENSG00000185880,ENSG00000186951,ENSG00000187510,ENSG00000236699,ENSG00000066697,ENSG00000068028,ENSG00000092529,ENSG00000096384,ENSG00000103423,ENSG00000104341,ENSG00000107485,ENSG00000118960,ENSG00000121766,ENSG00000123178,ENSG00000124181,ENSG00000124659,ENSG00000125571,ENSG00000126768,ENSG00000127423,ENSG00000129472,ENSG00000134198,ENSG00000134419,ENSG00000137822,ENSG00000140092,ENSG00000140320,ENSG00000149084,ENSG00000151962,ENSG00000152240,ENSG00000152684,ENSG00000162869,ENSG00000163072,ENSG00000163596,ENSG00000164252,ENSG00000165731,ENSG00000167861,ENSG00000168591,ENSG00000170312,ENSG00000177181,ENSG00000180155,ENSG00000181513,ENSG00000186977,ENSG00000187514,ENSG00000187778,ENSG00000198003,ENSG00000198081,ENSG00000229715,ENSG00000257949,ENSG00000260027,ENSG00000002834,ENSG00000054282,ENSG00000066248,ENSG00000066468,ENSG00000067225,ENSG00000070718,ENSG00000077721,ENSG00000077782,ENSG00000089916,ENSG00000096070,ENSG00000099817,ENSG00000101457,ENSG00000111224,ENSG00000111879,ENSG00000116299,ENSG00000119703,ENSG00000123388,ENSG00000123908,ENSG00000125945,ENSG00000131408,ENSG00000131738,ENSG00000133687,ENSG00000134248,ENSG00000138131,ENSG00000140632,ENSG00000146776,ENSG00000147533,ENSG00000147548,ENSG00000154822,ENSG00000157851,ENSG00000158246,ENSG00000166037,ENSG00000166272,ENSG00000167182,ENSG00000167193,ENSG00000169087,ENSG00000170469,ENSG00000170608,ENSG00000171345,ENSG00000173991,ENSG00000178104,ENSG00000178394,ENSG00000179094,ENSG00000182196,ENSG00000183666,ENSG00000185753,ENSG00000197157,ENSG00000203780,ENSG00000249481,ENSG00000039068","EFO_0005221"
"Macrilen","Macimorelin","MACIMORELIN","CHEMBL278623","Aeterna Zentaris","Growth hormone secretagogue receptor agonist","Other indication","Diagnosis of adult growth hormone deficiency","short stature due to GHSR deficiency","MONDO_0014403","Not serious","S,O","2017","CHEMBL278623","ENSG00000121853","ENSG00000121853,ENSG00000121764,ENSG00000116678,ENSG00000147955","NA"
"Margenza","Margetuximab","MARGETUXIMAB","CHEMBL2364649","MacroGenics","HER2-directed mAb","Oncology","HER2-positive breast cancer","HER2 Positive Breast Carcinoma","EFO_1000294","Serious","S,F","2020","CHEMBL2364649","ENSG00000141736","ENSG00000075415,ENSG00000080824,ENSG00000081237,ENSG00000086061,ENSG00000101082,ENSG00000115325,ENSG00000116161,ENSG00000116285,ENSG00000122707,ENSG00000123983,ENSG00000127022,ENSG00000138095,ENSG00000153201,ENSG00000160691,ENSG00000162434,ENSG00000067225,ENSG00000087266,ENSG00000121653,ENSG00000129946,ENSG00000134215,ENSG00000134242,ENSG00000144724,ENSG00000169047,ENSG00000174791,ENSG00000178568,ENSG00000179295,ENSG00000185046,ENSG00000000938,ENSG00000008735,ENSG00000100351,ENSG00000102189,ENSG00000105197,ENSG00000106278,ENSG00000109111,ENSG00000112473,ENSG00000130193,ENSG00000153233,ENSG00000189043,ENSG00000007264,ENSG00000014257,ENSG00000069345,ENSG00000071051,ENSG00000072135,ENSG00000082898,ENSG00000085832,ENSG00000090776,ENSG00000094631,ENSG00000105401,ENSG00000113108,ENSG00000127329,ENSG00000133124,ENSG00000136205,ENSG00000136573,ENSG00000148082,ENSG00000151422,ENSG00000151490,ENSG00000168439,ENSG00000168610,ENSG00000169398,ENSG00000189410,ENSG00000197122,ENSG00000010810,ENSG00000068654,ENSG00000070159,ENSG00000072274,ENSG00000096063,ENSG00000096384,ENSG00000105701,ENSG00000111077,ENSG00000114737,ENSG00000117461,ENSG00000143322,ENSG00000145675,ENSG00000145715,ENSG00000146648,ENSG00000160999,ENSG00000163399,ENSG00000165025,ENSG00000167193,ENSG00000173406,ENSG00000058262,ENSG00000064999,ENSG00000065361,ENSG00000100938,ENSG00000101213,ENSG00000102010,ENSG00000105647,ENSG00000108424,ENSG00000125170,ENSG00000125731,ENSG00000127947,ENSG00000132669,ENSG00000133056,ENSG00000135605,ENSG00000149177,ENSG00000155926,ENSG00000157168,ENSG00000165629,ENSG00000177885,ENSG00000197785,ENSG00000197943,ENSG00000198574,ENSG00000099942,ENSG00000101558,ENSG00000111252,ENSG00000113263,ENSG00000124181,ENSG00000140575,ENSG00000141736,ENSG00000152894,ENSG00000160293,ENSG00000185338,ENSG00000206052,ENSG00000027869,ENSG00000044574,ENSG00000074966,ENSG00000075336,ENSG00000075624,ENSG00000095585,ENSG00000097007,ENSG00000109684,ENSG00000111640,ENSG00000113648,ENSG00000115415,ENSG00000124164,ENSG00000128656,ENSG00000137076,ENSG00000137936,ENSG00000141738,ENSG00000141968,ENSG00000144749,ENSG00000166313","NA"
"Mavyret","Glecaprevir, pibrentasvir","GLECAPREVIR,PIBRENTASVIR","CHEMBL3545363,CHEMBL3545123","AbbVie","NS3/4A protease inhibitor plus a NS5A inhibitor","No human target","HCV","hepatitis C virus infection","EFO_0003047","Serious","P,B,F","2017","CHEMBL3545363,CHEMBL3545123","NA","NA","NA"
"Mayzent","Siponimod","SIPONIMOD","CHEMBL2336071","Novartis","S1P receptor modulator","Other indication","Relapsing forms of multiple sclerosis","relapsing-remitting multiple sclerosis","EFO_0003929","Serious","S","2019","CHEMBL2336071","ENSG00000170989","ENSG00000110848","MONDO_0005301"
"Mekinist","Trametinib","TRAMETINIB","CHEMBL2103875","GSK","MEK1 and MEK2 kinase inhibitor","Oncology","Unresectable or metastatic melanoma with BRAF(V600E) mutation as detected by an FDA-approved test","metastatic melanoma","EFO_0002617","Serious","S,O,F","2013","CHEMBL2103875","ENSG00000126934,ENSG00000169032","ENSG00000067225,ENSG00000127445,ENSG00000134308,ENSG00000164924,ENSG00000166167,ENSG00000172530,ENSG00000075711,ENSG00000100030,ENSG00000101843,ENSG00000108953,ENSG00000132155,ENSG00000141068,ENSG00000166946,ENSG00000171435,ENSG00000172680,ENSG00000175895,ENSG00000128245,ENSG00000102882,ENSG00000121022,ENSG00000166913,ENSG00000109971,ENSG00000134020,ENSG00000124678,ENSG00000170027,ENSG00000028116,ENSG00000127824,ENSG00000157764,ENSG00000078061,ENSG00000137693,ENSG00000165119,ENSG00000142192","EFO_0000756"
"Mektovi","Binimetinib","BINIMETINIB","CHEMBL3187723","Array BioPharma","MEK inhibitor","Oncology","BRAF-mutated melanoma","melanoma","EFO_0000756","Serious","S,O","2018","CHEMBL3187723","ENSG00000169032,ENSG00000126934","ENSG00000028116,ENSG00000078061,ENSG00000108953,ENSG00000124678,ENSG00000134020,ENSG00000134308,ENSG00000172680,ENSG00000127824,ENSG00000141068,ENSG00000075711,ENSG00000121022,ENSG00000127445,ENSG00000166167,ENSG00000157764,ENSG00000170027,ENSG00000109971,ENSG00000142192,ENSG00000165119,ENSG00000171435,ENSG00000172530,ENSG00000175895,ENSG00000102882,ENSG00000132155,ENSG00000166946,ENSG00000067225,ENSG00000100030,ENSG00000101843,ENSG00000128245,ENSG00000137693,ENSG00000164924,ENSG00000166913","NA"
"Mepsevii","Vestronidase alfa","VESTRONIDASEALFA","CHEMBL3707382","Ultragenyx","Recombinant human lysosomal ‚Äö√¢√†‚àö‚â†‚Äö√Ñ√∂‚àö¬¢¬¨√ü-glucuronidase","Other indication","Mucopolysaccharidosis VII","mucopolysaccharidosis type 7","MONDO_0009662","Serious","P,O,F","2017","CHEMBL3707382","ENSG00000169919","ENSG00000169919","NA"
"Monjuvi","Tafasitamab","TAFASITAMAB","CHEMBL4298047","MorphoSys","CD19-directed mAb","Oncology","DLBCL","diffuse large b-cell lymphoma","EFO_0000403","Serious","P,O,B,A,F","2020","CHEMBL4298047","ENSG00000177455","ENSG00000211899","EFO_1001938"
"Motegrity","Prucalopride","PRUCALOPRIDE","CHEMBL117287","Shire/Takeda","5-HT4-receptor agonist","Other indication","Chronic idiopathic constipation","constipation disorder","MONDO_0002203","Not serious","S","2018","CHEMBL117287","ENSG00000164270","ENSG00000164270,ENSG00000170775,ENSG00000204175","NA"
"Mounjaro","Tirzepatide","Tirzepatide","CHEMBL4297839","Eli Lilly","GIP receptor and GLP1 receptor agonist","Other indication","Type 2 diabetes","type 2 diabetes mellitus","MONDO_0005148","Not concordant","S","2022","CHEMBL4297839","ENSG00000010310,ENSG00000112164","ENSG00000115263,ENSG00000221880,ENSG00000197191,ENSG00000221837,ENSG00000272804,ENSG00000187766,ENSG00000264343,ENSG00000286219,ENSG00000159224,ENSG00000186860,ENSG00000188581,ENSG00000254997","Orphanet_79161,HP_0003076"
"Movantik","Naloxegol","NALOXEGOL","CHEMBL2219418","AstraZeneca","Opioid-receptor antagonist","Other indication","Opioid-induced constipation","Constipation","HP_0002019","Not serious","S","2014","CHEMBL2219418","ENSG00000112038","ENSG00000148483,ENSG00000158014,ENSG00000164081,ENSG00000168824,ENSG00000170545,ENSG00000172005,ENSG00000187513,ENSG00000198937,ENSG00000103249,ENSG00000113790,ENSG00000139644,ENSG00000177300,ENSG00000196470,ENSG00000198932,ENSG00000100528,ENSG00000101558,ENSG00000156284,ENSG00000171517,ENSG00000172375,ENSG00000175489,ENSG00000213658,ENSG00000134531,ENSG00000169903,ENSG00000125170,ENSG00000142089,ENSG00000149451,ENSG00000159840,ENSG00000196924,ENSG00000205279,ENSG00000121542,ENSG00000133065,ENSG00000142227,ENSG00000168515,ENSG00000168958,ENSG00000172243,ENSG00000256660,ENSG00000101460,ENSG00000103042,ENSG00000116729,ENSG00000121022,ENSG00000132965,ENSG00000134873,ENSG00000144063,ENSG00000151778,ENSG00000162975,ENSG00000177519,ENSG00000181788,ENSG00000185049,ENSG00000185883,ENSG00000197769,ENSG00000008283,ENSG00000010017,ENSG00000109099,ENSG00000113732,ENSG00000115307,ENSG00000241399,ENSG00000105223","NA"
"Moxidectin","Moxidectin","MOXIDECTIN","CHEMBL2104415","Medicines Development for Global Health","Antihelmintic GABA receptor and glutamate channel modulator","No human target","River blindness","ocular onchocerciasis","EFO_0007398","Not concordant","P,O","2018","CHEMBL2104415","NA","NA","NA"
"Mulpleta","Lusutrombopag","LUSUTROMBOPAG","CHEMBL2107831","Shionogi","Thrombopoietin receptor agonist","Other indication","Thrombocytopenia","thrombocytopenia","HP_0001873","Not concordant","P,F","2018","CHEMBL2107831","ENSG00000117400","ENSG00000096968","NA"
"Myalept","Metreleptin","METRELEPTIN","CHEMBL2107857","Amylin","Leptin analogue","Other indication","Leptin deficiency in patients with congenital or acquired generalized lipodystrophy","congenital generalized lipodystrophy","EFO_1000681","Serious","P,O,F","2014","CHEMBL2107857","ENSG00000116678","ENSG00000121853,ENSG00000174697,ENSG00000149177,ENSG00000116678,ENSG00000121764,ENSG00000179295,ENSG00000081237,ENSG00000150991,ENSG00000213625","NA"
"Natpara","Parathyroid hormone","PARATHYROIDHORMONE","CHEMBL2108078","NPS Pharma","Hormonal injection","Other indication","Hypocalcaemia in patients with hypoparathyroidism","hypoparathyroidism; Hypocalcemia","EFO_0009451,HP_0002901","Not concordant","S,O","2015","CHEMBL2108078","ENSG00000160801","ENSG00000168036,ENSG00000105991,ENSG00000179455,ENSG00000152266,ENSG00000087494,ENSG00000138867,ENSG00000143933,ENSG00000198668,ENSG00000128245,ENSG00000160014,ENSG00000204438,ENSG00000173473,ENSG00000115661,ENSG00000163060","NA"
"Nerlynx","Neratinib","NERATINIB","CHEMBL180022","Puma Biotechnology","EGFR, HER2 and HER4 irreversible kinase inhibitor","Oncology","HER2-overexpressed breast cancer","HER2 Positive Breast Carcinoma","EFO_1000294","Serious","S","2017","CHEMBL180022","ENSG00000146648,ENSG00000141736,ENSG00000178568","ENSG00000011485,ENSG00000067606,ENSG00000075415,ENSG00000080824,ENSG00000081237,ENSG00000086061,ENSG00000100591,ENSG00000101082,ENSG00000104756,ENSG00000110011,ENSG00000115325,ENSG00000116161,ENSG00000116285,ENSG00000122707,ENSG00000123983,ENSG00000124882,ENSG00000127022,ENSG00000135506,ENSG00000135823,ENSG00000138095,ENSG00000138363,ENSG00000139625,ENSG00000150403,ENSG00000153201,ENSG00000159352,ENSG00000160014,ENSG00000160691,ENSG00000162434,ENSG00000163697,ENSG00000167601,ENSG00000170248,ENSG00000178188,ENSG00000184557,ENSG00000185483,ENSG00000197102,ENSG00000198561,ENSG00000198853,ENSG00000012061,ENSG00000033327,ENSG00000044115,ENSG00000067225,ENSG00000067992,ENSG00000087266,ENSG00000100485,ENSG00000100614,ENSG00000101134,ENSG00000103876,ENSG00000105613,ENSG00000105971,ENSG00000105976,ENSG00000120053,ENSG00000121653,ENSG00000127824,ENSG00000129946,ENSG00000130558,ENSG00000131171,ENSG00000134215,ENSG00000134242,ENSG00000142949,ENSG00000144724,ENSG00000145335,ENSG00000164615,ENSG00000164924,ENSG00000169047,ENSG00000169375,ENSG00000170312,ENSG00000174791,ENSG00000177666,ENSG00000178568,ENSG00000179295,ENSG00000182585,ENSG00000183918,ENSG00000184144,ENSG00000185046,ENSG00000185499,ENSG00000198668,ENSG00000198799,ENSG00000204389,ENSG00000214193,ENSG00000000938,ENSG00000008735,ENSG00000011132,ENSG00000069869,ENSG00000078747,ENSG00000096060,ENSG00000096968,ENSG00000100351,ENSG00000102189,ENSG00000103653,ENSG00000105197,ENSG00000105974,ENSG00000106278,ENSG00000106299,ENSG00000109111,ENSG00000112473,ENSG00000113580,ENSG00000114805,ENSG00000126561,ENSG00000130193,ENSG00000130340,ENSG00000132155,ENSG00000136235,ENSG00000137267,ENSG00000142208,ENSG00000153233,ENSG00000154127,ENSG00000154710,ENSG00000158092,ENSG00000160255,ENSG00000165731,ENSG00000166913,ENSG00000168003,ENSG00000168036,ENSG00000174437,ENSG00000184524,ENSG00000186834,ENSG00000189043,ENSG00000196154,ENSG00000198399,ENSG00000240972,ENSG00000004478,ENSG00000006125,ENSG00000007264,ENSG00000014257,ENSG00000046653,ENSG00000061273,ENSG00000069345,ENSG00000071051,ENSG00000072135,ENSG00000080031,ENSG00000082898,ENSG00000085832,ENSG00000087586,ENSG00000090776,ENSG00000094631,ENSG00000101182,ENSG00000102309,ENSG00000105401,ENSG00000105649,ENSG00000109321,ENSG00000111816,ENSG00000113013,ENSG00000113108,ENSG00000115145,ENSG00000118363,ENSG00000123384,ENSG00000127329,ENSG00000133124,ENSG00000136205,ENSG00000136573,ENSG00000136810,ENSG00000138698,ENSG00000140600,ENSG00000142669,ENSG00000148053,ENSG00000148082,ENSG00000151422,ENSG00000151490,ENSG00000151491,ENSG00000153707,ENSG00000154229,ENSG00000154277,ENSG00000154556,ENSG00000159176,ENSG00000159228,ENSG00000162591,ENSG00000162704,ENSG00000168439,ENSG00000168610,ENSG00000169139,ENSG00000169398,ENSG00000170606,ENSG00000171132,ENSG00000172757,ENSG00000174808,ENSG00000175793,ENSG00000175866,ENSG00000176105,ENSG00000182473,ENSG00000185359,ENSG00000185634,ENSG00000189410,ENSG00000196396,ENSG00000197122,ENSG00000198909,ENSG00000204305,ENSG00000253729,ENSG00000008056,ENSG00000010810,ENSG00000039068,ENSG00000043462,ENSG00000050748,ENSG00000068654,ENSG00000070159,ENSG00000071537,ENSG00000072274,ENSG00000096063,ENSG00000096384,ENSG00000100324,ENSG00000105701,ENSG00000106070,ENSG00000107263,ENSG00000107643,ENSG00000109458,ENSG00000111077,ENSG00000113070,ENSG00000114737,ENSG00000117152,ENSG00000117461,ENSG00000124942,ENSG00000126581,ENSG00000131558,ENSG00000132670,ENSG00000132970,ENSG00000137193,ENSG00000137486,ENSG00000140009,ENSG00000141198,ENSG00000141480,ENSG00000143294,ENSG00000143322,ENSG00000144554,ENSG00000145675,ENSG00000145715,ENSG00000146648,ENSG00000149269,ENSG00000149925,ENSG00000158402,ENSG00000160999,ENSG00000163399,ENSG00000165025,ENSG00000167193,ENSG00000167552,ENSG00000173020,ENSG00000173406,ENSG00000175203,ENSG00000182718,ENSG00000184575,ENSG00000186868,ENSG00000188191,ENSG00000196961,ENSG00000034713,ENSG00000058262,ENSG00000064999,ENSG00000065361,ENSG00000085733,ENSG00000090520,ENSG00000092820,ENSG00000095370,ENSG00000100938,ENSG00000101213,ENSG00000102010,ENSG00000102606,ENSG00000104341,ENSG00000105647,ENSG00000107295,ENSG00000107317,ENSG00000108424,ENSG00000111679,ENSG00000115540,ENSG00000120694,ENSG00000125170,ENSG00000125731,ENSG00000127947,ENSG00000130706,ENSG00000132639,ENSG00000132669,ENSG00000133056,ENSG00000133961,ENSG00000135605,ENSG00000142627,ENSG00000143933,ENSG00000149177,ENSG00000155926,ENSG00000157168,ENSG00000161203,ENSG00000163235,ENSG00000165527,ENSG00000165629,ENSG00000166598,ENSG00000170581,ENSG00000177885,ENSG00000182636,ENSG00000183020,ENSG00000197785,ENSG00000197943,ENSG00000198574,ENSG00000204388,ENSG00000213658,ENSG00000250722,ENSG00000014641,ENSG00000057294,ENSG00000067182,ENSG00000091831,ENSG00000099942,ENSG00000101336,ENSG00000101558,ENSG00000104814,ENSG00000110711,ENSG00000111252,ENSG00000112578,ENSG00000113263,ENSG00000116254,ENSG00000124181,ENSG00000124207,ENSG00000126088,ENSG00000127191,ENSG00000132535,ENSG00000134308,ENSG00000137462,ENSG00000137693,ENSG00000138798,ENSG00000140575,ENSG00000141655,ENSG00000141736,ENSG00000142192,ENSG00000148180,ENSG00000152894,ENSG00000160293,ENSG00000169045,ENSG00000170293,ENSG00000170677,ENSG00000178078,ENSG00000185338,ENSG00000206052,ENSG00000027869,ENSG00000044574,ENSG00000074966,ENSG00000075336,ENSG00000075624,ENSG00000077232,ENSG00000088930,ENSG00000092758,ENSG00000095585,ENSG00000097007,ENSG00000100170,ENSG00000100280,ENSG00000103266,ENSG00000104904,ENSG00000105245,ENSG00000106211,ENSG00000109684,ENSG00000110395,ENSG00000111640,ENSG00000111669,ENSG00000113648,ENSG00000115085,ENSG00000115415,ENSG00000115904,ENSG00000117450,ENSG00000123908,ENSG00000124164,ENSG00000128656,ENSG00000130402,ENSG00000131016,ENSG00000131746,ENSG00000134853,ENSG00000135046,ENSG00000135052,ENSG00000135451,ENSG00000137076,ENSG00000137463,ENSG00000137936,ENSG00000141738,ENSG00000141968,ENSG00000144749,ENSG00000145016,ENSG00000146674,ENSG00000147010,ENSG00000149428,ENSG00000151834,ENSG00000154237,ENSG00000157500,ENSG00000173801,ENSG00000185896,ENSG00000254087,ENSG00000254772,ENSG00000269335,ENSG00000015479,ENSG00000042753,ENSG00000085063,ENSG00000109971,ENSG00000110651,ENSG00000166313,ENSG00000182511","NA"
"Nesina","Alogliptin","ALOGLIPTIN","CHEMBL376359","Takeda","DPP4 inhibitor","Other indication","Type 2 diabetes","type 2 diabetes mellitus","MONDO_0005148","Not concordant","S","2013","CHEMBL376359","ENSG00000197635","ENSG00000115263,ENSG00000120937,ENSG00000141433,ENSG00000172156,ENSG00000102962,ENSG00000118702,ENSG00000130640,ENSG00000131096,ENSG00000138755,ENSG00000197635,ENSG00000146469,ENSG00000164082,ENSG00000107562,ENSG00000169245,ENSG00000169248,ENSG00000271503,ENSG00000006128,ENSG00000081041,ENSG00000122585,ENSG00000159224","Orphanet_79161,HP_0003076"
"Netspot","Gallium Ga-68 dotatate","GALLIUMGA-68DOTATATE","CHEMBL4297340","Advanced Accelerator Applications","Radioactive diagnostic","Other indication","Neuroendocrine tumours","neuroendocrine neoplasm","EFO_1001901","Serious","P,O","2016","CHEMBL4297340","ENSG00000180616","ENSG00000141480,ENSG00000162009,ENSG00000145675,ENSG00000278195","NA"
"Neuraceq","Florbetaben-F18","FLORBETABEN-F18","CHEMBL566752","Piramal Imaging","Radioactive diagnostic agent","Other indication","Imaging of the brain to estimate density of neuritic amyloid-beta plaques","neuritic plaque measurement; Alzheimer disease","EFO_0006798,MONDO_0004975","Serious","S","2014","CHEMBL566752","ENSG00000142192","ENSG00000008382,ENSG00000010810,ENSG00000054523,ENSG00000070748,ENSG00000103415,ENSG00000104805,ENSG00000106333,ENSG00000107959,ENSG00000108387,ENSG00000108443,ENSG00000112592,ENSG00000118271,ENSG00000119041,ENSG00000119917,ENSG00000120885,ENSG00000132535,ENSG00000134243,ENSG00000142192,ENSG00000147224,ENSG00000158792,ENSG00000163932,ENSG00000170345,ENSG00000175344,ENSG00000177426,ENSG00000179399,ENSG00000185933,ENSG00000186868,ENSG00000188313,ENSG00000196262,ENSG00000196924,ENSG00000197971,ENSG00000198400,ENSG00000204301,ENSG00000205572,ENSG00000241563,ENSG00000002330,ENSG00000010017,ENSG00000011132,ENSG00000068001,ENSG00000078596,ENSG00000084234,ENSG00000108468,ENSG00000109971,ENSG00000111640,ENSG00000113575,ENSG00000115041,ENSG00000117984,ENSG00000120899,ENSG00000122861,ENSG00000124145,ENSG00000129515,ENSG00000132589,ENSG00000133816,ENSG00000137642,ENSG00000137801,ENSG00000140941,ENSG00000143933,ENSG00000144744,ENSG00000145675,ENSG00000147955,ENSG00000151694,ENSG00000154096,ENSG00000158747,ENSG00000158828,ENSG00000160307,ENSG00000161011,ENSG00000165025,ENSG00000168477,ENSG00000169783,ENSG00000169884,ENSG00000170276,ENSG00000178175,ENSG00000182240,ENSG00000183098,ENSG00000184144,ENSG00000184634,ENSG00000188157,ENSG00000198668,ENSG00000198805,ENSG00000256762,ENSG00000277586,ENSG00000278195,ENSG00000007047,ENSG00000011465,ENSG00000023318,ENSG00000065320,ENSG00000070182,ENSG00000082701,ENSG00000092201,ENSG00000105376,ENSG00000106211,ENSG00000112769,ENSG00000115884,ENSG00000126214,ENSG00000127824,ENSG00000133703,ENSG00000134318,ENSG00000136535,ENSG00000138095,ENSG00000138613,ENSG00000139329,ENSG00000142875,ENSG00000143801,ENSG00000144381,ENSG00000145335,ENSG00000147257,ENSG00000152256,ENSG00000160014,ENSG00000161202,ENSG00000164402,ENSG00000164885,ENSG00000168077,ENSG00000170312,ENSG00000171055,ENSG00000171564,ENSG00000171867,ENSG00000176884,ENSG00000177606,ENSG00000185825,ENSG00000188130,ENSG00000197746,ENSG00000198055,ENSG00000204305,ENSG00000205155,ENSG00000205542,ENSG00000210082,ENSG00000239697,ENSG00000014216,ENSG00000049540,ENSG00000072062,ENSG00000101439,ENSG00000102804,ENSG00000105851,ENSG00000107938,ENSG00000113140,ENSG00000113805,ENSG00000114646,ENSG00000121691,ENSG00000123384,ENSG00000123560,ENSG00000124214,ENSG00000128482,ENSG00000130522,ENSG00000132703,ENSG00000132773,ENSG00000133858,ENSG00000134853,ENSG00000135218,ENSG00000137463,ENSG00000137752,ENSG00000139318,ENSG00000141433,ENSG00000141551,ENSG00000142156,ENSG00000150093,ENSG00000151224,ENSG00000153002,ENSG00000156697,ENSG00000157450,ENSG00000157578,ENSG00000159593,ENSG00000160695,ENSG00000167004,ENSG00000170348,ENSG00000172466,ENSG00000179218,ENSG00000180210,ENSG00000196230,ENSG00000196531,ENSG00000196549,ENSG00000197386,ENSG00000221914,ENSG00000077942,ENSG00000100083,ENSG00000101204,ENSG00000101412,ENSG00000102030,ENSG00000105329,ENSG00000105974,ENSG00000108551,ENSG00000109501,ENSG00000115414,ENSG00000116288,ENSG00000117362,ENSG00000120948,ENSG00000122194,ENSG00000123080,ENSG00000123643,ENSG00000128052,ENSG00000130203,ENSG00000130669,ENSG00000131042,ENSG00000136156,ENSG00000138798,ENSG00000141434,ENSG00000146648,ENSG00000153234,ENSG00000157005,ENSG00000159023,ENSG00000166313,ENSG00000166598,ENSG00000166949,ENSG00000167755,ENSG00000167900,ENSG00000168385,ENSG00000168702,ENSG00000175203,ENSG00000181773,ENSG00000184203,ENSG00000184702,ENSG00000184937,ENSG00000197565,ENSG00000204264,ENSG00000204463,ENSG00000051382,ENSG00000070756,ENSG00000075651,ENSG00000080824,ENSG00000100505,ENSG00000102974,ENSG00000117505,ENSG00000119912,ENSG00000123143,ENSG00000128989,ENSG00000130234,ENSG00000132692,ENSG00000135698,ENSG00000136827,ENSG00000137098,ENSG00000137845,ENSG00000143369,ENSG00000144339,ENSG00000144619,ENSG00000148082,ENSG00000156475,ENSG00000157766,ENSG00000161955,ENSG00000163879,ENSG00000164953,ENSG00000165059,ENSG00000165916,ENSG00000166228,ENSG00000167770,ENSG00000168610,ENSG00000170315,ENSG00000171132,ENSG00000173548,ENSG00000183775,ENSG00000184986,ENSG00000188153,ENSG00000188517,ENSG00000196136,ENSG00000196712,ENSG00000196776,ENSG00000198959,ENSG00000204843,ENSG00000205302,ENSG00000232810,ENSG00000044574,ENSG00000064012,ENSG00000064300,ENSG00000067113,ENSG00000069424,ENSG00000075624,ENSG00000076248,ENSG00000078549,ENSG00000088832,ENSG00000089685,ENSG00000092969,ENSG00000099250,ENSG00000100985,ENSG00000105229,ENSG00000106305,ENSG00000116141,ENSG00000124222,ENSG00000126934,ENSG00000128595,ENSG00000130066,ENSG00000138449,ENSG00000140395,ENSG00000154277,ENSG00000157168,ENSG00000160963,ENSG00000162366,ENSG00000164305,ENSG00000166033,ENSG00000166851,ENSG00000168615,ENSG00000169604,ENSG00000171497,ENSG00000171603,ENSG00000172977,ENSG00000177706,ENSG00000178127,ENSG00000182585,ENSG00000185345,ENSG00000198840,ENSG00000242689,ENSG00000067560,ENSG00000069329,ENSG00000069696,ENSG00000073060,ENSG00000078114,ENSG00000080815,ENSG00000101266,ENSG00000113721,ENSG00000124788,ENSG00000131508,ENSG00000134259,ENSG00000134287,ENSG00000135823,ENSG00000139182,ENSG00000139719,ENSG00000141646,ENSG00000157212,ENSG00000158560,ENSG00000162604,ENSG00000167037,ENSG00000168765,ENSG00000171049,ENSG00000176697,ENSG00000189403,ENSG00000214087,ENSG00000241837,ENSG00000275700,ENSG00000051128,ENSG00000065154,ENSG00000066027,ENSG00000074317,ENSG00000100030,ENSG00000102879,ENSG00000105723,ENSG00000108107,ENSG00000111237,ENSG00000115091,ENSG00000118137,ENSG00000118526,ENSG00000121653,ENSG00000123091,ENSG00000125848,ENSG00000127022,ENSG00000127445,ENSG00000134709,ENSG00000135018,ENSG00000137312,ENSG00000146072,ENSG00000160691,ENSG00000162236,ENSG00000171314,ENSG00000172059,ENSG00000172115,ENSG00000196535,ENSG00000197442,ENSG00000254087,ENSG00000036672,ENSG00000062725,ENSG00000063660,ENSG00000087245,ENSG00000087884,ENSG00000108179,ENSG00000108578,ENSG00000115234,ENSG00000116133,ENSG00000123416,ENSG00000148798,ENSG00000163697,ENSG00000167552,ENSG00000168484,ENSG00000171989,ENSG00000172058,ENSG00000175582,ENSG00000196470,ENSG00000198736,ENSG00000198804,ENSG00000239886,ENSG00000006125,ENSG00000070808,ENSG00000105290,ENSG00000106617,ENSG00000109099,ENSG00000130024,ENSG00000143153,ENSG00000143196,ENSG00000143514,ENSG00000143870,ENSG00000144711,ENSG00000146731,ENSG00000166913,ENSG00000167772,ENSG00000173406,ENSG00000178741,ENSG00000182871,ENSG00000034053,ENSG00000072506,ENSG00000100285,ENSG00000102003,ENSG00000125656,ENSG00000125977,ENSG00000129219,ENSG00000132155,ENSG00000148400,ENSG00000185499,ENSG00000019169,ENSG00000107282,ENSG00000115318,ENSG00000133961,ENSG00000136238,ENSG00000136854,ENSG00000137947,ENSG00000162733,ENSG00000169375,ENSG00000172020,ENSG00000186318,ENSG00000071242,ENSG00000095970,ENSG00000102466,ENSG00000109846,ENSG00000113108,ENSG00000120910,ENSG00000163956,ENSG00000171791,ENSG00000173020,ENSG00000126767,ENSG00000131187,ENSG00000138685,ENSG00000140564,ENSG00000153071,ENSG00000172531,ENSG00000187554","NA"
"Nexletol","Bempedoic acid","BEMPEDOICACID","CHEMBL3545313","Esperion Therapeutics","ACL inhibitor","Other indication","HeFH or atherosclerotic cardiovascular disease","atherosclerosis; familial hypercholesterolemia","EFO_0003914,EFO_0004911","Serious","S","2020","CHEMBL3545313","ENSG00000131473","ENSG00000131473","NA"
"NexoBrid","Anacaulase","Anacaulase","NA","Mediwound","Proteolytic enzymes from pineapple plants","No human target","Eschar removal after thermal burns","NA","NA","NA","S,O","2022","NA","NA","NA","NA"
"Nextstellis","Drospirenone, estetrol","Drospirenone,estetrol","CHEMBL1230314,CHEMBL1509","Mayne Pharma","Spironolactone and oestrogen analogues","Other indication","To prevent pregnancy","reproductive behaviour measurement","EFO_0007862","Not serious","S","2021","CHEMBL1509,CHEMBL1230314","ENSG00000091831,ENSG00000140009,ENSG00000082175,ENSG00000151623","ENSG00000074696,ENSG00000084774,ENSG00000091513,ENSG00000100201,ENSG00000102054,ENSG00000105991,ENSG00000107937,ENSG00000124214,ENSG00000124228,ENSG00000125686,ENSG00000130783,ENSG00000132300,ENSG00000133226,ENSG00000135387,ENSG00000135624,ENSG00000135972,ENSG00000136450,ENSG00000137497,ENSG00000140396,ENSG00000140553,ENSG00000141367,ENSG00000142534,ENSG00000142937,ENSG00000143799,ENSG00000145741,ENSG00000149273,ENSG00000150907,ENSG00000151893,ENSG00000156697,ENSG00000165795,ENSG00000166946,ENSG00000166986,ENSG00000170144,ENSG00000172062,ENSG00000173039,ENSG00000185088,ENSG00000185591,ENSG00000189091,ENSG00000197122,ENSG00000197837,ENSG00000198718,ENSG00000198900,ENSG00000231500,ENSG00000274618,ENSG00000011485,ENSG00000052749,ENSG00000054118,ENSG00000054793,ENSG00000061794,ENSG00000092621,ENSG00000100462,ENSG00000107874,ENSG00000108298,ENSG00000108829,ENSG00000111679,ENSG00000115053,ENSG00000118689,ENSG00000126561,ENSG00000127603,ENSG00000130826,ENSG00000134987,ENSG00000135457,ENSG00000136146,ENSG00000138756,ENSG00000139675,ENSG00000143870,ENSG00000145425,ENSG00000147140,ENSG00000147604,ENSG00000158623,ENSG00000167216,ENSG00000172845,ENSG00000187555,ENSG00000196843,ENSG00000196924,ENSG00000197077,ENSG00000197191,ENSG00000215021,ENSG00000077235,ENSG00000095015,ENSG00000100320,ENSG00000100650,ENSG00000102081,ENSG00000102738,ENSG00000105939,ENSG00000108592,ENSG00000110090,ENSG00000116251,ENSG00000129691,ENSG00000132153,ENSG00000141456,ENSG00000149257,ENSG00000153147,ENSG00000159251,ENSG00000160310,ENSG00000164587,ENSG00000165119,ENSG00000165732,ENSG00000166619,ENSG00000167548,ENSG00000168610,ENSG00000170315,ENSG00000180530,ENSG00000196586,ENSG00000205571,ENSG00000215301,ENSG00000270882,ENSG00000273542,ENSG00000042753,ENSG00000087470,ENSG00000092841,ENSG00000105193,ENSG00000106397,ENSG00000107485,ENSG00000109606,ENSG00000109819,ENSG00000112559,ENSG00000114867,ENSG00000116478,ENSG00000118705,ENSG00000125931,ENSG00000128487,ENSG00000130193,ENSG00000130255,ENSG00000131051,ENSG00000134697,ENSG00000143575,ENSG00000147274,ENSG00000147548,ENSG00000148773,ENSG00000153827,ENSG00000156802,ENSG00000161547,ENSG00000163902,ENSG00000165502,ENSG00000167526,ENSG00000167978,ENSG00000169750,ENSG00000170889,ENSG00000173692,ENSG00000174748,ENSG00000176014,ENSG00000178035,ENSG00000178209,ENSG00000182944,ENSG00000186468,ENSG00000186930,ENSG00000187624,ENSG00000189266,ENSG00000197061,ENSG00000197728,ENSG00000197756,ENSG00000198431,ENSG00000270276,ENSG00000276180,ENSG00000278705,ENSG00000001497,ENSG00000006125,ENSG00000072110,ENSG00000096063,ENSG00000100284,ENSG00000100316,ENSG00000105640,ENSG00000106638,ENSG00000107223,ENSG00000107625,ENSG00000108654,ENSG00000113048,ENSG00000122779,ENSG00000123064,ENSG00000125484,ENSG00000125944,ENSG00000130254,ENSG00000132467,ENSG00000140988,ENSG00000142541,ENSG00000143621,ENSG00000143631,ENSG00000145220,ENSG00000148303,ENSG00000150316,ENSG00000160014,ENSG00000161016,ENSG00000166441,ENSG00000167604,ENSG00000168028,ENSG00000173801,ENSG00000178175,ENSG00000184432,ENSG00000188573,ENSG00000188846,ENSG00000239306,ENSG00000239789,ENSG00000241343,ENSG00000277157,ENSG00000280789,ENSG00000008988,ENSG00000026025,ENSG00000029363,ENSG00000077097,ENSG00000082175,ENSG00000091831,ENSG00000100393,ENSG00000100764,ENSG00000101306,ENSG00000102753,ENSG00000109320,ENSG00000114391,ENSG00000115468,ENSG00000119231,ENSG00000122140,ENSG00000123268,ENSG00000131023,ENSG00000132382,ENSG00000137656,ENSG00000140575,ENSG00000142235,ENSG00000143933,ENSG00000148180,ENSG00000155561,ENSG00000155974,ENSG00000160208,ENSG00000161960,ENSG00000162244,ENSG00000164934,ENSG00000171490,ENSG00000172216,ENSG00000175110,ENSG00000178896,ENSG00000183207,ENSG00000197535,ENSG00000203786,ENSG00000265681,ENSG00000276966,ENSG00000278637,ENSG00000005022,ENSG00000042429,ENSG00000070756,ENSG00000084676,ENSG00000087510,ENSG00000089280,ENSG00000100345,ENSG00000112306,ENSG00000115415,ENSG00000115875,ENSG00000117222,ENSG00000123416,ENSG00000128641,ENSG00000130787,ENSG00000131759,ENSG00000135250,ENSG00000135829,ENSG00000142655,ENSG00000143375,ENSG00000145675,ENSG00000146112,ENSG00000147403,ENSG00000151846,ENSG00000163346,ENSG00000164880,ENSG00000169813,ENSG00000170776,ENSG00000181163,ENSG00000182872,ENSG00000183495,ENSG00000186298,ENSG00000196396,ENSG00000197238,ENSG00000197785,ENSG00000198034,ENSG00000012048,ENSG00000063177,ENSG00000063244,ENSG00000065268,ENSG00000070495,ENSG00000072274,ENSG00000075151,ENSG00000075624,ENSG00000088205,ENSG00000089009,ENSG00000089157,ENSG00000101361,ENSG00000104356,ENSG00000104447,ENSG00000105127,ENSG00000105357,ENSG00000108312,ENSG00000109501,ENSG00000109971,ENSG00000110700,ENSG00000112592,ENSG00000115109,ENSG00000118181,ENSG00000118520,ENSG00000118523,ENSG00000124151,ENSG00000125691,ENSG00000131747,ENSG00000133315,ENSG00000134419,ENSG00000135372,ENSG00000135486,ENSG00000135679,ENSG00000137154,ENSG00000138434,ENSG00000140009,ENSG00000143546,ENSG00000146648,ENSG00000156030,ENSG00000158406,ENSG00000163938,ENSG00000171456,ENSG00000172977,ENSG00000174444,ENSG00000184363,ENSG00000187855,ENSG00000188313,ENSG00000197879,ENSG00000198668,ENSG00000213553,ENSG00000247077,ENSG00000275126,ENSG00000099783,ENSG00000110955,ENSG00000111875,ENSG00000116898,ENSG00000138078,ENSG00000148308,ENSG00000196591","NA"
"Nexviazyme","Avalglucosidase alfa","Avalglucosidasealfa","CHEMBL4594320","Sanofi","Recombinant alpha-glucosidase","Other indication","Pompe disease","glycogen storage disease II","MONDO_0009290","Serious","P,O,B,F","2021","CHEMBL4594320","ENSG00000171298","NA","NA"
"Ninlaro","Ixazomib","IXAZOMIB","CHEMBL2141296","Takeda","Oral proteasome inhibitor","Oncology","Multiple myeloma","multiple myeloma","EFO_0001378","Serious","P,O","2015","CHEMBL2141296","ENSG00000106588,ENSG00000126067,ENSG00000100519,ENSG00000136930,ENSG00000277791,ENSG00000129084,ENSG00000100902,ENSG00000100804,ENSG00000159377,ENSG00000240065,ENSG00000100567,ENSG00000222028,ENSG00000008018,ENSG00000130706,ENSG00000115233,ENSG00000103035,ENSG00000108344,ENSG00000100764,ENSG00000087191,ENSG00000204264,ENSG00000175166,ENSG00000185627,ENSG00000163636,ENSG00000197170,ENSG00000159352,ENSG00000165916,ENSG00000127922,ENSG00000173692,ENSG00000143106,ENSG00000108671,ENSG00000101182,ENSG00000161057,ENSG00000142507,ENSG00000013275,ENSG00000041357,ENSG00000099341,ENSG00000205220,ENSG00000154611","ENSG00000008018,ENSG00000023892,ENSG00000064218,ENSG00000069011,ENSG00000078902,ENSG00000099341,ENSG00000099875,ENSG00000100335,ENSG00000100906,ENSG00000101557,ENSG00000103202,ENSG00000105048,ENSG00000106211,ENSG00000107262,ENSG00000107485,ENSG00000107816,ENSG00000108671,ENSG00000114019,ENSG00000114107,ENSG00000115806,ENSG00000116922,ENSG00000117475,ENSG00000117505,ENSG00000119801,ENSG00000120937,ENSG00000124151,ENSG00000125531,ENSG00000126259,ENSG00000129355,ENSG00000131323,ENSG00000131773,ENSG00000132680,ENSG00000133103,ENSG00000135406,ENSG00000140009,ENSG00000140382,ENSG00000140464,ENSG00000140859,ENSG00000148704,ENSG00000151790,ENSG00000158636,ENSG00000158825,ENSG00000159352,ENSG00000159377,ENSG00000160200,ENSG00000165660,ENSG00000165916,ENSG00000167302,ENSG00000167987,ENSG00000168582,ENSG00000169592,ENSG00000169744,ENSG00000176155,ENSG00000176903,ENSG00000177685,ENSG00000178988,ENSG00000188566,ENSG00000196628,ENSG00000196976,ENSG00000197943,ENSG00000240386,ENSG00000249751,ENSG00000264343,ENSG00000268606,ENSG00000072201,ENSG00000087191,ENSG00000091831,ENSG00000092010,ENSG00000100151,ENSG00000100320,ENSG00000101182,ENSG00000101266,ENSG00000104518,ENSG00000104863,ENSG00000105245,ENSG00000105991,ENSG00000108417,ENSG00000109083,ENSG00000111670,ENSG00000114062,ENSG00000115392,ENSG00000119689,ENSG00000123240,ENSG00000124562,ENSG00000124788,ENSG00000130706,ENSG00000131165,ENSG00000135823,ENSG00000137575,ENSG00000138100,ENSG00000138867,ENSG00000140262,ENSG00000146425,ENSG00000150527,ENSG00000154127,ENSG00000154839,ENSG00000158062,ENSG00000164306,ENSG00000166068,ENSG00000167193,ENSG00000167604,ENSG00000170345,ENSG00000170819,ENSG00000171346,ENSG00000171723,ENSG00000172379,ENSG00000174796,ENSG00000175324,ENSG00000175325,ENSG00000179256,ENSG00000183640,ENSG00000184351,ENSG00000187556,ENSG00000187796,ENSG00000196391,ENSG00000197256,ENSG00000198959,ENSG00000221880,ENSG00000229809,ENSG00000244362,ENSG00000001626,ENSG00000011590,ENSG00000013275,ENSG00000030582,ENSG00000036257,ENSG00000049541,ENSG00000056558,ENSG00000057663,ENSG00000061337,ENSG00000065371,ENSG00000071539,ENSG00000091073,ENSG00000100206,ENSG00000100519,ENSG00000100522,ENSG00000100632,ENSG00000100764,ENSG00000103051,ENSG00000103275,ENSG00000103496,ENSG00000104408,ENSG00000105401,ENSG00000107404,ENSG00000111596,ENSG00000112343,ENSG00000115233,ENSG00000116750,ENSG00000117155,ENSG00000117408,ENSG00000123143,ENSG00000123349,ENSG00000124664,ENSG00000125835,ENSG00000127922,ENSG00000130066,ENSG00000131737,ENSG00000132963,ENSG00000133943,ENSG00000136436,ENSG00000136490,ENSG00000137266,ENSG00000139687,ENSG00000142507,ENSG00000143106,ENSG00000143156,ENSG00000143549,ENSG00000144395,ENSG00000147596,ENSG00000148660,ENSG00000157778,ENSG00000161682,ENSG00000164332,ENSG00000165417,ENSG00000165626,ENSG00000168404,ENSG00000170369,ENSG00000170903,ENSG00000170967,ENSG00000171360,ENSG00000171813,ENSG00000172409,ENSG00000175104,ENSG00000185811,ENSG00000186868,ENSG00000188581,ENSG00000196482,ENSG00000197170,ENSG00000223572,ENSG00000250067,ENSG00000251322,ENSG00000276293,NA,ENSG00000002834,ENSG00000006015,ENSG00000051128,ENSG00000068078,ENSG00000076201,ENSG00000076604,ENSG00000077092,ENSG00000081377,ENSG00000096063,ENSG00000100219,ENSG00000101331,ENSG00000101350,ENSG00000101367,ENSG00000101413,ENSG00000104964,ENSG00000105507,ENSG00000105617,ENSG00000106588,ENSG00000107187,ENSG00000109501,ENSG00000110801,ENSG00000114735,ENSG00000115271,ENSG00000117592,ENSG00000119906,ENSG00000125826,ENSG00000130598,ENSG00000135018,ENSG00000135363,ENSG00000136936,ENSG00000136940,ENSG00000138443,ENSG00000139496,ENSG00000139737,ENSG00000140416,ENSG00000141543,ENSG00000141985,ENSG00000143365,ENSG00000145916,ENSG00000147689,ENSG00000150636,ENSG00000151882,ENSG00000151967,ENSG00000162924,ENSG00000162961,ENSG00000163060,ENSG00000163093,ENSG00000163513,ENSG00000163818,ENSG00000166167,ENSG00000166394,ENSG00000167110,ENSG00000168301,ENSG00000168924,ENSG00000169612,ENSG00000171446,ENSG00000172059,ENSG00000175575,ENSG00000179271,ENSG00000179409,ENSG00000185345,ENSG00000185359,ENSG00000186153,ENSG00000186925,ENSG00000187650,ENSG00000197386,ENSG00000198443,ENSG00000198890,ENSG00000204599,ENSG00000204613,ENSG00000205352,ENSG00000218109,ENSG00000260287,ENSG00000265817,ENSG00000274749,ENSG00000062194,ENSG00000075399,ENSG00000084676,ENSG00000089006,ENSG00000099956,ENSG00000100030,ENSG00000100865,ENSG00000101945,ENSG00000105619,ENSG00000106511,ENSG00000117360,ENSG00000123091,ENSG00000125888,ENSG00000125968,ENSG00000126226,ENSG00000127191,ENSG00000131791,ENSG00000134504,ENSG00000135205,ENSG00000139437,ENSG00000142192,ENSG00000145358,ENSG00000146281,ENSG00000146457,ENSG00000146648,ENSG00000149380,ENSG00000154059,ENSG00000154118,ENSG00000155034,ENSG00000155974,ENSG00000156735,ENSG00000163636,ENSG00000166228,ENSG00000166949,ENSG00000168517,ENSG00000169877,ENSG00000170788,ENSG00000171401,ENSG00000172432,ENSG00000174943,ENSG00000176148,ENSG00000177700,ENSG00000178567,ENSG00000179348,ENSG00000179455,ENSG00000179958,ENSG00000183305,ENSG00000185594,ENSG00000186575,ENSG00000188011,ENSG00000188021,ENSG00000189337,ENSG00000196155,ENSG00000204843,ENSG00000205220,ENSG00000205861,ENSG00000240065,ENSG00000268651,ENSG00000272514,ENSG00000002822,ENSG00000013392,ENSG00000023902,ENSG00000077522,ENSG00000084764,ENSG00000090054,ENSG00000104435,ENSG00000104756,ENSG00000106012,ENSG00000108798,ENSG00000112182,ENSG00000113595,ENSG00000125522,ENSG00000126254,ENSG00000129084,ENSG00000132016,ENSG00000135250,ENSG00000136997,ENSG00000137947,ENSG00000143756,ENSG00000145945,ENSG00000153060,ENSG00000160062,ENSG00000160392,ENSG00000161405,ENSG00000161509,ENSG00000163602,ENSG00000164118,ENSG00000164591,ENSG00000165280,ENSG00000165643,ENSG00000166946,ENSG00000167994,ENSG00000170365,ENSG00000171345,ENSG00000173692,ENSG00000179082,ENSG00000185813,ENSG00000186977,ENSG00000187626,ENSG00000188906,ENSG00000196388,ENSG00000198963,ENSG00000204576,ENSG00000204889,ENSG00000225855,ENSG00000240694,ENSG00000250486,ENSG00000277791,ENSG00000004779,ENSG00000017797,ENSG00000054523,ENSG00000066185,ENSG00000066427,ENSG00000072062,ENSG00000090487,ENSG00000092208,ENSG00000095261,ENSG00000099942,ENSG00000100804,ENSG00000100902,ENSG00000101843,ENSG00000103035,ENSG00000103184,ENSG00000106331,ENSG00000106541,ENSG00000109079,ENSG00000112578,ENSG00000112877,ENSG00000113638,ENSG00000113916,ENSG00000119041,ENSG00000120925,ENSG00000124508,ENSG00000126067,ENSG00000130545,ENSG00000134152,ENSG00000136930,ENSG00000141084,ENSG00000142168,ENSG00000142686,ENSG00000145335,ENSG00000147010,ENSG00000148082,ENSG00000150991,ENSG00000152969,ENSG00000154359,ENSG00000155890,ENSG00000156795,ENSG00000161010,ENSG00000164647,ENSG00000165724,ENSG00000166889,ENSG00000167792,ENSG00000168002,ENSG00000168079,ENSG00000169155,ENSG00000172748,ENSG00000175166,ENSG00000178175,ENSG00000180667,ENSG00000180999,ENSG00000182195,ENSG00000183145,ENSG00000184033,ENSG00000185627,ENSG00000185800,ENSG00000186970,ENSG00000188629,ENSG00000188716,ENSG00000197084,ENSG00000197683,ENSG00000204713,ENSG00000242259,ENSG00000248712,ENSG00000254997,ENSG00000256073,ENSG00000264522,ENSG00000286219,ENSG00000035141,ENSG00000041357,ENSG00000068400,ENSG00000069667,ENSG00000073584,ENSG00000076242,ENSG00000080561,ENSG00000082512,ENSG00000087076,ENSG00000089280,ENSG00000094796,ENSG00000095066,ENSG00000097033,ENSG00000100055,ENSG00000100225,ENSG00000100567,ENSG00000100644,ENSG00000100911,ENSG00000101197,ENSG00000104147,ENSG00000104524,ENSG00000105392,ENSG00000108344,ENSG00000112130,ENSG00000115317,ENSG00000116147,ENSG00000119318,ENSG00000124762,ENSG00000125656,ENSG00000126337,ENSG00000128789,ENSG00000129187,ENSG00000137073,ENSG00000139112,ENSG00000139618,ENSG00000140743,ENSG00000149089,ENSG00000149257,ENSG00000151414,ENSG00000153551,ENSG00000158246,ENSG00000158716,ENSG00000159289,ENSG00000160207,ENSG00000161057,ENSG00000162692,ENSG00000163161,ENSG00000164080,ENSG00000164093,ENSG00000164438,ENSG00000164920,ENSG00000166200,ENSG00000166317,ENSG00000166407,ENSG00000166860,ENSG00000166886,ENSG00000166974,ENSG00000168066,ENSG00000168286,ENSG00000168646,ENSG00000171453,ENSG00000171700,ENSG00000177138,ENSG00000179218,ENSG00000179262,ENSG00000182985,ENSG00000183621,ENSG00000186628,ENSG00000187595,ENSG00000196323,ENSG00000198183,ENSG00000198883,ENSG00000204371,ENSG00000237289,ENSG00000243335,ENSG00000244537,ENSG00000269335,ENSG00000004487,ENSG00000008197,ENSG00000100109,ENSG00000120948,ENSG00000123388,ENSG00000132938,ENSG00000134480,ENSG00000185883","MONDO_0004095"
"Northera","Droxidopa","DROXIDOPA","CHEMBL2103827","Lundbeck","Synthetic amino-acid precursor of noradrenaline; MOA unknown","Other indication","Light-headedness in patients with neurogenic orthostatic hypotension","primary orthostatic hypotension","MONDO_0015914","Not serious","P,O,A,F","2014","CHEMBL2103827","ENSG00000169252,ENSG00000184160,ENSG00000043591,ENSG00000171873,ENSG00000150594,ENSG00000120907,ENSG00000170214,ENSG00000274286,ENSG00000188778","ENSG00000096070,ENSG00000111361,ENSG00000149380,ENSG00000047932,ENSG00000112559,ENSG00000113369,ENSG00000141480,ENSG00000158301,ENSG00000165119,ENSG00000171873,ENSG00000184160,ENSG00000106153,ENSG00000106462,ENSG00000131737,ENSG00000168807,ENSG00000187391,ENSG00000077254,ENSG00000111224,ENSG00000122705,ENSG00000134758,ENSG00000143001,ENSG00000163485,ENSG00000172164,ENSG00000183666,ENSG00000197122,ENSG00000197971,ENSG00000198932,ENSG00000081026,ENSG00000118985,ENSG00000129173,ENSG00000150594,ENSG00000151276,ENSG00000229715,ENSG00000074416,ENSG00000100603,ENSG00000121966,ENSG00000134769,ENSG00000159214,ENSG00000167964,ENSG00000169252,ENSG00000185359,ENSG00000186153,ENSG00000069696,ENSG00000130770,ENSG00000141367,ENSG00000152818,ENSG00000163749,ENSG00000175416,ENSG00000179455,ENSG00000180900,ENSG00000185658,ENSG00000198947,ENSG00000212864,ENSG00000240021,NA,ENSG00000101400,ENSG00000109062,ENSG00000134138,ENSG00000171867,ENSG00000175946,ENSG00000257727,ENSG00000119326","NA"
"Nourianz","Istradefylline","ISTRADEFYLLINE","CHEMBL431770","Kyowa Kirin","Adenosine receptor antagonist","Other indication","Parkinson disease episodes","Parkinson disease","MONDO_0005180","Serious","S","2019","CHEMBL431770","ENSG00000128271","ENSG00000105829,ENSG00000143933,ENSG00000170775,ENSG00000116729,ENSG00000170425,ENSG00000100321,ENSG00000103154,ENSG00000105443,ENSG00000114316,ENSG00000149295,ENSG00000160014,ENSG00000128271,ENSG00000163485,ENSG00000118432,ENSG00000198668","NA"
"Nubeqa","Darolutamide","DAROLUTAMIDE","CHEMBL4297185","Bayer","Androgen receptor inhibitor","Oncology","Prostate cancer","prostate cancer","MONDO_0008315","Serious","P,F","2019","CHEMBL4297185","ENSG00000169083","ENSG00000000938,ENSG00000012817,ENSG00000013561,ENSG00000110092,ENSG00000117450,ENSG00000125686,ENSG00000132437,ENSG00000145675,ENSG00000163565,ENSG00000164190,ENSG00000167548,ENSG00000168036,ENSG00000169291,ENSG00000176105,ENSG00000183918,ENSG00000197122,ENSG00000198646,ENSG00000010671,ENSG00000035720,ENSG00000107338,ENSG00000131746,ENSG00000134954,ENSG00000140396,ENSG00000185634,ENSG00000196684,ENSG00000197943,ENSG00000254087,ENSG00000079308,ENSG00000095585,ENSG00000115641,ENSG00000116030,ENSG00000124151,ENSG00000130522,ENSG00000136826,ENSG00000141867,ENSG00000160293,ENSG00000165025,ENSG00000165458,ENSG00000170365,ENSG00000171988,ENSG00000177885,ENSG00000178028,ENSG00000179295,ENSG00000182866,ENSG00000184557,ENSG00000100351,ENSG00000101213,ENSG00000106462,ENSG00000136504,ENSG00000141027,ENSG00000145715,ENSG00000157554,ENSG00000160691,ENSG00000169083,ENSG00000097007,ENSG00000101336,ENSG00000109685,ENSG00000111837,ENSG00000116288,ENSG00000141738,ENSG00000141968,ENSG00000148180,ENSG00000167193,ENSG00000184634,ENSG00000253729,ENSG00000266412,ENSG00000005339,ENSG00000084676,ENSG00000089280,ENSG00000118058,ENSG00000129514,ENSG00000129691,ENSG00000159388,ENSG00000170677,ENSG00000178585,ENSG00000004478,ENSG00000007264,ENSG00000068024,ENSG00000095370,ENSG00000124181,ENSG00000134215,ENSG00000160973,ENSG00000170734,ENSG00000182511,ENSG00000198574,ENSG00000204209,ENSG00000027869,ENSG00000105647,ENSG00000117461,ENSG00000136573,ENSG00000142515,ENSG00000143322,ENSG00000148082,ENSG00000172977,ENSG00000175215,ENSG00000196363,ENSG00000127870","NA"
"Nucala","Mepolizumab","MEPOLIZUMAB","CHEMBL2108429","GlaxoSmithKline","IL-5 antagonist","Other indication","Serious asthma","Status Asthmaticus","EFO_0008590","Serious","S,F","2015","CHEMBL2108429","ENSG00000113525","ENSG00000100368,ENSG00000091181","MONDO_0004979"
"Nulibry","Fosdenopterin","Fosdenopterin","CHEMBL2338675","BridgeBio","cPMP","Other indication","MoCD type A","sulfite oxidase deficiency due to molybdenum cofactor deficiency","MONDO_0020480","Serious","P,O,B","2021","CHEMBL2338675","ENSG00000164172","ENSG00000164172","NA"
"Nuplazid","Pimavanserin","PIMAVANSERIN","CHEMBL2111101","Acadia Pharmaceuticals","Atypical antipsychotic","Other indication","Hallucinations and delusions associated with Parkinson disease psychosis","Parkinson disease; psychosis","EFO_0005407,MONDO_0005180","Serious","P,B","2016","CHEMBL2111101","ENSG00000102468","ENSG00000135914,ENSG00000164082,ENSG00000107186,ENSG00000102468,ENSG00000147246,ENSG00000118432","NA"
"Nurtec ODT","Rimegepant","RIMEGEPANT","CHEMBL2178422","Biohaven","CGRP receptor antagonist","Other indication","Migraine","migraine disorder","MONDO_0005277","Not serious","S","2020","CHEMBL2178422","ENSG00000064989","ENSG00000148926,ENSG00000110680,ENSG00000131477,ENSG00000132329","NA"
"Nuzyra","Omadacycline","OMADACYCLINE","CHEMBL1689772","Paratek Pharmaceuticals","Tetracycline antibiotic","No human target","CABP and ABSSSI","bacterial pneumonia; skin disease caused by bacterial infection","EFO_1001272,MONDO_0024295","Serious","P,F","2018","CHEMBL1689772","NA","NA","NA"
"Ocaliva","Obeticholic acid","OBETICHOLICACID","CHEMBL566315","Intercept","FXR agonist","Other indication","Primary biliary cholangitis","primary biliary cirrhosis","EFO_1001486","Serious","P,O,A,F","2016","CHEMBL566315","ENSG00000012504","ENSG00000079246,ENSG00000084676,ENSG00000143171,ENSG00000145391,ENSG00000253729,ENSG00000204231,ENSG00000196419","EFO_0001422"
"Ocrevus","Ocrelizumab","OCRELIZUMAB","CHEMBL2108041","Roche/Genentech","CD20-directed cytolytic antibody","Other indication","Relapsing or primary progressive forms of multiple sclerosis","chronic progressive multiple sclerosis","EFO_0003840","Serious","P,B,F","2017","CHEMBL2108041","ENSG00000156738","ENSG00000148110,ENSG00000168685,ENSG00000090661,ENSG00000120370,ENSG00000126251,ENSG00000161609,ENSG00000170509,ENSG00000086159,ENSG00000145283,ENSG00000108960,ENSG00000116514,ENSG00000132563,ENSG00000157613,ENSG00000187783,ENSG00000198189,ENSG00000112212,ENSG00000124103,ENSG00000176946,ENSG00000080189,ENSG00000144648,ENSG00000156738,ENSG00000176435,ENSG00000204308,ENSG00000100652,ENSG00000122033,ENSG00000160856,ENSG00000168476,ENSG00000188167,ENSG00000213593,ENSG00000213921,ENSG00000036565","NA"
"Odomzo","Sonidegib","SONIDEGIB","CHEMBL2105737","Novartis","Smoothened inhibitor","Oncology","Basal cell carcinoma","basal cell carcinoma","EFO_0004193","Not serious","S","2015","CHEMBL2105737","ENSG00000128602","ENSG00000185920,ENSG00000186469","NA"
"Ofev","Nintedanib","NINTEDANIB","CHEMBL502835","Boehringer Ingelheim","Kinase inhibitor against PDGFRs, FGFRs, VEGFRs and FLT3","Other indication","IPF (idiopathic pulmonary fibrosis)","idiopathic pulmonary fibrosis","EFO_0000768","Serious","P,O,B,F","2014","CHEMBL502835","ENSG00000068078,ENSG00000113721,ENSG00000160867,ENSG00000077782,ENSG00000066468,ENSG00000134853,ENSG00000102755,ENSG00000128052,ENSG00000037280","ENSG00000004975,ENSG00000010278,ENSG00000040633,ENSG00000072182,ENSG00000077157,ENSG00000077721,ENSG00000077782,ENSG00000084072,ENSG00000094796,ENSG00000099817,ENSG00000100225,ENSG00000101290,ENSG00000101457,ENSG00000104341,ENSG00000104824,ENSG00000104892,ENSG00000109787,ENSG00000111328,ENSG00000111879,ENSG00000115145,ENSG00000119965,ENSG00000124762,ENSG00000125571,ENSG00000125945,ENSG00000131791,ENSG00000136404,ENSG00000140285,ENSG00000141738,ENSG00000145431,ENSG00000145675,ENSG00000147533,ENSG00000147548,ENSG00000148735,ENSG00000151490,ENSG00000152684,ENSG00000153044,ENSG00000155975,ENSG00000160961,ENSG00000163530,ENSG00000164743,ENSG00000166272,ENSG00000166508,ENSG00000171208,ENSG00000171223,ENSG00000178394,ENSG00000185246,ENSG00000185880,ENSG00000198003,ENSG00000198369,ENSG00000212864,ENSG00000278619,ENSG00000010379,ENSG00000011201,ENSG00000011332,ENSG00000039068,ENSG00000054282,ENSG00000066468,ENSG00000068028,ENSG00000072415,ENSG00000088970,ENSG00000089116,ENSG00000096070,ENSG00000099942,ENSG00000100311,ENSG00000100379,ENSG00000100603,ENSG00000103423,ENSG00000108961,ENSG00000113721,ENSG00000117475,ENSG00000120094,ENSG00000127329,ENSG00000127423,ENSG00000129472,ENSG00000131408,ENSG00000140320,ENSG00000141753,ENSG00000142798,ENSG00000143952,ENSG00000144724,ENSG00000147457,ENSG00000150630,ENSG00000154822,ENSG00000155926,ENSG00000156127,ENSG00000157851,ENSG00000159445,ENSG00000162869,ENSG00000163885,ENSG00000164916,ENSG00000165898,ENSG00000166579,ENSG00000168036,ENSG00000168779,ENSG00000170312,ENSG00000171345,ENSG00000173039,ENSG00000175866,ENSG00000181513,ENSG00000183640,ENSG00000184937,ENSG00000186951,ENSG00000187510,ENSG00000198034,ENSG00000242259,ENSG00000017797,ENSG00000037280,ENSG00000065054,ENSG00000066248,ENSG00000069535,ENSG00000079974,ENSG00000092068,ENSG00000092529,ENSG00000110395,ENSG00000110811,ENSG00000115165,ENSG00000115738,ENSG00000118972,ENSG00000119703,ENSG00000123388,ENSG00000124302,ENSG00000128052,ENSG00000130717,ENSG00000130830,ENSG00000134242,ENSG00000136982,ENSG00000138131,ENSG00000140632,ENSG00000143001,ENSG00000143382,ENSG00000146021,ENSG00000147144,ENSG00000147689,ENSG00000154237,ENSG00000154358,ENSG00000157193,ENSG00000160867,ENSG00000162624,ENSG00000166923,ENSG00000167965,ENSG00000168591,ENSG00000169087,ENSG00000170684,ENSG00000177181,ENSG00000178104,ENSG00000180155,ENSG00000185432,ENSG00000186451,ENSG00000187855,ENSG00000240021,ENSG00000244687,ENSG00000249481,ENSG00000249915,ENSG00000039650,ENSG00000041988,ENSG00000065361,ENSG00000101624,ENSG00000102178,ENSG00000105647,ENSG00000106615,ENSG00000107831,ENSG00000111224,ENSG00000113595,ENSG00000121766,ENSG00000124181,ENSG00000127947,ENSG00000130164,ENSG00000132334,ENSG00000134198,ENSG00000134419,ENSG00000136279,ENSG00000137822,ENSG00000140153,ENSG00000141582,ENSG00000142192,ENSG00000144381,ENSG00000144681,ENSG00000145715,ENSG00000146648,ENSG00000147647,ENSG00000149177,ENSG00000149357,ENSG00000150783,ENSG00000152102,ENSG00000162377,ENSG00000163596,ENSG00000163749,ENSG00000164252,ENSG00000166037,ENSG00000166225,ENSG00000166595,ENSG00000166925,ENSG00000167182,ENSG00000171357,ENSG00000173991,ENSG00000179348,ENSG00000182196,ENSG00000183304,ENSG00000185345,ENSG00000185869,ENSG00000186977,ENSG00000197122,ENSG00000198081,ENSG00000203780,ENSG00000204220,ENSG00000205808,ENSG00000205838,ENSG00000260027,ENSG00000264522,ENSG00000067225,ENSG00000070193,ENSG00000070718,ENSG00000087365,ENSG00000102145,ENSG00000102755,ENSG00000104064,ENSG00000104147,ENSG00000104413,ENSG00000107485,ENSG00000109083,ENSG00000123178,ENSG00000124659,ENSG00000126768,ENSG00000127914,ENSG00000129351,ENSG00000131737,ENSG00000136811,ENSG00000138685,ENSG00000140386,ENSG00000140941,ENSG00000147324,ENSG00000151962,ENSG00000152240,ENSG00000153233,ENSG00000154133,ENSG00000154764,ENSG00000158092,ENSG00000158246,ENSG00000161609,ENSG00000163492,ENSG00000168769,ENSG00000170608,ENSG00000171425,ENSG00000175592,ENSG00000177463,ENSG00000177885,ENSG00000178750,ENSG00000182040,ENSG00000186432,ENSG00000196396,ENSG00000198799,ENSG00000225855,ENSG00000236699,ENSG00000244362,ENSG00000269335,ENSG00000060982,ENSG00000064195,ENSG00000069869,ENSG00000073150,ENSG00000075388,ENSG00000076321,ENSG00000087077,ENSG00000096384,ENSG00000099814,ENSG00000099956,ENSG00000105401,ENSG00000109062,ENSG00000111679,ENSG00000116691,ENSG00000117153,ENSG00000117625,ENSG00000118523,ENSG00000123908,ENSG00000130770,ENSG00000132680,ENSG00000136738,ENSG00000139053,ENSG00000139219,ENSG00000140859,ENSG00000140995,ENSG00000147601,ENSG00000149084,ENSG00000158517,ENSG00000158773,ENSG00000160691,ENSG00000160972,ENSG00000162344,ENSG00000163875,ENSG00000166452,ENSG00000167193,ENSG00000167323,ENSG00000169495,ENSG00000170469,ENSG00000170500,ENSG00000171862,ENSG00000172399,ENSG00000177189,ENSG00000177606,ENSG00000183674,ENSG00000183856,ENSG00000184857,ENSG00000197157,ENSG00000203786,ENSG00000204619,ENSG00000066697,ENSG00000071082,ENSG00000075426,ENSG00000078328,ENSG00000089916,ENSG00000092010,ENSG00000095794,ENSG00000096063,ENSG00000100097,ENSG00000100519,ENSG00000106462,ENSG00000111241,ENSG00000112715,ENSG00000113070,ENSG00000113578,ENSG00000118985,ENSG00000123374,ENSG00000129173,ENSG00000131143,ENSG00000131351,ENSG00000133687,ENSG00000134962,ENSG00000136997,ENSG00000146776,ENSG00000151332,ENSG00000152894,ENSG00000163072,ENSG00000163995,ENSG00000167861,ENSG00000169905,ENSG00000171388,ENSG00000173933,ENSG00000174738,ENSG00000179094,ENSG00000179295,ENSG00000183666,ENSG00000185386,ENSG00000185658,ENSG00000187514,ENSG00000205439,ENSG00000229715,ENSG00000240184,ENSG00000257949,ENSG00000288547,ENSG00000002834,ENSG00000010810,ENSG00000068078,ENSG00000070018,ENSG00000081237,ENSG00000092108,ENSG00000093010,ENSG00000095539,ENSG00000099250,ENSG00000100916,ENSG00000102678,ENSG00000102931,ENSG00000104228,ENSG00000116299,ENSG00000116918,ENSG00000118960,ENSG00000119630,ENSG00000120333,ENSG00000123405,ENSG00000125968,ENSG00000126107,ENSG00000131738,ENSG00000134853,ENSG00000137478,ENSG00000140092,ENSG00000141232,ENSG00000142856,ENSG00000143340,ENSG00000143420,ENSG00000143507,ENSG00000148604,ENSG00000156831,ENSG00000158747,ENSG00000160695,ENSG00000164649,ENSG00000164675,ENSG00000165417,ENSG00000165731,ENSG00000166681,ENSG00000170262,ENSG00000170485,ENSG00000170677,ENSG00000179776,ENSG00000184515,ENSG00000185753,ENSG00000187678,ENSG00000187778,ENSG00000197461,ENSG00000203857,ENSG00000204472,ENSG00000221837,ENSG00000134248,ENSG00000134758,ENSG00000181781","NA"
"Olinvyk","Oliceridine","OLICERIDINE","CHEMBL2443262","Trevena","Opioid receptor agonist","Other indication","Acute pain","pain","EFO_0003843","Not serious","S,F","2020","CHEMBL2443262","ENSG00000112038","ENSG00000008283,ENSG00000168824,ENSG00000177300,ENSG00000185049,ENSG00000197769,ENSG00000133065,ENSG00000148483,ENSG00000158014,ENSG00000162975,ENSG00000169903,ENSG00000196470,ENSG00000205279,ENSG00000113790,ENSG00000121022,ENSG00000125170,ENSG00000144063,ENSG00000168515,ENSG00000171517,ENSG00000113732,ENSG00000115307,ENSG00000149451,ENSG00000172243,ENSG00000172375,ENSG00000175489,ENSG00000101558,ENSG00000105223,ENSG00000109099,ENSG00000116729,ENSG00000134873,ENSG00000142089,ENSG00000156284,ENSG00000164081,ENSG00000181788,ENSG00000185883,ENSG00000187513,ENSG00000198937,ENSG00000103042,ENSG00000134531,ENSG00000151778,ENSG00000159840,ENSG00000172005,ENSG00000196924,ENSG00000213658,ENSG00000256660,ENSG00000100528,ENSG00000121542,ENSG00000139644,ENSG00000142227,ENSG00000170545,ENSG00000198932,ENSG00000241399,ENSG00000010017,ENSG00000101460,ENSG00000103249,ENSG00000132965,ENSG00000168958,ENSG00000177519","NA"
"Olumiant","Baricitinib","BARICITINIB","CHEMBL2105759","Incyte/Eli Lilly","JAK inhibitor","Other indication","Rheumatoid arthritis","rheumatoid arthritis","EFO_0000685","Serious","S","2018","CHEMBL2105759","ENSG00000096968,ENSG00000162434","ENSG00000067225,ENSG00000100368,ENSG00000140941,ENSG00000096968,ENSG00000101460,ENSG00000115415,ENSG00000141736,ENSG00000115145,ENSG00000159110,ENSG00000091181,ENSG00000149177,ENSG00000168610,ENSG00000162434,ENSG00000196396,ENSG00000117400,ENSG00000134352,ENSG00000178188,ENSG00000065361,ENSG00000146648","NA"
"Olysio","Simeprevir","SIMEPREVIR","CHEMBL501849","Janssen","HCV NS3/4A protease inhibitor","No human target","Chronic HCV infection, as a component of a combination antiviral treatment regimen","hepatitis C virus infection","EFO_0003047","Serious","P,F","2013","CHEMBL501849","NA","NA","NA"
"Omegaven","Fish oil triglycerides","FISHOILTRIGLYCERIDES","CHEMBL4297535","Fresenius","Mixture of fatty acids","No human target","Parenteral nutrition-associated cholestasis","cholestasis","MONDO_0001751","Serious","P,O,F","2018","CHEMBL4297535","NA","NA","NA"
"Omlonti","Omidenepag isopropyl","Omidenepagisopropyl","CHEMBL4297666","Santen","Prostaglandin E2 receptor agonist","Other indication","Intraocular pressure in open-angle glaucoma or ocular hypertension","ocular hypertension, open-angle glaucoma","EFO_0004190,EFO_1001069","Serious","S","2022","CHEMBL4297666","ENSG00000125384","NA","NA"
"Ongentys","Opicapone","OPICAPONE","CHEMBL1089318","Neurocrine","COMT inhibitor","Other indication","Parkinson disease","parkinson disease","MONDO_0005180","Serious","S","2020","CHEMBL1089318","ENSG00000093010","ENSG00000071539,ENSG00000103266,ENSG00000126251,ENSG00000137210,ENSG00000148985,ENSG00000164626,ENSG00000177854,ENSG00000276070,ENSG00000039987,ENSG00000068078,ENSG00000102119,ENSG00000109501,ENSG00000125354,ENSG00000133028,ENSG00000148225,ENSG00000169562,ENSG00000189280,ENSG00000103269,ENSG00000105518,ENSG00000106049,ENSG00000126895,ENSG00000142583,ENSG00000143570,ENSG00000145283,ENSG00000174417,ENSG00000175324,ENSG00000182938,ENSG00000188735,ENSG00000204889,ENSG00000205808,ENSG00000005108,ENSG00000092068,ENSG00000118596,ENSG00000152078,ENSG00000157613,ENSG00000161202,ENSG00000185105,ENSG00000185897,ENSG00000235169,ENSG00000003056,ENSG00000004897,ENSG00000113811,ENSG00000146282,ENSG00000165269,ENSG00000166292,ENSG00000005486,ENSG00000111843,ENSG00000124103,ENSG00000133216,ENSG00000139514,ENSG00000163602,ENSG00000182093,ENSG00000183726,ENSG00000211584,ENSG00000099377,ENSG00000108651,ENSG00000117016,ENSG00000118655,ENSG00000165794,ENSG00000168899,ENSG00000169218,ENSG00000176087,ENSG00000188910,ENSG00000213694,ENSG00000049245,ENSG00000094796,ENSG00000100462,ENSG00000143147,ENSG00000148110,ENSG00000148180,ENSG00000168476,ENSG00000172548,ENSG00000175514,ENSG00000186501,ENSG00000188822,ENSG00000189433,ENSG00000196376,ENSG00000254997","NA"
"Onpattro","Patisiran","PATISIRAN","CHEMBL3989987","Alnylam Pharmaceuticals","TTR-directed small interfering RNA","Other indication","Hereditary TTR-mediated amyloidosis","hereditary ATTR amyloidosis","MONDO_0017132","Serious","P,O,B,F","2018","CHEMBL3989987","ENSG00000118271","ENSG00000104413,ENSG00000116039,ENSG00000129103,ENSG00000132016,ENSG00000167770,ENSG00000187037,ENSG00000187678,ENSG00000197153,ENSG00000264522,ENSG00000099864,ENSG00000115239,ENSG00000119537,ENSG00000123154,ENSG00000138207,ENSG00000145675,ENSG00000149557,ENSG00000170035,ENSG00000278828,ENSG00000287080,ENSG00000070476,ENSG00000076321,ENSG00000122042,ENSG00000142192,ENSG00000170004,ENSG00000198959,ENSG00000275379,ENSG00000026025,ENSG00000070061,ENSG00000087250,ENSG00000101911,ENSG00000119614,ENSG00000128272,ENSG00000130294,ENSG00000162852,ENSG00000165188,ENSG00000168936,ENSG00000169136,ENSG00000197409,ENSG00000286522,ENSG00000158941,ENSG00000159459,ENSG00000165171,ENSG00000165898,ENSG00000273983,ENSG00000054611,ENSG00000120253,ENSG00000128609,ENSG00000139372,ENSG00000143379,ENSG00000147724,ENSG00000163563,ENSG00000163885,ENSG00000165637,ENSG00000171055,ENSG00000275714,ENSG00000103154,ENSG00000106772,ENSG00000118271,ENSG00000140743,ENSG00000153885,ENSG00000166595,ENSG00000204305,ENSG00000242247,ENSG00000072415,ENSG00000105472,ENSG00000141030,ENSG00000196220,ENSG00000213380,ENSG00000274750,ENSG00000277775","NA"
"Opdivo","Nivolumab","NIVOLUMAB","CHEMBL2108738","Bristol-Myers Squibb","PD1 inhibitor","Oncology","Unresectable or metastatic melanoma","metastatic melanoma","EFO_0002617","Serious","P,O,B,A,F","2014","CHEMBL2108738","ENSG00000188389","ENSG00000121594,ENSG00000006125,ENSG00000120217,ENSG00000179295,ENSG00000197646","EFO_0000756"
"Opdualag","Relatlimab, nivolumab","Relatlimab,nivolumab","CHEMBL2108738,CHEMBL3990044","Bristol Myers Squibb","LAG3-targeted mAb plus PD1-targeted mAb","Oncology","Melanoma","melanoma","EFO_0000756","Serious","P,O,F","2022","CHEMBL3990044,CHEMBL2108738","ENSG00000188389,ENSG00000089692","ENSG00000006125,ENSG00000179295,ENSG00000120217,NA,ENSG00000197646,ENSG00000121594","NA"
"Opsumit","Macitentan","MACITENTAN","CHEMBL2103873","Actelion","Endothelin receptor antagonist","Other indication","Pulmonary arterial hypertension","pulmonary arterial hypertension","EFO_0001361","Serious","S,O","2013","CHEMBL2103873","ENSG00000136160,ENSG00000151617","NA,ENSG00000137486,ENSG00000141480","EFO_0000537"
"Orbactiv","Oritavancin","ORITAVANCIN","CHEMBL1688530","The Medicines Company","Semi-synthetic lipoglycopeptide","No human target","ABSSSI (Acute Bacterial Skin and Skin Structure Infections)","staphylococcal skin infections","EFO_1001849","Not serious","P","2014","CHEMBL1688530","NA","NA","NA"
"Orgovyx","Relugolix","RELUGOLIX","CHEMBL1800159","Myovant Sciences","GnRH receptor antagonist","Oncology","Prostate cancer","prostate cancer","MONDO_0008315","Serious","P","2020","CHEMBL1800159","ENSG00000109163","NA","NA"
"Orilissa","Elagolix sodium","ELAGOLIXSODIUM","CHEMBL502182","AbbVie","GnRH receptor antagonist","Other indication","Pain associated with endometriosis","adenomyosis; pain","MONDO_0010888,EFO_0003843","Not serious","P","2018","CHEMBL502182","ENSG00000109163","NA","NA"
"Orkambi","Ivacaftor, lumacaftor","IVACAFTOR,LUMACAFTOR","CHEMBL2010601,CHEMBL2103870","Vertex","CFTR potentiator plus CFTR corrector","Other indication","Cystic fibrosis in patients with homozygous DF508 CFTR mutation","cystic fibrosis","MONDO_0009061","Serious","P,O,B,F","2015","CHEMBL2010601,CHEMBL2103870","ENSG00000001626","ENSG00000082898,ENSG00000085063,ENSG00000100097,ENSG00000105568,ENSG00000113013,ENSG00000115484,ENSG00000128607,ENSG00000129083,ENSG00000136986,ENSG00000141510,ENSG00000143793,ENSG00000154582,ENSG00000155660,ENSG00000163468,ENSG00000175166,ENSG00000181163,ENSG00000196236,ENSG00000079246,ENSG00000096384,ENSG00000104783,ENSG00000105202,ENSG00000105835,ENSG00000113368,ENSG00000115268,ENSG00000126247,ENSG00000127022,ENSG00000131051,ENSG00000132646,ENSG00000146731,ENSG00000147140,ENSG00000160213,ENSG00000162909,ENSG00000166986,ENSG00000169045,ENSG00000170421,ENSG00000171793,ENSG00000172354,ENSG00000185825,ENSG00000197191,ENSG00000241685,ENSG00000069345,ENSG00000074800,ENSG00000109062,ENSG00000125844,ENSG00000125868,ENSG00000134333,ENSG00000135829,ENSG00000136153,ENSG00000149257,ENSG00000163220,ENSG00000164022,ENSG00000167815,ENSG00000172725,ENSG00000176014,ENSG00000197321,ENSG00000204308,ENSG00000249915,ENSG00000065150,ENSG00000065978,ENSG00000100345,ENSG00000100911,ENSG00000106366,ENSG00000108107,ENSG00000114353,ENSG00000117450,ENSG00000122566,ENSG00000134308,ENSG00000136628,ENSG00000138107,ENSG00000160789,ENSG00000168488,ENSG00000174437,ENSG00000189091,ENSG00000196419,ENSG00000204389,ENSG00000078369,ENSG00000086061,ENSG00000103363,ENSG00000106305,ENSG00000110880,ENSG00000116641,ENSG00000125970,ENSG00000132109,ENSG00000144381,ENSG00000149925,ENSG00000165280,ENSG00000176105,ENSG00000177731,ENSG00000181789,ENSG00000204388,ENSG00000011304,ENSG00000014216,ENSG00000044574,ENSG00000050405,ENSG00000058262,ENSG00000065054,ENSG00000073578,ENSG00000100764,ENSG00000106484,ENSG00000113194,ENSG00000115806,ENSG00000116560,ENSG00000128595,ENSG00000132589,ENSG00000132612,ENSG00000138594,ENSG00000140945,ENSG00000143549,ENSG00000164924,ENSG00000167553,ENSG00000169813,ENSG00000215301,ENSG00000001626,ENSG00000074696,ENSG00000075624,ENSG00000092820,ENSG00000093167,ENSG00000109133,ENSG00000109572,ENSG00000111057,ENSG00000117592,ENSG00000120265,ENSG00000120438,ENSG00000124207,ENSG00000124614,ENSG00000126803,ENSG00000127481,ENSG00000132341,ENSG00000132912,ENSG00000142871,ENSG00000143546,ENSG00000144713,ENSG00000165119,ENSG00000167085,ENSG00000172053,ENSG00000174502,ENSG00000174827,ENSG00000204628,ENSG00000213741,ENSG00000240972,ENSG00000030582,ENSG00000037474,ENSG00000047932,ENSG00000064547,ENSG00000089159,ENSG00000092199,ENSG00000100591,ENSG00000102119,ENSG00000105141,ENSG00000106211,ENSG00000108424,ENSG00000117906,ENSG00000130255,ENSG00000136238,ENSG00000138071,ENSG00000143556,ENSG00000158710,ENSG00000162244,ENSG00000163902,ENSG00000186716,ENSG00000213719,ENSG00000222038,ENSG00000242372,ENSG00000253729,ENSG00000254772,ENSG00000104824,ENSG00000117868,ENSG00000131620","NA"
"Orladeyo","Berotralstatc","BEROTRALSTAT","CHEMBL4594271","BioCryst","Plasma kallikrein inhibitor","#N/A","Hereditary angioedema","hereditary angioedema","MONDO_0019623","Serious","S,O,F","2020","CHEMBL4594271","ENSG00000164344","ENSG00000229140,ENSG00000115211,ENSG00000196715,ENSG00000126460,ENSG00000144061,ENSG00000110801,ENSG00000113889,ENSG00000152291,ENSG00000172123,ENSG00000100462,ENSG00000103202,ENSG00000147164,ENSG00000269556","NA"
"Osphena","Ospemifene","OSPEMIFENE","CHEMBL2105395","Shionogi","Oestrogen receptor modulator","Other indication","Moderate to Serious dyspareunia due to menopause","Dyspareunia","HP_0030016","Not serious","S","2013","CHEMBL2105395","ENSG00000091831,ENSG00000140009","ENSG00000012048,ENSG00000070495,ENSG00000072274,ENSG00000091513,ENSG00000092841,ENSG00000096063,ENSG00000100320,ENSG00000105357,ENSG00000107937,ENSG00000108312,ENSG00000112559,ENSG00000114867,ENSG00000115109,ENSG00000115415,ENSG00000118181,ENSG00000124214,ENSG00000130787,ENSG00000135372,ENSG00000135387,ENSG00000135972,ENSG00000138434,ENSG00000140009,ENSG00000141367,ENSG00000142534,ENSG00000142541,ENSG00000145425,ENSG00000148308,ENSG00000163938,ENSG00000169813,ENSG00000173801,ENSG00000175110,ENSG00000186468,ENSG00000198668,ENSG00000213553,ENSG00000276180,ENSG00000276966,ENSG00000011485,ENSG00000026025,ENSG00000052749,ENSG00000061794,ENSG00000074696,ENSG00000087470,ENSG00000089157,ENSG00000092621,ENSG00000099783,ENSG00000102753,ENSG00000108298,ENSG00000109320,ENSG00000110955,ENSG00000115468,ENSG00000116898,ENSG00000118689,ENSG00000118705,ENSG00000125484,ENSG00000132300,ENSG00000133315,ENSG00000137497,ENSG00000138756,ENSG00000140988,ENSG00000141456,ENSG00000142235,ENSG00000142937,ENSG00000143621,ENSG00000145741,ENSG00000148773,ENSG00000149257,ENSG00000151846,ENSG00000155561,ENSG00000156697,ENSG00000158406,ENSG00000163902,ENSG00000165502,ENSG00000167978,ENSG00000170144,ENSG00000172845,ENSG00000176014,ENSG00000178896,ENSG00000182872,ENSG00000182944,ENSG00000187555,ENSG00000187855,ENSG00000188573,ENSG00000189091,ENSG00000196924,ENSG00000197061,ENSG00000198718,ENSG00000205571,ENSG00000215301,ENSG00000280789,ENSG00000054793,ENSG00000063177,ENSG00000075151,ENSG00000089280,ENSG00000091831,ENSG00000100201,ENSG00000102081,ENSG00000104447,ENSG00000108829,ENSG00000118520,ENSG00000123268,ENSG00000124151,ENSG00000124228,ENSG00000130826,ENSG00000131051,ENSG00000138078,ENSG00000140553,ENSG00000143375,ENSG00000145675,ENSG00000146648,ENSG00000148303,ENSG00000149273,ENSG00000150316,ENSG00000159251,ENSG00000165119,ENSG00000166619,ENSG00000178209,ENSG00000183207,ENSG00000185088,ENSG00000186930,ENSG00000196396,ENSG00000196591,ENSG00000197122,ENSG00000197837,ENSG00000198900,ENSG00000215021,ENSG00000231500,ENSG00000278637,ENSG00000029363,ENSG00000077097,ENSG00000077235,ENSG00000084676,ENSG00000087510,ENSG00000100316,ENSG00000105991,ENSG00000106397,ENSG00000109606,ENSG00000112306,ENSG00000114391,ENSG00000117222,ENSG00000125944,ENSG00000127603,ENSG00000128641,ENSG00000130193,ENSG00000130783,ENSG00000134697,ENSG00000137656,ENSG00000143631,ENSG00000148180,ENSG00000150907,ENSG00000153147,ENSG00000153827,ENSG00000160310,ENSG00000165795,ENSG00000167526,ENSG00000169750,ENSG00000172062,ENSG00000184432,ENSG00000196586,ENSG00000197077,ENSG00000265681,ENSG00000275126,ENSG00000042429,ENSG00000042753,ENSG00000088205,ENSG00000089009,ENSG00000095015,ENSG00000100345,ENSG00000100393,ENSG00000101361,ENSG00000105127,ENSG00000105939,ENSG00000106638,ENSG00000107485,ENSG00000107625,ENSG00000109501,ENSG00000110090,ENSG00000111875,ENSG00000122140,ENSG00000125686,ENSG00000125931,ENSG00000128487,ENSG00000133226,ENSG00000134987,ENSG00000140396,ENSG00000145220,ENSG00000147604,ENSG00000158623,ENSG00000161960,ENSG00000162244,ENSG00000166441,ENSG00000167604,ENSG00000172216,ENSG00000172977,ENSG00000173692,ENSG00000183495,ENSG00000185591,ENSG00000198431,ENSG00000241343,ENSG00000274618,ENSG00000001497,ENSG00000005022,ENSG00000075624,ENSG00000084774,ENSG00000104356,ENSG00000107223,ENSG00000109971,ENSG00000113048,ENSG00000115053,ENSG00000115875,ENSG00000116251,ENSG00000116478,ENSG00000125691,ENSG00000131023,ENSG00000135250,ENSG00000140575,ENSG00000143575,ENSG00000143933,ENSG00000147140,ENSG00000156802,ENSG00000161547,ENSG00000165732,ENSG00000166946,ENSG00000167216,ENSG00000168028,ENSG00000170315,ENSG00000189266,ENSG00000197238,ENSG00000197535,ENSG00000197785,ENSG00000197879,ENSG00000198034,ENSG00000239789,ENSG00000270276,ENSG00000270882,ENSG00000065268,ENSG00000082175,ENSG00000100284,ENSG00000100462,ENSG00000105640,ENSG00000107874,ENSG00000108592,ENSG00000108654,ENSG00000118523,ENSG00000119231,ENSG00000123064,ENSG00000126561,ENSG00000130254,ENSG00000130255,ENSG00000131747,ENSG00000135457,ENSG00000135486,ENSG00000135624,ENSG00000136146,ENSG00000139675,ENSG00000143799,ENSG00000146112,ENSG00000147274,ENSG00000147403,ENSG00000147548,ENSG00000151893,ENSG00000156030,ENSG00000160014,ENSG00000160208,ENSG00000163346,ENSG00000164587,ENSG00000166986,ENSG00000173039,ENSG00000174444,ENSG00000174748,ENSG00000178035,ENSG00000180530,ENSG00000181163,ENSG00000188313,ENSG00000188846,ENSG00000197191,ENSG00000203786,ENSG00000239306,ENSG00000247077,ENSG00000277157,ENSG00000008988,ENSG00000054118,ENSG00000063244,ENSG00000072110,ENSG00000100650,ENSG00000100764,ENSG00000101306,ENSG00000102054,ENSG00000102738,ENSG00000110700,ENSG00000111679,ENSG00000122779,ENSG00000123416,ENSG00000129691,ENSG00000131759,ENSG00000132153,ENSG00000132382,ENSG00000132467,ENSG00000134419,ENSG00000135679,ENSG00000135829,ENSG00000136450,ENSG00000137154,ENSG00000143546,ENSG00000143870,ENSG00000161016,ENSG00000164880,ENSG00000164934,ENSG00000167548,ENSG00000170776,ENSG00000170889,ENSG00000171456,ENSG00000171490,ENSG00000178175,ENSG00000184363,ENSG00000186298,ENSG00000187624,ENSG00000196843,ENSG00000197728,ENSG00000197756,ENSG00000273542,ENSG00000278705,ENSG00000070756,ENSG00000105193,ENSG00000109819,ENSG00000155974","NA"
"Otezla","Apremilast","APREMILAST","CHEMBL514800","Celgene","Phosphodiesterase 4 inhibitor","Other indication","Psoriatic arthritis and plaque psoriasis","psoriatic arthritis; psoriasis vulgaris","EFO_0003778,EFO_1001494","Serious","S","2014","CHEMBL514800","ENSG00000105650,ENSG00000065989,ENSG00000113448,ENSG00000184588","ENSG00000063515,ENSG00000097033,ENSG00000106511,ENSG00000114395,ENSG00000141480,ENSG00000175676,ENSG00000005893,ENSG00000138794,ENSG00000183629,ENSG00000056558,ENSG00000121058,ENSG00000075142,ENSG00000171509,ENSG00000005102,ENSG00000158571,ENSG00000186908,ENSG00000169548,ENSG00000007372,ENSG00000153684,ENSG00000213809,ENSG00000140961,ENSG00000145358,ENSG00000197172,ENSG00000123240,NA,ENSG00000196504","NA,EFO_0000676"
"Oxbryta","Voxelotor","VOXELOTOR","CHEMBL4101807","Global Blood Therapeutics","Haemoglobin S polymerization inhibitor","Other indication","SCD (sickle cell disease)","sickle cell anemia","MONDO_0011382","Serious","P,O,B,A,F","2019","CHEMBL4101807","ENSG00000188536,ENSG00000206172,ENSG00000244734","ENSG00000176155,ENSG00000130656,ENSG00000131737,ENSG00000169877,ENSG00000196565,ENSG00000204889,ENSG00000213931,ENSG00000164867,ENSG00000244734,ENSG00000223609,ENSG00000286219,ENSG00000086506,ENSG00000094796,ENSG00000100243,ENSG00000117984,ENSG00000188536,ENSG00000206172,ENSG00000206177","NA"
"Oxervate","Cenegermin","CENEGERMIN","CHEMBL4297852","Domp‚Äö√Ñ√∂‚àö‚Ä†‚àö‚àÇ¬¨¬®¬¨¬©","Recombinant NGF","Other indication","Neurotrophic keratitis","keratitis","EFO_0009449","Not serious","P,O,B,F","2018","CHEMBL4297852","ENSG00000140538,ENSG00000198400,ENSG00000148053","ENSG00000058262,ENSG00000084754,ENSG00000096384,ENSG00000135333,ENSG00000142192,ENSG00000206052,ENSG00000071537,ENSG00000124181,ENSG00000144724,ENSG00000145675,ENSG00000148053,ENSG00000127022,ENSG00000146648,ENSG00000162733,ENSG00000151490,ENSG00000160691,ENSG00000006125,ENSG00000081237,ENSG00000134243,ENSG00000161011,ENSG00000196396,ENSG00000127947,ENSG00000134242,ENSG00000149177,ENSG00000067225,ENSG00000127329,ENSG00000140538,ENSG00000177169,ENSG00000206503,ENSG00000105976,ENSG00000134259,ENSG00000198400","NA"
"Oxlumo","Lumasiran","LUMASIRAN","CHEMBL4297779","Alnylam","HAO1-directed siRNA","Other indication","Hyperoxaluria type 1","primary hyperoxaluria type 1","MONDO_0009823","Serious","P,O,B","2020","CHEMBL4297779","ENSG00000101323","NA","NA"
"Ozempic","Semaglutide","SEMAGLUTIDE","CHEMBL2108724","Novo Nordisk","GLP1 receptor agonist","Other indication","Type 2 diabetes mellitus","type 2 diabetes mellitus","MONDO_0005148","Not concordant","S","2017","CHEMBL2108724","ENSG00000112164","ENSG00000221880,ENSG00000197191,ENSG00000221837,ENSG00000272804,ENSG00000187766,ENSG00000264343,ENSG00000286219,ENSG00000186860,ENSG00000188581,ENSG00000254997","Orphanet_79161,HP_0003076"
"PSMA-11 Ga-68","PSMA-11 Ga-68","PSMA-11GA-68","CHEMBL4297335","UCLA","Radioactive diagnostic","Other indication","Imaging, prostate cancer","prostate carcinoma","EFO_0001663","Serious","S","2020","CHEMBL4297335","ENSG00000142515","ENSG00000169083","NA"
"Padcev","Enfortumab vedotin","ENFORTUMABVEDOTIN","CHEMBL3301589","Astellas","Nectin-4-directed ADC","Oncology","Urothelial cancers","urothelial neoplasm","MONDO_0024337","Serious","P,B,A","2019","CHEMBL3301589","ENSG00000167552,ENSG00000176014,ENSG00000123416,ENSG00000167553,ENSG00000127824,ENSG00000196230,ENSG00000104833,ENSG00000137267,ENSG00000188229,ENSG00000258947,ENSG00000198033,ENSG00000101162,ENSG00000137285,ENSG00000261456,ENSG00000152086,ENSG00000143217","ENSG00000084774,ENSG00000086061,ENSG00000091831,ENSG00000097033,ENSG00000126934,ENSG00000136997,ENSG00000147676,ENSG00000155959,ENSG00000156261,ENSG00000161011,ENSG00000188906,ENSG00000196504,ENSG00000204843,ENSG00000265763,ENSG00000277586,ENSG00000102977,ENSG00000114416,ENSG00000129559,ENSG00000131697,ENSG00000136319,ENSG00000145555,NA,ENSG00000069345,ENSG00000116106,ENSG00000123349,ENSG00000126581,ENSG00000141837,ENSG00000145335,ENSG00000156475,ENSG00000163468,ENSG00000164924,ENSG00000166046,ENSG00000166091,ENSG00000166170,ENSG00000170801,ENSG00000177674,ENSG00000178127,ENSG00000183386,ENSG00000186868,ENSG00000204463,ENSG00000080824,ENSG00000090520,ENSG00000102119,ENSG00000124214,ENSG00000133112,ENSG00000142192,ENSG00000143575,ENSG00000162946,ENSG00000166226,ENSG00000167552,ENSG00000196730,ENSG00000254999,ENSG00000268606,ENSG00000005893,ENSG00000026025,ENSG00000100603,ENSG00000105993,ENSG00000112208,ENSG00000114904,ENSG00000115317,ENSG00000120438,ENSG00000123358,ENSG00000138794,ENSG00000143256,ENSG00000146648,ENSG00000160181,ENSG00000167900,ENSG00000177606,ENSG00000179218,ENSG00000182168,ENSG00000183305,ENSG00000001626,ENSG00000054523,ENSG00000083799,ENSG00000110400,ENSG00000115514,ENSG00000123609,ENSG00000127824,ENSG00000151849,ENSG00000176148,ENSG00000065361,ENSG00000094631,ENSG00000102003,ENSG00000109501,ENSG00000119689,ENSG00000130779,ENSG00000142168,ENSG00000143217,ENSG00000146731,ENSG00000150753,ENSG00000166135,ENSG00000258947,ENSG00000092330,ENSG00000103423,ENSG00000104427,ENSG00000106211,ENSG00000115484,ENSG00000123416,ENSG00000133124,ENSG00000135624,ENSG00000139517,ENSG00000147601,ENSG00000151414,ENSG00000152359,ENSG00000167553,ENSG00000173020,ENSG00000177954,ENSG00000197386,ENSG00000204548","NA"
"Palynziq","Pegvaliase","PEGVALIASE","CHEMBL4297802","BioMarin Pharmaceutical","PAL replacement therapy","No human target","Phenylketonuria","phenylketonuria","MONDO_0009861","Serious","P,O,F","2018","CHEMBL4297802","NA","NA","NA"
"Parsabiv","Etelcalcetide","VELCALCETIDE","CHEMBL3545184","Amgen/Kai Pharmaceuticals","Calcium-sensing receptor agonist","Other indication","Secondary hyperparathyroidism in patients with chronic kidney disease on haemodialysis","hyperparathyroidism","EFO_0008506","Not serious","S","2017","CHEMBL3545184","ENSG00000036828","ENSG00000036828,ENSG00000086598","NA"
"Pemazyre","Pemigatinib","PEMIGATINIB","CHEMBL4297522","Incyte","FGFR1-3 kinase inhibitor","Oncology","Cholangiocarcinoma","cholangiocarcinoma","EFO_0005221","Serious","P,O,B,A","2020","CHEMBL4297522","ENSG00000068078,ENSG00000077782,ENSG00000066468","ENSG00000041988,ENSG00000072182,ENSG00000084072,ENSG00000100519,ENSG00000102678,ENSG00000104147,ENSG00000111241,ENSG00000115165,ENSG00000116691,ENSG00000118972,ENSG00000124302,ENSG00000125968,ENSG00000134419,ENSG00000136738,ENSG00000136811,ENSG00000140285,ENSG00000140859,ENSG00000147144,ENSG00000150783,ENSG00000153044,ENSG00000154358,ENSG00000158246,ENSG00000162377,ENSG00000163530,ENSG00000164743,ENSG00000166037,ENSG00000166925,ENSG00000167965,ENSG00000168591,ENSG00000168769,ENSG00000170312,ENSG00000171357,ENSG00000177885,ENSG00000180155,ENSG00000183666,ENSG00000186977,ENSG00000197157,ENSG00000212864,ENSG00000017797,ENSG00000040633,ENSG00000068078,ENSG00000069869,ENSG00000070718,ENSG00000075388,ENSG00000077157,ENSG00000077721,ENSG00000079974,ENSG00000095794,ENSG00000099817,ENSG00000100916,ENSG00000104413,ENSG00000104824,ENSG00000107485,ENSG00000118960,ENSG00000119703,ENSG00000125571,ENSG00000130770,ENSG00000141582,ENSG00000143507,ENSG00000147457,ENSG00000156831,ENSG00000158517,ENSG00000160867,ENSG00000162624,ENSG00000163072,ENSG00000163492,ENSG00000164252,ENSG00000164675,ENSG00000166595,ENSG00000168779,ENSG00000170262,ENSG00000170469,ENSG00000171345,ENSG00000178750,ENSG00000183304,ENSG00000184515,ENSG00000187678,ENSG00000198081,ENSG00000203857,ENSG00000204619,ENSG00000236699,ENSG00000249481,ENSG00000010379,ENSG00000060982,ENSG00000067225,ENSG00000070193,ENSG00000072415,ENSG00000088970,ENSG00000096384,ENSG00000099956,ENSG00000102931,ENSG00000104064,ENSG00000104228,ENSG00000105401,ENSG00000109083,ENSG00000113070,ENSG00000118523,ENSG00000124181,ENSG00000127423,ENSG00000134248,ENSG00000134962,ENSG00000136997,ENSG00000139219,ENSG00000140153,ENSG00000144681,ENSG00000149357,ENSG00000154764,ENSG00000154822,ENSG00000163596,ENSG00000166452,ENSG00000167323,ENSG00000167861,ENSG00000168036,ENSG00000169905,ENSG00000170485,ENSG00000171425,ENSG00000172399,ENSG00000175592,ENSG00000177189,ENSG00000179348,ENSG00000181513,ENSG00000184857,ENSG00000185345,ENSG00000185753,ENSG00000186451,ENSG00000187855,ENSG00000011332,ENSG00000064195,ENSG00000071082,ENSG00000075426,ENSG00000076321,ENSG00000102178,ENSG00000110811,ENSG00000116299,ENSG00000119965,ENSG00000120333,ENSG00000123178,ENSG00000123388,ENSG00000130717,ENSG00000130830,ENSG00000136982,ENSG00000137478,ENSG00000140995,ENSG00000142856,ENSG00000143001,ENSG00000143340,ENSG00000143952,ENSG00000147324,ENSG00000158747,ENSG00000163875,ENSG00000166681,ENSG00000173991,ENSG00000175866,ENSG00000182196,ENSG00000185658,ENSG00000185869,ENSG00000185880,ENSG00000187778,ENSG00000198003,ENSG00000240184,ENSG00000242259,ENSG00000244362,ENSG00000260027,ENSG00000264522,ENSG00000004975,ENSG00000039068,ENSG00000069535,ENSG00000077782,ENSG00000087365,ENSG00000092010,ENSG00000095539,ENSG00000099814,ENSG00000101457,ENSG00000102145,ENSG00000106462,ENSG00000107831,ENSG00000109787,ENSG00000111328,ENSG00000113578,ENSG00000115145,ENSG00000116918,ENSG00000123405,ENSG00000124659,ENSG00000124762,ENSG00000126768,ENSG00000131143,ENSG00000131351,ENSG00000131791,ENSG00000138685,ENSG00000140092,ENSG00000140386,ENSG00000147533,ENSG00000147601,ENSG00000147647,ENSG00000147689,ENSG00000148604,ENSG00000151332,ENSG00000151962,ENSG00000152240,ENSG00000154237,ENSG00000156127,ENSG00000166272,ENSG00000167182,ENSG00000170500,ENSG00000173039,ENSG00000173933,ENSG00000183856,ENSG00000186951,ENSG00000278619,ENSG00000002834,ENSG00000066248,ENSG00000066697,ENSG00000089116,ENSG00000092068,ENSG00000100603,ENSG00000104341,ENSG00000108961,ENSG00000111224,ENSG00000115738,ENSG00000118985,ENSG00000120094,ENSG00000121766,ENSG00000123374,ENSG00000127914,ENSG00000136279,ENSG00000141232,ENSG00000141753,ENSG00000143382,ENSG00000145675,ENSG00000148735,ENSG00000149084,ENSG00000152684,ENSG00000157851,ENSG00000159445,ENSG00000160961,ENSG00000162869,ENSG00000163885,ENSG00000166225,ENSG00000166508,ENSG00000169087,ENSG00000170608,ENSG00000170684,ENSG00000171208,ENSG00000174738,ENSG00000177606,ENSG00000179094,ENSG00000179295,ENSG00000182040,ENSG00000183640,ENSG00000183674,ENSG00000185432,ENSG00000187514,ENSG00000225855,ENSG00000240021,ENSG00000244687,ENSG00000054282,ENSG00000065361,ENSG00000100225,ENSG00000101290,ENSG00000104892,ENSG00000106615,ENSG00000111879,ENSG00000113595,ENSG00000126107,ENSG00000129173,ENSG00000129351,ENSG00000131738,ENSG00000132680,ENSG00000133687,ENSG00000134198,ENSG00000134758,ENSG00000137822,ENSG00000140941,ENSG00000143420,ENSG00000146021,ENSG00000146776,ENSG00000152102,ENSG00000160972,ENSG00000163995,ENSG00000165898,ENSG00000166579,ENSG00000171223,ENSG00000177181,ENSG00000177463,ENSG00000185246,ENSG00000185386,ENSG00000187510,ENSG00000198034,ENSG00000204220,ENSG00000204472,ENSG00000039650,ENSG00000066468,ENSG00000068028,ENSG00000073150,ENSG00000078328,ENSG00000092529,ENSG00000096070,ENSG00000100379,ENSG00000103423,ENSG00000117475,ENSG00000117625,ENSG00000123908,ENSG00000125945,ENSG00000129472,ENSG00000131408,ENSG00000136404,ENSG00000138131,ENSG00000139053,ENSG00000140320,ENSG00000140632,ENSG00000144381,ENSG00000147548,ENSG00000158773,ENSG00000160695,ENSG00000163749,ENSG00000164649,ENSG00000165417,ENSG00000170677,ENSG00000171388,ENSG00000178104,ENSG00000178394,ENSG00000181781,ENSG00000184937,ENSG00000198369,ENSG00000203780,ENSG00000205838,ENSG00000229715,ENSG00000257949,ENSG00000288547,ENSG00000011201,ENSG00000089916,ENSG00000093010,ENSG00000155975,ENSG00000167193","NA"
"Pepaxto","Melphalan flufenamide","Melphalanflufenamide","CHEMBL4303060","Oncopeptides","Peptide-conjugated alkylating drug","NA","Multiple myeloma","multiple myeloma","EFO_0001378","Serious","P,O,A","2021","CHEMBL4303060","NA","NA","MONDO_0004095"
"Pifeltro","Doravirine","DORAVIRINE","CHEMBL2364608","Merck & Co.","NNRTI","No human target","HIV","hiv infection","EFO_0000764","Serious","S","2018","CHEMBL2364608","NA","NA","NA"
"Piqray","Alpelisib","ALPELISIB","CHEMBL2396661","Novartis","PI3K inhibitor","Oncology","Breast cancer","breast cancer","MONDO_0007254","Serious","P","2019","CHEMBL2396661","ENSG00000121879","ENSG00000100368,ENSG00000197386,ENSG00000169047,ENSG00000177885,ENSG00000066427,ENSG00000105647,ENSG00000121879,ENSG00000124788,ENSG00000170145,ENSG00000065361,ENSG00000117461,ENSG00000145675,ENSG00000170345","NA"
"Pizensy","Lactitol","LACTITOL","CHEMBL1661","Braintree Labs","Osmotic laxative","No human target","Chronic idiopathic constipation","Chronic constipation","HP_0012450","Not serious","S","2020","CHEMBL1661","NA","NA","NA"
"Plegridy","Peginterferon beta-1A","PEGINTERFERONBETA-1A","CHEMBL2108677","Biogen Idec","Long-acting interferon-beta1A","Other indication","Relapsing multiple sclerosis","relapsing-remitting multiple sclerosis","EFO_0003929","Serious","S","2014","CHEMBL2108677","ENSG00000142166,ENSG00000159110","ENSG00000170581,ENSG00000005339,ENSG00000072803,ENSG00000188379,ENSG00000177047,ENSG00000213928,ENSG00000162434,ENSG00000105397,ENSG00000115415,ENSG00000159110,ENSG00000104341,ENSG00000204628","MONDO_0005301"
"Pluvicto","Lutetium Lu-177 vipivotide tetraxetan","LutetiumLu-177vipivotidetetraxetan","CHEMBL4594406","Novartis","PSMA-binding radioligand therapeutic agent","Oncology","PSMA-positive prostate cancer","prostate carcinoma","EFO_0001663","Serious","P,B","2022","CHEMBL4594406","ENSG00000142515","ENSG00000169083","NA"
"Polivy","Polatuzumab vedotin","POLATUZUMABVEDOTIN","CHEMBL3301582","Roche","CD79b-directed ADC","Oncology","Diffuse large B-cell lymphoma","diffuse large b-cell lymphoma","EFO_0000403","Serious","P,O,B,A","2019","CHEMBL3301582","ENSG00000137285,ENSG00000196230,ENSG00000167553,ENSG00000258947,ENSG00000167552,ENSG00000123416,ENSG00000104833,ENSG00000152086,ENSG00000198033,ENSG00000101162,ENSG00000137267,ENSG00000127824,ENSG00000007312,ENSG00000176014,ENSG00000188229,ENSG00000261456","ENSG00000116106,ENSG00000119689,ENSG00000123416,ENSG00000129559,ENSG00000135624,ENSG00000145335,ENSG00000151414,ENSG00000161011,ENSG00000186868,ENSG00000123349,ENSG00000123358,ENSG00000123609,ENSG00000131697,ENSG00000139517,ENSG00000141837,ENSG00000162946,ENSG00000166135,ENSG00000167552,ENSG00000183386,ENSG00000196504,ENSG00000277586,ENSG00000007312,ENSG00000026025,ENSG00000104969,ENSG00000105993,ENSG00000112208,ENSG00000120438,ENSG00000127824,ENSG00000163468,ENSG00000177954,ENSG00000258947,ENSG00000001626,ENSG00000080824,ENSG00000086061,ENSG00000102977,ENSG00000114904,ENSG00000133112,ENSG00000143256,ENSG00000152359,ENSG00000166046,ENSG00000170801,ENSG00000177674,ENSG00000188906,ENSG00000065361,ENSG00000083799,ENSG00000091831,ENSG00000100603,ENSG00000102119,ENSG00000114416,ENSG00000115317,ENSG00000126581,ENSG00000126934,ENSG00000130779,ENSG00000136997,ENSG00000138794,ENSG00000143575,ENSG00000146731,ENSG00000147601,ENSG00000177606,ENSG00000183305,ENSG00000197386,NA,ENSG00000005893,ENSG00000090520,ENSG00000092330,ENSG00000102003,ENSG00000104427,ENSG00000106211,ENSG00000133124,ENSG00000156475,ENSG00000160181,ENSG00000166226,ENSG00000167553,ENSG00000176148,ENSG00000182168,ENSG00000197860,ENSG00000254999,ENSG00000265763,ENSG00000054523,ENSG00000069345,ENSG00000094631,ENSG00000097033,ENSG00000103423,ENSG00000136319,ENSG00000145555,ENSG00000146648,ENSG00000151849,ENSG00000156261,ENSG00000166170,ENSG00000167900,ENSG00000179218,ENSG00000204843,ENSG00000268606,ENSG00000084774,ENSG00000109501,ENSG00000115484,ENSG00000115514,ENSG00000124214,ENSG00000142168,ENSG00000142192,ENSG00000147676,ENSG00000150753,ENSG00000155959,ENSG00000164924,ENSG00000173020,ENSG00000178127,ENSG00000196730,ENSG00000204463,ENSG00000166091","EFO_1001938"
"Pomalyst","Pomalidomide","POMALIDOMIDE","CHEMBL43452","Celgene","Immunomodulatory antineoplastic agent","Oncology","Multiple myeloma","multiple myeloma","EFO_0001378","Serious","S,O,F","2013","CHEMBL43452","ENSG00000167986,ENSG00000100387,ENSG00000139842,ENSG00000113851","ENSG00000130311,ENSG00000143164,ENSG00000159069,ENSG00000178691,ENSG00000221864,ENSG00000043093,ENSG00000121022,ENSG00000124788,ENSG00000143207,ENSG00000158290,ENSG00000166266,ENSG00000055130,ENSG00000099364,ENSG00000100991,ENSG00000106462,ENSG00000113851,ENSG00000128908,ENSG00000130766,ENSG00000132716,ENSG00000142784,ENSG00000160963,ENSG00000163960,ENSG00000169727,ENSG00000174842,ENSG00000182308,ENSG00000185811,ENSG00000036672,ENSG00000074266,ENSG00000105717,ENSG00000109320,ENSG00000113712,ENSG00000119599,ENSG00000131508,ENSG00000134086,ENSG00000139842,ENSG00000144524,ENSG00000168209,ENSG00000172059,ENSG00000197386,ENSG00000198945,ENSG00000099804,ENSG00000109099,ENSG00000111652,ENSG00000115415,ENSG00000117222,ENSG00000129559,ENSG00000130725,ENSG00000138081,ENSG00000139990,ENSG00000145604,ENSG00000157110,ENSG00000167986,ENSG00000168090,ENSG00000198612,ENSG00000100387,ENSG00000101442,ENSG00000108094,ENSG00000141030,ENSG00000165280,ENSG00000188906,ENSG00000065717,ENSG00000096384,ENSG00000099812,ENSG00000100897,ENSG00000111530,ENSG00000113558,ENSG00000134574,ENSG00000145041,ENSG00000166192,ENSG00000198876,ENSG00000101349,ENSG00000166333,ENSG00000177885,ENSG00000143476","MONDO_0004095"
"Ponvory","Ponesimod","Ponesimod","CHEMBL1096146","J&J","S1P receptor modulator","Other indication","Relapsing multiple sclerosis","multiple sclerosis","MONDO_0005301","Serious","S","2021","CHEMBL1096146","ENSG00000170989","ENSG00000110848","NA"
"Portrazza","Necitumumab","NECITUMUMAB","CHEMBL1743047","Eli Lilly","EGFR antagonist","Oncology","NSCLC","non-small cell lung carcinoma","EFO_0003060","Serious","S,O,F","2015","CHEMBL1743047","ENSG00000146648","ENSG00000008735,ENSG00000012061,ENSG00000043462,ENSG00000061273,ENSG00000067606,ENSG00000069345,ENSG00000081237,ENSG00000090520,ENSG00000100170,ENSG00000100591,ENSG00000104341,ENSG00000104756,ENSG00000104904,ENSG00000106211,ENSG00000107317,ENSG00000110395,ENSG00000110651,ENSG00000113070,ENSG00000115085,ENSG00000115415,ENSG00000120053,ENSG00000124942,ENSG00000126561,ENSG00000127329,ENSG00000130340,ENSG00000131016,ENSG00000134308,ENSG00000136573,ENSG00000138363,ENSG00000142669,ENSG00000143322,ENSG00000143933,ENSG00000151491,ENSG00000160014,ENSG00000162704,ENSG00000163235,ENSG00000182636,ENSG00000182718,ENSG00000183918,ENSG00000198909,ENSG00000000938,ENSG00000006125,ENSG00000058262,ENSG00000064999,ENSG00000091831,ENSG00000096384,ENSG00000100614,ENSG00000103876,ENSG00000107643,ENSG00000111816,ENSG00000115145,ENSG00000115540,ENSG00000116254,ENSG00000117152,ENSG00000117461,ENSG00000124207,ENSG00000133124,ENSG00000135506,ENSG00000135823,ENSG00000136205,ENSG00000137267,ENSG00000140575,ENSG00000141198,ENSG00000146648,ENSG00000154556,ENSG00000157500,ENSG00000158092,ENSG00000160255,ENSG00000166313,ENSG00000168036,ENSG00000171132,ENSG00000174791,ENSG00000182473,ENSG00000186868,ENSG00000196961,ENSG00000197943,ENSG00000204388,ENSG00000213658,ENSG00000214193,ENSG00000004478,ENSG00000008056,ENSG00000044115,ENSG00000044574,ENSG00000071537,ENSG00000080031,ENSG00000096060,ENSG00000096968,ENSG00000100324,ENSG00000102606,ENSG00000105245,ENSG00000105976,ENSG00000113013,ENSG00000113580,ENSG00000114805,ENSG00000118363,ENSG00000121653,ENSG00000125731,ENSG00000126088,ENSG00000126581,ENSG00000132669,ENSG00000133961,ENSG00000135046,ENSG00000137463,ENSG00000142208,ENSG00000145016,ENSG00000145335,ENSG00000147010,ENSG00000148053,ENSG00000148082,ENSG00000149177,ENSG00000154277,ENSG00000154710,ENSG00000159352,ENSG00000161203,ENSG00000169375,ENSG00000170312,ENSG00000182511,ENSG00000184557,ENSG00000185046,ENSG00000185483,ENSG00000185634,ENSG00000186834,ENSG00000197122,ENSG00000198561,ENSG00000206052,ENSG00000014641,ENSG00000042753,ENSG00000071051,ENSG00000075415,ENSG00000101182,ENSG00000102189,ENSG00000103653,ENSG00000109321,ENSG00000109684,ENSG00000109971,ENSG00000110011,ENSG00000111252,ENSG00000111679,ENSG00000113263,ENSG00000115325,ENSG00000127191,ENSG00000129946,ENSG00000141480,ENSG00000141655,ENSG00000142949,ENSG00000144749,ENSG00000149428,ENSG00000168003,ENSG00000169047,ENSG00000170248,ENSG00000170293,ENSG00000172757,ENSG00000178568,ENSG00000183020,ENSG00000184524,ENSG00000196154,ENSG00000198668,ENSG00000015479,ENSG00000027869,ENSG00000046653,ENSG00000057294,ENSG00000067992,ENSG00000072135,ENSG00000077232,ENSG00000092820,ENSG00000097007,ENSG00000101336,ENSG00000103266,ENSG00000105974,ENSG00000106299,ENSG00000107295,ENSG00000110711,ENSG00000111640,ENSG00000114737,ENSG00000124882,ENSG00000127824,ENSG00000134242,ENSG00000134853,ENSG00000135052,ENSG00000137076,ENSG00000137486,ENSG00000140600,ENSG00000141736,ENSG00000142627,ENSG00000143294,ENSG00000149925,ENSG00000155926,ENSG00000165025,ENSG00000165731,ENSG00000167601,ENSG00000169045,ENSG00000169398,ENSG00000174808,ENSG00000198853,ENSG00000204389,ENSG00000033327,ENSG00000034713,ENSG00000065361,ENSG00000067182,ENSG00000087586,ENSG00000099942,ENSG00000100280,ENSG00000101082,ENSG00000101213,ENSG00000101558,ENSG00000105971,ENSG00000106070,ENSG00000109458,ENSG00000117450,ENSG00000120694,ENSG00000131746,ENSG00000132155,ENSG00000150403,ENSG00000151834,ENSG00000153707,ENSG00000154237,ENSG00000159176,ENSG00000163697,ENSG00000164615,ENSG00000165527,ENSG00000167552,ENSG00000170606,ENSG00000177885,ENSG00000179295,ENSG00000184575,ENSG00000185499,ENSG00000185896,ENSG00000188191,ENSG00000189043,ENSG00000198799,ENSG00000254087,ENSG00000269335,ENSG00000011132,ENSG00000011485,ENSG00000050748,ENSG00000094631,ENSG00000095370,ENSG00000101134,ENSG00000102309,ENSG00000104814,ENSG00000105401,ENSG00000105613,ENSG00000116285,ENSG00000123384,ENSG00000124181,ENSG00000125170,ENSG00000127947,ENSG00000130402,ENSG00000131558,ENSG00000132970,ENSG00000138798,ENSG00000140009,ENSG00000141968,ENSG00000142192,ENSG00000144554,ENSG00000144724,ENSG00000145675,ENSG00000145715,ENSG00000149269,ENSG00000159228,ENSG00000162591,ENSG00000166598,ENSG00000168610,ENSG00000170581,ENSG00000173801,ENSG00000174437,ENSG00000175203,ENSG00000175866,ENSG00000178078,ENSG00000178188,ENSG00000184144,ENSG00000185359,ENSG00000197102,ENSG00000198399,ENSG00000204305,ENSG00000240972,ENSG00000253729,ENSG00000067225,ENSG00000069869,ENSG00000080824,ENSG00000085063,ENSG00000085733,ENSG00000088930,ENSG00000092758,ENSG00000100351,ENSG00000100485,ENSG00000102010,ENSG00000105647,ENSG00000105701,ENSG00000107263,ENSG00000111669,ENSG00000113108,ENSG00000115904,ENSG00000123908,ENSG00000130558,ENSG00000130706,ENSG00000131171,ENSG00000132639,ENSG00000132670,ENSG00000136810,ENSG00000137193,ENSG00000137462,ENSG00000138698,ENSG00000139625,ENSG00000146674,ENSG00000148180,ENSG00000154127,ENSG00000154229,ENSG00000157168,ENSG00000158402,ENSG00000160691,ENSG00000164924,ENSG00000166913,ENSG00000167193,ENSG00000168439,ENSG00000169139,ENSG00000170677,ENSG00000173020,ENSG00000175793,ENSG00000176105,ENSG00000177666,ENSG00000182585,ENSG00000196396,ENSG00000250722,ENSG00000254772,ENSG00000039068,ENSG00000105649,ENSG00000133056,ENSG00000136235","NA"
"Poteligeo","Mogamulizumab","MOGAMULIZUMAB","CHEMBL1743041","Kyowa Hakko Kirin","CCR4 antibody","Oncology","mycosis fungoides or Sezary syndrome","mycosis fungoides","EFO_1001051","Serious","P,O,B","2018","CHEMBL1743041","ENSG00000183813","ENSG00000102970","NA"
"Praluent","Alirocumab","ALIROCUMAB","CHEMBL2109540","Sanofi","PCSK9 inhibitor","Other indication","LDL lowering","low density lipoprotein cholesterol measurement","EFO_0004611","Not serious","P","2015","CHEMBL2109540","ENSG00000169174","ENSG00000177706,ENSG00000130164,ENSG00000087245,ENSG00000182718,ENSG00000169174","NA"
"Praxbind","Idarucizumab","IDARUCIZUMAB","CHEMBL3544996","Boehringer Ingelheim","Dabigatran-binding mAb fragment","No human target","Reversal of anticoagulant effects of dabigatran","response to anticoagulant","GO_0061476","Not serious","P,O,B,A","2015","CHEMBL3544996","NA","NA","NA"
"Pretomanid","Pretomanid","PRETOMANID","CHEMBL227875","Pfizer/Mylan","Antimycobacterial","No human target","Tuberculosis","tuberculosis","MONDO_0018076","Serious","P,O,F","2019","CHEMBL227875","NA","NA","NA"
"Prevymis","Letermovir","LETERMOVIR","CHEMBL1241951","Merck & Co.","CMV DNA terminase complex inhibitor","No human target","Prophylaxis of CMV (cytomegalovirus)","cytomegalovirus infection","EFO_0001062","Serious","P,O,B,F","2017","CHEMBL1241951","NA","NA","NA"
"Pylarify","Piflufolastat F-18","PiflufolastatF-18","CHEMBL4297334","Progenics","Radiolabelled PSMA imaging agent","Other indication","Prostate cancer imaging","prostate carcinoma","EFO_0001663","Serious","P","2021","CHEMBL4297334","ENSG00000086205","ENSG00000114529","NA"
"Pyrukynd","Mitapivat","Mitapivat","CHEMBL4299940","Agios","Pyruvate kinase activator","Other indication","Haemolytic anaemia due to PK deficiency","hemolytic anemia","EFO_0005558","Serious","P,O,F","2022","CHEMBL4299940","ENSG00000143627","ENSG00000178773","NA"
"Qelbree","Viloxazine","Viloxazine","CHEMBL306700","Supernus","SNRI","Other indication","ADHD","attention deficit hyperactivity disorder","EFO_0003888","Not serious","S","2021","CHEMBL306700","ENSG00000103546","ENSG00000100151","NA"
"Qinlock","Ripretinib","RIPRETINIB","CHEMBL4216467","Deciphera","KIT and PDGFRA kinase inhibitor","Oncology","GIST","gastrointestinal stromal tumor","MONDO_0011719","Serious","P,O,B,F","2020","CHEMBL4216467","ENSG00000157404,ENSG00000134853","ENSG00000049130,ENSG00000097007,ENSG00000100351,ENSG00000101213,ENSG00000111077,ENSG00000136573,ENSG00000137936,ENSG00000145715,ENSG00000170677,ENSG00000197461,ENSG00000105647,ENSG00000171150,ENSG00000136205,ENSG00000161609,ENSG00000176105,ENSG00000179295,ENSG00000184557,ENSG00000196684,ENSG00000197943,ENSG00000074966,ENSG00000096063,ENSG00000117461,ENSG00000120833,ENSG00000143322,ENSG00000145431,ENSG00000160691,ENSG00000000938,ENSG00000027869,ENSG00000071051,ENSG00000095585,ENSG00000107338,ENSG00000111252,ENSG00000124181,ENSG00000134215,ENSG00000158092,ENSG00000198574,ENSG00000067225,ENSG00000115085,ENSG00000135605,ENSG00000145675,ENSG00000167193,ENSG00000197122,ENSG00000254087,ENSG00000035720,ENSG00000092108,ENSG00000095370,ENSG00000101082,ENSG00000101336,ENSG00000129946,ENSG00000141738,ENSG00000142192,ENSG00000149177,ENSG00000165025,ENSG00000177885,ENSG00000182511,ENSG00000183918,ENSG00000087266,ENSG00000099942,ENSG00000100311,ENSG00000113721,ENSG00000146648,ENSG00000148082,ENSG00000182866,ENSG00000185634,ENSG00000205808,ENSG00000079308","NA"
"Qulipta","Atogepant","Atogepant","CHEMBL3991065","AbbVie","CGRP receptor antagonist","Other indication","Episodic migraine","migraine disorder","MONDO_0005277","Not serious","S","2021","CHEMBL3991065","ENSG00000064989","ENSG00000148926,ENSG00000110680,ENSG00000131477,ENSG00000132329","NA"
"Quviviq","Daridorexant","Daridorexant","CHEMBL4297590","Idorsia","Orexin receptor antagonist","Other indication","Insomnia","insomnia","EFO_0004698","Not serious","S","2022","CHEMBL4297590","ENSG00000121764,ENSG00000137252","ENSG00000121853,ENSG00000196262,ENSG00000116678","EFO_0005271,EFO_0008568"
"Radicava","Edaravone","EDARAVONE","CHEMBL290916","Mitsubishi Tanabe","Unknown (radical scavenger)","No human target","ALS (amyotrophic lateral sclerosis)","amyotrophic lateral sclerosis","MONDO_0004976","Serious","S,O","2017","CHEMBL290916","NA","NA","NA"
"Rapivab","Peramivir","PERAMIVIR,PERAMIVIR","CHEMBL3989402,CHEMBL139367","BioCryst","Neuraminidase inhibitor","No human target","Influenza infection","influenza","EFO_0007328","Not serious","S,F","2014","CHEMBL3989402,CHEMBL139367","NA","NA","NA"
"Reblozyl","Luspatercept","LUSPATERCEPT","CHEMBL3039545","Celgene/BMS","Erythroid maturation agent","Other indication","Anaemia in beta-thalassaemia","beta thalassemia; anemia","MONDO_0002280,MONDO_0019402","Serious","P,O,F","2019","CHEMBL3039545","ENSG00000105329,ENSG00000092969,ENSG00000119699","ENSG00000049323,ENSG00000105991,ENSG00000173714,ENSG00000175294,ENSG00000159455,ENSG00000160305,ENSG00000185962,ENSG00000187238,ENSG00000142192,ENSG00000183668,ENSG00000231924,ENSG00000106511,ENSG00000137507,ENSG00000163202,ENSG00000186844,ENSG00000212721,ENSG00000106799,ENSG00000106991,ENSG00000138448,ENSG00000187180,ENSG00000197191,ENSG00000076248,ENSG00000138615,ENSG00000188581,ENSG00000151615,ENSG00000105329,ENSG00000130475,ENSG00000137801,ENSG00000197084,ENSG00000119699,ENSG00000143382,ENSG00000172155,ENSG00000163430,ENSG00000069702,ENSG00000110031,ENSG00000163513,ENSG00000185624,ENSG00000187766,ENSG00000221880,ENSG00000127578","NA"
"Recarbrio","Cilastatin, imipenem, relebactam","CILASTATIN,IMIPENEM,RELEBACTAM","CHEMBL766,CHEMBL148,CHEMBL3301605","Merck & Co.","A renal dehydropeptidase inhibitor, a penem antibacterial and a beta-lactamase inhibitor","No human target","Complicated urinary tract and complicated intra-abdominal infections","urinary tract infection","EFO_0003103","Not serious","P,F","2019","CHEMBL766,CHEMBL148,CHEMBL3301605","ENSG00000015413,NA","ENSG00000062725,ENSG00000198954,NA","NA"
"Relyvrio","Sodium phenylbutyrate, taurursodiol","Sodiumphenylbutyrate,taurursodiol","CHEMBL1746,CHEMBL272427","Amylyx","Mechanism unknown","No human target","Amyotrophic lateral sclerosis","amyotrophic lateral sclerosis","MONDO_0004976","Serious","P,O","2022","CHEMBL1746,CHEMBL272427","NA","NA","NA"
"Repatha","Evolocumab","EVOLOCUMAB","CHEMBL2364655","Amgen","PCSK9 inhibitor","Other indication","LDL lowering","LDL cholesterol change measurement","EFO_0007804","Not serious","S,O","2015","CHEMBL2364655","ENSG00000169174","ENSG00000087245,ENSG00000177706,ENSG00000130164,ENSG00000169174,ENSG00000182718","NA"
"Retevmo","Selpercatinib","SELPERCATINIB","CHEMBL4559134","Eli Lilly/Loxo Oncology","RET kinase inhibitor","Oncology","RET fusion-positive NSCLC and thyroid cancer","non-small cell lung carcinoma; thyroid cancer","EFO_0003060,MONDO_0002108","Serious","P,O,B,A","2020","CHEMBL4559134","ENSG00000108091,ENSG00000165731,ENSG00000170759","ENSG00000023608,ENSG00000104695,ENSG00000109670,ENSG00000110395,ENSG00000115641,ENSG00000120896,ENSG00000127445,ENSG00000132938,ENSG00000134308,ENSG00000141013,ENSG00000160207,ENSG00000107187,ENSG00000124181,ENSG00000154845,ENSG00000160867,ENSG00000170027,ENSG00000188191,ENSG00000005249,ENSG00000031691,ENSG00000102021,ENSG00000106511,ENSG00000140382,ENSG00000146648,ENSG00000171094,ENSG00000196391,ENSG00000007372,ENSG00000108091,ENSG00000137076,ENSG00000138136,ENSG00000156735,ENSG00000164305,ENSG00000177842,ENSG00000179562,ENSG00000106536,ENSG00000149923,ENSG00000163820,ENSG00000170759,ENSG00000264343,ENSG00000106052,ENSG00000127903,ENSG00000164924,ENSG00000223501,ENSG00000196150,ENSG00000128245,ENSG00000180447,ENSG00000105568,ENSG00000160062,ENSG00000165731,ENSG00000067225,ENSG00000100055,ENSG00000166484,ENSG00000168002,ENSG00000168610,ENSG00000101266,ENSG00000106785,ENSG00000149806,ENSG00000154237,ENSG00000163126,ENSG00000169136,ENSG00000269335,ENSG00000017797,ENSG00000096401,ENSG00000100109,ENSG00000140743,ENSG00000148356,ENSG00000113575,ENSG00000166913","NA"
"Revcovi","Elapegademase","ELAPEGADEMASE","CHEMBL3990026","Leadiant Biosciences","Recombinant adenosine deaminase","Other indication","ADA-SCID","Serious combined immunodeficiency, autosomal recessive, t cell-negative, b cell-negative, nk cell-negative, due to adenosine deaminase deficiency","MONDO_0007064","Serious","P,O,F","2018","CHEMBL3990026","ENSG00000196839","NA","NA"
"Rexulti","Brexpiprazole","BREXPIPRAZOLE","CHEMBL2105760","Otsuka","Atypical antipsychotic","Other indication","MDD and schizophrenia","major depressive disorder; schizophrenia","MONDO_0002009,MONDO_0005090","Serious","S","2015","CHEMBL2105760","ENSG00000102468,ENSG00000178394,ENSG00000149295","ENSG00000102468,ENSG00000077782,ENSG00000147955,ENSG00000166573,ENSG00000164082,ENSG00000135914,ENSG00000149295,ENSG00000107186,ENSG00000118432,ENSG00000162946,ENSG00000142319,ENSG00000183840,ENSG00000128271,ENSG00000078369,ENSG00000147246","NA"
"Reyvow","Lasmiditan","LASMIDITAN","CHEMBL3039520","Eli Lilly","Serotonin (5-HT) 1F receptor agonist","Other indication","Migraine with or without aura","migraine disorder","MONDO_0005277","Not serious","S","2019","CHEMBL3039520","ENSG00000179097","NA","NA"
"Rezlidhia","Olutasidenib","Olutasidenib","CHEMBL4297610","Rigel/Forma","IDH1 inhibitor","Oncology","IDH1-mutated AML","acute myeloid leukemia","EFO_0000222","Serious","S,O","2022","CHEMBL4297610","ENSG00000138413","ENSG00000149257,ENSG00000114062,ENSG00000072062,ENSG00000261371,ENSG00000151414,ENSG00000179218,ENSG00000119689,ENSG00000138413,ENSG00000163513,ENSG00000198668","NA"
"Rezurock","Belumosudil","Belumosudil","CHEMBL2005186","Kadmon","ROCK2 kinase inhibitor","Other indication","Chronic GVHD","graft versus host disease","MONDO_0013730","Serious","P,O,B","2021","CHEMBL2005186","ENSG00000067900,ENSG00000134318","ENSG00000150510,ENSG00000168610,ENSG00000133055,ENSG00000074319,ENSG00000120289,ENSG00000135363,ENSG00000272514,ENSG00000140992,ENSG00000067560,ENSG00000067900,ENSG00000173457,ENSG00000186141,ENSG00000213341,ENSG00000171877,ENSG00000142192","NA"
"Rhopressa","Netarsudil","NETARSUDIL","CHEMBL4594250","Aerie Pharmaceuticals","RHO kinase inhibitor","Other indication","Open-angle glaucoma or ocular hypertension","open-angle glaucoma; ocular hypertension","EFO_0004190,EFO_1001069","Serious","P","2017","CHEMBL4594250","ENSG00000067900,ENSG00000134318","ENSG00000067900,ENSG00000074319,ENSG00000135363,ENSG00000213341,ENSG00000067560,ENSG00000140992,ENSG00000150510,ENSG00000120289,ENSG00000133055,ENSG00000186141,ENSG00000173457,ENSG00000171877,ENSG00000142192,ENSG00000272514,ENSG00000168610","NA"
"Rinvoq","Upadacitinib","UPADACITINIB","CHEMBL3622821","AbbVie","JAK inhibitor","Other indication","Rheumatoid arthritis","rheumatoid arthritis","EFO_0000685","Serious","S","2019","CHEMBL3622821","ENSG00000105639,ENSG00000096968,ENSG00000105397,ENSG00000162434","ENSG00000067225,ENSG00000076604,ENSG00000104517,ENSG00000100368,ENSG00000102316,ENSG00000140941,ENSG00000142166,ENSG00000197191,ENSG00000096968,ENSG00000101460,ENSG00000115415,ENSG00000115484,ENSG00000120438,ENSG00000131196,ENSG00000141736,ENSG00000156261,ENSG00000204889,ENSG00000096384,ENSG00000115145,ENSG00000159110,ENSG00000183386,ENSG00000072201,ENSG00000091181,ENSG00000103266,ENSG00000105639,ENSG00000149177,ENSG00000165119,ENSG00000168610,ENSG00000143514,ENSG00000146731,ENSG00000162434,ENSG00000196396,ENSG00000269335,ENSG00000106541,ENSG00000112232,ENSG00000117400,ENSG00000131773,ENSG00000134352,ENSG00000178188,ENSG00000187109,ENSG00000205531,ENSG00000011243,ENSG00000065361,ENSG00000087460,ENSG00000094796,ENSG00000138738,ENSG00000146648,ENSG00000170581,ENSG00000197978","NA"
"Rolvedon","Eflapegrastim","Eflapegrastim","CHEMBL3833384","Spectrum","Leukocyte growth factor","Other indication","Incidence of infection in non-myeloid malignancies, with myelosuppressive drugs","infection","EFO_0000544","Serious","S","2022","CHEMBL3833384","ENSG00000119535","ENSG00000108342,ENSG00000168610,ENSG00000150991","Orphanet_169142"
"Rozlytrek","Entrectinib","ENTRECTINIB","CHEMBL1983268","Roche","TRKA, TRKB, TRKC, ROS1 and ALK inhibitor","Oncology","NTRK fusion-positive solid tumours and ROS1-positive NSCLC","non-small cell lung carcinoma","EFO_0003060","Serious","P,O,B,A","2019","CHEMBL1983268","ENSG00000198400,ENSG00000171094,ENSG00000140538,ENSG00000148053,ENSG00000047936","ENSG00000081237,ENSG00000127329,ENSG00000151490,ENSG00000162733,ENSG00000189292,ENSG00000006125,ENSG00000058262,ENSG00000096384,ENSG00000146648,ENSG00000171094,ENSG00000198400,ENSG00000206503,ENSG00000071537,ENSG00000105976,ENSG00000127022,ENSG00000148053,ENSG00000149177,ENSG00000206052,ENSG00000111679,ENSG00000134259,ENSG00000106278,ENSG00000134242,ENSG00000165731,ENSG00000177169,ENSG00000196711,ENSG00000084754,ENSG00000124181,ENSG00000127947,ENSG00000134243,ENSG00000140538,ENSG00000142192,ENSG00000144724,ENSG00000145675,ENSG00000067225,ENSG00000135333,ENSG00000160691,ENSG00000161011,ENSG00000196396","NA"
"Rubraca","Rucaparib","RUCAPARIB","CHEMBL1173055","Clovis Oncology","PARP inhibitor","Oncology","BRCA-positive ovarian cancer","ovarian cancer","MONDO_0008170","Serious","P,O,B,A","2016","CHEMBL1173055","ENSG00000129484,ENSG00000143799,ENSG00000041880","ENSG00000064703,ENSG00000072609,ENSG00000100442,ENSG00000124216,ENSG00000130816,ENSG00000144681,ENSG00000154511,ENSG00000157554,ENSG00000159335,ENSG00000165138,ENSG00000165392,ENSG00000166845,ENSG00000166884,ENSG00000196419,ENSG00000227345,ENSG00000240563,ENSG00000278828,ENSG00000011638,ENSG00000092847,ENSG00000102882,ENSG00000147874,ENSG00000167987,ENSG00000169955,ENSG00000275379,ENSG00000101191,ENSG00000116209,ENSG00000124596,ENSG00000134684,ENSG00000136240,ENSG00000138684,ENSG00000160208,ENSG00000169551,ENSG00000175198,ENSG00000178764,ENSG00000213699,ENSG00000273983,ENSG00000287080,ENSG00000004700,ENSG00000079246,ENSG00000104490,ENSG00000119698,ENSG00000147885,ENSG00000150991,ENSG00000152102,ENSG00000168036,ENSG00000169621,ENSG00000189043,ENSG00000198900,ENSG00000275714,ENSG00000131778,ENSG00000140481,ENSG00000144354,ENSG00000169490,ENSG00000169598,ENSG00000245848,ENSG00000286522,ENSG00000078269,ENSG00000082805,ENSG00000091831,ENSG00000106511,ENSG00000116815,ENSG00000141510,ENSG00000148702,ENSG00000162892,ENSG00000163637,ENSG00000173614,ENSG00000196511,ENSG00000203852,ENSG00000213801,ENSG00000253729,ENSG00000274750,ENSG00000277775,ENSG00000063978,ENSG00000073050,ENSG00000113163,ENSG00000133318,ENSG00000137074,ENSG00000156052,ENSG00000158773,ENSG00000178075,ENSG00000188486,ENSG00000189403,ENSG00000197153,ENSG00000197409,ENSG00000007038,ENSG00000100030,ENSG00000101412,ENSG00000101938,ENSG00000105229,ENSG00000118518,ENSG00000131747,ENSG00000143799,ENSG00000148737,ENSG00000151553,ENSG00000154767,ENSG00000159884,ENSG00000164305,ENSG00000164338,ENSG00000168298,ENSG00000176658,ENSG00000198830,ENSG00000143321,ENSG00000168395,ENSG00000183598,ENSG00000203811","NA"
"Rukobia","Fostemsavir","FOSTEMSAVIR","CHEMBL3301594","ViiV Healthcare","Attachment inhibitor","No human target","HIV","hiv infection","EFO_0000764","Serious","P,B,F","2020","CHEMBL3301594","NA","NA","NA"
"Rybrevant","Amivantamab","Amivantamab","CHEMBL4297774","J&J","EGFRxMETR bispecific antibody","Oncology","EGFR exon 20-mutated NSCLC","non-small cell lung carcinoma","EFO_0003060","Serious","P,B,A","2021","CHEMBL4297774","ENSG00000146648,ENSG00000105976","ENSG00000008735,ENSG00000012061,ENSG00000043462,ENSG00000061273,ENSG00000067606,ENSG00000069345,ENSG00000081237,ENSG00000090520,ENSG00000100170,ENSG00000100591,ENSG00000104341,ENSG00000104756,ENSG00000104904,ENSG00000105251,ENSG00000106211,ENSG00000107317,ENSG00000110395,ENSG00000110651,ENSG00000113070,ENSG00000115085,ENSG00000115415,ENSG00000120053,ENSG00000124942,ENSG00000126561,ENSG00000127329,ENSG00000130340,ENSG00000131016,ENSG00000134308,ENSG00000136573,ENSG00000138363,ENSG00000142669,ENSG00000143322,ENSG00000143933,ENSG00000151490,ENSG00000151491,ENSG00000160014,ENSG00000162704,ENSG00000163235,ENSG00000182636,ENSG00000182718,ENSG00000183918,ENSG00000196576,ENSG00000198909,ENSG00000000938,ENSG00000006125,ENSG00000035720,ENSG00000058262,ENSG00000064999,ENSG00000074966,ENSG00000079308,ENSG00000091831,ENSG00000096384,ENSG00000100614,ENSG00000103876,ENSG00000107643,ENSG00000111816,ENSG00000115145,ENSG00000115290,ENSG00000115540,ENSG00000116254,ENSG00000117152,ENSG00000117461,ENSG00000120833,ENSG00000124207,ENSG00000133124,ENSG00000135506,ENSG00000135823,ENSG00000136205,ENSG00000137267,ENSG00000140575,ENSG00000141198,ENSG00000146648,ENSG00000154556,ENSG00000157500,ENSG00000158092,ENSG00000160255,ENSG00000166313,ENSG00000168036,ENSG00000171132,ENSG00000171150,ENSG00000174791,ENSG00000182473,ENSG00000185338,ENSG00000186868,ENSG00000196961,ENSG00000197943,ENSG00000198574,ENSG00000204388,ENSG00000213658,ENSG00000214193,ENSG00000004478,ENSG00000008056,ENSG00000044115,ENSG00000044574,ENSG00000071537,ENSG00000080031,ENSG00000096060,ENSG00000096968,ENSG00000100324,ENSG00000102606,ENSG00000105245,ENSG00000105976,ENSG00000107338,ENSG00000113013,ENSG00000113580,ENSG00000114805,ENSG00000118363,ENSG00000121653,ENSG00000125731,ENSG00000126088,ENSG00000126581,ENSG00000132669,ENSG00000133961,ENSG00000135046,ENSG00000135605,ENSG00000137463,ENSG00000142208,ENSG00000145016,ENSG00000145335,ENSG00000147010,ENSG00000148053,ENSG00000148082,ENSG00000149177,ENSG00000154277,ENSG00000154710,ENSG00000159352,ENSG00000161203,ENSG00000169375,ENSG00000170312,ENSG00000182511,ENSG00000184557,ENSG00000185046,ENSG00000185483,ENSG00000185634,ENSG00000186834,ENSG00000197122,ENSG00000198561,ENSG00000206052,ENSG00000007264,ENSG00000010017,ENSG00000014641,ENSG00000042753,ENSG00000071051,ENSG00000075415,ENSG00000101182,ENSG00000102189,ENSG00000103423,ENSG00000103653,ENSG00000109321,ENSG00000109684,ENSG00000109971,ENSG00000110011,ENSG00000111077,ENSG00000111252,ENSG00000111679,ENSG00000113263,ENSG00000115325,ENSG00000127191,ENSG00000129946,ENSG00000141480,ENSG00000141655,ENSG00000141738,ENSG00000142949,ENSG00000144749,ENSG00000149428,ENSG00000168003,ENSG00000169047,ENSG00000170248,ENSG00000170293,ENSG00000172757,ENSG00000178568,ENSG00000183020,ENSG00000184524,ENSG00000196154,ENSG00000198668,ENSG00000010671,ENSG00000015479,ENSG00000027869,ENSG00000046653,ENSG00000057294,ENSG00000067992,ENSG00000072135,ENSG00000077232,ENSG00000092820,ENSG00000097007,ENSG00000101336,ENSG00000103266,ENSG00000105974,ENSG00000106299,ENSG00000107295,ENSG00000110711,ENSG00000111640,ENSG00000114737,ENSG00000124882,ENSG00000127824,ENSG00000134215,ENSG00000134242,ENSG00000134853,ENSG00000135052,ENSG00000137076,ENSG00000137486,ENSG00000140600,ENSG00000141736,ENSG00000142627,ENSG00000143294,ENSG00000149925,ENSG00000152894,ENSG00000155926,ENSG00000163563,ENSG00000164050,ENSG00000165025,ENSG00000165731,ENSG00000167601,ENSG00000169045,ENSG00000169398,ENSG00000174808,ENSG00000196684,ENSG00000198753,ENSG00000198853,ENSG00000204389,ENSG00000019991,ENSG00000033327,ENSG00000034713,ENSG00000065361,ENSG00000067182,ENSG00000087586,ENSG00000099942,ENSG00000100280,ENSG00000101082,ENSG00000101213,ENSG00000101558,ENSG00000105971,ENSG00000106070,ENSG00000109458,ENSG00000117450,ENSG00000120694,ENSG00000131746,ENSG00000132155,ENSG00000150403,ENSG00000151834,ENSG00000153707,ENSG00000154237,ENSG00000159176,ENSG00000163697,ENSG00000164615,ENSG00000165527,ENSG00000167552,ENSG00000170606,ENSG00000177885,ENSG00000179295,ENSG00000182866,ENSG00000184575,ENSG00000185499,ENSG00000185896,ENSG00000188191,ENSG00000189043,ENSG00000198799,ENSG00000254087,ENSG00000269335,ENSG00000011132,ENSG00000011485,ENSG00000050748,ENSG00000094631,ENSG00000095370,ENSG00000101134,ENSG00000102309,ENSG00000104814,ENSG00000105401,ENSG00000105613,ENSG00000115687,ENSG00000116285,ENSG00000123384,ENSG00000124181,ENSG00000125170,ENSG00000127947,ENSG00000130402,ENSG00000131558,ENSG00000132970,ENSG00000137936,ENSG00000138798,ENSG00000140009,ENSG00000140538,ENSG00000141968,ENSG00000142192,ENSG00000144554,ENSG00000144724,ENSG00000145675,ENSG00000145715,ENSG00000149269,ENSG00000159228,ENSG00000160999,ENSG00000162591,ENSG00000166598,ENSG00000168610,ENSG00000170581,ENSG00000173801,ENSG00000174437,ENSG00000175203,ENSG00000175866,ENSG00000178078,ENSG00000178188,ENSG00000184144,ENSG00000185359,ENSG00000197102,ENSG00000198399,ENSG00000204305,ENSG00000240972,ENSG00000253729,ENSG00000067225,ENSG00000069869,ENSG00000070159,ENSG00000080824,ENSG00000085063,ENSG00000085733,ENSG00000087266,ENSG00000088930,ENSG00000092758,ENSG00000100351,ENSG00000100485,ENSG00000102010,ENSG00000105647,ENSG00000105701,ENSG00000107263,ENSG00000111669,ENSG00000113108,ENSG00000115904,ENSG00000123908,ENSG00000130558,ENSG00000130706,ENSG00000131171,ENSG00000132639,ENSG00000132670,ENSG00000136810,ENSG00000137193,ENSG00000137462,ENSG00000138698,ENSG00000139625,ENSG00000146674,ENSG00000148180,ENSG00000154127,ENSG00000154229,ENSG00000157168,ENSG00000158402,ENSG00000160691,ENSG00000164924,ENSG00000165458,ENSG00000166913,ENSG00000167193,ENSG00000168439,ENSG00000169139,ENSG00000170677,ENSG00000173020,ENSG00000175793,ENSG00000176105,ENSG00000177666,ENSG00000182585,ENSG00000196396,ENSG00000250722,ENSG00000254772,ENSG00000039068,ENSG00000105649,ENSG00000133056,ENSG00000136235,ENSG00000160293","NA"
"Rydapt","Midostaurin","MIDOSTAURIN","CHEMBL608533","Novartis","FLT3 inhibitor","Oncology","FLT3-positive AML","acute myeloid leukemia, FLT3 internal tandem duplication","MONDO_0100415","Serious","P,O,B,F","2017","CHEMBL608533","ENSG00000166501,ENSG00000163558,ENSG00000184304,ENSG00000065675,ENSG00000113721,ENSG00000154229,ENSG00000134853,ENSG00000157404,ENSG00000128052,ENSG00000115825,ENSG00000122025,ENSG00000067606,ENSG00000171132,ENSG00000027075,ENSG00000163932,ENSG00000126583","ENSG00000004487,ENSG00000007047,ENSG00000039068,ENSG00000067606,ENSG00000070018,ENSG00000070831,ENSG00000100031,ENSG00000100311,ENSG00000101082,ENSG00000111679,ENSG00000115825,ENSG00000122025,ENSG00000127561,ENSG00000128052,ENSG00000131899,ENSG00000136205,ENSG00000139329,ENSG00000145335,ENSG00000146674,ENSG00000146729,ENSG00000152684,ENSG00000152894,ENSG00000156603,ENSG00000163435,ENSG00000164916,ENSG00000165025,ENSG00000168803,ENSG00000179776,ENSG00000183918,ENSG00000185122,ENSG00000186765,ENSG00000196628,ENSG00000196684,ENSG00000197822,ENSG00000198286,ENSG00000212901,ENSG00000276966,ENSG00000278705,ENSG00000011566,ENSG00000067445,ENSG00000072818,ENSG00000076248,ENSG00000094796,ENSG00000100097,ENSG00000100351,ENSG00000112667,ENSG00000115738,ENSG00000119335,ENSG00000134853,ENSG00000137193,ENSG00000148498,ENSG00000155926,ENSG00000158092,ENSG00000158406,ENSG00000158517,ENSG00000159184,ENSG00000163803,ENSG00000171132,ENSG00000171150,ENSG00000172020,ENSG00000179295,ENSG00000181449,ENSG00000184500,ENSG00000184557,ENSG00000185386,ENSG00000203786,ENSG00000286522,ENSG00000010671,ENSG00000035720,ENSG00000049130,ENSG00000067225,ENSG00000099942,ENSG00000105647,ENSG00000105851,ENSG00000111077,ENSG00000113721,ENSG00000115085,ENSG00000117461,ENSG00000124181,ENSG00000126583,ENSG00000127329,ENSG00000131467,ENSG00000131747,ENSG00000136485,ENSG00000143252,ENSG00000144724,ENSG00000145431,ENSG00000151490,ENSG00000152076,ENSG00000155463,ENSG00000170153,ENSG00000171345,ENSG00000182108,ENSG00000184845,ENSG00000187601,ENSG00000197837,ENSG00000198799,ENSG00000242220,ENSG00000274618,ENSG00000006432,ENSG00000065675,ENSG00000070808,ENSG00000072518,ENSG00000079308,ENSG00000086300,ENSG00000087077,ENSG00000087266,ENSG00000095370,ENSG00000100146,ENSG00000101751,ENSG00000104408,ENSG00000106070,ENSG00000106511,ENSG00000108588,ENSG00000124145,ENSG00000134242,ENSG00000142192,ENSG00000142798,ENSG00000150630,ENSG00000154319,ENSG00000163814,ENSG00000166169,ENSG00000167461,ENSG00000176105,ENSG00000177885,ENSG00000182196,ENSG00000182899,ENSG00000184117,ENSG00000197122,ENSG00000205808,ENSG00000244122,ENSG00000273542,ENSG00000273983,ENSG00000275126,ENSG00000277157,ENSG00000278828,ENSG00000008517,ENSG00000011201,ENSG00000037280,ENSG00000074966,ENSG00000084754,ENSG00000096063,ENSG00000096384,ENSG00000099250,ENSG00000106565,ENSG00000109062,ENSG00000111237,ENSG00000117153,ENSG00000119487,ENSG00000119650,ENSG00000127947,ENSG00000131737,ENSG00000134086,ENSG00000134215,ENSG00000135605,ENSG00000138029,ENSG00000141738,ENSG00000143322,ENSG00000144182,ENSG00000145675,ENSG00000146648,ENSG00000155906,ENSG00000156711,ENSG00000160691,ENSG00000163932,ENSG00000167182,ENSG00000169495,ENSG00000171241,ENSG00000172530,ENSG00000173890,ENSG00000178184,ENSG00000182866,ENSG00000183421,ENSG00000197409,ENSG00000198105,ENSG00000221837,ENSG00000274750,ENSG00000275379,ENSG00000276180,ENSG00000278637,ENSG00000010810,ENSG00000033800,ENSG00000055950,ENSG00000065054,ENSG00000065150,ENSG00000072422,ENSG00000081237,ENSG00000084234,ENSG00000100711,ENSG00000101213,ENSG00000105401,ENSG00000107338,ENSG00000108010,ENSG00000112303,ENSG00000120833,ENSG00000125354,ENSG00000132334,ENSG00000136238,ENSG00000137936,ENSG00000141510,ENSG00000142208,ENSG00000149269,ENSG00000157764,ENSG00000160877,ENSG00000161609,ENSG00000164483,ENSG00000169813,ENSG00000170677,ENSG00000184304,ENSG00000186153,ENSG00000198574,ENSG00000243414,ENSG00000249915,ENSG00000269335,ENSG00000270882,ENSG00000275714,ENSG00000277775,ENSG00000010278,ENSG00000101336,ENSG00000101624,ENSG00000102981,ENSG00000104064,ENSG00000111087,ENSG00000111252,ENSG00000112715,ENSG00000124171,ENSG00000128595,ENSG00000129946,ENSG00000133961,ENSG00000136573,ENSG00000137185,ENSG00000139926,ENSG00000148082,ENSG00000153233,ENSG00000161011,ENSG00000164144,ENSG00000166923,ENSG00000167193,ENSG00000167792,ENSG00000170185,ENSG00000171862,ENSG00000176903,ENSG00000182511,ENSG00000185291,ENSG00000185432,ENSG00000186432,ENSG00000187624,ENSG00000196396,ENSG00000196642,ENSG00000197061,ENSG00000220205,ENSG00000254087,ENSG00000261371,ENSG00000287080,ENSG00000000938,ENSG00000027869,ENSG00000040199,ENSG00000071051,ENSG00000081913,ENSG00000092108,ENSG00000092330,ENSG00000097007,ENSG00000105287,ENSG00000108561,ENSG00000116701,ENSG00000120054,ENSG00000131788,ENSG00000133106,ENSG00000137166,ENSG00000142867,ENSG00000145715,ENSG00000149177,ENSG00000154229,ENSG00000157193,ENSG00000158769,ENSG00000164924,ENSG00000166501,ENSG00000167685,ENSG00000185634,ENSG00000197153,ENSG00000197238,ENSG00000197461,ENSG00000197943,ENSG00000204305,ENSG00000205439,ENSG00000256043,ENSG00000270276,ENSG00000073350,ENSG00000095585,ENSG00000125148,ENSG00000128245,ENSG00000163558","EFO_0000222"
"Rylaze","Asparaginase erwinia chrysanthemi","Asparaginaseerwiniachrysanthemi","CHEMBL1863514","Jazz","Recombinant asparagine-specific enzyme","NA","ALL and LBL, in patients allergic to E. coli-derived products","acute lymphoblastic leukemia; lymphoblastic lymphoma","EFO_0000220,MONDO_0000873","Serious","S,O,F","2021","CHEMBL1863514","NA","NA","NA"
"Saphnelo","Anifrolumab","Anifrolumab","CHEMBL2364653","AstraZeneca","IFNAR-targeted mAb","Other indication","SLE","systemic lupus erythematosus","MONDO_0007915","Serious","S,F","2021","CHEMBL2364653","ENSG00000142166","ENSG00000072803,ENSG00000105397,ENSG00000170581,ENSG00000115415,ENSG00000177047,ENSG00000104341","NA"
"Sarclisa","Isatuximab","ISATUXIMAB","CHEMBL3545131","Sanofi","CD38-directed mAb","Oncology","Multiple myeloma","multiple myeloma","EFO_0001378","Serious","S,O","2020","CHEMBL3545131","ENSG00000004468","NA","MONDO_0004095"
"Savaysa","Edoxaban","EDOXABAN","CHEMBL1269025","Daiichi Sankyo","Factor Xa inhibitor","Other indication","Risk of stroke and systemic embolism in NVAF, and deep vein thrombosis","atrial fibrillation; deep vein thrombosis","EFO_0000275,EFO_0003907","Serious","S","2015","CHEMBL1269025","ENSG00000126218","ENSG00000117601,ENSG00000140093,ENSG00000188021,ENSG00000106333,ENSG00000286219","NA"
"Scemblix","Asciminib","Asciminib","CHEMBL4208229","Novartis","ABL/BCR-ABL1  kinase inhibitor","Oncology","Ph+ CML","Blast Phase Chronic Myelogenous Leukemia; BCR-ABL1 Positive","EFO_1000131","Serious","P,O,B,A,F","2021","CHEMBL4208229","ENSG00000097007","ENSG00000104973,ENSG00000138443,ENSG00000146648,ENSG00000168036,ENSG00000171914,ENSG00000185499,ENSG00000120896,ENSG00000122025,ENSG00000164924,ENSG00000067225,ENSG00000116288,ENSG00000128245,ENSG00000135250,ENSG00000160255,ENSG00000166913,ENSG00000145335,ENSG00000065361,ENSG00000088888,ENSG00000112290,ENSG00000174791,ENSG00000175793,ENSG00000178568,ENSG00000196396,ENSG00000104814,ENSG00000114383,ENSG00000121634,ENSG00000126561,ENSG00000136754,ENSG00000141968,ENSG00000157404,ENSG00000167193,ENSG00000170027,ENSG00000188906,ENSG00000197122,ENSG00000241794,ENSG00000094796,ENSG00000099942,ENSG00000105974,ENSG00000107338,ENSG00000149311,ENSG00000169083,ENSG00000064309,ENSG00000095637,ENSG00000107263,ENSG00000108953,ENSG00000137845,ENSG00000141736,ENSG00000154237,ENSG00000173757,ENSG00000196730,ENSG00000198900,ENSG00000204410,ENSG00000225830","EFO_0000339"
"Scenesse","Afamelanotide","AFAMELANOTIDE","CHEMBL441738","Clinuvel","Melanocortin 1 receptor agonist","Other indication","Erythropoietic protoporphyria","erythropoietic protoporphyria","MONDO_0001676","Serious","P,O,F","2019","CHEMBL441738","ENSG00000258839","ENSG00000054277","EFO_1000752"
"Seysara","Sarecycline","SARECYCLINE","CHEMBL2364632","Allergan","Tetracycline antibiotic","No human target","Serious acne vulgaris","acne","EFO_0003894","Not serious","S","2018","CHEMBL2364632","NA","NA","NA"
"Siliq","Brodalumab","BRODALUMAB","CHEMBL1742996","Valeant Pharmaceuticals","IL-17RA antagonist","Other indication","Plaque psoriasis","psoriasis vulgaris","EFO_1001494","Not serious","S","2017","CHEMBL1742996","ENSG00000177663","NA","EFO_0000676"
"Sivextro","Tedizolid","TEDIZOLID","CHEMBL1257051","Cubist","Oxazolidinone-class antibacterial","No human target","ABSSSI (Acute Bacterial Skin and Skin Structure Infections)","staphylococcal skin infections","EFO_1001849","Not serious","P","2014","CHEMBL1257051","NA","NA","NA"
"Skyrizi","Risankizumab","RISANKIZUMAB","CHEMBL3990029","AbbVie","IL-23 antagonist","Other indication","Plaque psoriasis","psoriasis vulgaris","EFO_1001494","Not serious","S","2019","CHEMBL3990029","ENSG00000110944,ENSG00000113302","ENSG00000162594,ENSG00000168811,ENSG00000110944,ENSG00000113302,ENSG00000162735","EFO_0000676"
"Skytrofa","Lonapegsomatropin","Lonapegsomatropin","CHEMBL4298185","Ascendis Pharma","PEGylated human growth hormone","Other indication","Growth failure due to GHD","Growth delay","HP_0001510","Not serious","S,O","2021","CHEMBL4298185","ENSG00000112964","ENSG00000127329,ENSG00000127947,ENSG00000175354,ENSG00000134242,ENSG00000158092,ENSG00000196396,ENSG00000070159,ENSG00000149177,ENSG00000152894,ENSG00000164086,ENSG00000169410,ENSG00000259384,ENSG00000080031,ENSG00000081237,ENSG00000112964","EFO_0004339"
"Sogroya","Somapacitan","SOMAPACITAN","CHEMBL3707290","Novo Nordisk","Growth hormone analogue","Other indication","Growth hormone deficiency","short stature due to partial GHR deficiency","MONDO_0011420","Not serious","S","2020","CHEMBL3707290","ENSG00000112964","ENSG00000127329,ENSG00000175354,ENSG00000080031,ENSG00000149177,ENSG00000152894,ENSG00000127947,ENSG00000158092,ENSG00000164086,ENSG00000070159,ENSG00000112964,ENSG00000134242,ENSG00000081237,ENSG00000169410,ENSG00000196396,ENSG00000259384","NA"
"Solosec","Secnidazole","SECNIDAZOLE","CHEMBL498847","Lupin","Nitroimidazole antimicrobial","No human target","Bacterial vaginosis","bacterial vaginosis","EFO_0003932","Not serious","P,F","2017","CHEMBL498847","NA","NA","NA"
"Sotyktu","Deucravacitinib","Deucravacitinib","CHEMBL4435170","Bristol Myers Squibb","TYK2 inhibitor","Other indication","Plaque psoriasis","psoriasis vulgaris","EFO_1001494","Not serious","S","2022","CHEMBL4435170","ENSG00000105397","ENSG00000138738,ENSG00000183386,ENSG00000197191,ENSG00000142166,ENSG00000143514,ENSG00000094796,ENSG00000131773,ENSG00000011243,ENSG00000076604,ENSG00000096384,ENSG00000106541,ENSG00000165119,ENSG00000112232,ENSG00000170581,ENSG00000197978,ENSG00000204889","EFO_0000676"
"Sovaldi","Sofosbuvir","SOFOSBUVIR","CHEMBL1259059","Gilead","HCV nucleotide analogue NS5B polymerase inhibitor","No human target","Chronic HCV infection, as a component of a combination antiviral treatment regimen","hepatitis C virus infection","EFO_0003047","Serious","P,B,F","2013","CHEMBL1259059","NA","NA","NA"
"Spevigo","Spesolimab","Spesolimab","CHEMBL4297911","Boehringer Ingelheim","IL-36R-targeted mAb","Other indication","Generalized pustular psoriasis flares","psoriasis 14, pustular","MONDO_0013626","Not concordant","P,O,B","2022","CHEMBL4297911","ENSG00000196083,ENSG00000115598","ENSG00000115594,ENSG00000125538,ENSG00000115590,NA","NA"
"Spinraza","Nusinersen","NUSINERSEN","CHEMBL3301572","Biogen/Ionis Pharmaceuticals","ASO designed to target SMN2 pre-mRNA","Other indication","Spinal muscular atrophy","spinal muscular atrophy","EFO_0008525","Serious","P,O,F","2016","CHEMBL3301572","ENSG00000205571","ENSG00000113790,ENSG00000123892,ENSG00000125531,ENSG00000126945,ENSG00000171055,ENSG00000183640,ENSG00000186925,ENSG00000204410,ENSG00000064703,ENSG00000079805,ENSG00000109534,ENSG00000112578,ENSG00000138398,ENSG00000142252,ENSG00000149089,ENSG00000160679,ENSG00000163517,ENSG00000172336,ENSG00000179409,ENSG00000185386,ENSG00000186930,ENSG00000186977,ENSG00000205302,ENSG00000125835,ENSG00000160948,ENSG00000179222,ENSG00000186451,ENSG00000187191,ENSG00000092208,ENSG00000102471,ENSG00000104381,ENSG00000105202,ENSG00000108424,ENSG00000108590,ENSG00000132591,ENSG00000137463,ENSG00000143889,ENSG00000152147,ENSG00000167037,ENSG00000177138,ENSG00000180098,ENSG00000181222,ENSG00000010810,ENSG00000033800,ENSG00000087365,ENSG00000089280,ENSG00000100462,ENSG00000134996,ENSG00000139343,ENSG00000140009,ENSG00000144711,ENSG00000175899,ENSG00000197386,ENSG00000197442,ENSG00000240432,ENSG00000244362,ENSG00000082516,ENSG00000099956,ENSG00000105323,ENSG00000109103,ENSG00000121058,ENSG00000136379,ENSG00000169057,ENSG00000176108,ENSG00000176302,ENSG00000182004,ENSG00000100138,ENSG00000101888,ENSG00000102048,ENSG00000104164,ENSG00000104852,ENSG00000115317,ENSG00000132382,ENSG00000134046,ENSG00000158710,ENSG00000164675,ENSG00000167088,ENSG00000171453,ENSG00000172062,ENSG00000184351,ENSG00000184724,ENSG00000187026,ENSG00000268988,ENSG00000023734,ENSG00000046647,ENSG00000107290,ENSG00000116918,ENSG00000141499,ENSG00000143977,ENSG00000151923,ENSG00000164404,ENSG00000176105,ENSG00000185246,ENSG00000198353,ENSG00000198513,ENSG00000205571,ENSG00000125743,ENSG00000168090","NA"
"Steglatro","Ertugliflozin","ERTUGLIFLOZIN","CHEMBL1770248","Merck & Co./Pfizer","SGLT2 inhibitor","Other indication","Type 2 diabetes mellitus","type 2 diabetes mellitus","MONDO_0005148","Not concordant","S","2017","CHEMBL1770248","ENSG00000140675","NA","Orphanet_79161,HP_0003076"
"Strensiq","Asfotase alfa","ASFOTASEALFA","CHEMBL2108311","Alexion","Alkaline phosphatase","Other indication","Hypophosphatasia","hypophosphatasia","MONDO_0018570","Serious","P,O,B,F","2015","CHEMBL2108311","ENSG00000162551","ENSG00000006062","NA"
"Striverdi Respimat","Olodaterol","OLODATEROL","CHEMBL605846","Boehringer Ingelheim","Long-acting beta2-adrenoceptor agonist","Other indication","COPD","chronic obstructive pulmonary disease","EFO_0000341","Serious","S","2014","CHEMBL605846","ENSG00000169252","ENSG00000130770,ENSG00000143001,ENSG00000111361,ENSG00000118985,ENSG00000212864,ENSG00000229715,ENSG00000106462,ENSG00000129173,ENSG00000183666,ENSG00000185658,ENSG00000197971,ENSG00000074416,ENSG00000100603,ENSG00000113369,ENSG00000109062,ENSG00000111224,ENSG00000134758,ENSG00000163485,ENSG00000163749,ENSG00000081026,ENSG00000096070,ENSG00000165119,ENSG00000240021,ENSG00000077254,ENSG00000141480,ENSG00000171867,ENSG00000197122,ENSG00000169252","NA"
"Sunlenca","Lenacapavir","Lenacapavir","CHEMBL4594438","Gilead","HIV-1 capsid inhibitor","No human target","HIV-1 infection","HIV-1 infection","EFO_0000180","NA","P,B,F","2022","CHEMBL4594438","NA","NA","NA"
"Sunosi","Solriamfetol","SOLRIAMFETOL","CHEMBL4297620","Jazz","Dopamine and noradrenaline reuptake inhibitor","No human target","Excessive sleepiness due to narcolepsy or obstructive sleep apnoea","hypersomnia; narcolepsy; obstructive sleep apnea","MONDO_0021107,EFO_0003918,EFO_0005246","Serious","S,O","2019","CHEMBL4297620","NA","NA","NA,EFO_0005271"
"Sylvant","Siltuximab","SILTUXIMAB","CHEMBL1743070","Janssen Biotech","IL-6-specific antibody","Other indication","Multicentric Castleman's disease","Castleman disease","MONDO_0015564","Serious","P,O","2014","CHEMBL1743070","ENSG00000136244","ENSG00000134352,ENSG00000109906,ENSG00000134243,ENSG00000177706,ENSG00000137642,ENSG00000160712","NA"
"Symdeko","Tezacaftor, ivacaftor","TEZACAFTOR,IVACAFTOR","CHEMBL3544914,CHEMBL2010601","Vertex Pharmaceuticals","CFTR corrector and CFTR potentiator","Other indication","Cystic fibrosis","cystic fibrosis","MONDO_0009061","Serious","P,O,B,F","2018","CHEMBL3544914,CHEMBL2010601","ENSG00000001626","ENSG00000082898,ENSG00000085063,ENSG00000100097,ENSG00000105568,ENSG00000113013,ENSG00000115484,ENSG00000128607,ENSG00000129083,ENSG00000136986,ENSG00000141510,ENSG00000143793,ENSG00000154582,ENSG00000155660,ENSG00000163468,ENSG00000175166,ENSG00000181163,ENSG00000196236,ENSG00000079246,ENSG00000096384,ENSG00000104783,ENSG00000105202,ENSG00000105835,ENSG00000113368,ENSG00000115268,ENSG00000126247,ENSG00000127022,ENSG00000131051,ENSG00000132646,ENSG00000146731,ENSG00000147140,ENSG00000160213,ENSG00000162909,ENSG00000166986,ENSG00000169045,ENSG00000170421,ENSG00000171793,ENSG00000172354,ENSG00000185825,ENSG00000197191,ENSG00000241685,ENSG00000069345,ENSG00000074800,ENSG00000109062,ENSG00000125844,ENSG00000125868,ENSG00000134333,ENSG00000135829,ENSG00000136153,ENSG00000149257,ENSG00000163220,ENSG00000164022,ENSG00000167815,ENSG00000172725,ENSG00000176014,ENSG00000197321,ENSG00000204308,ENSG00000249915,ENSG00000065150,ENSG00000065978,ENSG00000100345,ENSG00000100911,ENSG00000106366,ENSG00000108107,ENSG00000114353,ENSG00000117450,ENSG00000122566,ENSG00000134308,ENSG00000136628,ENSG00000138107,ENSG00000160789,ENSG00000168488,ENSG00000174437,ENSG00000189091,ENSG00000196419,ENSG00000204389,ENSG00000078369,ENSG00000086061,ENSG00000103363,ENSG00000106305,ENSG00000110880,ENSG00000116641,ENSG00000125970,ENSG00000132109,ENSG00000144381,ENSG00000149925,ENSG00000165280,ENSG00000176105,ENSG00000177731,ENSG00000181789,ENSG00000204388,ENSG00000011304,ENSG00000014216,ENSG00000044574,ENSG00000050405,ENSG00000058262,ENSG00000065054,ENSG00000073578,ENSG00000100764,ENSG00000106484,ENSG00000113194,ENSG00000115806,ENSG00000116560,ENSG00000128595,ENSG00000132589,ENSG00000132612,ENSG00000138594,ENSG00000140945,ENSG00000143549,ENSG00000164924,ENSG00000167553,ENSG00000169813,ENSG00000215301,ENSG00000001626,ENSG00000074696,ENSG00000075624,ENSG00000092820,ENSG00000093167,ENSG00000109133,ENSG00000109572,ENSG00000111057,ENSG00000117592,ENSG00000120265,ENSG00000120438,ENSG00000124207,ENSG00000124614,ENSG00000126803,ENSG00000127481,ENSG00000132341,ENSG00000132912,ENSG00000142871,ENSG00000143546,ENSG00000144713,ENSG00000165119,ENSG00000167085,ENSG00000172053,ENSG00000174502,ENSG00000174827,ENSG00000204628,ENSG00000213741,ENSG00000240972,ENSG00000030582,ENSG00000037474,ENSG00000047932,ENSG00000064547,ENSG00000089159,ENSG00000092199,ENSG00000100591,ENSG00000102119,ENSG00000105141,ENSG00000106211,ENSG00000108424,ENSG00000117906,ENSG00000130255,ENSG00000136238,ENSG00000138071,ENSG00000143556,ENSG00000158710,ENSG00000162244,ENSG00000163902,ENSG00000186716,ENSG00000213719,ENSG00000222038,ENSG00000242372,ENSG00000253729,ENSG00000254772,ENSG00000104824,ENSG00000117868,ENSG00000131620","NA"
"Symproic","Naldemedine","NALDEMEDINE","CHEMBL2105755","Shionogi","Opioid antagonist","Other indication","Opioid-induced constipation","Constipation","HP_0002019","Not serious","S","2017","CHEMBL2105755","ENSG00000112038","ENSG00000148483,ENSG00000158014,ENSG00000164081,ENSG00000168824,ENSG00000170545,ENSG00000172005,ENSG00000187513,ENSG00000198937,ENSG00000103249,ENSG00000113790,ENSG00000139644,ENSG00000177300,ENSG00000196470,ENSG00000198932,ENSG00000100528,ENSG00000101558,ENSG00000156284,ENSG00000171517,ENSG00000172375,ENSG00000175489,ENSG00000213658,ENSG00000134531,ENSG00000169903,ENSG00000125170,ENSG00000142089,ENSG00000149451,ENSG00000159840,ENSG00000196924,ENSG00000205279,ENSG00000121542,ENSG00000133065,ENSG00000142227,ENSG00000168515,ENSG00000168958,ENSG00000172243,ENSG00000256660,ENSG00000101460,ENSG00000103042,ENSG00000116729,ENSG00000121022,ENSG00000132965,ENSG00000134873,ENSG00000144063,ENSG00000151778,ENSG00000162975,ENSG00000177519,ENSG00000181788,ENSG00000185049,ENSG00000185883,ENSG00000197769,ENSG00000008283,ENSG00000010017,ENSG00000109099,ENSG00000113732,ENSG00000115307,ENSG00000241399,ENSG00000105223","NA"
"TPOXX","Tecovirimat","TECOVIRIMAT","CHEMBL1257073","SIGA Technologies","Viral p37 protein inhibitor","No human target","Smallpox","smallpox","MONDO_0004651","Serious","P,O,F","2018","CHEMBL1257073","NA","NA","NA"
"Tabrecta","Capmatinib","CAPMATINIB","CHEMBL3188267","Novartis","MET kinase inhibitor","Oncology","NSCLC","non-small cell lung carcinoma","EFO_0003060","Serious","P,O,B,A","2020","CHEMBL3188267","ENSG00000105976","ENSG00000081237,ENSG00000104341,ENSG00000105251,ENSG00000110395,ENSG00000115085,ENSG00000127329,ENSG00000136573,ENSG00000143322,ENSG00000151490,ENSG00000183918,ENSG00000196576,ENSG00000000938,ENSG00000035720,ENSG00000074966,ENSG00000079308,ENSG00000115290,ENSG00000117461,ENSG00000120833,ENSG00000136205,ENSG00000146648,ENSG00000158092,ENSG00000171150,ENSG00000185338,ENSG00000197943,ENSG00000198574,ENSG00000105976,ENSG00000107338,ENSG00000135605,ENSG00000148082,ENSG00000149177,ENSG00000182511,ENSG00000184557,ENSG00000185634,ENSG00000197122,ENSG00000007264,ENSG00000010017,ENSG00000071051,ENSG00000103423,ENSG00000111077,ENSG00000111252,ENSG00000113263,ENSG00000129946,ENSG00000141738,ENSG00000010671,ENSG00000027869,ENSG00000101336,ENSG00000134215,ENSG00000152894,ENSG00000163563,ENSG00000164050,ENSG00000165025,ENSG00000196684,ENSG00000198753,ENSG00000019991,ENSG00000101082,ENSG00000101213,ENSG00000131746,ENSG00000177885,ENSG00000179295,ENSG00000182866,ENSG00000254087,ENSG00000095370,ENSG00000115687,ENSG00000124181,ENSG00000127947,ENSG00000137936,ENSG00000140538,ENSG00000144724,ENSG00000145675,ENSG00000145715,ENSG00000160999,ENSG00000178188,ENSG00000067225,ENSG00000070159,ENSG00000087266,ENSG00000105647,ENSG00000160691,ENSG00000165458,ENSG00000167193,ENSG00000170677,ENSG00000176105,ENSG00000196396,ENSG00000160293","NA"
"Tafinlar","Dabrafenib","DABRAFENIB","CHEMBL2028663","GSK","Kinase inhibitor with activity against BRAFV600E, BRAFV600K, BRAFV600D, wild-type BRAF and other kinases","Oncology","Unresectable or metastatic melanoma with BRAF(V600E) mutation as detected by an FDA-approved test","metastatic melanoma","EFO_0002617","Serious","S,O,F","2013","CHEMBL2028663","ENSG00000157764","ENSG00000095015,ENSG00000134308,ENSG00000141564,ENSG00000164924,ENSG00000175793,ENSG00000105401,ENSG00000108953,ENSG00000132155,ENSG00000174775,ENSG00000113013,ENSG00000128245,ENSG00000133703,ENSG00000187555,ENSG00000166913,ENSG00000169032,ENSG00000109971,ENSG00000140575,ENSG00000170027,ENSG00000171132,ENSG00000044574,ENSG00000096384,ENSG00000157764,ENSG00000213281,ENSG00000078061,ENSG00000126934","EFO_0000756"
"Tagrisso","Osimertinib","OSIMERTINIB","CHEMBL3353410","AstraZeneca","EGFR inhibitor","Oncology","NSCLC with EGFRT790M mutations","non-small cell lung carcinoma","EFO_0003060","Serious","P,O,B,A,F","2015","CHEMBL3353410","ENSG00000146648","ENSG00000008735,ENSG00000012061,ENSG00000043462,ENSG00000061273,ENSG00000067606,ENSG00000069345,ENSG00000081237,ENSG00000090520,ENSG00000100170,ENSG00000100591,ENSG00000104341,ENSG00000104756,ENSG00000104904,ENSG00000106211,ENSG00000107317,ENSG00000110395,ENSG00000110651,ENSG00000113070,ENSG00000115085,ENSG00000115415,ENSG00000120053,ENSG00000124942,ENSG00000126561,ENSG00000127329,ENSG00000130340,ENSG00000131016,ENSG00000134308,ENSG00000136573,ENSG00000138363,ENSG00000142669,ENSG00000143322,ENSG00000143933,ENSG00000151491,ENSG00000160014,ENSG00000162704,ENSG00000163235,ENSG00000182636,ENSG00000182718,ENSG00000183918,ENSG00000198909,ENSG00000000938,ENSG00000006125,ENSG00000058262,ENSG00000064999,ENSG00000091831,ENSG00000096384,ENSG00000100614,ENSG00000103876,ENSG00000107643,ENSG00000111816,ENSG00000115145,ENSG00000115540,ENSG00000116254,ENSG00000117152,ENSG00000117461,ENSG00000124207,ENSG00000133124,ENSG00000135506,ENSG00000135823,ENSG00000136205,ENSG00000137267,ENSG00000140575,ENSG00000141198,ENSG00000146648,ENSG00000154556,ENSG00000157500,ENSG00000158092,ENSG00000160255,ENSG00000166313,ENSG00000168036,ENSG00000171132,ENSG00000174791,ENSG00000182473,ENSG00000186868,ENSG00000196961,ENSG00000197943,ENSG00000204388,ENSG00000213658,ENSG00000214193,ENSG00000004478,ENSG00000008056,ENSG00000044115,ENSG00000044574,ENSG00000071537,ENSG00000080031,ENSG00000096060,ENSG00000096968,ENSG00000100324,ENSG00000102606,ENSG00000105245,ENSG00000105976,ENSG00000113013,ENSG00000113580,ENSG00000114805,ENSG00000118363,ENSG00000121653,ENSG00000125731,ENSG00000126088,ENSG00000126581,ENSG00000132669,ENSG00000133961,ENSG00000135046,ENSG00000137463,ENSG00000142208,ENSG00000145016,ENSG00000145335,ENSG00000147010,ENSG00000148053,ENSG00000148082,ENSG00000149177,ENSG00000154277,ENSG00000154710,ENSG00000159352,ENSG00000161203,ENSG00000169375,ENSG00000170312,ENSG00000182511,ENSG00000184557,ENSG00000185046,ENSG00000185483,ENSG00000185634,ENSG00000186834,ENSG00000197122,ENSG00000198561,ENSG00000206052,ENSG00000014641,ENSG00000042753,ENSG00000071051,ENSG00000075415,ENSG00000101182,ENSG00000102189,ENSG00000103653,ENSG00000109321,ENSG00000109684,ENSG00000109971,ENSG00000110011,ENSG00000111252,ENSG00000111679,ENSG00000113263,ENSG00000115325,ENSG00000127191,ENSG00000129946,ENSG00000141480,ENSG00000141655,ENSG00000142949,ENSG00000144749,ENSG00000149428,ENSG00000168003,ENSG00000169047,ENSG00000170248,ENSG00000170293,ENSG00000172757,ENSG00000178568,ENSG00000183020,ENSG00000184524,ENSG00000196154,ENSG00000198668,ENSG00000015479,ENSG00000027869,ENSG00000046653,ENSG00000057294,ENSG00000067992,ENSG00000072135,ENSG00000077232,ENSG00000092820,ENSG00000097007,ENSG00000101336,ENSG00000103266,ENSG00000105974,ENSG00000106299,ENSG00000107295,ENSG00000110711,ENSG00000111640,ENSG00000114737,ENSG00000124882,ENSG00000127824,ENSG00000134242,ENSG00000134853,ENSG00000135052,ENSG00000137076,ENSG00000137486,ENSG00000140600,ENSG00000141736,ENSG00000142627,ENSG00000143294,ENSG00000149925,ENSG00000155926,ENSG00000165025,ENSG00000165731,ENSG00000167601,ENSG00000169045,ENSG00000169398,ENSG00000174808,ENSG00000198853,ENSG00000204389,ENSG00000033327,ENSG00000034713,ENSG00000065361,ENSG00000067182,ENSG00000087586,ENSG00000099942,ENSG00000100280,ENSG00000101082,ENSG00000101213,ENSG00000101558,ENSG00000105971,ENSG00000106070,ENSG00000109458,ENSG00000117450,ENSG00000120694,ENSG00000131746,ENSG00000132155,ENSG00000150403,ENSG00000151834,ENSG00000153707,ENSG00000154237,ENSG00000159176,ENSG00000163697,ENSG00000164615,ENSG00000165527,ENSG00000167552,ENSG00000170606,ENSG00000177885,ENSG00000179295,ENSG00000184575,ENSG00000185499,ENSG00000185896,ENSG00000188191,ENSG00000189043,ENSG00000198799,ENSG00000254087,ENSG00000269335,ENSG00000011132,ENSG00000011485,ENSG00000050748,ENSG00000094631,ENSG00000095370,ENSG00000101134,ENSG00000102309,ENSG00000104814,ENSG00000105401,ENSG00000105613,ENSG00000116285,ENSG00000123384,ENSG00000124181,ENSG00000125170,ENSG00000127947,ENSG00000130402,ENSG00000131558,ENSG00000132970,ENSG00000138798,ENSG00000140009,ENSG00000141968,ENSG00000142192,ENSG00000144554,ENSG00000144724,ENSG00000145675,ENSG00000145715,ENSG00000149269,ENSG00000159228,ENSG00000162591,ENSG00000166598,ENSG00000168610,ENSG00000170581,ENSG00000173801,ENSG00000174437,ENSG00000175203,ENSG00000175866,ENSG00000178078,ENSG00000178188,ENSG00000184144,ENSG00000185359,ENSG00000197102,ENSG00000198399,ENSG00000204305,ENSG00000240972,ENSG00000253729,ENSG00000067225,ENSG00000069869,ENSG00000080824,ENSG00000085063,ENSG00000085733,ENSG00000088930,ENSG00000092758,ENSG00000100351,ENSG00000100485,ENSG00000102010,ENSG00000105647,ENSG00000105701,ENSG00000107263,ENSG00000111669,ENSG00000113108,ENSG00000115904,ENSG00000123908,ENSG00000130558,ENSG00000130706,ENSG00000131171,ENSG00000132639,ENSG00000132670,ENSG00000136810,ENSG00000137193,ENSG00000137462,ENSG00000138698,ENSG00000139625,ENSG00000146674,ENSG00000148180,ENSG00000154127,ENSG00000154229,ENSG00000157168,ENSG00000158402,ENSG00000160691,ENSG00000164924,ENSG00000166913,ENSG00000167193,ENSG00000168439,ENSG00000169139,ENSG00000170677,ENSG00000173020,ENSG00000175793,ENSG00000176105,ENSG00000177666,ENSG00000182585,ENSG00000196396,ENSG00000250722,ENSG00000254772,ENSG00000039068,ENSG00000105649,ENSG00000133056,ENSG00000136235","NA"
"Takhzyro","Lanadelumab","LANADELUMAB","CHEMBL3545189","Dyax/Shire","Kallikrein antibody","Other indication","Hereditary angioedema","hereditary angioedema","MONDO_0019623","Serious","P,O,B,F","2018","CHEMBL3545189","ENSG00000164344","ENSG00000229140,ENSG00000115211,ENSG00000196715,ENSG00000126460,ENSG00000144061,ENSG00000110801,ENSG00000113889,ENSG00000152291,ENSG00000172123,ENSG00000100462,ENSG00000103202,ENSG00000147164,ENSG00000269556","NA"
"Taltz","Ixekizumab","IXEKIZUMAB","CHEMBL1743034","Eli Lilly","IL-17A antagonist","Other indication","Plaque psoriasis","psoriasis vulgaris","EFO_1001494","Not serious","S","2016","CHEMBL1743034","ENSG00000112115","ENSG00000132768,ENSG00000185774","EFO_0000676"
"Talzenna","Talazoparib","TALAZOPARIB","CHEMBL3137320","Pfizer","PARP inhibitor","Oncology","BRCA-mutated HER2-negative breast cancer","HER2 negative breast carcinoma","EFO_0009780","Serious","P","2018","CHEMBL3137320","ENSG00000129484,ENSG00000143799","ENSG00000101191,ENSG00000116209,ENSG00000133318,ENSG00000138684,ENSG00000169551,ENSG00000175198,ENSG00000197409,ENSG00000275379,ENSG00000287080,ENSG00000007038,ENSG00000124596,ENSG00000134684,ENSG00000150991,ENSG00000154511,ENSG00000157554,ENSG00000165138,ENSG00000178075,ENSG00000196419,ENSG00000198830,ENSG00000273983,ENSG00000275714,ENSG00000278828,ENSG00000078269,ENSG00000100442,ENSG00000102882,ENSG00000131778,ENSG00000141510,ENSG00000151553,ENSG00000169490,ENSG00000169955,ENSG00000274750,ENSG00000092847,ENSG00000100030,ENSG00000118518,ENSG00000136240,ENSG00000140481,ENSG00000144681,ENSG00000148702,ENSG00000148737,ENSG00000156052,ENSG00000166884,ENSG00000169621,ENSG00000189043,ENSG00000196511,ENSG00000101412,ENSG00000101938,ENSG00000104490,ENSG00000105229,ENSG00000119698,ENSG00000143321,ENSG00000152102,ENSG00000162892,ENSG00000164338,ENSG00000168298,ENSG00000173614,ENSG00000178764,ENSG00000188486,ENSG00000197153,ENSG00000227345,ENSG00000004700,ENSG00000079246,ENSG00000082805,ENSG00000091831,ENSG00000137074,ENSG00000147874,ENSG00000160208,ENSG00000165392,ENSG00000168036,ENSG00000169598,ENSG00000245848,ENSG00000286522,ENSG00000011638,ENSG00000064703,ENSG00000124216,ENSG00000130816,ENSG00000144354,ENSG00000147885,ENSG00000159884,ENSG00000163637,ENSG00000166845,ENSG00000168395,ENSG00000176658,ENSG00000189403,ENSG00000198900,ENSG00000213801,ENSG00000063978,ENSG00000072609,ENSG00000073050,ENSG00000113163,ENSG00000116815,ENSG00000143799,ENSG00000154767,ENSG00000158773,ENSG00000159335,ENSG00000164305,ENSG00000167987,ENSG00000213699,ENSG00000240563,ENSG00000253729,ENSG00000277775,ENSG00000131747","EFO_0000305"
"Tanzeum","Albiglutide","ALBIGLUTIDE","CHEMBL2107841","GlaxoSmithKline","GLP1-receptor agonist","Other indication","Type 2 diabetes","type 2 diabetes mellitus","MONDO_0005148","Not concordant","S","2014","CHEMBL2107841","ENSG00000112164","ENSG00000221880,ENSG00000197191,ENSG00000221837,ENSG00000272804,ENSG00000187766,ENSG00000264343,ENSG00000286219,ENSG00000186860,ENSG00000188581,ENSG00000254997","Orphanet_79161,HP_0003076"
"Tavalisse","Fostamatinib","FOSTAMATINIB","CHEMBL2103830","Rigel Pharmaceuticals","SYK inhibitor","Other indication","Immune thrombocytopenic purpura","autoimmune thrombocytopenic purpura","EFO_0007160","Serious","S,O","2018","CHEMBL2103830","ENSG00000165025","ENSG00000065361,ENSG00000103490,ENSG00000154127,ENSG00000155313,ENSG00000160691,ENSG00000172466,ENSG00000084234,ENSG00000104894,ENSG00000108578,ENSG00000158560,ENSG00000175899,ENSG00000157404,ENSG00000165025,ENSG00000182866,ENSG00000027869,ENSG00000067225,ENSG00000105976,ENSG00000110395,ENSG00000147601,ENSG00000175104,ENSG00000109458,ENSG00000112773,ENSG00000158869,ENSG00000162711,ENSG00000198851,ENSG00000123384,ENSG00000135077,ENSG00000136238,ENSG00000139117,ENSG00000145675,ENSG00000158747,ENSG00000168610,ENSG00000172531,ENSG00000204389,ENSG00000012124,ENSG00000122025,ENSG00000124181,ENSG00000127022,ENSG00000146648,ENSG00000169083,ENSG00000141736,ENSG00000142192,ENSG00000169509,ENSG00000178568","NA"
"Tavneos","Avacopan","Avacopan","CHEMBL3989871","ChemoCentryx","Complement 5a receptor antagonist","Other indication","ANCA-associated vasculitis","Anti-neutrophil cytoplasmic antibody-associated vasculitis","MONDO_0015492","Serious","S,O","2021","CHEMBL3989871","ENSG00000197405","NA","NA"
"Tazverik","Tazemetostat","TAZEMETOSTAT","CHEMBL3414621","Epizyme","EZH2 inhibitor","Oncology","Epithelioid sarcoma","epithelioid sarcoma","MONDO_0017387","Serious","P,O,A,F","2020","CHEMBL3414621","ENSG00000106462","ENSG00000068078,ENSG00000100387,ENSG00000132475,ENSG00000112511,ENSG00000168283,ENSG00000171456,ENSG00000008083,ENSG00000070748,ENSG00000119403,ENSG00000130816,ENSG00000158290,ENSG00000085224,ENSG00000139154,ENSG00000168610,ENSG00000221837,ENSG00000143033,ENSG00000167986,ENSG00000074266,ENSG00000096717,ENSG00000102054,ENSG00000105810,ENSG00000119772,ENSG00000163041,ENSG00000166068,ENSG00000182923,ENSG00000273604,ENSG00000169083,ENSG00000169252,ENSG00000196233,ENSG00000088305,ENSG00000162521,ENSG00000178691,ENSG00000101945","EFO_1001968"
"Tecentriq","Atezolizumab","ATEZOLIZUMAB","CHEMBL3707227","Genentech","PDL1 inhibitor","Oncology","Urothelial carcinoma","urothelial carcinoma","EFO_0008528","Serious","P,B,A","2016","CHEMBL3707227","ENSG00000120217","ENSG00000188389,ENSG00000091317,ENSG00000197646,ENSG00000121594,ENSG00000183723","NA"
"Tecfidera","Dimethyl fumarate","DIMETHYLFUMARATE","CHEMBL2107333","Biogen Idec","MOA unknown; activates NRF2 pathway","Other indication","Relapsing forms of multiple sclerosis","relapsing-remitting multiple sclerosis","EFO_0003929","Serious","S","2013","CHEMBL2107333","ENSG00000079999","ENSG00000057663,ENSG00000101266,ENSG00000127990,ENSG00000160051,ENSG00000163001,ENSG00000177459,ENSG00000052126,ENSG00000095397,ENSG00000099864,ENSG00000100065,ENSG00000100814,ENSG00000104365,ENSG00000130766,ENSG00000137802,ENSG00000140941,ENSG00000145979,ENSG00000170325,ENSG00000178209,ENSG00000184675,ENSG00000093000,ENSG00000108395,ENSG00000122707,ENSG00000126464,ENSG00000139219,ENSG00000140987,ENSG00000144597,ENSG00000168209,ENSG00000064999,ENSG00000090339,ENSG00000115267,ENSG00000116044,ENSG00000119596,ENSG00000120705,ENSG00000147601,ENSG00000152784,ENSG00000166068,ENSG00000169136,ENSG00000170296,ENSG00000066117,ENSG00000108821,ENSG00000109466,ENSG00000114796,ENSG00000123154,ENSG00000138439,ENSG00000156795,ENSG00000170180,ENSG00000171444,ENSG00000188112,ENSG00000232040,ENSG00000083093,ENSG00000149269,ENSG00000161011,ENSG00000164611,ENSG00000168887,ENSG00000173250,ENSG00000180370,ENSG00000197771,ENSG00000036257,ENSG00000082641,ENSG00000108381,ENSG00000124496,ENSG00000157680,ENSG00000160255,ENSG00000164830,ENSG00000166925,ENSG00000170860,ENSG00000173598,ENSG00000178078,ENSG00000181929,ENSG00000185567,ENSG00000197961,ENSG00000254986,ENSG00000030582,ENSG00000092820,ENSG00000109501,ENSG00000136830,ENSG00000146021,ENSG00000164109,ENSG00000173039,ENSG00000152092,ENSG00000187514","MONDO_0005301"
"Tecvayli","Teclistamab","Teclistamab","CHEMBL4594505","J&J","BCMA _ CD3 bispecific antibody","Oncology","Multiple myeloma","multiple myeloma","EFO_0001378","Serious","P,O,B,A","2022","CHEMBL4594505","ENSG00000160654,ENSG00000167286,ENSG00000198851,ENSG00000048462","ENSG00000134531,ENSG00000197860,ENSG00000071051,ENSG00000158092,ENSG00000176171,ENSG00000187066,ENSG00000187713,ENSG00000213658,ENSG00000127564,ENSG00000139644,ENSG00000109099,ENSG00000121680,ENSG00000126777,ENSG00000131037,ENSG00000162300,ENSG00000115085,ENSG00000121900,ENSG00000172005,ENSG00000139291,ENSG00000149451,ENSG00000153551,ENSG00000165025,ENSG00000169550","MONDO_0004095"
"Tegsedi","Inotersen","INOTERSEN","CHEMBL4297770","Ionis Pharmaceuticals","TTR-directed antisense oligonucleotide","Other indication","Hereditary TTR-mediated amyloidosis","hereditary ATTR amyloidosis","MONDO_0017132","Serious","P,O,F","2018","CHEMBL4297770","ENSG00000118271","ENSG00000104413,ENSG00000116039,ENSG00000129103,ENSG00000132016,ENSG00000167770,ENSG00000187037,ENSG00000187678,ENSG00000197153,ENSG00000264522,ENSG00000099864,ENSG00000115239,ENSG00000119537,ENSG00000123154,ENSG00000138207,ENSG00000145675,ENSG00000149557,ENSG00000170035,ENSG00000278828,ENSG00000287080,ENSG00000070476,ENSG00000076321,ENSG00000122042,ENSG00000142192,ENSG00000170004,ENSG00000198959,ENSG00000275379,ENSG00000026025,ENSG00000070061,ENSG00000087250,ENSG00000101911,ENSG00000119614,ENSG00000128272,ENSG00000130294,ENSG00000162852,ENSG00000165188,ENSG00000168936,ENSG00000169136,ENSG00000197409,ENSG00000286522,ENSG00000158941,ENSG00000159459,ENSG00000165171,ENSG00000165898,ENSG00000273983,ENSG00000054611,ENSG00000120253,ENSG00000128609,ENSG00000139372,ENSG00000143379,ENSG00000147724,ENSG00000163563,ENSG00000163885,ENSG00000165637,ENSG00000171055,ENSG00000275714,ENSG00000103154,ENSG00000106772,ENSG00000118271,ENSG00000140743,ENSG00000153885,ENSG00000166595,ENSG00000204305,ENSG00000242247,ENSG00000072415,ENSG00000105472,ENSG00000141030,ENSG00000196220,ENSG00000213380,ENSG00000274750,ENSG00000277775","NA"
"Tepezza","Teprotumumab","TEPROTUMUMAB","CHEMBL1743079","Horizon Therapeutics","IGF1R-directed mAb","Other indication","Thyroid eye disease","Graves disease","EFO_0004237","Not concordant","P,O,B,F","2020","CHEMBL1743079","ENSG00000140443","ENSG00000117461,ENSG00000138795,ENSG00000150093,ENSG00000168036,ENSG00000145675,ENSG00000166913,ENSG00000111679,ENSG00000170027,ENSG00000100614,ENSG00000105647,ENSG00000196396,ENSG00000103653,ENSG00000135679,ENSG00000115041,ENSG00000164047,ENSG00000106070,ENSG00000108953,ENSG00000115290,ENSG00000160691,ENSG00000179295,ENSG00000196914,ENSG00000017427,ENSG00000140443,ENSG00000171105","NA"
"Tepmetko","Tepotinib","Tepotinib","CHEMBL3402762","EMD Serono","MET kinase inhibitor","Oncology","NSCLC","non-small cell lung carcinoma","EFO_0003060","Serious","P,O,A","2021","CHEMBL3402762","ENSG00000105976","ENSG00000081237,ENSG00000104341,ENSG00000105251,ENSG00000110395,ENSG00000115085,ENSG00000127329,ENSG00000136573,ENSG00000143322,ENSG00000151490,ENSG00000183918,ENSG00000196576,ENSG00000000938,ENSG00000035720,ENSG00000074966,ENSG00000079308,ENSG00000115290,ENSG00000117461,ENSG00000120833,ENSG00000136205,ENSG00000146648,ENSG00000158092,ENSG00000171150,ENSG00000185338,ENSG00000197943,ENSG00000198574,ENSG00000105976,ENSG00000107338,ENSG00000135605,ENSG00000148082,ENSG00000149177,ENSG00000182511,ENSG00000184557,ENSG00000185634,ENSG00000197122,ENSG00000007264,ENSG00000010017,ENSG00000071051,ENSG00000103423,ENSG00000111077,ENSG00000111252,ENSG00000113263,ENSG00000129946,ENSG00000141738,ENSG00000010671,ENSG00000027869,ENSG00000101336,ENSG00000134215,ENSG00000152894,ENSG00000163563,ENSG00000164050,ENSG00000165025,ENSG00000196684,ENSG00000198753,ENSG00000019991,ENSG00000101082,ENSG00000101213,ENSG00000131746,ENSG00000177885,ENSG00000179295,ENSG00000182866,ENSG00000254087,ENSG00000095370,ENSG00000115687,ENSG00000124181,ENSG00000127947,ENSG00000137936,ENSG00000140538,ENSG00000144724,ENSG00000145675,ENSG00000145715,ENSG00000160999,ENSG00000178188,ENSG00000067225,ENSG00000070159,ENSG00000087266,ENSG00000105647,ENSG00000160691,ENSG00000165458,ENSG00000167193,ENSG00000170677,ENSG00000176105,ENSG00000196396,ENSG00000160293","NA"
"Terlivaz","Terlipressin","Terlipressin","CHEMBL2135460","Mallinckrodt","Vasopressin receptor agonist","Other indication","Kidney function in hepatorenal syndrome","Hepatorenal syndrome","MONDO_0001382","Serious","P,O,F","2022","CHEMBL2135460","ENSG00000166148","ENSG00000144476","HP_0006554"
"Tezspire","Tezepelumab","Tezepelumab","CHEMBL3707229","Astrazeneca/Amgen","TSLP-targeted mAb","Other indication","Serious asthma","asthma","MONDO_0004979","Serious","P","2021","CHEMBL3707229","ENSG00000145777","ENSG00000269335,ENSG00000171867","EFO_0004842"
"Tibsovo","Ivosidenib","IVOSIDENIB","CHEMBL3989958","Agios Pharmaceuticals","IDH1 inhibitor","Oncology","IDH1-mutated AML, Locally Advanced or Metastatic Cholangiocarcinoma (*)","acute myeloid leukemia; cholangiocarcinoma","EFO_0000222,EFO_0005221","Serious","P,O,F","2018","CHEMBL3989958","ENSG00000138413","ENSG00000149257,ENSG00000114062,ENSG00000119689,ENSG00000163513,ENSG00000261371,ENSG00000072062,ENSG00000151414,ENSG00000179218,ENSG00000138413,ENSG00000198668","NA"
"Tissueblue","Brilliant Blue G","BRILLIANTBLUEG","CHEMBL4173394","Dutch Ophthalmic Research","Brilliant Blue G dye","No human target","Staining the internal limiting membrane","NA","NA","NA","P,O","2019","CHEMBL4173394","NA","NA","NA"
"Tivdak","Tisotumab vedotin","Tisotumabvedotin","CHEMBL4297841","Seagen/Genmab","Tissue-factor-directed ADC","Oncology","Cervical cancer","cervical cancer","MONDO_0002974","Serious","P,A","2021","CHEMBL4297841","ENSG00000167553,ENSG00000176014,ENSG00000167552,ENSG00000196230,ENSG00000152086,ENSG00000198033,ENSG00000127824,ENSG00000101162,ENSG00000258947,ENSG00000123416,ENSG00000137267,ENSG00000104833,ENSG00000188229,ENSG00000117525,ENSG00000137285,ENSG00000261456","ENSG00000001626,ENSG00000105993,ENSG00000119689,ENSG00000123609,ENSG00000130779,ENSG00000131697,ENSG00000139517,ENSG00000142168,ENSG00000151414,ENSG00000166170,ENSG00000167553,ENSG00000170801,ENSG00000197386,ENSG00000204843,ENSG00000265763,ENSG00000026025,ENSG00000115317,ENSG00000115514,ENSG00000123416,ENSG00000127824,ENSG00000129559,ENSG00000146648,ENSG00000151849,ENSG00000152359,ENSG00000167552,ENSG00000178127,ENSG00000005893,ENSG00000065361,ENSG00000080824,ENSG00000097033,ENSG00000100603,ENSG00000102003,ENSG00000123358,ENSG00000126934,ENSG00000135624,ENSG00000143256,ENSG00000146731,ENSG00000155959,ENSG00000177954,ENSG00000182168,ENSG00000188906,ENSG00000083799,ENSG00000094631,ENSG00000102977,ENSG00000114416,ENSG00000123349,ENSG00000124214,ENSG00000133124,ENSG00000138794,ENSG00000166091,ENSG00000173020,ENSG00000196730,ENSG00000254999,ENSG00000258947,ENSG00000057593,ENSG00000090520,ENSG00000106211,ENSG00000115484,ENSG00000126581,ENSG00000136319,ENSG00000136997,ENSG00000141837,ENSG00000143575,ENSG00000145555,ENSG00000161011,ENSG00000176148,ENSG00000179218,ENSG00000204463,ENSG00000268606,NA,ENSG00000054523,ENSG00000069345,ENSG00000103423,ENSG00000109501,ENSG00000116106,ENSG00000116983,ENSG00000147601,ENSG00000156475,ENSG00000160181,ENSG00000162946,ENSG00000164924,ENSG00000166046,ENSG00000166135,ENSG00000167900,ENSG00000196504,ENSG00000091831,ENSG00000092330,ENSG00000102119,ENSG00000104427,ENSG00000112208,ENSG00000120438,ENSG00000147676,ENSG00000150753,ENSG00000156261,ENSG00000163468,ENSG00000177606,ENSG00000183305,ENSG00000183386,ENSG00000186868,ENSG00000084774,ENSG00000086061,ENSG00000114904,ENSG00000133112,ENSG00000142192,ENSG00000145335,ENSG00000166226,ENSG00000177674,ENSG00000277586","NA"
"Tivicay","Dolutegravir","DOLUTEGRAVIR","CHEMBL1229211","ViiV","HIV1 integrase strand transfer inhibitor","No human target","HIV1 infection in adults and children, in combination with other antiretroviral agents","HIV infection","EFO_0000764","Serious","P,F","2013","CHEMBL1229211","NA","NA","NA"
"Tremfya","Guselkumab","GUSELKUMAB","CHEMBL2364648","Janssen/Johnson & Johnson","IL-23 blocker","Other indication","Plaque psoriasis","psoriasis vulgaris","EFO_1001494","Not serious","P","2017","CHEMBL2364648","ENSG00000110944,ENSG00000113302","ENSG00000162594,ENSG00000168811,ENSG00000110944,ENSG00000113302,ENSG00000162735","EFO_0000676"
"Tresiba","Insulin degludec","INSULINDEGLUDEC","CHEMBL2107869","Novo Nordisk","Long-acting insulin","Other indication","Diabetes","diabetes mellitus","EFO_0000400","Not concordant","S","2015","CHEMBL2107869","ENSG00000171105","ENSG00000127329,ENSG00000141480,ENSG00000127947,ENSG00000140443,ENSG00000149177,ENSG00000151490,ENSG00000074696,ENSG00000169047,ENSG00000081237,ENSG00000135439,ENSG00000144724,ENSG00000164109,ENSG00000167065,ENSG00000171105,ENSG00000106070,ENSG00000124181,ENSG00000153233,ENSG00000178188,ENSG00000185950,ENSG00000254647,ENSG00000011465,ENSG00000017427,ENSG00000075624,ENSG00000094796,ENSG00000145675,ENSG00000160691,ENSG00000179295,ENSG00000027644,ENSG00000070159,ENSG00000152894,ENSG00000196396,ENSG00000197594","NA"
"Trikafta","Tezacaftor, elexacaftor, ivacaftor","TEZACAFTOR,ELEXACAFTOR,IVACAFTOR","CHEMBL3544914,CHEMBL4298128,CHEMBL2010601","Vertex","Two CFTR correctors and a CFTR potentiator","Other indication","Most common gene mutation that causes cystic fibrosis","cystic fibrosis","MONDO_0009061","Serious","P,O,B,F","2019","CHEMBL3544914,CHEMBL4298128,CHEMBL2010601","ENSG00000001626","ENSG00000082898,ENSG00000085063,ENSG00000100097,ENSG00000105568,ENSG00000113013,ENSG00000115484,ENSG00000128607,ENSG00000129083,ENSG00000136986,ENSG00000141510,ENSG00000143793,ENSG00000154582,ENSG00000155660,ENSG00000163468,ENSG00000175166,ENSG00000181163,ENSG00000196236,ENSG00000079246,ENSG00000096384,ENSG00000104783,ENSG00000105202,ENSG00000105835,ENSG00000113368,ENSG00000115268,ENSG00000126247,ENSG00000127022,ENSG00000131051,ENSG00000132646,ENSG00000146731,ENSG00000147140,ENSG00000160213,ENSG00000162909,ENSG00000166986,ENSG00000169045,ENSG00000170421,ENSG00000171793,ENSG00000172354,ENSG00000185825,ENSG00000197191,ENSG00000241685,ENSG00000069345,ENSG00000074800,ENSG00000109062,ENSG00000125844,ENSG00000125868,ENSG00000134333,ENSG00000135829,ENSG00000136153,ENSG00000149257,ENSG00000163220,ENSG00000164022,ENSG00000167815,ENSG00000172725,ENSG00000176014,ENSG00000197321,ENSG00000204308,ENSG00000249915,ENSG00000065150,ENSG00000065978,ENSG00000100345,ENSG00000100911,ENSG00000106366,ENSG00000108107,ENSG00000114353,ENSG00000117450,ENSG00000122566,ENSG00000134308,ENSG00000136628,ENSG00000138107,ENSG00000160789,ENSG00000168488,ENSG00000174437,ENSG00000189091,ENSG00000196419,ENSG00000204389,ENSG00000078369,ENSG00000086061,ENSG00000103363,ENSG00000106305,ENSG00000110880,ENSG00000116641,ENSG00000125970,ENSG00000132109,ENSG00000144381,ENSG00000149925,ENSG00000165280,ENSG00000176105,ENSG00000177731,ENSG00000181789,ENSG00000204388,ENSG00000011304,ENSG00000014216,ENSG00000044574,ENSG00000050405,ENSG00000058262,ENSG00000065054,ENSG00000073578,ENSG00000100764,ENSG00000106484,ENSG00000113194,ENSG00000115806,ENSG00000116560,ENSG00000128595,ENSG00000132589,ENSG00000132612,ENSG00000138594,ENSG00000140945,ENSG00000143549,ENSG00000164924,ENSG00000167553,ENSG00000169813,ENSG00000215301,ENSG00000001626,ENSG00000074696,ENSG00000075624,ENSG00000092820,ENSG00000093167,ENSG00000109133,ENSG00000109572,ENSG00000111057,ENSG00000117592,ENSG00000120265,ENSG00000120438,ENSG00000124207,ENSG00000124614,ENSG00000126803,ENSG00000127481,ENSG00000132341,ENSG00000132912,ENSG00000142871,ENSG00000143546,ENSG00000144713,ENSG00000165119,ENSG00000167085,ENSG00000172053,ENSG00000174502,ENSG00000174827,ENSG00000204628,ENSG00000213741,ENSG00000240972,ENSG00000030582,ENSG00000037474,ENSG00000047932,ENSG00000064547,ENSG00000089159,ENSG00000092199,ENSG00000100591,ENSG00000102119,ENSG00000105141,ENSG00000106211,ENSG00000108424,ENSG00000117906,ENSG00000130255,ENSG00000136238,ENSG00000138071,ENSG00000143556,ENSG00000158710,ENSG00000162244,ENSG00000163902,ENSG00000186716,ENSG00000213719,ENSG00000222038,ENSG00000242372,ENSG00000253729,ENSG00000254772,ENSG00000104824,ENSG00000117868,ENSG00000131620","NA"
"Trodelvy","Sacituzumab govitecan","SACITUZUMABGOVITECAN","CHEMBL3545262","Immunomedics/Gilead","TROP2-directed ADC, with topoisomerase inhibitor","Oncology","Triple-negative breast cancer (and advanced or metastatic urothelial cancer (mUC)*)","triple-negative breast cancer; urothelial carcinoma","EFO_0005537,EFO_0008528","Serious","P,B,A,F","2020","CHEMBL3545262","ENSG00000198900,ENSG00000184292","ENSG00000131747,ENSG00000131876,ENSG00000136997,ENSG00000143799,ENSG00000153187,ENSG00000162692,ENSG00000174231,ENSG00000015285,ENSG00000115053,ENSG00000125944,ENSG00000135486,ENSG00000135829,ENSG00000167034,ENSG00000221880,ENSG00000091831,ENSG00000122566,ENSG00000187766,ENSG00000097007,ENSG00000116560,ENSG00000181163,ENSG00000187837,ENSG00000205867,ENSG00000092199,ENSG00000100201,ENSG00000147140,ENSG00000253729,ENSG00000136450,ENSG00000144028,ENSG00000165732,ENSG00000066044,ENSG00000165119,ENSG00000187180","NA"
"Trogarzo","Ibalizumab","IBALIZUMAB","CHEMBL1743029","TaiMed Biologics/Theratechnologies","CD4 antibody","Other indication","HIV","hiv infection","EFO_0000764","Serious","P,O,B,F","2018","CHEMBL1743029","ENSG00000010610","ENSG00000010610,ENSG00000097033,ENSG00000182866,ENSG00000005893,ENSG00000160791","NA"
"Trulance","Plecanatide","PLECANATIDE","CHEMBL2103867","Synergy Pharmaceuticals","Guanylate cyclase C agonist","Other indication","Chronic idiopathic constipation","Chronic constipation","HP_0012450","Not serious","S","2017","CHEMBL2103867","ENSG00000070019","ENSG00000172367,ENSG00000174827","NA"
"Trulicity","Dulaglutide","DULAGLUTIDE","CHEMBL2108027","Eli Lilly","GLP1-receptor agonist","Other indication","Type 2 diabetes","type 2 diabetes mellitus","MONDO_0005148","Not concordant","S","2014","CHEMBL2108027","ENSG00000112164","ENSG00000221880,ENSG00000197191,ENSG00000221837,ENSG00000272804,ENSG00000187766,ENSG00000264343,ENSG00000286219,ENSG00000186860,ENSG00000188581,ENSG00000254997","Orphanet_79161,HP_0003076"
"Truseltiq","Infigratinib","Infigratinib","CHEMBL1852688","BridgeBio","FGFR2 kinase inhibitor","Oncology","FGFR2-mutated bile duct cancer","bile duct cancer","MONDO_0003059","Serious","P,O,A,F","2021","CHEMBL1852688","ENSG00000068078,ENSG00000077782,ENSG00000066468,ENSG00000160867","ENSG00000072415,ENSG00000075388,ENSG00000099956,ENSG00000100519,ENSG00000111241,ENSG00000111879,ENSG00000113595,ENSG00000118960,ENSG00000127914,ENSG00000129173,ENSG00000129472,ENSG00000131143,ENSG00000131351,ENSG00000131738,ENSG00000132680,ENSG00000134758,ENSG00000134962,ENSG00000136279,ENSG00000139219,ENSG00000140092,ENSG00000143420,ENSG00000147601,ENSG00000147647,ENSG00000147689,ENSG00000154237,ENSG00000158773,ENSG00000163749,ENSG00000163875,ENSG00000166272,ENSG00000167323,ENSG00000168779,ENSG00000169087,ENSG00000170684,ENSG00000183640,ENSG00000187678,ENSG00000198369,ENSG00000229715,ENSG00000240184,ENSG00000066697,ENSG00000069535,ENSG00000077157,ENSG00000084072,ENSG00000096070,ENSG00000110811,ENSG00000116299,ENSG00000121766,ENSG00000123178,ENSG00000127423,ENSG00000131408,ENSG00000144381,ENSG00000150783,ENSG00000151332,ENSG00000154822,ENSG00000156127,ENSG00000160695,ENSG00000162344,ENSG00000164675,ENSG00000165417,ENSG00000166579,ENSG00000167182,ENSG00000167965,ENSG00000173933,ENSG00000177463,ENSG00000178394,ENSG00000180155,ENSG00000184515,ENSG00000185753,ENSG00000187855,ENSG00000197157,ENSG00000198081,ENSG00000203780,ENSG00000204220,ENSG00000204472,ENSG00000278619,ENSG00000076321,ENSG00000078328,ENSG00000079974,ENSG00000092529,ENSG00000100916,ENSG00000104824,ENSG00000106462,ENSG00000107485,ENSG00000115165,ENSG00000115738,ENSG00000123405,ENSG00000124762,ENSG00000125968,ENSG00000146021,ENSG00000146776,ENSG00000147533,ENSG00000149084,ENSG00000149357,ENSG00000152240,ENSG00000154764,ENSG00000160972,ENSG00000162624,ENSG00000164649,ENSG00000166037,ENSG00000166925,ENSG00000170312,ENSG00000171345,ENSG00000171388,ENSG00000174738,ENSG00000175866,ENSG00000177181,ENSG00000178104,ENSG00000185869,ENSG00000212864,ENSG00000242259,ENSG00000244362,ENSG00000288547,ENSG00000010379,ENSG00000011332,ENSG00000039068,ENSG00000060982,ENSG00000065361,ENSG00000066468,ENSG00000067225,ENSG00000096384,ENSG00000100225,ENSG00000101457,ENSG00000102678,ENSG00000104228,ENSG00000104413,ENSG00000105401,ENSG00000108961,ENSG00000109787,ENSG00000117625,ENSG00000123374,ENSG00000125945,ENSG00000130717,ENSG00000130770,ENSG00000138685,ENSG00000140941,ENSG00000140995,ENSG00000141753,ENSG00000145675,ENSG00000152102,ENSG00000153044,ENSG00000154358,ENSG00000158517,ENSG00000160867,ENSG00000165731,ENSG00000166225,ENSG00000166508,ENSG00000168036,ENSG00000171208,ENSG00000171223,ENSG00000172399,ENSG00000173991,ENSG00000179094,ENSG00000179348,ENSG00000183674,ENSG00000187514,ENSG00000203857,ENSG00000257949,ENSG00000011201,ENSG00000070193,ENSG00000072182,ENSG00000075426,ENSG00000089916,ENSG00000093010,ENSG00000100603,ENSG00000101290,ENSG00000102145,ENSG00000104064,ENSG00000111328,ENSG00000116918,ENSG00000118523,ENSG00000118985,ENSG00000119703,ENSG00000120094,ENSG00000120333,ENSG00000123388,ENSG00000124181,ENSG00000129351,ENSG00000130830,ENSG00000131791,ENSG00000133687,ENSG00000134248,ENSG00000136997,ENSG00000137478,ENSG00000137822,ENSG00000139053,ENSG00000148604,ENSG00000151962,ENSG00000157851,ENSG00000160961,ENSG00000162377,ENSG00000162869,ENSG00000163885,ENSG00000168769,ENSG00000170485,ENSG00000170677,ENSG00000177189,ENSG00000181513,ENSG00000184857,ENSG00000185432,ENSG00000186951,ENSG00000187778,ENSG00000198003,ENSG00000204619,ENSG00000249481,ENSG00000017797,ENSG00000068078,ENSG00000071082,ENSG00000077721,ENSG00000077782,ENSG00000087365,ENSG00000092010,ENSG00000092068,ENSG00000099814,ENSG00000100379,ENSG00000102931,ENSG00000104147,ENSG00000104341,ENSG00000109083,ENSG00000111224,ENSG00000113578,ENSG00000116691,ENSG00000117475,ENSG00000119965,ENSG00000124302,ENSG00000125571,ENSG00000140153,ENSG00000140320,ENSG00000143001,ENSG00000143382,ENSG00000143507,ENSG00000143952,ENSG00000147548,ENSG00000152684,ENSG00000155975,ENSG00000156831,ENSG00000163072,ENSG00000163596,ENSG00000164743,ENSG00000165898,ENSG00000166452,ENSG00000167861,ENSG00000168591,ENSG00000169905,ENSG00000173039,ENSG00000177606,ENSG00000179295,ENSG00000186977,ENSG00000198034,ENSG00000205838,ENSG00000225855,ENSG00000264522,ENSG00000004975,ENSG00000039650,ENSG00000054282,ENSG00000089116,ENSG00000095539,ENSG00000099817,ENSG00000103423,ENSG00000104892,ENSG00000106615,ENSG00000107831,ENSG00000118972,ENSG00000124659,ENSG00000126107,ENSG00000134198,ENSG00000134419,ENSG00000136404,ENSG00000136982,ENSG00000140285,ENSG00000140632,ENSG00000141232,ENSG00000141582,ENSG00000142856,ENSG00000144681,ENSG00000147144,ENSG00000147324,ENSG00000159445,ENSG00000163530,ENSG00000164252,ENSG00000166595,ENSG00000166681,ENSG00000170262,ENSG00000170500,ENSG00000170608,ENSG00000171357,ENSG00000175592,ENSG00000178750,ENSG00000182040,ENSG00000182196,ENSG00000185246,ENSG00000185386,ENSG00000186451,ENSG00000002834,ENSG00000040633,ENSG00000041988,ENSG00000064195,ENSG00000066248,ENSG00000068028,ENSG00000069869,ENSG00000070718,ENSG00000073150,ENSG00000088970,ENSG00000095794,ENSG00000102178,ENSG00000113070,ENSG00000115145,ENSG00000123908,ENSG00000126768,ENSG00000136738,ENSG00000136811,ENSG00000138131,ENSG00000140386,ENSG00000140859,ENSG00000143340,ENSG00000147457,ENSG00000148735,ENSG00000158246,ENSG00000163995,ENSG00000167193,ENSG00000170469,ENSG00000171425,ENSG00000181781,ENSG00000183304,ENSG00000183666,ENSG00000183856,ENSG00000184937,ENSG00000185345,ENSG00000185658,ENSG00000187510,ENSG00000236699,ENSG00000240021,ENSG00000244687,ENSG00000260027,ENSG00000158747,ENSG00000163492,ENSG00000177885,ENSG00000185880","NA"
"Tukysa","Tucatinib","TUCATINIB","CHEMBL3989868","Seagen","HER2 kinase inhibitor","Oncology","HER2-positive breast cancer","HER2 Positive Breast Carcinoma","EFO_1000294","Serious","P,O,B,F","2020","CHEMBL3989868","ENSG00000141736","ENSG00000075415,ENSG00000080824,ENSG00000081237,ENSG00000086061,ENSG00000101082,ENSG00000115325,ENSG00000116161,ENSG00000116285,ENSG00000122707,ENSG00000123983,ENSG00000127022,ENSG00000138095,ENSG00000153201,ENSG00000160691,ENSG00000162434,ENSG00000067225,ENSG00000087266,ENSG00000121653,ENSG00000129946,ENSG00000134215,ENSG00000134242,ENSG00000144724,ENSG00000169047,ENSG00000174791,ENSG00000178568,ENSG00000179295,ENSG00000185046,ENSG00000000938,ENSG00000008735,ENSG00000100351,ENSG00000102189,ENSG00000105197,ENSG00000106278,ENSG00000109111,ENSG00000112473,ENSG00000130193,ENSG00000153233,ENSG00000189043,ENSG00000007264,ENSG00000014257,ENSG00000069345,ENSG00000071051,ENSG00000072135,ENSG00000082898,ENSG00000085832,ENSG00000090776,ENSG00000094631,ENSG00000105401,ENSG00000113108,ENSG00000127329,ENSG00000133124,ENSG00000136205,ENSG00000136573,ENSG00000148082,ENSG00000151422,ENSG00000151490,ENSG00000168439,ENSG00000168610,ENSG00000169398,ENSG00000189410,ENSG00000197122,ENSG00000010810,ENSG00000068654,ENSG00000070159,ENSG00000072274,ENSG00000096063,ENSG00000096384,ENSG00000105701,ENSG00000111077,ENSG00000114737,ENSG00000117461,ENSG00000143322,ENSG00000145675,ENSG00000145715,ENSG00000146648,ENSG00000160999,ENSG00000163399,ENSG00000165025,ENSG00000167193,ENSG00000173406,ENSG00000058262,ENSG00000064999,ENSG00000065361,ENSG00000100938,ENSG00000101213,ENSG00000102010,ENSG00000105647,ENSG00000108424,ENSG00000125170,ENSG00000125731,ENSG00000127947,ENSG00000132669,ENSG00000133056,ENSG00000135605,ENSG00000149177,ENSG00000155926,ENSG00000157168,ENSG00000165629,ENSG00000177885,ENSG00000197785,ENSG00000197943,ENSG00000198574,ENSG00000099942,ENSG00000101558,ENSG00000111252,ENSG00000113263,ENSG00000124181,ENSG00000140575,ENSG00000141736,ENSG00000152894,ENSG00000160293,ENSG00000185338,ENSG00000206052,ENSG00000027869,ENSG00000044574,ENSG00000074966,ENSG00000075336,ENSG00000075624,ENSG00000095585,ENSG00000097007,ENSG00000109684,ENSG00000111640,ENSG00000113648,ENSG00000115415,ENSG00000124164,ENSG00000128656,ENSG00000137076,ENSG00000137936,ENSG00000141738,ENSG00000141968,ENSG00000144749,ENSG00000166313","NA"
"Turalio","Pexidartinib","PEXIDARTINIB","CHEMBL3813873","Daiichi Sankyo","CSF1R, KIT and FLT3 inhibitor","Oncology","Tenosynovial giant cell tumour","Tenosynovial Giant Cell Tumor","EFO_1000562","Serious","P,O,B","2019","CHEMBL3813873","ENSG00000122025,ENSG00000157404,ENSG00000182578","ENSG00000010810,ENSG00000071051,ENSG00000074966,ENSG00000124181,ENSG00000134215,ENSG00000145715,ENSG00000158092,ENSG00000185634,ENSG00000095370,ENSG00000133216,ENSG00000136205,ENSG00000177885,ENSG00000179295,ENSG00000184371,ENSG00000197122,ENSG00000101213,ENSG00000117461,ENSG00000143322,ENSG00000145675,ENSG00000167193,ENSG00000170677,ENSG00000182511,ENSG00000198574,ENSG00000000938,ENSG00000097007,ENSG00000101082,ENSG00000111252,ENSG00000122025,ENSG00000148082,ENSG00000160691,ENSG00000182578,ENSG00000183918,ENSG00000196684,ENSG00000027869,ENSG00000035720,ENSG00000067225,ENSG00000095585,ENSG00000100351,ENSG00000106070,ENSG00000107338,ENSG00000120833,ENSG00000129946,ENSG00000101336,ENSG00000115085,ENSG00000135333,ENSG00000136573,ENSG00000137936,ENSG00000165025,ENSG00000269335,ENSG00000049130,ENSG00000087266,ENSG00000099942,ENSG00000149177,ENSG00000171150,ENSG00000176105,ENSG00000254087,ENSG00000079308,ENSG00000111077,ENSG00000135605,ENSG00000182866,ENSG00000184557,ENSG00000197943,ENSG00000105647,ENSG00000141738,ENSG00000157368","MONDO_0002171"
"Tymlos","Abaloparatide","ABALOPARATIDE","CHEMBL3301581","Radius Health","Parathyroid hormone-related protein","Other indication","Osteoporosis","osteoporosis","EFO_0003882","Not serious","S","2017","CHEMBL3301581","ENSG00000160801","ENSG00000173473,ENSG00000152266,ENSG00000115661,ENSG00000160014,ENSG00000198668,ENSG00000087494,ENSG00000105991,ENSG00000138867,ENSG00000179455,ENSG00000204438,ENSG00000143933,ENSG00000168036,ENSG00000128245,ENSG00000163060","NA"
"Tzield","Teplizumab","Teplizumab","CHEMBL1743078","Provention Bio","CD3-targeted antibody","Other indication","Delay onset of type 1 diabetes","type 1 diabetes mellitus","MONDO_0005147","Not concordant","P,B","2022","CHEMBL1743078","ENSG00000198851","ENSG00000158092,ENSG00000127564,ENSG00000162300,ENSG00000131037,ENSG00000115085,ENSG00000149451,ENSG00000169550,ENSG00000176171,ENSG00000071051,ENSG00000165025","NA"
"Ubrelvy","Ubrogepant","UBROGEPANT","CHEMBL2364638","Allergan","CGRP receptor antagonist","Other indication","Migraine with or without aura","migraine disorder","MONDO_0005277","Not serious","S","2019","CHEMBL2364638","ENSG00000064989","ENSG00000148926,ENSG00000110680,ENSG00000131477,ENSG00000132329","NA"
"Ukoniq","Umbralisib","Umbralisib","CHEMBL3948730","TG Therapeutics","PI3Kdelta and CK1epsilon inhibitor","Oncology","MZL, follicular lymphoma","MZL; follicular lymphoma","EFO_1000630,MONDO_0018906","Serious","P,O,B,A","2021","CHEMBL3948730","ENSG00000097007,ENSG00000213923,ENSG00000171608","ENSG00000067225,ENSG00000096384,ENSG00000099942,ENSG00000104814,ENSG00000107338,ENSG00000108953,ENSG00000112290,ENSG00000116288,ENSG00000122025,ENSG00000135679,ENSG00000157404,ENSG00000167193,ENSG00000173320,ENSG00000178568,ENSG00000064309,ENSG00000075391,ENSG00000101447,ENSG00000105287,ENSG00000128245,ENSG00000138443,ENSG00000151748,ENSG00000153707,ENSG00000161202,ENSG00000168710,ENSG00000169122,ENSG00000180921,ENSG00000185499,ENSG00000214655,ENSG00000241794,ENSG00000064652,ENSG00000095637,ENSG00000110171,ENSG00000132549,ENSG00000137845,ENSG00000141736,ENSG00000149311,ENSG00000157657,ENSG00000168036,ENSG00000204315,ENSG00000225830,ENSG00000078674,ENSG00000103126,ENSG00000117461,ENSG00000135250,ENSG00000160255,ENSG00000168143,ENSG00000168876,ENSG00000169083,ENSG00000175793,ENSG00000188906,ENSG00000198900,ENSG00000006607,ENSG00000094796,ENSG00000105974,ENSG00000107404,ENSG00000123575,ENSG00000125898,ENSG00000132326,ENSG00000166913,ENSG00000171914,ENSG00000114383,ENSG00000121671,ENSG00000124486,ENSG00000146648,ENSG00000164924,ENSG00000196363,ENSG00000104973,ENSG00000141968,ENSG00000145335,ENSG00000147689,ENSG00000171444,ENSG00000184731,ENSG00000197122,ENSG00000107263,ENSG00000121634,ENSG00000126561,ENSG00000204410,ENSG00000008405,ENSG00000065361,ENSG00000148396,ENSG00000170027,ENSG00000173757,ENSG00000174791,ENSG00000134982,ENSG00000136754,ENSG00000145675,ENSG00000157020,ENSG00000179094,ENSG00000088888,ENSG00000113712,ENSG00000120896,ENSG00000196396,ENSG00000196730,ENSG00000004975,ENSG00000154237,ENSG00000197822","NA,EFO_0000183"
"Ultomiris","Ravulizumab","RAVULIZUMAB","CHEMBL3989986","Alexion","Complement inhibitor","Other indication","Paroxysmal nocturnal haemoglobinuria, atypical hemolytic uremic syndrome (*), generalized myasthenia gravis AChR+ (*)","paroxysmal nocturnal hemoglobinuria, atypical hemolytic-uremic syndrome, Myasthenia gravis","EFO_0004991,MONDO_0016244,MONDO_0100244","Serious","S,O","2018","CHEMBL3989986","ENSG00000106804","ENSG00000106536,ENSG00000166569,ENSG00000197993,ENSG00000021852,ENSG00000147155,ENSG00000169446,ENSG00000157613,ENSG00000165120,ENSG00000086159,ENSG00000157131,ENSG00000164040,ENSG00000112936,ENSG00000113600,ENSG00000165138,ENSG00000242019,ENSG00000039537,ENSG00000166881,ENSG00000176919,ENSG00000244414","NA"
"Unituxin","Dinutuximab","DINUTUXIMAB","CHEMBL3137342","United Therapeutics","GD2-binding mAb","NA","Neuroblastoma","neuroblastoma","EFO_0000621","Serious","P,O","2015","CHEMBL3137342","NA","NA","NA"
"Uplizna","Inebilizumab","INEBILIZUMAB","CHEMBL2109334","Viela Bio","CD19-directed mAb","Other indication","NMOSD","neuromyelitis optica","EFO_0004256","Serious","S,O,B","2020","CHEMBL2109334","ENSG00000177455","ENSG00000211899","MONDO_0000568"
"Uptravi","Selexipag","SELEXIPAG","CHEMBL238804","Actelion","Prostacyclin receptor agonist","Other indication","Pulmonary arterial hypertension","pulmonary arterial hypertension","EFO_0001361","Serious","S,O","2015","CHEMBL238804","ENSG00000160013","NA","EFO_0000537"
"Vabomere","Meropenem, vaborbactam","MEROPENEM,VABORBACTAM","CHEMBL127,CHEMBL3317857","The Medicines Company/Rempex Pharmaceuticals","Carbapenem antimicrobial plus a ‚Äö√¢√†‚àö‚â†‚Äö√Ñ√∂‚àö¬¢¬¨√ü-lactamase inhibitor","No human target","Complicated urinary tract infections","urinary tract infection","EFO_0003103","Not serious","P,F","2017","CHEMBL127,CHEMBL3317857","NA","NA","NA"
"Vabysmo","Faricimab","Faricimab","CHEMBL4297750","Roche/Genentech","VEGF _ ANG2 bispecific antibody","Other indication","nAMD and DME","age-related macular degeneration","EFO_0001365","Not serious","S","2022","CHEMBL4297750","ENSG00000112715,ENSG00000091879","ENSG00000112715,ENSG00000080189,ENSG00000148346,ENSG00000169562,ENSG00000102755,ENSG00000155755,ENSG00000099250,ENSG00000120156,ENSG00000128052","NA"
"Varubi","Rolapitant","ROLAPITANT","CHEMBL3707331","Tesaro","Neurokinin 1 receptor antagonist","Other indication","Nausea and vomiting associated with chemotherapy","Chemotherapy-induced nausea and vomiting","EFO_0006911","Not serious","S","2015","CHEMBL3707331","ENSG00000115353","ENSG00000198937,ENSG00000105677","NA"
"Veklury","Remdesivir","REMDESIVIR","CHEMBL4065616","Gilead","Nucleotide analogue RNA polymerase inhibitor","No human target","COVID-19","covid-19","MONDO_0100096","Serious","P,F","2020","CHEMBL4065616","NA","NA","NA"
"Veltassa","Patiromer sorbitex","PATIROMERSORBITEX","CHEMBL2107840","Relypsa","Potassium binder","No human target","Hyperkalaemia","Hyperkalemia","HP_0002153","Not concordant","S","2015","CHEMBL2107840","NA","NA","NA"
"Venclexta","Venetoclax","VENETOCLAX","CHEMBL3137309","AbbVie","BCL-2 inhibitor","Oncology","Chronic lymphocytic leukaemia","chronic lymphocytic leukemia","EFO_0000095","Serious","P,O,B,A","2016","CHEMBL3137309","ENSG00000171791","ENSG00000087088,ENSG00000105701,ENSG00000169682,ENSG00000188906,ENSG00000015475,ENSG00000100030,ENSG00000143514,ENSG00000171552,ENSG00000198625,ENSG00000002330,ENSG00000091592,ENSG00000104765,ENSG00000113575,ENSG00000141510,ENSG00000142168,ENSG00000141682,ENSG00000123358,ENSG00000126581,ENSG00000171791,ENSG00000221823,ENSG00000100290,ENSG00000142192,ENSG00000153094,ENSG00000185825,ENSG00000029363,ENSG00000105327,ENSG00000145354,ENSG00000030110,ENSG00000110497","NA"
"Verquvo","Vericiguat","Vericiguat","CHEMBL4066936","Merck & Co./Bayer","sGC stimulator","Other indication","Chronic heart failure","coronary artery disease","EFO_0001645","Serious","P,F","2021","CHEMBL4066936","ENSG00000152402,ENSG00000123201,ENSG00000061918,ENSG00000164116","ENSG00000075711,ENSG00000101400,ENSG00000074319,ENSG00000164116,ENSG00000172164,ENSG00000180900,ENSG00000061918,ENSG00000132535,ENSG00000063515","NA"
"Verzenio","Abemaciclib","ABEMACICLIB","CHEMBL3301610","Eli Lilly","CDK4/6 inhibitor","Oncology","HR-positive, HER2-negative breast cancer","HER2 negative breast carcinoma","EFO_0009780","Serious","P,B,F","2017","CHEMBL3301610","ENSG00000135446,ENSG00000105810","ENSG00000096060,ENSG00000100211,ENSG00000104859,ENSG00000111087,ENSG00000111276,ENSG00000116754,ENSG00000119866,ENSG00000132646,ENSG00000134709,ENSG00000136754,ENSG00000147130,ENSG00000147883,ENSG00000160570,ENSG00000196388,ENSG00000204610,ENSG00000065883,ENSG00000088325,ENSG00000096384,ENSG00000096717,ENSG00000097046,ENSG00000111701,ENSG00000116604,ENSG00000129355,ENSG00000145687,ENSG00000159216,ENSG00000175197,ENSG00000197444,ENSG00000197933,ENSG00000213676,ENSG00000072736,ENSG00000080839,ENSG00000103343,ENSG00000106462,ENSG00000134480,ENSG00000137497,ENSG00000148516,ENSG00000164548,ENSG00000065328,ENSG00000100461,ENSG00000105227,ENSG00000118689,ENSG00000134283,ENSG00000134324,ENSG00000143379,ENSG00000161956,ENSG00000163950,ENSG00000165804,ENSG00000168779,ENSG00000171540,ENSG00000171843,ENSG00000181896,ENSG00000198026,ENSG00000237441,ENSG00000080824,ENSG00000088881,ENSG00000099326,ENSG00000115875,ENSG00000134058,ENSG00000139517,ENSG00000147889,ENSG00000172403,ENSG00000206181,ENSG00000066279,ENSG00000073111,ENSG00000094804,ENSG00000108349,ENSG00000111206,ENSG00000112576,ENSG00000136450,ENSG00000143442,ENSG00000144560,ENSG00000152467,ENSG00000154277,ENSG00000154548,ENSG00000179750,ENSG00000198176,ENSG00000204463,ENSG00000005302,ENSG00000016082,ENSG00000102921,ENSG00000103479,ENSG00000118816,ENSG00000140464,ENSG00000164190,ENSG00000165588,ENSG00000095637,ENSG00000100146,ENSG00000101745,ENSG00000105401,ENSG00000110092,ENSG00000118971,ENSG00000119139,ENSG00000123080,ENSG00000124762,ENSG00000126767,ENSG00000134532,ENSG00000136709,ENSG00000136997,ENSG00000139687,ENSG00000155090,ENSG00000161405,ENSG00000161547,ENSG00000185122,ENSG00000197343,ENSG00000205250,ENSG00000109819,ENSG00000136527,ENSG00000163877,ENSG00000182606,ENSG00000184708","EFO_0000305"
"Viberzi","Eluxadoline","ELUXADOLINE","CHEMBL2159122","Allergan","Mu-opioid receptor agonist","Other indication","Irritable bowel syndrome","irritable bowel syndrome","EFO_0000555","Not serious","P,F","2015","CHEMBL2159122","ENSG00000112038","ENSG00000101460,ENSG00000113732,ENSG00000139644,ENSG00000170545,ENSG00000172005,ENSG00000121022,ENSG00000177519,ENSG00000196470,ENSG00000196924,ENSG00000205279,ENSG00000241399,ENSG00000116729,ENSG00000132965,ENSG00000134531,ENSG00000162975,ENSG00000177300,ENSG00000185049,ENSG00000010017,ENSG00000100528,ENSG00000105223,ENSG00000125170,ENSG00000133065,ENSG00000148483,ENSG00000149451,ENSG00000169903,ENSG00000181788,ENSG00000185883,ENSG00000197769,ENSG00000134873,ENSG00000144063,ENSG00000151778,ENSG00000156284,ENSG00000187513,ENSG00000198932,ENSG00000101558,ENSG00000159840,ENSG00000164081,ENSG00000172243,ENSG00000198937,ENSG00000008283,ENSG00000103042,ENSG00000109099,ENSG00000113790,ENSG00000115307,ENSG00000121542,ENSG00000168515,ENSG00000168824,ENSG00000168958,ENSG00000171517,ENSG00000172375,ENSG00000175489,ENSG00000103249,ENSG00000142089,ENSG00000142227,ENSG00000213658,ENSG00000256660,ENSG00000158014","NA"
"Viekira Pak","Ombitasvir, paritaprevir, dasabuvir, ritonavir","OMBITASVIR,PARITAPREVIR,DASABUVIR,RITONAVIR","CHEMBL163,CHEMBL3127326,CHEMBL3391662,CHEMBL3137312","AbbVie","An NS5A inhibitor plus an NS3A- and NS4A-protease inhibitor plus a non-nucleoside NS5B-palm-polymerase inhibitor plus a CYP3A inhibitor","Other indication","Chronic HCV genotype 1 infection","hepatitis C virus infection","EFO_0003047","Serious","P,B,F","2014","CHEMBL3127326,CHEMBL3391662,CHEMBL3137312,CHEMBL163","ENSG00000160868,ENSG00000106258,NA,ENSG00000160870,ENSG00000021461","ENSG00000187624,ENSG00000197386,ENSG00000166347,NA,ENSG00000101856,ENSG00000221829","NA"
"Viltepso","Viltolarsen","VILTOLARSEN","CHEMBL4298062","Nippon Shinyaku","Dystrophin splicing modifier","Other indication","Duchenne muscular dystrophy","duchenne muscular dystrophy","MONDO_0010679","Serious","P,O,A,F","2020","CHEMBL4298062","ENSG00000198947","ENSG00000152240,ENSG00000171345,ENSG00000101400,ENSG00000168807,ENSG00000171873,ENSG00000119326,ENSG00000138101,ENSG00000173402,ENSG00000187555,ENSG00000101076,ENSG00000171621,ENSG00000134769,ENSG00000172164,ENSG00000100151","NA"
"Vimizim","Elosulfase alfa","ELOSULFASEALFA","CHEMBL2108676","BioMarin","Hydrolytic lysosomal glycosaminoglycan-specific enzyme","Other indication","Mucopolysaccharidosis type IVA","mucopolysaccharidosis type 4A","MONDO_0009659","Serious","P,O,F","2014","CHEMBL2108676","ENSG00000141012","NA","NA"
"Vitrakvi","Larotrectinib","LAROTRECTINIB","CHEMBL3889654","Loxo Oncology/Bayer","TRKA, TRKB and TRKC inhibitor","Oncology","NTRK-positive solid cancers","salivary gland cancer; soft tissue sarcoma; thyroid cancer","EFO_1001968,MONDO_0002108,MONDO_0004669","Serious","P,O,B,A","2018","CHEMBL3889654","ENSG00000140538,ENSG00000198400,ENSG00000148053","ENSG00000105976,ENSG00000127329,ENSG00000134243,ENSG00000134259,ENSG00000144724,ENSG00000081237,ENSG00000124181,ENSG00000148053,ENSG00000160691,ENSG00000058262,ENSG00000067225,ENSG00000096384,ENSG00000140538,ENSG00000149177,ENSG00000196396,ENSG00000071537,ENSG00000127022,ENSG00000146648,ENSG00000206503,ENSG00000135333,ENSG00000198400,ENSG00000206052,ENSG00000127947,ENSG00000177169,ENSG00000151490,ENSG00000162733,ENSG00000006125,ENSG00000084754,ENSG00000134242,ENSG00000142192,ENSG00000161011,ENSG00000145675","NA"
"Vivjoa","Oteseconazole","Oteseconazole","CHEMBL3311228","Mycovia","Azole antifungal","No human target","Vulvovaginal candidiasis","vulvovaginal candidiasis","EFO_0007543","NA","P,F","2022","CHEMBL3311228","NA","NA","NA"
"Vizamyl","Flutemetamol F-18","FLUTEMETAMOLF-18","CHEMBL2042122","GE Healthcare","Radioactive diagnostic agent","Other indication","PET imaging of the brain to estimate beta-amyloid neuritic plaque density in patients who are being evaluated for Alzheimer's disease","neuritic plaque measurement; Alzheimer disease","EFO_0006798,MONDO_0004975","Serious","S","2013","CHEMBL2042122","ENSG00000142192","ENSG00000008382,ENSG00000010810,ENSG00000054523,ENSG00000070748,ENSG00000103415,ENSG00000104805,ENSG00000106333,ENSG00000107959,ENSG00000108387,ENSG00000108443,ENSG00000112592,ENSG00000118271,ENSG00000119041,ENSG00000119917,ENSG00000120885,ENSG00000132535,ENSG00000134243,ENSG00000142192,ENSG00000147224,ENSG00000158792,ENSG00000163932,ENSG00000170345,ENSG00000175344,ENSG00000177426,ENSG00000179399,ENSG00000185933,ENSG00000186868,ENSG00000188313,ENSG00000196262,ENSG00000196924,ENSG00000197971,ENSG00000198400,ENSG00000204301,ENSG00000205572,ENSG00000241563,ENSG00000002330,ENSG00000010017,ENSG00000011132,ENSG00000068001,ENSG00000078596,ENSG00000084234,ENSG00000108468,ENSG00000109971,ENSG00000111640,ENSG00000113575,ENSG00000115041,ENSG00000117984,ENSG00000120899,ENSG00000122861,ENSG00000124145,ENSG00000129515,ENSG00000132589,ENSG00000133816,ENSG00000137642,ENSG00000137801,ENSG00000140941,ENSG00000143933,ENSG00000144744,ENSG00000145675,ENSG00000147955,ENSG00000151694,ENSG00000154096,ENSG00000158747,ENSG00000158828,ENSG00000160307,ENSG00000161011,ENSG00000165025,ENSG00000168477,ENSG00000169783,ENSG00000169884,ENSG00000170276,ENSG00000178175,ENSG00000182240,ENSG00000183098,ENSG00000184144,ENSG00000184634,ENSG00000188157,ENSG00000198668,ENSG00000198805,ENSG00000256762,ENSG00000277586,ENSG00000278195,ENSG00000007047,ENSG00000011465,ENSG00000023318,ENSG00000065320,ENSG00000070182,ENSG00000082701,ENSG00000092201,ENSG00000105376,ENSG00000106211,ENSG00000112769,ENSG00000115884,ENSG00000126214,ENSG00000127824,ENSG00000133703,ENSG00000134318,ENSG00000136535,ENSG00000138095,ENSG00000138613,ENSG00000139329,ENSG00000142875,ENSG00000143801,ENSG00000144381,ENSG00000145335,ENSG00000147257,ENSG00000152256,ENSG00000160014,ENSG00000161202,ENSG00000164402,ENSG00000164885,ENSG00000168077,ENSG00000170312,ENSG00000171055,ENSG00000171564,ENSG00000171867,ENSG00000176884,ENSG00000177606,ENSG00000185825,ENSG00000188130,ENSG00000197746,ENSG00000198055,ENSG00000204305,ENSG00000205155,ENSG00000205542,ENSG00000210082,ENSG00000239697,ENSG00000014216,ENSG00000049540,ENSG00000072062,ENSG00000101439,ENSG00000102804,ENSG00000105851,ENSG00000107938,ENSG00000113140,ENSG00000113805,ENSG00000114646,ENSG00000121691,ENSG00000123384,ENSG00000123560,ENSG00000124214,ENSG00000128482,ENSG00000130522,ENSG00000132703,ENSG00000132773,ENSG00000133858,ENSG00000134853,ENSG00000135218,ENSG00000137463,ENSG00000137752,ENSG00000139318,ENSG00000141433,ENSG00000141551,ENSG00000142156,ENSG00000150093,ENSG00000151224,ENSG00000153002,ENSG00000156697,ENSG00000157450,ENSG00000157578,ENSG00000159593,ENSG00000160695,ENSG00000167004,ENSG00000170348,ENSG00000172466,ENSG00000179218,ENSG00000180210,ENSG00000196230,ENSG00000196531,ENSG00000196549,ENSG00000197386,ENSG00000221914,ENSG00000077942,ENSG00000100083,ENSG00000101204,ENSG00000101412,ENSG00000102030,ENSG00000105329,ENSG00000105974,ENSG00000108551,ENSG00000109501,ENSG00000115414,ENSG00000116288,ENSG00000117362,ENSG00000120948,ENSG00000122194,ENSG00000123080,ENSG00000123643,ENSG00000128052,ENSG00000130203,ENSG00000130669,ENSG00000131042,ENSG00000136156,ENSG00000138798,ENSG00000141434,ENSG00000146648,ENSG00000153234,ENSG00000157005,ENSG00000159023,ENSG00000166313,ENSG00000166598,ENSG00000166949,ENSG00000167755,ENSG00000167900,ENSG00000168385,ENSG00000168702,ENSG00000175203,ENSG00000181773,ENSG00000184203,ENSG00000184702,ENSG00000184937,ENSG00000197565,ENSG00000204264,ENSG00000204463,ENSG00000051382,ENSG00000070756,ENSG00000075651,ENSG00000080824,ENSG00000100505,ENSG00000102974,ENSG00000117505,ENSG00000119912,ENSG00000123143,ENSG00000128989,ENSG00000130234,ENSG00000132692,ENSG00000135698,ENSG00000136827,ENSG00000137098,ENSG00000137845,ENSG00000143369,ENSG00000144339,ENSG00000144619,ENSG00000148082,ENSG00000156475,ENSG00000157766,ENSG00000161955,ENSG00000163879,ENSG00000164953,ENSG00000165059,ENSG00000165916,ENSG00000166228,ENSG00000167770,ENSG00000168610,ENSG00000170315,ENSG00000171132,ENSG00000173548,ENSG00000183775,ENSG00000184986,ENSG00000188153,ENSG00000188517,ENSG00000196136,ENSG00000196712,ENSG00000196776,ENSG00000198959,ENSG00000204843,ENSG00000205302,ENSG00000232810,ENSG00000044574,ENSG00000064012,ENSG00000064300,ENSG00000067113,ENSG00000069424,ENSG00000075624,ENSG00000076248,ENSG00000078549,ENSG00000088832,ENSG00000089685,ENSG00000092969,ENSG00000099250,ENSG00000100985,ENSG00000105229,ENSG00000106305,ENSG00000116141,ENSG00000124222,ENSG00000126934,ENSG00000128595,ENSG00000130066,ENSG00000138449,ENSG00000140395,ENSG00000154277,ENSG00000157168,ENSG00000160963,ENSG00000162366,ENSG00000164305,ENSG00000166033,ENSG00000166851,ENSG00000168615,ENSG00000169604,ENSG00000171497,ENSG00000171603,ENSG00000172977,ENSG00000177706,ENSG00000178127,ENSG00000182585,ENSG00000185345,ENSG00000198840,ENSG00000242689,ENSG00000067560,ENSG00000069329,ENSG00000069696,ENSG00000073060,ENSG00000078114,ENSG00000080815,ENSG00000101266,ENSG00000113721,ENSG00000124788,ENSG00000131508,ENSG00000134259,ENSG00000134287,ENSG00000135823,ENSG00000139182,ENSG00000139719,ENSG00000141646,ENSG00000157212,ENSG00000158560,ENSG00000162604,ENSG00000167037,ENSG00000168765,ENSG00000171049,ENSG00000176697,ENSG00000189403,ENSG00000214087,ENSG00000241837,ENSG00000275700,ENSG00000051128,ENSG00000065154,ENSG00000066027,ENSG00000074317,ENSG00000100030,ENSG00000102879,ENSG00000105723,ENSG00000108107,ENSG00000111237,ENSG00000115091,ENSG00000118137,ENSG00000118526,ENSG00000121653,ENSG00000123091,ENSG00000125848,ENSG00000127022,ENSG00000127445,ENSG00000134709,ENSG00000135018,ENSG00000137312,ENSG00000146072,ENSG00000160691,ENSG00000162236,ENSG00000171314,ENSG00000172059,ENSG00000172115,ENSG00000196535,ENSG00000197442,ENSG00000254087,ENSG00000036672,ENSG00000062725,ENSG00000063660,ENSG00000087245,ENSG00000087884,ENSG00000108179,ENSG00000108578,ENSG00000115234,ENSG00000116133,ENSG00000123416,ENSG00000148798,ENSG00000163697,ENSG00000167552,ENSG00000168484,ENSG00000171989,ENSG00000172058,ENSG00000175582,ENSG00000196470,ENSG00000198736,ENSG00000198804,ENSG00000239886,ENSG00000006125,ENSG00000070808,ENSG00000105290,ENSG00000106617,ENSG00000109099,ENSG00000130024,ENSG00000143153,ENSG00000143196,ENSG00000143514,ENSG00000143870,ENSG00000144711,ENSG00000146731,ENSG00000166913,ENSG00000167772,ENSG00000173406,ENSG00000178741,ENSG00000182871,ENSG00000034053,ENSG00000072506,ENSG00000100285,ENSG00000102003,ENSG00000125656,ENSG00000125977,ENSG00000129219,ENSG00000132155,ENSG00000148400,ENSG00000185499,ENSG00000019169,ENSG00000107282,ENSG00000115318,ENSG00000133961,ENSG00000136238,ENSG00000136854,ENSG00000137947,ENSG00000162733,ENSG00000169375,ENSG00000172020,ENSG00000186318,ENSG00000071242,ENSG00000095970,ENSG00000102466,ENSG00000109846,ENSG00000113108,ENSG00000120910,ENSG00000163956,ENSG00000171791,ENSG00000173020,ENSG00000126767,ENSG00000131187,ENSG00000138685,ENSG00000140564,ENSG00000153071,ENSG00000172531,ENSG00000187554","NA"
"Vizimpro","Dacomitinib","DACOMITINIB","CHEMBL2105719","Pfizer","EGFR inhibitor","Oncology","EGFR-mutated NSCLC","non-small cell lung carcinoma","EFO_0003060","Serious","P,O","2018","CHEMBL2105719","ENSG00000141736,ENSG00000146648,ENSG00000178568","ENSG00000008735,ENSG00000012061,ENSG00000043462,ENSG00000061273,ENSG00000067606,ENSG00000068654,ENSG00000069345,ENSG00000078747,ENSG00000081237,ENSG00000086061,ENSG00000090520,ENSG00000100170,ENSG00000100591,ENSG00000104341,ENSG00000104756,ENSG00000104904,ENSG00000106211,ENSG00000107317,ENSG00000108424,ENSG00000110395,ENSG00000110651,ENSG00000113070,ENSG00000115085,ENSG00000115415,ENSG00000120053,ENSG00000124942,ENSG00000126561,ENSG00000127329,ENSG00000130340,ENSG00000131016,ENSG00000134308,ENSG00000136573,ENSG00000138363,ENSG00000142669,ENSG00000143322,ENSG00000143933,ENSG00000151422,ENSG00000151490,ENSG00000151491,ENSG00000160014,ENSG00000162434,ENSG00000162704,ENSG00000163235,ENSG00000182636,ENSG00000182718,ENSG00000183918,ENSG00000197785,ENSG00000198909,ENSG00000000938,ENSG00000006125,ENSG00000010810,ENSG00000014257,ENSG00000058262,ENSG00000064999,ENSG00000074966,ENSG00000085832,ENSG00000091831,ENSG00000096063,ENSG00000096384,ENSG00000100614,ENSG00000103876,ENSG00000107643,ENSG00000111816,ENSG00000112578,ENSG00000115145,ENSG00000115540,ENSG00000116254,ENSG00000117152,ENSG00000117461,ENSG00000124164,ENSG00000124207,ENSG00000133124,ENSG00000135506,ENSG00000135823,ENSG00000136205,ENSG00000137267,ENSG00000140575,ENSG00000141198,ENSG00000146648,ENSG00000154556,ENSG00000157500,ENSG00000158092,ENSG00000160255,ENSG00000166313,ENSG00000168036,ENSG00000171132,ENSG00000174791,ENSG00000182473,ENSG00000185338,ENSG00000186868,ENSG00000196961,ENSG00000197943,ENSG00000198574,ENSG00000204388,ENSG00000213658,ENSG00000214193,ENSG00000004478,ENSG00000008056,ENSG00000044115,ENSG00000044574,ENSG00000071537,ENSG00000080031,ENSG00000090776,ENSG00000096060,ENSG00000096968,ENSG00000100324,ENSG00000100938,ENSG00000102606,ENSG00000105245,ENSG00000105976,ENSG00000112473,ENSG00000113013,ENSG00000113580,ENSG00000114805,ENSG00000118363,ENSG00000121653,ENSG00000125731,ENSG00000126088,ENSG00000126581,ENSG00000127022,ENSG00000132669,ENSG00000133961,ENSG00000135046,ENSG00000135605,ENSG00000137463,ENSG00000142208,ENSG00000145016,ENSG00000145335,ENSG00000147010,ENSG00000148053,ENSG00000148082,ENSG00000149177,ENSG00000153201,ENSG00000154277,ENSG00000154710,ENSG00000159352,ENSG00000161203,ENSG00000165629,ENSG00000169375,ENSG00000170312,ENSG00000173406,ENSG00000182511,ENSG00000184557,ENSG00000185046,ENSG00000185483,ENSG00000185634,ENSG00000186834,ENSG00000197122,ENSG00000198561,ENSG00000206052,ENSG00000007264,ENSG00000014641,ENSG00000042753,ENSG00000071051,ENSG00000075415,ENSG00000101182,ENSG00000102189,ENSG00000103653,ENSG00000109111,ENSG00000109321,ENSG00000109684,ENSG00000109971,ENSG00000110011,ENSG00000111077,ENSG00000111252,ENSG00000111679,ENSG00000113263,ENSG00000115325,ENSG00000127191,ENSG00000128656,ENSG00000129946,ENSG00000141480,ENSG00000141655,ENSG00000141738,ENSG00000142949,ENSG00000144749,ENSG00000149428,ENSG00000168003,ENSG00000169047,ENSG00000170248,ENSG00000170293,ENSG00000172757,ENSG00000178568,ENSG00000183020,ENSG00000184524,ENSG00000196154,ENSG00000198668,ENSG00000015479,ENSG00000027869,ENSG00000046653,ENSG00000057294,ENSG00000067992,ENSG00000072135,ENSG00000075336,ENSG00000075624,ENSG00000077232,ENSG00000082898,ENSG00000092820,ENSG00000095585,ENSG00000097007,ENSG00000101336,ENSG00000103266,ENSG00000105974,ENSG00000106278,ENSG00000106299,ENSG00000107295,ENSG00000110711,ENSG00000111640,ENSG00000114737,ENSG00000116161,ENSG00000124882,ENSG00000127824,ENSG00000130193,ENSG00000132535,ENSG00000134215,ENSG00000134242,ENSG00000134853,ENSG00000135052,ENSG00000137076,ENSG00000137486,ENSG00000138095,ENSG00000140600,ENSG00000141736,ENSG00000142627,ENSG00000143294,ENSG00000149925,ENSG00000152894,ENSG00000155926,ENSG00000165025,ENSG00000165731,ENSG00000167601,ENSG00000169045,ENSG00000169398,ENSG00000174808,ENSG00000198853,ENSG00000204389,ENSG00000033327,ENSG00000034713,ENSG00000065361,ENSG00000067182,ENSG00000087586,ENSG00000099942,ENSG00000100280,ENSG00000101082,ENSG00000101213,ENSG00000101558,ENSG00000105971,ENSG00000106070,ENSG00000109458,ENSG00000113648,ENSG00000117450,ENSG00000120694,ENSG00000131746,ENSG00000132155,ENSG00000137693,ENSG00000150403,ENSG00000151834,ENSG00000153707,ENSG00000154237,ENSG00000159176,ENSG00000163399,ENSG00000163697,ENSG00000164615,ENSG00000165527,ENSG00000167552,ENSG00000170606,ENSG00000177885,ENSG00000179295,ENSG00000184575,ENSG00000185499,ENSG00000185896,ENSG00000188191,ENSG00000189043,ENSG00000198799,ENSG00000254087,ENSG00000269335,ENSG00000011132,ENSG00000011485,ENSG00000050748,ENSG00000094631,ENSG00000095370,ENSG00000101134,ENSG00000102309,ENSG00000104814,ENSG00000105197,ENSG00000105401,ENSG00000105613,ENSG00000116285,ENSG00000123384,ENSG00000123983,ENSG00000124181,ENSG00000125170,ENSG00000127947,ENSG00000130402,ENSG00000131558,ENSG00000132970,ENSG00000137936,ENSG00000138798,ENSG00000140009,ENSG00000141968,ENSG00000142192,ENSG00000144554,ENSG00000144724,ENSG00000145675,ENSG00000145715,ENSG00000149269,ENSG00000153233,ENSG00000159228,ENSG00000160999,ENSG00000162591,ENSG00000166598,ENSG00000168610,ENSG00000170581,ENSG00000173801,ENSG00000174437,ENSG00000175203,ENSG00000175866,ENSG00000178078,ENSG00000178188,ENSG00000184144,ENSG00000185359,ENSG00000197102,ENSG00000198399,ENSG00000204305,ENSG00000240972,ENSG00000253729,ENSG00000067225,ENSG00000069869,ENSG00000070159,ENSG00000072274,ENSG00000080824,ENSG00000085063,ENSG00000085733,ENSG00000087266,ENSG00000088930,ENSG00000092758,ENSG00000100351,ENSG00000100485,ENSG00000102010,ENSG00000105647,ENSG00000105701,ENSG00000107263,ENSG00000111669,ENSG00000113108,ENSG00000115904,ENSG00000122707,ENSG00000123908,ENSG00000130558,ENSG00000130706,ENSG00000131171,ENSG00000132639,ENSG00000132670,ENSG00000135451,ENSG00000136810,ENSG00000137193,ENSG00000137462,ENSG00000138698,ENSG00000139625,ENSG00000146674,ENSG00000148180,ENSG00000154127,ENSG00000154229,ENSG00000157168,ENSG00000158402,ENSG00000160691,ENSG00000164924,ENSG00000166913,ENSG00000167193,ENSG00000168439,ENSG00000169139,ENSG00000170677,ENSG00000173020,ENSG00000175793,ENSG00000176105,ENSG00000177666,ENSG00000182585,ENSG00000189410,ENSG00000196396,ENSG00000250722,ENSG00000254772,ENSG00000039068,ENSG00000105649,ENSG00000133056,ENSG00000136235,ENSG00000160293","NA"
"Vonjo","Pacritinib","Pacritinib","CHEMBL2035187","CTI Biopharma","JAK2 inhibitor","Oncology","Myelofibrosis","myelofibrosis","MONDO_0044903","Serious","P,O,A,F","2022","CHEMBL2035187","ENSG00000122025,ENSG00000096968","ENSG00000099942,ENSG00000149177,ENSG00000167193,ENSG00000196396,ENSG00000097007,ENSG00000101460,ENSG00000106070,ENSG00000115415,ENSG00000122025,ENSG00000165025,ENSG00000010810,ENSG00000096968,ENSG00000091181,ENSG00000117400,ENSG00000145715,ENSG00000170677,ENSG00000179295,ENSG00000136573,ENSG00000146648,ENSG00000178188,ENSG00000182866,ENSG00000065361,ENSG00000079308,ENSG00000100368,ENSG00000140941,ENSG00000162434,ENSG00000176105,ENSG00000269335,ENSG00000067225,ENSG00000143322","NA"
"Voquezna Triple Pak","Vonoprazan, amoxicillin, clarithromycin","Vonoprazan,amoxicillin,clarithromycin","CHEMBL2079130,CHEMBL1082,CHEMBL1741","Phathom","Potassium-competitive acid blocker plus a penicillin class antibacterial plus a macrolide antimicrobial","Other indication","Helicobacter pylori infection","Helicobacter pylori infectious disease","EFO_1000961","Not serious","P,F","2022","CHEMBL2079130,CHEMBL1082,CHEMBL1741","ENSG00000105675,NA,ENSG00000186009","NA,ENSG00000126251,ENSG00000126970,ENSG00000166946","NA"
"Vosevi","Sofosbuvir, velpatasvir, voxilaprevir","SOFOSBUVIR,VELPATASVIR,VOXILAPREVIR","CHEMBL1259059,CHEMBL3545062,CHEMBL3707372","Gilead Sciences","Nucleotide analogue NS5B polymerase inhibitor plus an NS5A inhibitor plus an NS3/4A protease inhibitor","No human target","HCV","hepatitis C virus infection","EFO_0003047","Serious","P,B","2017","CHEMBL1259059,CHEMBL3545062,CHEMBL3707372","NA","NA","NA"
"Voxzogo","Vosoritide","Vosoritide","CHEMBL3707276","Biomarin","CNP analogue","Other indication","Achondroplasia","achondroplasia","MONDO_0007037","Not serious","P,O,A","2021","CHEMBL3707276","ENSG00000159899","NA","Orphanet_329191,EFO_0004339"
"Vraylar","Cariprazine","CARIPRAZINE","CHEMBL2028019","Forest","Atypical antipsychotic","Other indication","Schizophrenia and bipolar 1 disorder","Schizophrenia; bipolar disorder","MONDO_0005090,MONDO_0004985","Serious","S","2015","CHEMBL2028019","ENSG00000151577,ENSG00000149295","NA,ENSG00000147955,ENSG00000149295,ENSG00000162946,ENSG00000078369,ENSG00000118432,ENSG00000128271,ENSG00000142319","NA"
"Vtama","Tapinarof","Tapinarof","CHEMBL259571","Dermavant","Aryl hydrocarbon receptor agonist","Other indication","Plaque psoriasis","psoriasis vulgaris","EFO_1001494","Not serious","S","2022","CHEMBL259571","ENSG00000106546","ENSG00000111912,ENSG00000143437,ENSG00000110711,ENSG00000196498","EFO_0000676"
"Vyepti","Eptinezumab","EPTINEZUMAB","CHEMBL3833320","Lundbeck","CGRP-directed mAb","Other indication","Migraine","migraine disorder","MONDO_0005277","Not serious","S","2020","CHEMBL3833320","ENSG00000110680,ENSG00000175868","ENSG00000064989,ENSG00000157087,ENSG00000186469,ENSG00000058668,ENSG00000087460,ENSG00000110680,ENSG00000132329,ENSG00000185043,ENSG00000078369,ENSG00000167522","NA"
"Vyleesi","Bremelanotide","BREMELANOTIDE","CHEMBL2070241","Amag","Melanocortin receptor agonist","Other indication","Hypoactive sexual desire disorder","sexual dysfunction","EFO_0004714","Not serious","S","2019","CHEMBL2070241","ENSG00000166603","NA","EFO_0008343"
"Vyndaqel","Tafamidis","TAFAMIDIS","CHEMBL2103837","Pfizer/Foldrx","Transthyretin stabilizer","Other indication","Heart disease caused by ATTR-CM","cardiomyopathy","EFO_0000318","Serious","P,O,B,F","2019","CHEMBL2103837","ENSG00000118271","ENSG00000076321,ENSG00000087250,ENSG00000106772,ENSG00000118271,ENSG00000122042,ENSG00000129103,ENSG00000138207,ENSG00000143379,ENSG00000145675,ENSG00000159459,ENSG00000166595,ENSG00000168936,ENSG00000197153,ENSG00000275714,ENSG00000099864,ENSG00000103154,ENSG00000123154,ENSG00000142192,ENSG00000163563,ENSG00000171055,ENSG00000187037,ENSG00000213380,ENSG00000070061,ENSG00000072415,ENSG00000163885,ENSG00000165637,ENSG00000169136,ENSG00000197409,ENSG00000204305,ENSG00000149557,ENSG00000153885,ENSG00000165188,ENSG00000167770,ENSG00000170035,ENSG00000198959,ENSG00000274750,ENSG00000287080,ENSG00000054611,ENSG00000105472,ENSG00000147724,ENSG00000275379,ENSG00000101911,ENSG00000116039,ENSG00000119614,ENSG00000158941,ENSG00000264522,ENSG00000286522,ENSG00000128609,ENSG00000162852,ENSG00000165171,ENSG00000165898,ENSG00000170004,ENSG00000187678,ENSG00000278828,ENSG00000026025,ENSG00000070476,ENSG00000104413,ENSG00000115239,ENSG00000119537,ENSG00000128272,ENSG00000130294,ENSG00000132016,ENSG00000139372,ENSG00000140743,ENSG00000196220,ENSG00000242247,ENSG00000273983,ENSG00000277775,ENSG00000120253,ENSG00000141030","NA"
"Vyondys 53","Golodirsen","GOLODIRSEN","CHEMBL4297762","Sarepta","Exon 53 skipping antisense","Other indication","Duchenne muscular dystrophy","duchenne muscular dystrophy","MONDO_0010679","Serious","P,O,A,F","2019","CHEMBL4297762","ENSG00000198947","ENSG00000152240,ENSG00000171345,ENSG00000101400,ENSG00000168807,ENSG00000171873,ENSG00000119326,ENSG00000138101,ENSG00000173402,ENSG00000187555,ENSG00000101076,ENSG00000171621,ENSG00000134769,ENSG00000172164,ENSG00000100151","NA"
"Vyvgart","Efgartigimod alfa","Efgartigimodalfa","CHEMBL4297551","Argenx","FcRn-binding Fc fragment","Other indication","Myasthenia gravis","Myasthenia gravis","EFO_0004991","Serious","S,O,F","2021","CHEMBL4297551","ENSG00000104870","ENSG00000196937,ENSG00000110375,ENSG00000164007,ENSG00000166710,ENSG00000109099,ENSG00000163631,ENSG00000171840","NA"
"Vyzulta","Latanoprostene bunod","LATANOPROSTENEBUNOD","CHEMBL2364612","Bausch and Lomb/Valeant Pharmaceuticals","Prostaglandin analogue","Other indication","Intraocular pressure","intraocular pressure measurement","EFO_0004695","Not serious","S","2017","CHEMBL2364612","ENSG00000122420","NA","NA"
"Wakix","Pitolisant","PITOLISANT","CHEMBL462605","Harmony","H3-receptor antagonist/inverse agonist","Other indication","Excessive sleepiness due to narcolepsy","narcolepsy","MONDO_0021107","Serious","P,O,F","2019","CHEMBL462605","ENSG00000101180","NA","NA"
"Welireg","Belzutifan","Belzutifan","CHEMBL4585668","Merck & Co.","HIF-2alpha inhibitor","Oncology","von Hippel-Lindau disease","von Hippel-Lindau disease","MONDO_0008667","Serious","P,O","2021","CHEMBL4585668","ENSG00000116016","ENSG00000134086,ENSG00000143437,ENSG00000152256,ENSG00000135930,ENSG00000104408,ENSG00000140463,ENSG00000166949,ENSG00000135766,ENSG00000138592,ENSG00000029153,ENSG00000133794,ENSG00000165140,ENSG00000173933,ENSG00000136878","EFO_0000681"
"Winlevi","Clascoterone","CLASCOTERONE","CHEMBL3590187","Cassiopea SpA","Androgen receptor inhibitor","Other indication","Acne vulgaris","acne","EFO_0003894","Not serious","S","2020","CHEMBL3590187","ENSG00000169083","ENSG00000000938,ENSG00000097007,ENSG00000105647,ENSG00000124151,ENSG00000125686,ENSG00000130522,ENSG00000134215,ENSG00000148082,ENSG00000169291,ENSG00000084676,ENSG00000107338,ENSG00000110092,ENSG00000141738,ENSG00000160293,ENSG00000176105,ENSG00000179295,ENSG00000198646,ENSG00000266412,ENSG00000007264,ENSG00000068024,ENSG00000100351,ENSG00000117461,ENSG00000141027,ENSG00000159388,ENSG00000160691,ENSG00000170365,ENSG00000185634,ENSG00000254087,ENSG00000004478,ENSG00000027869,ENSG00000079308,ENSG00000101336,ENSG00000115641,ENSG00000117450,ENSG00000131746,ENSG00000140396,ENSG00000141968,ENSG00000142515,ENSG00000164190,ENSG00000168036,ENSG00000169083,ENSG00000196684,ENSG00000035720,ENSG00000089280,ENSG00000101213,ENSG00000116288,ENSG00000132437,ENSG00000134954,ENSG00000136504,ENSG00000141867,ENSG00000167548,ENSG00000170734,ENSG00000178585,ENSG00000197943,ENSG00000010671,ENSG00000013561,ENSG00000124181,ENSG00000129514,ENSG00000129691,ENSG00000145675,ENSG00000157554,ENSG00000160973,ENSG00000165025,ENSG00000167193,ENSG00000170677,ENSG00000175215,ENSG00000182866,ENSG00000197122,ENSG00000095370,ENSG00000106462,ENSG00000111837,ENSG00000118058,ENSG00000127870,ENSG00000143322,ENSG00000145715,ENSG00000148180,ENSG00000178028,ENSG00000182511,ENSG00000183918,ENSG00000184557,ENSG00000196363,ENSG00000198574,ENSG00000204209,ENSG00000005339,ENSG00000012817,ENSG00000109685,ENSG00000116030,ENSG00000136573,ENSG00000136826,ENSG00000163565,ENSG00000165458,ENSG00000171988,ENSG00000172977,ENSG00000177885,ENSG00000184634,ENSG00000253729,ENSG00000095585","NA"
"Xadago","Safinamide","SAFINAMIDE","CHEMBL396778","US WorldMeds","MAO-B inhibitor","Other indication","Parkinson disease","Parkinson disease","MONDO_0005180","Serious","S","2017","CHEMBL396778","ENSG00000069535","ENSG00000005893,ENSG00000068078,ENSG00000135018,ENSG00000138794,ENSG00000166068,ENSG00000189221,ENSG00000196504,ENSG00000132341,ENSG00000172059,ENSG00000174775,ENSG00000163050,ENSG00000005486,ENSG00000097033,ENSG00000139496,ENSG00000070748,ENSG00000119392,ENSG00000203667,ENSG00000102466,ENSG00000148180","NA"
"Xcopri","Cenobamate","CENOBAMATE","CHEMBL3989949","SK Life Science","Unknown","Other indication","Partial onset seizures","seizure","HP_0001250","Not concordant","S","2019","CHEMBL3989949","ENSG00000136531,ENSG00000169432,ENSG00000183873,ENSG00000153253,ENSG00000144285,ENSG00000185313,ENSG00000196876,ENSG00000007314,ENSG00000163285,ENSG00000268089,ENSG00000151834,ENSG00000113327,ENSG00000102287,ENSG00000163288,ENSG00000094755,ENSG00000145863,ENSG00000145864,ENSG00000182256,ENSG00000109158,ENSG00000011677,ENSG00000186297,ENSG00000136546,ENSG00000187730,ENSG00000022355,ENSG00000168356,ENSG00000166206","ENSG00000015171,ENSG00000069869,ENSG00000105711,ENSG00000123240,ENSG00000124713,ENSG00000143933,ENSG00000146648,ENSG00000160014,ENSG00000163060,ENSG00000170296,ENSG00000172530,NA,ENSG00000102466,ENSG00000165724,ENSG00000185238,ENSG00000064999,ENSG00000100908,ENSG00000126457,ENSG00000112559,ENSG00000137693,ENSG00000145349,ENSG00000198668,ENSG00000264343,ENSG00000113327,ENSG00000101460,ENSG00000135018,ENSG00000172554,ENSG00000187555,ENSG00000022355,ENSG00000070159,ENSG00000114279,ENSG00000151150,ENSG00000166206","NA"
"Xeglyze","Abametapir","ABAMETAPIR","CHEMBL2205807","Dr Reddy‚Äö√Ñ√∂‚àö√ë‚àö‚àÇ‚Äö√†√∂‚àö√´‚Äö√†√∂‚Äö√†√á‚Äö√Ñ√∂‚àö‚Ä†‚àö‚àÇ‚Äö√†√∂‚àö¬¥‚Äö√Ñ√∂‚àö‚Ä†‚àö‚àÇ¬¨¬®‚Äö√Ñ¬¢s","Metalloproteinase inhibitor","No human target","Head lice","lice infestation","MONDO_0003472","Not serious","S","2020","CHEMBL2205807","NA","NA","NA"
"Xenleta","Lefamulin","LEFAMULIN","CHEMBL3291398","Nabriva","Pleuromutilin antibacterial","No human target","CABP","bacterial pneumonia","EFO_1001272","Serious","P,F","2019","CHEMBL3291398","NA","NA","NA"
"Xenoview","Xenon Xe 129 hyperpolarized","XenonXe129hyperpolarized","CHEMBL4594411","Polarean","Hyperpolarized contrast agent","No human target","MRI-evaluation of lung ventilation","NA","NA","NA","S","2022","CHEMBL4594411","NA","NA","NA"
"Xenpozyme","Olipudase alfa","Olipudasealfa","CHEMBL3707358","Sanofi/Genzyme","Acid sphingomyelinase ERT","Other indication","Acid sphingomyelinase deficiency","acid sphingomyelinase deficiency","MONDO_0100464","Serious","P,O,B,F","2022","CHEMBL3707358","ENSG00000166311","ENSG00000165806,ENSG00000064012","NA"
"Xepi","Ozenoxacin","OZENOXACIN","CHEMBL3990047","Ferrer Internacional","Quinolone antimicrobial","No human target","Impetigo due to Staphylococcus aureus or Streptococcus pyogenes","impetigo","EFO_1000714","Not serious","S","2017","CHEMBL3990047","NA","NA","NA"
"Xerava","Eravacycline","ERAVACYCLINE","CHEMBL1951095","Tetraphase Pharmaceuticals","Tetracycline antibiotic","No human target","Complicated intra-abdominal infections","infectious disease","EFO_0005741","Serious","P,F","2018","CHEMBL1951095","NA","NA","NA"
"Xermelo","Telotristat etiprate","TELOTRISTATETIPRATE","CHEMBL3348963","Lexicon Pharmaceuticals","Tryptophan hydroxylase inhibitor","Other indication","Carcinoid syndrome diarrhoea","carcinoid syndrome; Diarrhea","EFO_1000852,HP_0002014","Not serious","P,O,F","2017","CHEMBL3348963","ENSG00000129167,ENSG00000139287","ENSG00000126581,ENSG00000140368,ENSG00000145919,NA,ENSG00000115806,ENSG00000163867","NA"
"Xiidra","Lifitegrast","LIFITEGRAST","CHEMBL2048028","Shire Pharmaceuticals","LFA1 antagonist","Other indication","Dry eye disease","dry eye syndrome","EFO_1000906","Not serious","P","2016","CHEMBL2048028","ENSG00000160255,ENSG00000005844","ENSG00000137710,ENSG00000187766,ENSG00000204936,ENSG00000079999,ENSG00000120708,ENSG00000166927,ENSG00000185046,ENSG00000197191,ENSG00000273514,ENSG00000076662,ENSG00000114638,ENSG00000144366,ENSG00000171914,ENSG00000047634,ENSG00000097007,ENSG00000105376,ENSG00000121653,ENSG00000010017,ENSG00000011454,ENSG00000143382,ENSG00000151491,ENSG00000163762,ENSG00000197753,ENSG00000094796,ENSG00000128335,ENSG00000146648,ENSG00000264343,ENSG00000081237,ENSG00000090339,ENSG00000108669,ENSG00000122033,ENSG00000140678,ENSG00000141030,ENSG00000286219","NA"
"Xofigo","Radium RA 223 dichloride","RADIUMRA223DICHLORIDE","CHEMBL2107816","Bayer","Alpha particle-emitting radioactive therapeutic","No human target","Castration-resistant prostate cancer","prostate cancer","MONDO_0008315","Serious","P,F","2013","CHEMBL2107816","NA","NA","NA"
"Xofluza","Baloxavir marboxil","BALOXAVIRMARBOXIL","CHEMBL4297503","Shionogi/Roche","Polymerase acidic endonuclease inhibitor","No human target","Acute uncomplicated influenza","influenza","EFO_0007328","Not serious","P","2018","CHEMBL4297503","NA","NA","NA"
"Xospata","Gilteritinib","GILTERITINIB","CHEMBL3301622","Astellas","FLT3 inhibitor","Oncology","FLT3-positive AML","acute myeloid leukemia","EFO_0000222","Serious","P,O,B,F","2018","CHEMBL3301622","ENSG00000122025,ENSG00000167601","ENSG00000010810,ENSG00000106070,ENSG00000145675,ENSG00000146648,ENSG00000179295,ENSG00000079308,ENSG00000096384,ENSG00000097007,ENSG00000105401,ENSG00000177885,ENSG00000122025,ENSG00000170677,ENSG00000124181,ENSG00000176105,ENSG00000182866,ENSG00000269335,ENSG00000127022,ENSG00000142627,ENSG00000143322,ENSG00000167193,ENSG00000099942,ENSG00000136573,ENSG00000145715,ENSG00000183087,ENSG00000102738,ENSG00000165025","NA"
"Xpovio","Selinexor","SELINEXOR","CHEMBL3545185","Karyopharm Therapeutics","XPO1 inhibitor","Oncology","Multiple myeloma","multiple myeloma","EFO_0001378","Serious","P,O,A,F","2019","CHEMBL3545185","ENSG00000082898","ENSG00000001626,ENSG00000137574,ENSG00000123908,ENSG00000135829,ENSG00000141736,ENSG00000141510,ENSG00000164924,ENSG00000089685,ENSG00000162692,ENSG00000169371","MONDO_0004095"
"Xtoro","Finafloxacin","FINAFLOXACIN","CHEMBL1908370","Alcon","Fluoroquinolone antimicrobial","No human target","Acute otitis externa (swimmer's ear)","otitis externa","EFO_0009560","Not serious","P","2014","CHEMBL1908370","NA","NA","NA"
"Xuriden","Uridine","URIDINE","CHEMBL100259","Wellstat","Pyrimidine analogue","No human target","Hereditary orotic aciduria","Hereditary orotic aciduria","Orphanet_30","Serious","P,O,B","2015","CHEMBL100259","NA","NA","NA"
"Yondelis","Trabectedin","TRABECTEDIN","CHEMBL450449","Johnson & Johnson","Alkylating drug","NA","Liposarcoma or leiomyosarcoma","liposarcoma; leiomyosarcoma","EFO_0000564,EFO_0000569","Serious","P,O","2015","CHEMBL450449","NA","NA","NA"
"Yupelri","Revefenacin","REVEFENACIN","CHEMBL3833319","Theravance Biopharma/Mylan","Long-acting muscarinic receptor antagonist","Other indication","COPD","chronic obstructive pulmonary disease","EFO_0000341","Serious","S","2018","CHEMBL3833319","ENSG00000133019","ENSG00000184984","NA"
"Zegalogue","Dasiglucagon","Dasiglucagon","CHEMBL4297741","Zealand Pharma","Glucagon receptor agonist","Other indication","Serious hypoglycaemia","GCGR-related hyperglucagonemia","EFO_0001360","Serious","S","2021","CHEMBL4297741","ENSG00000215644","NA","NA"
"Zejula","Niraparib","NIRAPARIB","CHEMBL1094636","Tesaro","PARP inhibitor","Oncology","Epithelial ovarian, fallopian tube or primary peritoneal cancer","fallopian tube cancer; ovarian epithelial tumor; primary peritoneal carcinoma","MONDO_0002158,MONDO_0002229,MONDO_0015686","Serious","P,O,B,F","2017","CHEMBL1094636","ENSG00000129484,ENSG00000143799","ENSG00000007038,ENSG00000104490,ENSG00000116209,ENSG00000131778,ENSG00000134684,ENSG00000138684,ENSG00000143321,ENSG00000144681,ENSG00000159335,ENSG00000197153,ENSG00000004700,ENSG00000092847,ENSG00000100030,ENSG00000130816,ENSG00000140481,ENSG00000143799,ENSG00000150991,ENSG00000162892,ENSG00000168298,ENSG00000168395,ENSG00000169621,ENSG00000169955,ENSG00000189043,ENSG00000198900,ENSG00000227345,ENSG00000273983,ENSG00000278828,ENSG00000063978,ENSG00000116815,ENSG00000148737,ENSG00000158773,ENSG00000163637,ENSG00000198830,ENSG00000275714,ENSG00000011638,ENSG00000073050,ENSG00000137074,ENSG00000141510,ENSG00000147885,ENSG00000166884,ENSG00000196419,ENSG00000197409,ENSG00000274750,ENSG00000136240,ENSG00000164338,ENSG00000245848,ENSG00000275379,ENSG00000277775,ENSG00000064703,ENSG00000105229,ENSG00000124216,ENSG00000168036,ENSG00000169598,ENSG00000286522,ENSG00000118518,ENSG00000154511,ENSG00000156052,ENSG00000159884,ENSG00000160208,ENSG00000167987,ENSG00000188486,ENSG00000213801,ENSG00000100442,ENSG00000101191,ENSG00000113163,ENSG00000119698,ENSG00000151553,ENSG00000169490,ENSG00000178764,ENSG00000213699,ENSG00000240563,ENSG00000287080,ENSG00000082805,ENSG00000148702,ENSG00000152102,ENSG00000157554,ENSG00000169551,ENSG00000173614,ENSG00000078269,ENSG00000091831,ENSG00000154767,ENSG00000165138,ENSG00000102882,ENSG00000144354,ENSG00000072609,ENSG00000133318,ENSG00000196511,ENSG00000124596,ENSG00000147874,ENSG00000165392,ENSG00000175198,ENSG00000178075,ENSG00000189403,ENSG00000101412,ENSG00000101938,ENSG00000079246,ENSG00000131747,ENSG00000164305,ENSG00000253729,ENSG00000176658,ENSG00000166845","NA"
"Zemdri","Plazomicin","PLAZOMICIN","CHEMBL1650559","Achaogen","Aminoglycoside antibacterial","No human target","Urinary tract infections","urinary tract infection","EFO_0003103","Not serious","P","2018","CHEMBL1650559","NA","NA","NA"
"Zepatier","Elbasvir, grazoprevir","ELBASVIR,GRAZOPREVIR","CHEMBL3039514,CHEMBL2063090","Merck & Co.","NS5A inhibitor plus NS3/4A protease inhibitor","No human target","HCV genotypes 1 and 4","hepatitis C virus infection","EFO_0003047","Serious","P,B","2016","CHEMBL3039514,CHEMBL2063090","NA","NA","NA"
"Zeposia","Ozanimod","OZANIMOD","CHEMBL3707247","Celgene/Bristol Myers Squibb","S1P receptor modulator","Other indication","Multiple sclerosis","multiple sclerosis","MONDO_0005301","Serious","S","2020","CHEMBL3707247","ENSG00000170989","ENSG00000110848","NA"
"Zepzelca","Lurbinectedin","LURBINECTEDIN","CHEMBL4297516","Jazz","Alkylating drug","NA","Small-cell lung cancer","small cell lung carcinoma","EFO_0000702","Serious","P,O,A","2020","CHEMBL4297516","NA","NA","NA"
"Zerbaxa","Ceftolozane, tazobactam","CEFTOLOZANE,TAZOBACTAM","CHEMBL2103872,CHEMBL404","Cubist","A cephalosporin antibacterial plus a beta-lactamase inhibitor","No human target","Complicated intra-abdominal infections and complicated urinary tract infections","infection","EFO_0000544","Serious","P,F","2014","CHEMBL2103872,CHEMBL404","NA","NA","Orphanet_169142"
"Zinbryta","Daclizumab","DACLIZUMAB","CHEMBL1201605","Biogen","IL-2-targeted mAb","Other indication","Multiple sclerosis","multiple sclerosis","MONDO_0005301","Serious","S","2016","CHEMBL1201605","ENSG00000147168,ENSG00000100385,ENSG00000134460","ENSG00000077238,ENSG00000244411,ENSG00000264343,ENSG00000147168,ENSG00000164136,ENSG00000187766,ENSG00000115687,ENSG00000134470,ENSG00000071539,ENSG00000109471,ENSG00000113520","NA"
"Zinplava","Bezlotoxumab","BEZLOTOXUMAB","CHEMBL2108670","Merck & Co.","mAb against Clostridium difficile toxin","No human target","C. difficile recurrence","clostridium difficile infection","EFO_0009130","Serious","P,F","2016","CHEMBL2108670","NA","NA","NA"
"Zokinvy","Lonafarnib","LONAFARNIB","CHEMBL298734","Eiger","Farnesyltransferase inhibitor","Other indication","HGPS","hutchinson-gilford progeria syndrome","MONDO_0008310","Serious","P,O,B","2020","CHEMBL298734","ENSG00000257365,ENSG00000168522","ENSG00000133619,ENSG00000168522,ENSG00000037965,ENSG00000164219,ENSG00000172482,ENSG00000257365,ENSG00000157540,ENSG00000166068,ENSG00000185800,ENSG00000105771,ENSG00000171953,ENSG00000159214,ENSG00000164438,ENSG00000221838,ENSG00000221963","NA"
"Zontivity","Vorapaxar","VORAPAXAR","CHEMBL493982","Merck & Co.","Protease-activated receptor 1 antagonist","Other indication","Thrombotic cardiovascular events (after myocardial infarction or with peripheral arterial disease*)","myocardial infarction; peripheral arterial disease","EFO_0000612,EFO_0004265","Serious","S,F","2014","CHEMBL493982","ENSG00000181104","ENSG00000101000,ENSG00000180210","NA"
"Ztalmy","Ganaxolone","Ganaxolone","CHEMBL1568698","Marinus","GABAA receptor positive allosteric modulator","Other indication","Seizures associated with CDD","Epileptic encephalopathy","HP_0200134","Serious","P,O","2022","CHEMBL1568698","ENSG00000268089,ENSG00000022355,ENSG00000166206,ENSG00000187730,ENSG00000151834,ENSG00000163285,ENSG00000113327,ENSG00000109158,ENSG00000182256,ENSG00000186297,ENSG00000145864,ENSG00000011677,ENSG00000145863,ENSG00000102287,ENSG00000163288,ENSG00000094755","ENSG00000124713,ENSG00000166206,ENSG00000135018,ENSG00000146648,ENSG00000113327,ENSG00000123240,ENSG00000170296,ENSG00000264343,ENSG00000022355,ENSG00000112559,NA","NA"
"Zulresso","Brexanolone","BREXANOLONE","CHEMBL207538","Sage Therapeutics","GABAA-receptor-positive modulator","Other indication","Postpartum depression","postpartum depression","EFO_0007453","Not concordant","P,B","2019","CHEMBL207538","ENSG00000268089,ENSG00000113327,ENSG00000022355,ENSG00000163285,ENSG00000166206,ENSG00000151834,ENSG00000187730,ENSG00000163288,ENSG00000145863,ENSG00000102287,ENSG00000011677,ENSG00000182256,ENSG00000145864,ENSG00000186297,ENSG00000109158,ENSG00000094755","ENSG00000124713,ENSG00000170296,ENSG00000113327,ENSG00000123240,ENSG00000166206,ENSG00000022355,ENSG00000146648,ENSG00000264343,NA,ENSG00000112559,ENSG00000135018","MONDO_0002050"
"Zurampic","Lesinurad","LESINURAD","CHEMBL2105720","AstraZeneca","URAT1 inhibitor","Other indication","Gout","gout","EFO_0004274","Not serious","S","2015","CHEMBL2105720","ENSG00000197891","ENSG00000169375","NA"
"Zydelig","Idelalisib","IDELALISIB","CHEMBL2216870","Gilead Sciences","PI3K‚Äöp110-delta subunit inhibitor","Other indication","CLL, B-cell non-Hodgkin lymphoma and SLL","chronic lymphocytic leukemia; B-cell non-Hodgkins lymphoma","EFO_0000095,EFO_1001938","Serious","P,O,B,A,F","2014","CHEMBL2216870","ENSG00000171608","ENSG00000145675,ENSG00000117461","NA"
"Zykadia","Ceritinib","CERITINIB","CHEMBL2403108","Novartis","Kinase inhibitor against ALK, IGF1R, insulin receptor and ROS1","Oncology","ALK-positive metastatic NSCLC","non-small cell lung carcinoma","EFO_0003060","Serious","P,O,B,A","2014","CHEMBL2403108","ENSG00000181163,ENSG00000171094,ENSG00000143924","ENSG00000107833,ENSG00000127329,ENSG00000162692,ENSG00000186432,ENSG00000189292,ENSG00000055332,ENSG00000091831,ENSG00000096384,ENSG00000114030,ENSG00000171094,ENSG00000198900,ENSG00000102753,ENSG00000115163,ENSG00000135842,ENSG00000149177,ENSG00000167755,ENSG00000254093,ENSG00000001626,ENSG00000116478,ENSG00000136929,ENSG00000158806,ENSG00000161956,ENSG00000176340,ENSG00000071894,ENSG00000106278,ENSG00000132382,ENSG00000137154,ENSG00000141510,ENSG00000151414,ENSG00000153827,ENSG00000165731,ENSG00000170515,ENSG00000178999,ENSG00000087586,ENSG00000101266,ENSG00000107882,ENSG00000161813,ENSG00000181163,ENSG00000196711,ENSG00000104408,ENSG00000144724,ENSG00000067225,ENSG00000116030,ENSG00000135679,ENSG00000137203,ENSG00000141456,ENSG00000147889,ENSG00000160208,ENSG00000164924,ENSG00000164362","NA"
"Zynlonta","Loncastuximab tesirine","Loncastuximabtesirine","CHEMBL4297778","ADC Therapeutics","CD19-targeted ADC","Oncology","B-cell lymphoma","B-cell non-Hodgkins lymphoma","EFO_1001938","Serious","P,O,A","2021","CHEMBL4297778","ENSG00000177455","ENSG00000211899","NA"
